<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:ynews="http://news.yahoo.com/rss/">
    <channel>
        <title>Nova Reader - Subject</title>
        <link>https://www.novareader.co</link>
        <description>Default RSS Feed</description>
        <language>en-us</language>
        <copyright>Newgen KnowledgeWorks</copyright>
        <item>
            <title><![CDATA[Dynamically elongated associative toehold for tuning DNA circuit kinetics and thermodynamics]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766074041215-548eabd0-ef9b-422d-9137-7bfad1ab17bf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab212</link>
            <description><![CDATA[<p class="para" id="N65541">Associative toehold is a powerful concept enabling efficient combinatorial computation in DNA circuit. A longer association length boosts circuit kinetics and equilibrium signal but results in higher leak rate. We reconcile this trade-off by using a hairpin lock design to dynamically elongate the effective associative toehold length in response to the input target. Design guidelines were established to achieve robust elongation without incurring additional leakages. Three hairpin initiators with different combinations of elongated associative toehold (4 → 6 nt, 5 → 8 nt and 6 → 9 nt) were shortlisted from the design framework for further discussion. The circuit performance improved in terms of reaction kinetics, equilibrium signal generated and limit of detection. Overall, the elongated associative toehold served as a built-in function to stabilize and favour the forward, desired reaction when triggered.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ablation of Mto1 in zebrafish exhibited hypertrophic cardiomyopathy manifested by mitochondrion RNA maturation deficiency]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073977425-0e684539-57da-4db8-805f-4f6c53e32757/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab228</link>
            <description><![CDATA[<p class="para" id="N65541">Deficient maturations of mitochondrial transcripts are linked to clinical abnormalities but their pathophysiology remains elusive. Previous investigations showed that pathogenic variants in <i>MTO1</i> for the biosynthesis of τm<sup>5</sup>U of tRNA<sup>Glu</sup>, tRNA<sup>Gln</sup>, tRNA<sup>Lys</sup>, tRNA<sup>Trp</sup> and tRNA<sup>Leu(UUR)</sup> were associated with hypertrophic cardiomyopathy (HCM). Using <i>mto1</i> knock-out(KO) zebrafish generated by CRISPR/Cas9 system, we demonstrated the pleiotropic effects of Mto1 deficiency on mitochondrial RNA maturations. The perturbed structure and stability of tRNAs caused by <i>mto1</i> deletion were evidenced by conformation changes and sensitivity to S1-mediated digestion of tRNA<sup>Gln</sup>, tRNA<sup>Lys</sup>, tRNA<sup>Trp</sup> and tRNA<sup>Leu(UUR)</sup>. Notably, <i>mto1<sup>KO</sup></i> zebrafish exhibited the global decreases in the aminoacylation of mitochondrial tRNAs with the taurine modification. Strikingly, ablated <i>mto1</i> mediated the expression of <i>MTPAP</i> and caused the altered polyadenylation of <i>cox1</i>, <i>cox3</i>, and <i>nd1</i> mRNAs. Immunoprecipitation assay indicated the interaction of MTO1 with MTPAP related to mRNA polyadenylation. These alterations impaired mitochondrial translation and reduced activities of oxidative phosphorylation complexes. These mitochondria dysfunctions caused heart development defects and hypertrophy of cardiomyocytes and myocardial fiber disarray in ventricles. These cardiac defects in the <i>mto1<sup>KO</sup></i> zebrafish recapitulated the clinical phenotypes in HCM patients carrying the <i>MTO1</i> mutation(s). Our findings highlighted the critical role of <i>MTO1</i> in mitochondrial transcript maturation and their pathological consequences in hypertrophic cardiomyopathy.</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Characteristic chemical probing patterns of loop motifs improve prediction accuracy of RNA secondary structures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073968062-acc5fbb8-4fdd-4ba0-8bf7-f91342b85f5a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab250</link>
            <description><![CDATA[<p class="para" id="N65541">RNA structures play a fundamental role in nearly every aspect of cellular physiology and pathology. Gaining insights into the functions of RNA molecules requires accurate predictions of RNA secondary structures. However, the existing thermodynamic folding models remain less accurate than desired, even when chemical probing data, such as selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE) reactivities, are used as restraints. Unlike most SHAPE-directed algorithms that only consider SHAPE restraints for base pairing, we extract two-dimensional structural features encoded in SHAPE data and establish robust relationships between characteristic SHAPE patterns and loop motifs of various types (hairpin, internal, and bulge) and lengths (2–11 nucleotides). Such characteristic SHAPE patterns are closely related to the sugar pucker conformations of loop residues. Based on these patterns, we propose a computational method, SHAPELoop, which refines the predicted results of the existing methods, thereby further improving their prediction accuracy. In addition, SHAPELoop can provide information about local or global structural rearrangements (including pseudoknots) and help researchers to easily test their hypothesized secondary structures.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mechanical and structural properties of archaeal hypernucleosomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073939343-3d8461d8-08fc-4fe7-8355-91872db4c36d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1196</link>
            <description><![CDATA[<p class="para" id="N65541">Many archaea express histones, which organize the genome and play a key role in gene regulation. The structure and function of archaeal histone–DNA complexes remain however largely unclear. Recent studies show formation of hypernucleosomes consisting of DNA wrapped around an ‘endless’ histone-protein core. However, if and how such a hypernucleosome structure assembles on a long DNA substrate and which interactions provide for its stability, remains unclear. Here, we describe micromanipulation studies of complexes of the histones HMfA and HMfB with DNA. Our experiments show hypernucleosome assembly which results from cooperative binding of histones to DNA, facilitated by weak stacking interactions between neighboring histone dimers. Furthermore, rotational force spectroscopy demonstrates that the HMfB–DNA complex has a left-handed chirality, but that torque can drive it in a right-handed conformation. The structure of the hypernucleosome thus depends on stacking interactions, torque, and force. <i>In vivo</i>, such modulation of the archaeal hypernucleosome structure may play an important role in transcription regulation in response to environmental changes.</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DeCompress: tissue compartment deconvolution of targeted mRNA expression panels using compressed sensing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073926598-5f043ccf-f05d-4d91-94b6-c9c395951e58/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab031</link>
            <description><![CDATA[<p class="para" id="N65541">Targeted mRNA expression panels, measuring up to 800 genes, are used in academic and clinical settings due to low cost and high sensitivity for archived samples. Most samples assayed on targeted panels originate from bulk tissue comprised of many cell types, and cell-type heterogeneity confounds biological signals. Reference-free methods are used when cell-type-specific expression references are unavailable, but limited feature spaces render implementation challenging in targeted panels. Here, we present <i>DeCompress</i>, a semi-reference-free deconvolution method for targeted panels. <i>DeCompress</i> leverages a reference RNA-seq or microarray dataset from similar tissue to expand the feature space of targeted panels using compressed sensing. Ensemble reference-free deconvolution is performed on this artificially expanded dataset to estimate cell-type proportions and gene signatures. In simulated mixtures, four public cell line mixtures, and a targeted panel (1199 samples; 406 genes) from the Carolina Breast Cancer Study, <i>DeCompress</i> recapitulates cell-type proportions with less error than reference-free methods and finds biologically relevant compartments. We integrate compartment estimates into <i>cis</i>-eQTL mapping in breast cancer, identifying a tumor-specific <i>cis</i>-eQTL for <i>CCR3</i> (C–C Motif Chemokine Receptor 3) at a risk locus. <i>DeCompress</i> improves upon reference-free methods without requiring expression profiles from pure cell populations, with applications in genomic analyses and clinical settings.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073863820-fd040987-6341-41a2-b0f7-d86dbd145a74/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab151</link>
            <description><![CDATA[<p class="para" id="N65541">Tumours with mutations in the <i>BRCA1</i>/<i>BRCA2</i> genes have impaired double-stranded DNA break repair, compromised replication fork protection and increased sensitivity to replication blocking agents, a phenotype collectively known as ‘BRCAness’. Tumours with a BRCAness phenotype become dependent on alternative repair pathways that are error-prone and introduce specific patterns of somatic mutations across the genome. The increasing availability of next-generation sequencing data of tumour samples has enabled identification of distinct mutational signatures associated with BRCAness. These signatures reveal that alternative repair pathways, including Polymerase θ-mediated alternative end-joining and RAD52-mediated single strand annealing are active in BRCA1/2-deficient tumours, pointing towards potential therapeutic targets in these tumours. Additionally, insight into the mutations and consequences of unrepaired DNA lesions may also aid in the identification of BRCA-like tumours lacking <i>BRCA1</i>/<i>BRCA2</i> gene inactivation. This is clinically relevant, as these tumours respond favourably to treatment with DNA-damaging agents, including PARP inhibitors or cisplatin, which have been successfully used to treat patients with BRCA1/2-defective tumours. In this review, we aim to provide insight in the origins of the mutational landscape associated with BRCAness by exploring the molecular biology of alternative DNA repair pathways, which may represent actionable therapeutic targets in in these cells.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Systematic identification of A-to-I RNA editing in zebrafish development and adult organs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073724923-433983c3-bf0f-40b7-a5b2-70e797886fee/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab247</link>
            <description><![CDATA[<p class="para" id="N65541">A-to-I RNA editing is a common post transcriptional mechanism, mediated by the Adenosine deaminase that acts on RNA (ADAR) enzymes, that increases transcript and protein diversity. The study of RNA editing is limited by the absence of editing maps for most model organisms, hindering the understanding of its impact on various physiological conditions. Here, we mapped the vertebrate developmental landscape of A-to-I RNA editing, and generated the first comprehensive atlas of editing sites in zebrafish. Tens of thousands unique editing events and 149 coding sites were identified with high-accuracy. Some of these edited sites are conserved between zebrafish and humans. Sequence analysis of RNA over seven developmental stages revealed high levels of editing activity in early stages of embryogenesis, when embryos rely on maternal mRNAs and proteins. In contrast to the other organisms studied so far, the highest levels of editing were detected in the zebrafish ovary and testes. This resource can serve as the basis for understanding of the role of editing during zebrafish development and maturity.</p>]]></description>
            <pubDate><![CDATA[2021-04-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Nanomechanics of G-quadruplexes within the promoter of the <i>KIT</i> oncogene]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073546242-42ce2704-2b41-4b10-b737-1b9258a884cf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab079</link>
            <description><![CDATA[<p class="para" id="N65541">G-quadruplexes (G4s) are tetrahelical DNA structures stabilized by four guanines paired via Hoogsteen hydrogen bonds into quartets. While their presence within eukaryotic DNA is known to play a key role in regulatory processes, their functional mechanisms are still under investigation. In the present work, we analysed the nanomechanical properties of three G4s present within the promoter of the <i>KIT</i> proto-oncogene from a single-molecule point of view through the use of magnetic tweezers (MTs). The study of DNA extension fluctuations under negative supercoiling allowed us to identify a characteristic fingerprint of G4 folding. We further analysed the energetic contribution of G4 to the double-strand denaturation process in the presence of negative supercoiling, and we observed a reduction in the energy required for strands separation.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Nebula: ultra-efficient mapping-free structural variant genotyper]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073527239-588a0ffd-a019-4727-86b4-2bcd0a265f20/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab025</link>
            <description><![CDATA[<p class="para" id="N65541">Large scale catalogs of common genetic variants (including indels and structural variants) are being created using data from second and third generation whole-genome sequencing technologies. However, the genotyping of these variants in newly sequenced samples is a nontrivial task that requires extensive computational resources. Furthermore, current approaches are mostly limited to only specific types of variants and are generally prone to various errors and ambiguities when genotyping complex events. We are proposing an ultra-efficient approach for genotyping any type of structural variation that is not limited by the shortcomings and complexities of current mapping-based approaches. Our method Nebula utilizes the changes in the count of <i>k</i>-mers to predict the genotype of structural variants. We have shown that not only Nebula is an order of magnitude faster than mapping based approaches for genotyping structural variants, but also has comparable accuracy to state-of-the-art approaches. Furthermore, Nebula is a generic framework not limited to any specific type of event. Nebula is publicly available at https://github.com/Parsoa/Nebula.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Genome-wide characterization of human minisatellite VNTRs: population-specific alleles and gene expression differences]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073467810-b878639e-cdbe-4d83-b2cb-fe78bf54c3ec/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab224</link>
            <description><![CDATA[<p class="para" id="N65541">Variable Number Tandem Repeats (VNTRs) are tandem repeat (TR) loci that vary in copy number across a population. Using our program, VNTRseek, we analyzed human whole genome sequencing datasets from 2770 individuals in order to detect minisatellite VNTRs, i.e., those with pattern sizes ≥7 bp. We detected 35 638 VNTR loci and classified 5676 as commonly polymorphic (i.e. with non-reference alleles occurring in &gt;5% of the population). Commonly polymorphic VNTR loci were found to be enriched in genomic regions with regulatory function, i.e. transcription start sites and enhancers. Investigation of the commonly polymorphic VNTRs in the context of population ancestry revealed that 1096 loci contained population-specific alleles and that those could be used to classify individuals into super-populations with near-perfect accuracy. Search for quantitative trait loci (eQTLs), among the VNTRs proximal to genes, indicated that in 187 genes expression differences correlated with VNTR genotype. We validated our predictions in several ways, including experimentally, through the identification of predicted alleles in long reads, and by comparisons showing consistency between sequencing platforms. This study is the most comprehensive analysis of minisatellite VNTRs in the human population to date.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Eukaryote specific RNA and protein features facilitate assembly and catalysis of H/ACA snoRNPs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073216469-eda3f73c-73d6-4918-8ad1-ca7aa9fd87de/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab177</link>
            <description><![CDATA[<p class="para" id="N65541">H/ACA Box ribonucleoprotein complexes (RNPs) play a major role in modification of rRNA and snRNA, catalyzing the sequence specific pseudouridylation in eukaryotes and archaea. This enzymatic reaction takes place on a substrate RNA recruited via base pairing to an internal loop of the snoRNA. Eukaryotic snoRNPs contain the four proteins Nop10, Cbf5, Gar1 and Nhp2, with Cbf5 as the catalytic subunit. In contrast to archaeal H/ACA RNPs, eukaryotic snoRNPs contain several conserved features in both the snoRNA as well as the protein components. Here, we reconstituted the eukaryotic H/ACA RNP containing snR81 as a guide RNA <i>in vitro</i> and report on the effects of these eukaryote specific features on complex assembly and enzymatic activity. We compare their contribution to pseudouridylation activity for stand-alone hairpins versus the bipartite RNP. Using single molecule FRET spectroscopy, we investigated the role of the different eukaryote-specific proteins and domains on RNA folding and complex assembly, and assessed binding of substrate RNA to the RNP. Interestingly, we found diverging effects for the two hairpins of snR81, suggesting hairpin-specific requirements for folding and RNP formation. Our results for the first time allow assessing interactions between the individual hairpin RNPs in the context of the full, bipartite snoRNP.</p>]]></description>
            <pubDate><![CDATA[2021-04-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>Escherichia coli</i> RNase E can efficiently replace RNase Y in <i>Bacillus subtilis</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073210487-4b75a7c0-ce7d-4bfb-a8ce-3661a2ba020e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab216</link>
            <description><![CDATA[<p class="para" id="N65541">RNase Y and RNase E are disparate endoribonucleases that govern global mRNA turnover/processing in the two evolutionary distant bacteria <i>Bacillus subtilis</i> and <i>Escherichia coli</i>, respectively. The two enzymes share a similar <i>in vitro</i> cleavage specificity and subcellular localization. To evaluate the potential equivalence in biological function between the two enzymes <i>in vivo</i> we analyzed whether and to what extent RNase E is able to replace RNase Y in <i>B. subtilis</i>. Full-length RNase E almost completely restores wild type growth of the <i>rny</i> mutant. This is matched by a surprising reversal of transcript profiles both of individual genes and on a genome-wide scale. The single most important parameter to efficient complementation is the requirement for RNase E to localize to the inner membrane while truncation of the C-terminal sequences corresponding to the degradosome scaffold has only a minor effect. We also compared the <i>in vitro</i> cleavage activity for the major decay initiating ribonucleases Y, E and J and show that no conclusions can be drawn with respect to their activity <i>in vivo</i>. Our data confirm the notion that RNase Y and RNase E have evolved through convergent evolution towards a low specificity endonuclease activity universally important in bacteria.</p>]]></description>
            <pubDate><![CDATA[2021-03-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Nearest-neighbour transition-state analysis for nucleic acid kinetics]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073203104-5cba8cbf-3ab5-4074-864a-042eaf371b09/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab205</link>
            <description><![CDATA[<p class="para" id="N65541">We used stopped-flow to monitor hypochromicity for 43 oligonucleotide duplexes to study nucleic acid kinetics and extract transition-state parameters for association and dissociation. Reactions were performed in 1.0 M NaCl (for literature comparisons) and 2.2 mM MgCl<sub>2</sub> (PCR conditions). Dissociation kinetics depended on sequence, increased exponentially with temperature, and transition-state parameters inversely correlated to thermodynamic parameters (<i>r</i> = −0.99). Association had no consistent enthalpic component, varied little with temperature or sequence, and poorly correlated to thermodynamic parameters (<i>r</i> = 0.28). Average association rates decreased 78% in MgCl<sub>2</sub> compared to NaCl while dissociation was relatively insensitive to ionic conditions. A nearest-neighbour kinetic model for dissociation predicted rate constants within 3-fold of literature values (<i>n</i> = 11). However, a nearest-neighbour model for association appeared overparameterized and inadequate for predictions. Kinetic predictions were used to simulate published high-speed (&lt;1 min) melting analysis and extreme (&lt;2 min) PCR experiments. Melting simulations predicted apparent melting temperatures increase on average 2.4°C when temperature ramp rates increased from 0.1 to 32°C/s, compared to 2.8°C reported in the literature. PCR simulations revealed that denaturation kinetics are dependent on the thermocycling profile. Simulations overestimated annealing efficiencies at shorter annealing times and suggested that polymerase interactions contribute to primer-template complex stability at extension temperatures.</p>]]></description>
            <pubDate><![CDATA[2021-04-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Histone deacetylases control lysine acetylation of ribosomal proteins in rice]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073180209-1b8aaec1-73b7-420e-8aba-09965ca958f8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab244</link>
            <description><![CDATA[<p class="para" id="N65541">Lysine acetylation (Kac) is well known to occur in histones for chromatin function and epigenetic regulation. In addition to histones, Kac is also detected in a large number of proteins with diverse biological functions. However, Kac function and regulatory mechanism for most proteins are unclear. In this work, we studied mutation effects of rice genes encoding cytoplasm-localized histone deacetylases (HDAC) on protein acetylome and found that the HDAC protein HDA714 was a major deacetylase of the rice non-histone proteins including many ribosomal proteins (r-proteins) and translation factors that were extensively acetylated. HDA714 loss-of-function mutations increased Kac levels but reduced abundance of r-proteins. <i>In vitro</i> and <i>in vivo</i> experiments showed that HDA714 interacted with r-proteins and reduced their Kac. Substitutions of lysine by arginine (depleting Kac) in several r-proteins enhance, while mutations of lysine to glutamine (mimicking Kac) decrease their stability in transient expression system. Ribo-seq analysis revealed that the <i>hda714</i> mutations resulted in increased ribosome stalling frequency. Collectively, the results uncover Kac as a functional posttranslational modification of r-proteins which is controlled by histone deacetylases, extending the role of Kac in gene expression to protein translational regulation.</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Conserved DNA sequence features underlie pervasive RNA polymerase pausing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073139851-9105c5fe-61ff-478e-9521-7324dcc4e859/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab208</link>
            <description><![CDATA[<p class="para" id="N65541">Pausing of transcribing RNA polymerase is regulated and creates opportunities to control gene expression. Research in metazoans has so far mainly focused on RNA polymerase II (Pol II) promoter-proximal pausing leaving the pervasive nature of pausing and its regulatory potential in mammalian cells unclear. Here, we developed a pause detecting algorithm (PDA) for nucleotide-resolution occupancy data and a new native elongating transcript sequencing approach, termed nested NET-seq, that strongly reduces artifactual peaks commonly misinterpreted as pausing sites. Leveraging PDA and nested NET-seq reveal widespread genome-wide Pol II pausing at single-nucleotide resolution in human cells. Notably, the majority of Pol II pauses occur outside of promoter-proximal gene regions primarily along the gene-body of transcribed genes. Sequence analysis combined with machine learning modeling reveals DNA sequence properties underlying widespread transcriptional pausing including a new pause motif. Interestingly, key sequence determinants of RNA polymerase pausing are conserved between human cells and bacteria. These studies indicate pervasive sequence-induced transcriptional pausing in human cells and the knowledge of exact pause locations implies potential functional roles in gene expression.</p>]]></description>
            <pubDate><![CDATA[2021-03-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DNA polymerase D temporarily connects primase to the CMG-like helicase before interacting with proliferating cell nuclear antigen]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073128161-956e3ad4-f44d-42b6-8f57-bc061f6e7c04/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab243</link>
            <description><![CDATA[<p class="para" id="N65541">The eukaryotic replisome is comprised of three family-B DNA polymerases (Polα, δ and ϵ). Polα forms a stable complex with primase to synthesize short RNA-DNA primers, which are subsequently elongated by Polδ and Polϵ in concert with proliferating cell nuclear antigen (PCNA). In some species of archaea, family-D DNA polymerase (PolD) is the only DNA polymerase essential for cell viability, raising the question of how it alone conducts the bulk of DNA synthesis. We used a hyperthermophilic archaeon, <i>Thermococcus kodakarensis</i>, to demonstrate that PolD connects primase to the archaeal replisome before interacting with PCNA. Whereas PolD stably connects primase to GINS, a component of CMG helicase, cryo-EM analysis indicated a highly flexible PolD–primase complex. A conserved hydrophobic motif at the C-terminus of the DP2 subunit of PolD, a PIP (PCNA-Interacting Peptide) motif, was critical for the interaction with primase. The dissociation of primase was induced by DNA-dependent binding of PCNA to PolD. Point mutations in the alternative PIP-motif of DP2 abrogated the molecular switching that converts the archaeal replicase from <i>de novo</i> to processive synthesis mode.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The effect of flanking bases on direct and triplet sensitized cyclobutane pyrimidine dimer formation in DNA depends on the dipyrimidine, wavelength and the photosensitizer]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073119502-755b3e83-8707-4f9c-9734-df85ec891937/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab214</link>
            <description><![CDATA[<p class="para" id="N65541">Cyclobutane pyrimidine dimers (CPDs) are the major products of DNA produced by direct absorption of UV light, and result in C to T mutations linked to human skin cancers. Most recently a new pathway to CPDs in melanocytes has been discovered that has been proposed to arise from a chemisensitized pathway involving a triplet sensitizer that increases mutagenesis by increasing the percentage of C-containing CPDs. To investigate how triplet sensitization may differ from direct UV irradiation, CPD formation was quantified in a 129-mer DNA designed to contain all 64 possible NYYN sequences. CPD formation with UVB light varied about 2-fold between dipyrimidines and 12-fold with flanking sequence and was most frequent at Y<span style="text-decoration: underline">YY</span>R and least frequent for G<span style="text-decoration: underline">YY</span>N sites in accord with a charge transfer quenching mechanism. In contrast, photosensitized CPD formation greatly favored TT over C-containing sites, more so for norfloxacin (NFX) than acetone, in accord with their differing triplet energies. While the sequence dependence for photosensitized TT CPD formation was similar to UVB light, there were significant differences, especially between NFX and acetone that could be largely explained by the ability of NFX to intercalate into DNA.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766073119502-755b3e83-8707-4f9c-9734-df85ec891937/assets/gkab214gra1.jpg" alt="By using a sequence designed to contain all possible NYYN sites, the effect of the dipyrimidine and its flanking sequence, as well as wavelength, and sensitizer on the relative frequency of cyclobutane pyrimidine dimer formation was revealed."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      By using a sequence designed to contain all possible NYYN sites, the effect of the dipyrimidine and its flanking sequence, as well as wavelength, and sensitizer on the relative frequency of cyclobutane pyrimidine dimer formation was revealed.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[INT-Hi-C reveals distinct chromatin architecture in endosperm and leaf tissues of <i>Arabidopsis</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073111989-3481000b-09e4-46c7-a6b6-da031efc8a43/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab191</link>
            <description><![CDATA[<p class="para" id="N65541">Higher-order chromatin structure undergoes striking changes in response to various developmental and environmental signals, causing distinct cell types to adopt specific chromatin organization. High throughput chromatin conformation capture (Hi-C) allows studying higher-order chromatin structure; however, this technique requires substantial amounts of starting material, which has limited the establishment of cell type-specific higher-order chromatin structure in plants. To overcome this limitation, we established a protocol that is applicable to a limited amount of nuclei by combining the INTACT (isolation of nuclei tagged in specific cell types) method and Hi-C (INT-Hi-C). Using this INT-Hi-C protocol, we generated Hi-C data from INTACT purified endosperm and leaf nuclei. Our INT-Hi-C data from leaf accurately reiterated chromatin interaction patterns derived from conventional leaf Hi-C data. We found that the higher-order chromatin organization of mixed leaf tissues and endosperm differs and that DNA methylation and repressive histone marks positively correlate with the chromatin compaction level. We furthermore found that self-looped interacting genes have increased expression in leaves and endosperm and that interacting intergenic regions negatively impact on gene expression in the endosperm. Last, we identified several imprinted genes involved in long-range and <i>trans</i> interactions exclusively in endosperm. Our study provides evidence that the endosperm adopts a distinct higher-order chromatin structure that differs from other cell types in plants and that chromatin interactions influence transcriptional activity.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Single-molecule insight into stalled replication fork rescue in <i>Escherichia coli</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073099543-937e1f2c-1601-499f-b88a-ac3d16be86c0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab142</link>
            <description><![CDATA[<p class="para" id="N65541">DNA replication forks stall at least once per cell cycle in <i>Escherichia coli</i>. DNA replication must be restarted if the cell is to survive. Restart is a multi-step process requiring the sequential action of several proteins whose actions are dictated by the nature of the impediment to fork progression. When fork progress is impeded, the sequential actions of SSB, RecG and the RuvABC complex are required for rescue. In contrast, when a template discontinuity results in the forked DNA breaking apart, the actions of the RecBCD pathway enzymes are required to resurrect the fork so that replication can resume. In this review, we focus primarily on the significant insight gained from single-molecule studies of individual proteins, protein complexes, and also, partially reconstituted regression and RecBCD pathways. This insight is related to the bulk-phase biochemical data to provide a comprehensive review of each protein or protein complex as it relates to stalled DNA replication fork rescue.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Crystal structure and functional implication of a bacterial cyclic AMP–AMP–GMP synthetase]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073091882-391adc8f-881a-4793-bf56-1fa65fe5f42d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab165</link>
            <description><![CDATA[<p class="para" id="N65541">Mammalian cyclic GMP-AMP synthase (cGAS) and its homologue dinucleotide cyclase in <i>Vibrio cholerae</i> (<i>Vc</i>DncV) produce cyclic dinucleotides (CDNs) that participate in the defense against viral infection. Recently, scores of new cGAS/DncV-like nucleotidyltransferases (CD-NTases) were discovered, which produce various CDNs and cyclic trinucleotides (CTNs) as second messengers. Here, we present the crystal structures of <i>Ec</i>CdnD, a CD-NTase from <i>Enterobacter cloacae</i> that produces cyclic AMP-AMP-GMP, in its apo-form and in complex with ATP, ADP and AMPcPP, an ATP analogue. Despite the similar overall architecture, the protein shows significant structural variations from other CD-NTases. Adjacent to the donor substrate, another nucleotide is bound to the acceptor binding site by a non-productive mode. Isothermal titration calorimetry results also suggest the presence of two ATP binding sites. GTP alone does not bind to <i>Ec</i>CdnD, which however binds to pppApG, a possible intermediate. The enzyme is active on ATP or a mixture of ATP and GTP, and the best metal cofactor is Mg<sup>2+</sup>. The conserved residues Asp69 and Asp71 are essential for catalysis, as indicated by the loss of activity in the mutants. Based on structural analysis and comparison with <i>Vc</i>DncV and RNA polymerase, a tentative catalytic pathway for the CTN-producing <i>Ec</i>CdnD is proposed.</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Myod1 and GR coordinate myofiber-specific transcriptional enhancers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073080928-41a6ef86-5d5e-4150-85bf-bcfd0c5b57c7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab226</link>
            <description><![CDATA[<p class="para" id="N65541">Skeletal muscle is a dynamic tissue the size of which can be remodeled through the concerted actions of various cues. Here, we investigated the skeletal muscle transcriptional program and identified key tissue-specific regulatory genetic elements. Our results show that Myod1 is bound to numerous skeletal muscle enhancers in collaboration with the glucocorticoid receptor (GR) to control gene expression. Remarkably, transcriptional activation controlled by these factors occurs through direct contacts with the promoter region of target genes, via the CpG-bound transcription factor Nrf1, and the formation of Ctcf-anchored chromatin loops, in a myofiber-specific manner. Moreover, we demonstrate that GR negatively controls muscle mass and strength in mice by down-regulating anabolic pathways. Taken together, our data establish Myod1, GR and Nrf1 as key players of muscle-specific enhancer-promoter communication that orchestrate myofiber size regulation.</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A benchmark and an algorithm for detecting germline transposon insertions and measuring <i>de novo</i> transposon insertion frequencies]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073073367-da71feca-18a6-4ae8-9149-e6bba705723d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab010</link>
            <description><![CDATA[<p class="para" id="N65541">Transposons are genomic parasites, and their new insertions can cause instability and spur the evolution of their host genomes. Rapid accumulation of short-read whole-genome sequencing data provides a great opportunity for studying new transposon insertions and their impacts on the host genome. Although many algorithms are available for detecting transposon insertions, the task remains challenging and existing tools are not designed for identifying <i>de novo</i> insertions. Here, we present a new benchmark fly dataset based on PacBio long-read sequencing and a new method TEMP2 for detecting germline insertions and measuring <i>de novo</i> ‘singleton’ insertion frequencies in eukaryotic genomes. TEMP2 achieves high sensitivity and precision for detecting germline insertions when compared with existing tools using both simulated data in fly and experimental data in fly and human. Furthermore, TEMP2 can accurately assess the frequencies of <i>de novo</i> transposon insertions even with high levels of chimeric reads in simulated datasets; such chimeric reads often occur during the construction of short-read sequencing libraries. By applying TEMP2 to published data on hybrid dysgenic flies inflicted by de-repressed <i>P-elements</i>, we confirmed the continuous new insertions of <i>P-elements</i> in dysgenic offspring before they regain piRNAs for <i>P-element</i> repression. TEMP2 is freely available at Github: https://github.com/weng-lab/TEMP2.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A conserved BAH module within mammalian BAHD1 connects H3K27me3 to Polycomb gene silencing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073042004-6d5cbb68-17a6-4a4b-88af-4aaead27d7ed/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab210</link>
            <description><![CDATA[<p class="para" id="N65541">Trimethylation of histone H3 lysine 27 (H3K27me3) is important for gene silencing and imprinting, (epi)genome organization and organismal development. In a prevalent model, the functional readout of H3K27me3 in mammalian cells is achieved through the H3K27me3-recognizing chromodomain harbored within the chromobox (CBX) component of canonical Polycomb repressive complex 1 (cPRC1), which induces chromatin compaction and gene repression. Here, we report that binding of H3K27me3 by a Bromo Adjacent Homology (BAH) domain harbored within BAH domain-containing protein 1 (BAHD1) is required for overall BAHD1 targeting to chromatin and for optimal repression of the H3K27me3-demarcated genes in mammalian cells. Disruption of direct interaction between BAHD1<sup>BAH</sup> and H3K27me3 by point mutagenesis leads to chromatin remodeling, notably, increased histone acetylation, at its Polycomb gene targets. Mice carrying an H3K27me3-interaction-defective mutation of Bahd1<sup>BAH</sup> causes marked embryonic lethality, showing a requirement of this pathway for normal development. Altogether, this work demonstrates an H3K27me3-initiated signaling cascade that operates through a conserved BAH ‘reader’ module within BAHD1 in mammals.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766073042004-6d5cbb68-17a6-4a4b-88af-4aaead27d7ed/assets/gkab210gra1.jpg" alt="A mammalian H3K27me3-transduction pathway operates through an H3K27me3-specific ‘reader’ module (BAH) of BAHD1, which assembles a complex with corepressors (HDACs and others) for suppressing histone acetylation and repressing expression at Polycomb target genes."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      A mammalian H3K27me3-transduction pathway operates through an H3K27me3-specific ‘reader’ module (BAH) of BAHD1, which assembles a complex with corepressors (HDACs and others) for suppressing histone acetylation and repressing expression at Polycomb target genes.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-04-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DM3Loc: multi-label mRNA subcellular localization prediction and analysis based on multi-head self-attention mechanism]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073021048-b54e7c18-f08e-4bff-a129-dacfa4e6d118/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab016</link>
            <description><![CDATA[<p class="para" id="N65541">Subcellular localization of messenger RNAs (mRNAs), as a prevalent mechanism, gives precise and efficient control for the translation process. There is mounting evidence for the important roles of this process in a variety of cellular events. Computational methods for mRNA subcellular localization prediction provide a useful approach for studying mRNA functions. However, few computational methods were designed for mRNA subcellular localization prediction and their performance have room for improvement. Especially, there is still no available tool to predict for mRNAs that have multiple localization annotations. In this paper, we propose a multi-head self-attention method, DM3Loc, for multi-label mRNA subcellular localization prediction. Evaluation results show that DM3Loc outperforms existing methods and tools in general. Furthermore, DM3Loc has the interpretation ability to analyze RNA-binding protein motifs and key signals on mRNAs for subcellular localization. Our analyses found hundreds of instances of mRNA isoform-specific subcellular localizations and many significantly enriched gene functions for mRNAs in different subcellular localizations.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Molecular mechanism of RNase R substrate sensitivity for RNA ribose methylation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073014404-2f7552db-6447-4e1e-95ef-92c56283201e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab202</link>
            <description><![CDATA[<p class="para" id="N65541">RNA 2′-<i>O</i>-methylation is widely distributed and plays important roles in various cellular processes. <i>Mycoplasma genitalium</i> RNase R (<i>Mg</i>R), a prokaryotic member of the RNase II/RNB family, is a 3′-5′ exoribonuclease and is particularly sensitive to RNA 2′-<i>O</i>-methylation. However, how RNase R interacts with various RNA species and exhibits remarkable sensitivity to substrate 2′-<i>O</i>-methyl modifications remains elusive. Here we report high-resolution crystal structures of <i>Mg</i>R in apo form and in complex with various RNA substrates. The structural data together with extensive biochemical analysis quantitively illustrate <i>Mg</i>R’s ribonuclease activity and significant sensitivity to RNA 2′-<i>O</i>-methylation. Comparison to its related homologs reveals an exquisite mechanism for the recognition and degradation of RNA substrates. Through structural and mutagenesis studies, we identified proline 277 to be responsible for the significant sensitivity of <i>Mg</i>R to RNA 2′-<i>O</i>-methylation within the RNase II/RNB family. We also generated several <i>Mg</i>R variants with modulated activities. Our work provides a mechanistic understanding of <i>Mg</i>R activity that can be harnessed as a powerful RNA analytical tool that will open up a new venue for RNA 2′-<i>O</i>-methylations research in biological and clinical samples.</p>]]></description>
            <pubDate><![CDATA[2021-03-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766073004612-4252b18e-0074-48d0-9840-18e76fc294a5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab209</link>
            <description><![CDATA[<p class="para" id="N65541">Although overexpression of EZH2, a catalytic subunit of the polycomb repressive complex 2 (PRC2), is an eminent feature of various cancers, the regulation of its abundance and function remains insufficiently understood. We report here that the PRC2 complex is physically associated with ubiquitin-specific protease USP7 in cancer cells where USP7 acts to deubiquitinate and stabilize EZH2. Interestingly, we found that USP7-catalyzed H2BK120ub1 deubiquitination is a prerequisite for chromatin loading of PRC2 thus H3K27 trimethylation, and this process is not affected by H2AK119 ubiquitination catalyzed by PRC1. Genome-wide analysis of the transcriptional targets of the USP7/PRC2 complex identified a cohort of genes including <i>FOXO1</i> that are involved in cell growth and proliferation. We demonstrated that the USP7/PRC2 complex drives cancer cell proliferation and tumorigenesis <i>in vitro</i> and <i>in vivo</i>. We showed that the expression of both USP7 and EZH2 elevates during tumor progression, corresponding to a diminished FOXO1 expression, and the level of the expression of USP7 and EZH2 strongly correlates with histological grades and prognosis of tumor patients. These results reveal a dual role for USP7 in the regulation of the abundance and function of EZH2, supporting the pursuit of USP7 as a therapeutic target for cancer intervention.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Water structure around a left-handed Z-DNA fragment analyzed by cryo neutron crystallography]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072959463-e750a83d-71a0-4dd7-b1c7-c92d813bb52f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab264</link>
            <description><![CDATA[<p class="para" id="N65541">Even in high-quality X-ray crystal structures of oligonucleotides determined at a resolution of 1 Å or higher, the orientations of first-shell water molecules remain unclear. We used cryo neutron crystallography to gain insight into the H-bonding patterns of water molecules around the left-handed Z-DNA duplex [d(CGCGCG)]<sub>2</sub>. The neutron density visualized at 1.5 Å resolution for the first time allows us to pinpoint the orientations of most of the water molecules directly contacting the DNA and of many second-shell waters. In particular, H-bond acceptor and donor patterns for water participating in prominent hydration motifs inside the minor groove, on the convex surface or bridging nucleobase and phosphate oxygen atoms are finally revealed. Several water molecules display entirely unexpected orientations. For example, a water molecule located at H-bonding distance from O6 keto oxygen atoms of two adjacent guanines directs both its deuterium atoms away from the keto groups. Exocyclic amino groups of guanine (N2) and cytosine (N4) unexpectedly stabilize waters H-bonded to O2 keto oxygens from adjacent cytosines and O6 keto oxygens from adjacent guanines, respectively. Our structure offers the most detailed view to date of DNA solvation in the solid-state undistorted by metal ions or polyamines.</p>]]></description>
            <pubDate><![CDATA[2021-04-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The rDNA is biomolecular condensate formed by polymer–polymer phase separation and is sequestered in the nucleolus by transcription and R-loops]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072952497-d471c4df-012f-4f3b-a348-035f96801867/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab229</link>
            <description><![CDATA[<p class="para" id="N65541">The nucleolus is the site of ribosome biosynthesis encompassing the ribosomal DNA (rDNA) locus in a phase separated state within the nucleus. In budding yeast, we find the rDNA locus and Cdc14, a protein phosphatase that co-localizes with the rDNA, behave like a condensate formed by polymer–polymer phase separation, while ribonucleoproteins behave like a condensate formed by liquid-liquid phase separation. The compaction of the rDNA and Cdc14’s nucleolar distribution are dependent on the concentration of DNA cross-linkers. In contrast, ribonucleoprotein nucleolar distribution is independent of the concentration of DNA cross-linkers and resembles droplets <i>in vivo</i> upon replacement of the endogenous rDNA locus with high-copy plasmids. When ribosomal RNA is transcribed from the plasmids by Pol II, the rDNA–binding proteins and ribonucleoprotein signals are weakly correlated, but upon repression of transcription, ribonucleoproteins form a single, stable droplet that excludes rDNA-binding proteins from its center. Degradation of RNA–DNA hybrid structures, known as R-loops, by overexpression of RNase H1 results in the physical exclusion of the rDNA locus from the nucleolar center. Thus, the rDNA locus is a polymer–polymer phase separated condensate that relies on transcription and physical contact with RNA transcripts to remain encapsulated within the nucleolus.</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Nucleosome composition regulates the histone H3 tail conformational ensemble and accessibility]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072929930-6325fba9-1e8f-4c04-bc31-d115cdcf6969/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab246</link>
            <description><![CDATA[<p class="para" id="N65541">Hexasomes and tetrasomes are intermediates in nucleosome assembly and disassembly. Their formation is promoted by histone chaperones, ATP-dependent remodelers, and RNA polymerase II. In addition, hexasomes are maintained in transcribed genes and could be an important regulatory factor. While nucleosome composition has been shown to affect the structure and accessibility of DNA, its influence on histone tails is largely unknown. Here, we investigate the conformational dynamics of the H3 tail in the hexasome and tetrasome. Using a combination of NMR spectroscopy, MD simulations, and trypsin proteolysis, we find that the conformational ensemble of the H3 tail is regulated by nucleosome composition. As has been found for the nucleosome, the H3 tails bind robustly to DNA within the hexasome and tetrasome, but upon loss of the H2A/H2B dimer, we determined that the adjacent H3 tail has an altered conformational ensemble, increase in dynamics, and increase in accessibility. Similar to observations of DNA dynamics, this is seen to be asymmetric in the hexasome. Our results indicate that nucleosome composition has the potential to regulate chromatin signaling and ultimately help shape the chromatin landscape.</p>]]></description>
            <pubDate><![CDATA[2021-04-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Coevolution of ribosomal RNA expansion segment 7<sup>L</sup> and assembly factor Noc2p specializes the ribosome biogenesis pathway between <i>Saccharomyces cerevisiae</i> and <i>Candida albicans</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072912199-e8b0e254-f6cd-4cd9-ab4b-feea70504a46/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab218</link>
            <description><![CDATA[<p class="para" id="N65541">Ribosomes of different species share an evolutionarily conserved core, exhibiting flexible shells formed partially by the addition of species-specific ribosomal RNAs (rRNAs) with largely unexplored functions. In this study, we showed that by swapping the <i>Saccharomyces cerevisiae</i> 25S rRNA genes with non-<i>S. cerevisiae</i> homologs, species-specific rRNA variations caused moderate to severe pre-rRNA processing defects. Specifically, rRNA substitution by the <i>Candida albicans</i> caused severe growth defects and deficient pre-rRNA processing. We observed that such defects could be attributed primarily to variations in expansion segment 7L (ES7<sup>L</sup>) and could be restored by an assembly factor Noc2p mutant (Noc2p-K384R). We showed that swapping ES7<sup>L</sup> attenuated the incorporation of Noc2p and other proteins (Erb1p, Rrp1p, Rpl6p and Rpl7p) into pre-ribosomes, and this effect could be compensated for by Noc2p-K384R. Furthermore, replacement of Noc2p with ortholog from <i>C. albicans</i> could also enhance the incorporation of Noc2p and the above proteins into pre-ribosomes and consequently restore normal growth. Taken together, our findings help to elucidate the roles played by the species-specific rRNA variations in ribosomal biogenesis and further provide evidence that coevolution of rRNA expansion segments and cognate assembly factors specialized the ribosome biogenesis pathway, providing further insights into the function and evolution of ribosome.</p>]]></description>
            <pubDate><![CDATA[2021-04-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A functional LSD1 coregulator screen reveals a novel transcriptional regulatory cascade connecting R-loop homeostasis with epigenetic regulation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072871625-556e5576-4981-4b83-be64-ad04090e92f3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab180</link>
            <description><![CDATA[<p class="para" id="N65541">The lysine specific demethylase 1 (LSD1) plays a pivotal role in cellular differentiation by regulating the expression of key developmental genes in concert with different coregulatory proteins. This process is impaired in different cancer types and incompletely understood. To comprehensively identify functional coregulators of LSD1, we established a novel tractable fluorescent reporter system to monitor LSD1 activity in living cells. Combining this reporter system with a state-of-the-art multiplexed RNAi screen, we identify the DEAD-box helicase 19A (DDX19A) as a novel coregulator and demonstrate that suppression of <i>Ddx19a</i> results in an increase of R-loops and reduced LSD1-mediated gene silencing. We further show that DDX19A binds to tri-methylated lysine 27 of histone 3 (H3K27me3) and it regulates gene expression through the removal of transcription promoting R-loops. Our results uncover a novel transcriptional regulatory cascade where the downregulation of genes is dependent on the LSD1 mediated demethylation of histone H3 lysine 4 (H3K4). This allows the polycomb repressive complex 2 (PRC2) to methylate H3K27, which serves as a binding site for DDX19A. Finally, the binding of DDX19A leads to the efficient removal of R-loops at active promoters, which further de-represses LSD1 and PRC2, establishing a positive feedback loop leading to a robust repression of the target gene.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766072871625-556e5576-4981-4b83-be64-ad04090e92f3/assets/gkab180gra1.jpg" alt="Model of the regulatory cascade for transcriptional repression, which depends on the removal of transcription-associated R-loops downstream of LSD1 activity."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Model of the regulatory cascade for transcriptional repression, which depends on the removal of transcription-associated R-loops downstream of LSD1 activity.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-04-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The HIV-1 nucleocapsid chaperone protein forms locally compacted globules on long double-stranded DNA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072846482-e8729951-664b-4cba-a143-fb84394f998d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab236</link>
            <description><![CDATA[<p class="para" id="N65541">The nucleocapsid (NC) protein plays key roles in Human Immunodeficiency Virus 1 (HIV-1) replication, notably by condensing and protecting the viral RNA genome and by chaperoning its reverse transcription into double-stranded DNA (dsDNA). Recent findings suggest that integration of viral dsDNA into the host genome, and hence productive infection, is linked to a small subpopulation of viral complexes where reverse transcription was completed within the intact capsid. Therefore, the synthesized dsDNA has to be tightly compacted, most likely by NC, to prevent breaking of the capsid in these complexes. To investigate NC’s ability to compact viral dsDNA, we here characterize the compaction of single dsDNA molecules under unsaturated NC binding conditions using nanofluidic channels. Compaction is shown to result from accumulation of NC at one or few compaction sites, which leads to small dsDNA condensates. NC preferentially initiates compaction at flexible regions along the dsDNA, such as AT-rich regions and DNA ends. Upon further NC binding, these condensates develop into a globular state containing the whole dsDNA molecule. These findings support NC’s role in viral dsDNA compaction within the mature HIV-1 capsid and suggest a possible scenario for the gradual dsDNA decondensation upon capsid uncoating and NC loss.</p>]]></description>
            <pubDate><![CDATA[2021-04-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Rational engineering of a modular bacterial CRISPR–Cas activation platform with expanded target range]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072830486-3ac37407-1322-4396-bdb9-db9a5c795b7e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab211</link>
            <description><![CDATA[<p class="para" id="N65541">CRISPR–Cas activator (CRISPRa) systems that selectively turn on transcription of a target gene are a potentially transformative technology for programming cellular function. While in eukaryotes versatile CRISPRa systems exist, in bacteria these systems suffer from a limited ability to activate different genes due to strict distance-dependent requirements of functional target binding sites, and require greater customization to optimize performance in different genetic and cellular contexts. To address this, we apply a rational protein engineering approach to create a new CRISPRa platform that is highly modular to allow for easy customization and has increased targeting flexibility through harnessing engineered Cas proteins. We first demonstrate that transcription activation domains can be recruited by CRISPR–Cas through noncovalent protein-protein interactions, which allows each component to be encoded on separate and easily interchangeable plasmid elements. We then exploit this modularity to rapidly screen a library of different activation domains, creating new systems with distinct regulatory properties. Furthermore, we demonstrate that by harnessing a library of circularly permuted Cas proteins, we can create CRISPRa systems that have different target binding site requirements, which together, allow for expanded target range.</p>]]></description>
            <pubDate><![CDATA[2021-04-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Crystal structures of N-terminally truncated telomerase reverse transcriptase from fungi<a href="#FN2"><sup>‡</sup></a>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072824327-286141f0-eba5-44f8-8a5e-156515e32e5e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab261</link>
            <description><![CDATA[<p class="para" id="N65541">Telomerase plays critical roles in cellular aging, in the emergence and/or development of cancer, and in the capacity for stem-cell renewal, consists of a catalytic telomerase reverse transcriptase (TERT) and a template-encoding RNA (TER). TERs from diverse organisms contain two conserved structural elements: the template-pseudoknot (T-PK) and a helical three-way junction (TWJ). Species-specific features of the structure and function of telomerase make obtaining a more in-depth understanding of the molecular mechanism of telomerase particularly important. Here, we report the first structural studies of N-terminally truncated TERTs from <i>Candida albicans</i> and <i>Candida tropicalis</i> in apo form and complexed with their respective TWJs in several conformations. We found that <i>Candida</i> TERT proteins perform only one round of telomere addition in the presence or absence of PK/TWJ and display standard reverse transcriptase activity. The C-terminal domain adopts at least two extreme conformations and undergoes conformational interconversion, which regulates the catalytic activity. Most importantly, we identified a conserved tertiary structural motif, called the U-motif, which interacts with the reverse transcriptase domain and is crucial for catalytic activity. Together these results shed new light on the structure and mechanics of fungal TERTs, which show common TERT characteristics, but also display species-specific features.</p>]]></description>
            <pubDate><![CDATA[2021-04-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Single cell epigenetic visualization assay]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072818409-0606c8a3-b73f-44c5-89bc-92d20b3446c6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab009</link>
            <description><![CDATA[<p class="para" id="N65541">Characterization of the epigenetic status of individual cells remains a challenge. Current sequencing approaches have limited coverage, and it is difficult to assign an epigenetic status to the transcription state of individual gene alleles in the same cell. To address these limitations, a targeted microscopy-based epigenetic visualization assay (EVA) was developed for detection and quantification of epigenetic marks at genes of interest in single cells. The assay is based on an <i>in situ</i> biochemical reaction between an antibody-conjugated alkaline phosphatase bound to the epigenetic mark of interest, and a 5′-phosphorylated fluorophore-labeled DNA oligo tethered to a target gene by gene-specific oligonucleotides. When the epigenetic mark is present at the gene, phosphate group removal by the phosphatase protects the oligo from λ-exonuclease activity providing a quantitative fluorescent readout. We applied EVA to measure 5-methylcytosine (5mC) and H3K9Ac levels at different genes and the HIV-1 provirus in human cell lines. To link epigenetic marks to gene transcription, EVA was combined with RNA-FISH. Higher 5mC levels at the silenced compared to transcribed <i>XIST</i> gene alleles in female somatic cells validated this approach and demonstrated that EVA can be used to relate epigenetic marks to the transcription status of individual gene alleles.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766072818409-0606c8a3-b73f-44c5-89bc-92d20b3446c6/assets/gkab009gra1.jpg" alt="Epigenetic mark visualization at a gene of interest. Alkaline phosphatase (AP) is recruited to the epigenetic mark (purple) as an antibody conjugate. Gene specific oligonucleotides anchor phosphorylated sensor oligo (red) annealed to a detector oligo (green). When the epigenetic mark is present at the gene, the AP-dephosphorylated oligo survives subsequent λ-exonuclease treatment. The presence of the epigenetic mark at the gene is quantitated using the ratio of detector/sensor signal intensities (green/red)."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Epigenetic mark visualization at a gene of interest. Alkaline phosphatase (AP) is recruited to the epigenetic mark (purple) as an antibody conjugate. Gene specific oligonucleotides anchor phosphorylated sensor oligo (red) annealed to a detector oligo (green). When the epigenetic mark is present at the gene, the AP-dephosphorylated oligo survives subsequent λ-exonuclease treatment. The presence of the epigenetic mark at the gene is quantitated using the ratio of detector/sensor signal intensities (green/red).</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mechanism of REST/NRSF regulation of clustered protocadherin α genes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072812311-fcdbd046-2732-4cbc-b22d-c88d0b0a51fc/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab248</link>
            <description><![CDATA[<p class="para" id="N65541">Repressor element-1 silencing transcription factor (REST) or neuron-restrictive silencer factor (NRSF) is a zinc-finger (ZF) containing transcriptional repressor that recognizes thousands of neuron-restrictive silencer elements (NRSEs) in mammalian genomes. How REST/NRSF regulates gene expression remains incompletely understood. Here, we investigate the binding pattern and regulation mechanism of REST/NRSF in the clustered protocadherin (<i>PCDH</i>) genes. We find that REST/NRSF directionally forms base-specific interactions with NRSEs via tandem ZFs in an anti-parallel manner but with striking conformational changes. In addition, REST/NRSF recruitment to the <i>HS5–1</i> enhancer leads to the decrease of long-range enhancer-promoter interactions and downregulation of the clustered <i>PCDHα</i> genes. Thus, REST/NRSF represses <i>PCDHα</i> gene expression through directional binding to a repertoire of NRSEs within the distal enhancer and variable target genes.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Global RNA profiles show target selectivity and physiological effects of peptide-delivered antisense antibiotics]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072803074-108c5838-1626-472e-b130-e88887f71e69/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab242</link>
            <description><![CDATA[<p class="para" id="N65541">Antisense peptide nucleic acids (PNAs) inhibiting mRNAs of essential genes provide a straight-forward way to repurpose our knowledge of bacterial regulatory RNAs for development of programmable species-specific antibiotics. While there is ample proof of PNA efficacy, their target selectivity and impact on bacterial physiology are poorly understood. Moreover, while antibacterial PNAs are typically designed to block mRNA translation, effects on target mRNA levels are not well-investigated. Here, we pioneer the use of global RNA-seq analysis to decipher PNA activity in a transcriptome-wide manner. We find that PNA-based antisense oligomer conjugates robustly decrease mRNA levels of the widely-used target gene, <i>acpP</i>, in <i>Salmonella enterica</i>, with limited off-target effects. Systematic analysis of several different PNA-carrier peptides attached not only shows different bactericidal efficiency, but also activation of stress pathways. In particular, KFF-, RXR- and Tat-PNA conjugates especially induce the PhoP/Q response, whereas the latter two additionally trigger several distinct pathways. We show that constitutive activation of the PhoP/Q response can lead to Tat-PNA resistance, illustrating the utility of RNA-seq for understanding PNA antibacterial activity. In sum, our study establishes an experimental framework for the design and assessment of PNA antimicrobials in the long-term quest to use these for precision editing of microbiota.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[SIRT3 consolidates heterochromatin and counteracts senescence]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072795095-653cbbeb-62af-4390-ab18-b49d07084830/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab161</link>
            <description><![CDATA[<p class="para" id="N65541">Sirtuin 3 (SIRT3) is an NAD<sup>+</sup>-dependent deacetylase linked to a broad range of physiological and pathological processes, including aging and aging-related diseases. However, the role of SIRT3 in regulating human stem cell homeostasis remains unclear. Here we found that SIRT3 expression was downregulated in senescent human mesenchymal stem cells (hMSCs). CRISPR/Cas9-mediated depletion of SIRT3 led to compromised nuclear integrity, loss of heterochromatin and accelerated senescence in hMSCs. Further analysis indicated that SIRT3 interacted with nuclear envelope proteins and heterochromatin-associated proteins. SIRT3 deficiency resulted in the detachment of genomic lamina-associated domains (LADs) from the nuclear lamina, increased chromatin accessibility and aberrant repetitive sequence transcription. The re-introduction of SIRT3 rescued the disorganized heterochromatin and the senescence phenotypes. Taken together, our study reveals a novel role for SIRT3 in stabilizing heterochromatin and counteracting hMSC senescence, providing new potential therapeutic targets to ameliorate aging-related diseases.</p>]]></description>
            <pubDate><![CDATA[2021-03-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Nse5/6 is a negative regulator of the ATPase activity of the Smc5/6 complex]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072785875-0553f309-ecd5-4144-a813-fbd553116087/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab234</link>
            <description><![CDATA[<p class="para" id="N65541">The multi-component Smc5/6 complex plays a critical role in the resolution of recombination intermediates formed during mitosis and meiosis, and in the cellular response to replication stress. Using recombinant proteins, we have reconstituted a series of defined <i>Saccharomyces cerevisiae</i> Smc5/6 complexes, visualised them by negative stain electron microscopy, and tested their ability to function as an ATPase. We find that only the six protein ‘holo-complex’ is capable of turning over ATP and that its activity is significantly increased by the addition of double-stranded DNA to reaction mixes. Furthermore, stimulation is wholly dependent on functional ATP-binding pockets in both Smc5 and Smc6. Importantly, we demonstrate that budding yeast Nse5/6 acts as a negative regulator of Smc5/6 ATPase activity, binding to the head-end of the complex to suppress turnover, irrespective of the DNA-bound status of the complex.</p>]]></description>
            <pubDate><![CDATA[2021-04-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Pif1 helicase is actively inhibited during meiotic recombination which restrains gene conversion tract length]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072778955-bdda65d2-ff2e-4d65-a6ed-9067d6358ba7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab232</link>
            <description><![CDATA[<p class="para" id="N65541">Meiotic recombination ensures proper chromosome segregation to form viable gametes and results in gene conversions events between homologs. Conversion tracts are shorter in meiosis than in mitotically dividing cells. This results at least in part from the binding of a complex, containing the Mer3 helicase and the MutLβ heterodimer, to meiotic recombination intermediates. The molecular actors inhibited by this complex are elusive. The Pif1 DNA helicase is known to stimulate DNA polymerase delta (Pol δ) -mediated DNA synthesis from D-loops, allowing long synthesis required for break-induced replication. We show that Pif1 is also recruited genome wide to meiotic DNA double-strand break (DSB) sites. We further show that Pif1, through its interaction with PCNA, is required for the long gene conversions observed in the absence of MutLβ recruitment to recombination sites. <i>In vivo</i>, Mer3 interacts with the PCNA clamp loader RFC, and <i>in vitro</i>, Mer3-MutLβ ensemble inhibits Pif1-stimulated D-loop extension by Pol δ and RFC-PCNA. Mechanistically, our results suggest that Mer3-MutLβ may compete with Pif1 for binding to RFC-PCNA. Taken together, our data show that Pif1’s activity that promotes meiotic DNA repair synthesis is restrained by the Mer3-MutLβ ensemble which in turn prevents long gene conversion tracts and possibly associated mutagenesis.</p>]]></description>
            <pubDate><![CDATA[2021-04-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A phage satellite tunes inducing phage gene expression using a domesticated endonuclease to balance inhibition and virion hijacking]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072772215-33595ea9-8cc9-4601-8d12-a00abe318cff/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab207</link>
            <description><![CDATA[<p class="para" id="N65541">Bacteria persist under constant threat of predation by bacterial viruses (phages). Bacteria-phage conflicts result in evolutionary arms races often driven by mobile genetic elements (MGEs). One such MGE, a phage satellite in <i>Vibrio cholerae</i> called PLE, provides specific and robust defense against a pervasive lytic phage, ICP1. The interplay between PLE and ICP1 has revealed strategies for molecular parasitism allowing PLE to hijack ICP1 processes in order to mobilize. Here, we describe the mechanism of PLE-mediated transcriptional manipulation of ICP1 structural gene transcription. PLE encodes a novel DNA binding protein, CapR, that represses ICP1’s capsid morphogenesis operon. Although CapR is sufficient for the degree of capsid repression achieved by PLE, its activity does not hinder the ICP1 lifecycle. We explore the consequences of repression of this operon, demonstrating that more stringent repression achieved through CRISPRi restricts both ICP1 and PLE. We also discover that PLE transduces in modified ICP1-like particles. Examination of CapR homologs led to the identification of a suite of ICP1-encoded homing endonucleases, providing a putative origin for the satellite-encoded repressor. This work unveils a facet of the delicate balance of satellite-mediated inhibition aimed at blocking phage production while successfully mobilizing in a phage-derived particle.</p>]]></description>
            <pubDate><![CDATA[2021-04-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Impact of 3-deazapurine nucleobases on RNA properties]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072764224-32ae7b48-643a-44dd-9dcf-40208264e82b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab256</link>
            <description><![CDATA[<p class="para" id="N65541">Deazapurine nucleosides such as 3-deazaadenosine (c<sup>3</sup>A) are crucial for atomic mutagenesis studies of functional RNAs. They were the key for our current mechanistic understanding of ribosomal peptide bond formation and of phosphodiester cleavage in recently discovered small ribozymes, such as twister and pistol RNAs. Here, we present a comprehensive study on the impact of c<sup>3</sup>A and the thus far underinvestigated 3-deazaguanosine (c<sup>3</sup>G) on RNA properties. We found that these nucleosides can decrease thermodynamic stability of base pairing to a significant extent. The effects are much more pronounced for 3-deazapurine nucleosides compared to their constitutional isomers of 7-deazapurine nucleosides (c<sup>7</sup>G, c<sup>7</sup>A). We furthermore investigated base pair opening dynamics by solution NMR spectroscopy and revealed significantly enhanced imino proton exchange rates. Additionally, we solved the X-ray structure of a c<sup>3</sup>A-modified RNA and visualized the hydration pattern of the minor groove. Importantly, the characteristic water molecule that is hydrogen-bonded to the purine N3 atom and always observed in a natural double helix is lacking in the 3-deazapurine-modified counterpart. Both, the findings by NMR and X-ray crystallographic methods hence provide a rationale for the reduced pairing strength. Taken together, our comparative study is a first major step towards a comprehensive understanding of this important class of nucleoside modifications.</p>]]></description>
            <pubDate><![CDATA[2021-04-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A purine loop and the primer binding site are critical for the selective encapsidation of mouse mammary tumor virus genomic RNA by Pr77<sup>Gag</sup>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766072732565-b5b31c35-f0b5-408f-8bf7-694a1ddbb54f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab223</link>
            <description><![CDATA[<p class="para" id="N65541">Retroviral RNA genome (gRNA) harbors <i>cis</i>-acting sequences that facilitate its specific packaging from a pool of other viral and cellular RNAs by binding with high-affinity to the viral Gag protein during virus assembly. However, the molecular intricacies involved during selective gRNA packaging are poorly understood. Binding and footprinting assays on mouse mammary tumor virus (MMTV) gRNA with purified Pr77<sup>Gag</sup> along with in cell gRN<span style="text-decoration: line-through">A</span> packaging study identified two Pr77<sup>Gag</sup> binding sites constituting critical, non-redundant packaging signals. These included: a purine loop in a bifurcated stem-loop containing the gRNA dimerization initiation site, and the primer binding site (PBS). Despite these sites being present on both unspliced and spliced RNAs, Pr77<sup>Gag</sup> specifically bound to unspliced RNA, since only that could adopt the native bifurcated stem–loop structure containing looped purines. These results map minimum structural elements required to initiate MMTV gRNA packaging, distinguishing features that are conserved amongst divergent retroviruses from those perhaps unique to MMTV. Unlike purine-rich motifs frequently associated with packaging signals, direct involvement of PBS in gRNA packaging has not been documented in retroviruses. These results enhance our understanding of retroviral gRNA packaging/assembly, making it not only a target for novel therapeutic interventions, but also development of safer gene therapy vectors.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766072732565-b5b31c35-f0b5-408f-8bf7-694a1ddbb54f/assets/gkab223gra1.jpg" alt="A single stranded purines (ssPurine) loop in a bifurcated stem-loop structure containing the genomic RNA dimerization initiation site (DIS) hairpin, and the primer binding site (PBS) play a crucial role in the packaging of MMTV genomic RNA by recruiting Pr77Gag precursor polyprotein."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      A single stranded purines (ssPurine) loop in a bifurcated stem-loop structure containing the genomic RNA dimerization initiation site (DIS) hairpin, and the primer binding site (PBS) play a crucial role in the packaging of MMTV genomic RNA by recruiting Pr77<sup>Gag</sup> precursor polyprotein.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-04-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structures of <i>Neisseria gonorrhoeae</i> MtrR-operator complexes reveal molecular mechanisms of DNA recognition and antibiotic resistance-conferring clinical mutations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037594588-d26cf7b3-23c0-4d3b-b5b6-f4e202a2dfac/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab213</link>
            <description><![CDATA[<p class="para" id="N65541">Mutations within the <i>mtrR</i> gene are commonly found amongst multidrug resistant clinical isolates of <i>Neisseria gonorrhoeae</i>, which has been labelled a superbug by the Centers for Disease Control and Prevention. These mutations appear to contribute to antibiotic resistance by interfering with the ability of MtrR to bind to and repress expression of its target genes, which include the <i>mtrCDE</i> multidrug efflux transporter genes and the <i>rpoH</i> oxidative stress response sigma factor gene. However, the DNA-recognition mechanism of MtrR and the consensus sequence within these operators to which MtrR binds has remained unknown. In this work, we report the crystal structures of MtrR bound to the <i>mtrCDE</i> and <i>rpoH</i> operators, which reveal a conserved, but degenerate, DNA consensus binding site 5′-MCRTRCRN<sub>4</sub>YGYAYGK-3′. We complement our structural data with a comprehensive mutational analysis of key MtrR-DNA contacts to reveal their importance for MtrR-DNA binding both <i>in vitro</i> and <i>in vivo</i>. Furthermore, we model and generate common clinical mutations of MtrR to provide plausible biochemical explanations for the contribution of these mutations to multidrug resistance in <i>N. gonorrhoeae</i>. Collectively, our findings unveil key biological mechanisms underlying the global stress responses of <i>N. gonorrhoeae</i>.</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Profiling of RNA ribose methylation in <i>Arabidopsis thaliana</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037587217-72b6606c-e282-459a-b147-9fe8d7dc00ff/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab196</link>
            <description><![CDATA[<p class="para" id="N65541">Eukaryotic rRNAs and snRNAs are decorated with abundant 2′-<i>O</i>-methylated nucleotides (Nm) that are predominantly synthesized by box C/D snoRNA-guided enzymes. In the model plant <i>Arabidopsis thaliana</i>, C/D snoRNAs have been well categorized, but there is a lack of systematic mapping of Nm. Here, we applied RiboMeth-seq to profile Nm in cytoplasmic, chloroplast and mitochondrial rRNAs and snRNAs. We identified 111 Nm in cytoplasmic rRNAs and 19 Nm in snRNAs and assigned guide for majority of the detected sites using an updated snoRNA list. At least four sites are directed by guides with multiple specificities as shown in yeast. We found that C/D snoRNAs frequently form extra pairs with nearby sequences of methylation sites, potentially facilitating the substrate binding. Chloroplast and mitochondrial rRNAs contain five almost identical methylation sites, including two novel sites mediating ribosomal subunit joining. Deletion of FIB1 or FIB2 gene reduced the accumulation of C/D snoRNA and rRNA methylation with FIB1 playing a bigger role in methylation. Our data reveal the comprehensive 2′-<i>O</i>-methylation maps for Arabidopsis rRNAs and snRNAs and would facilitate study of their function and biosynthesis.</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Regulation of RNA editing by intracellular acidification]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037578781-7aad46f1-bfda-449c-8d2b-fdd1b6ba09d9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab157</link>
            <description><![CDATA[<p class="para" id="N65541">The hydrolytic deamination of adenosine-to-inosine (A-to-I) by RNA editing is a widespread post-transcriptional modification catalyzed by the <span style="text-decoration: underline">a</span>denosine <span style="text-decoration: underline">d</span>e<span style="text-decoration: underline">a</span>minase acting on <span style="text-decoration: underline">R</span>NA (ADAR) family of proteins. ADAR-mediated RNA editing modulates cellular pathways involved in innate immunity, RNA splicing, RNA interference, and protein recoding, and has been investigated as a strategy for therapeutic intervention of genetic disorders. Despite advances in basic and translational research, the mechanisms regulating RNA editing are poorly understood. Though several <i>trans</i>-acting regulators of editing have been shown to modulate ADAR protein expression, previous studies have not identified factors that modulate ADAR catalytic activity. Here, we show that RNA editing increases upon intracellular acidification, and that these effects are predominantly explained by both enhanced ADAR base-flipping and deamination rate at acidic pH. We also show that the extent of RNA editing increases with the reduction in pH associated with conditions of cellular hypoxia.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766037578781-7aad46f1-bfda-449c-8d2b-fdd1b6ba09d9/assets/gkab157gra1.jpg" alt="Intracellular acidification drives protonation of a conserved glutamate in the ADAR deaminase domain, which in turn enhances base-flipping and increases the extent of RNA editing."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Intracellular acidification drives protonation of a conserved glutamate in the ADAR deaminase domain, which in turn enhances base-flipping and increases the extent of RNA editing.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Interaction of the NRF2 and p63 transcription factors promotes keratinocyte proliferation in the epidermis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037569496-c0618d99-1377-4d73-a5cf-cb308c205d47/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab167</link>
            <description><![CDATA[<p class="para" id="N65541">Epigenetic regulation of cell and tissue function requires the coordinated action of transcription factors. However, their combinatorial activities during regeneration remain largely unexplored. Here, we discover an unexpected interaction between the cytoprotective transcription factor NRF2 and p63- a key player in epithelial morphogenesis. Chromatin immunoprecipitation combined with sequencing and reporter assays identifies enhancers and promoters that are simultaneously activated by NRF2 and p63 in human keratinocytes. Modeling of p63 and NRF2 binding to nucleosomal DNA suggests their chromatin-assisted interaction. Pharmacological and genetic activation of NRF2 increases NRF2–p63 binding to enhancers and promotes keratinocyte proliferation, which involves the common NRF2–p63 target cyclin-dependent kinase 12. These results unravel a collaborative function of NRF2 and p63 in the control of epidermal renewal and suggest their combined activation as a strategy to promote repair of human skin and other stratified epithelia.</p>]]></description>
            <pubDate><![CDATA[2021-03-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Choice of fluorophore affects dynamic DNA nanostructures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037552707-a1671b78-73f0-4df9-bd2f-8fd0c1cbdb50/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab201</link>
            <description><![CDATA[<p class="para" id="N65541">The ability to dynamically remodel DNA origami structures or functional nanodevices is highly desired in the field of DNA nanotechnology. Concomitantly, the use of fluorophores to track and validate the dynamics of such DNA-based architectures is commonplace and often unavoidable. It is therefore crucial to be aware of the side effects of popular fluorophores, which are often exchanged without considering the potential impact on the system. Here, we show that the choice of fluorophore can strongly affect the reconfiguration of DNA nanostructures. To this end, we encapsulate a triple-stranded DNA (tsDNA) into water-in-oil compartments and functionalize their periphery with a single-stranded DNA handle (ssDNA). Thus, the tsDNA can bind and unbind from the periphery by reversible opening of the triplex and subsequent strand displacement. Using a combination of experiments, molecular dynamics (MD) simulations, and reaction-diffusion modelling, we demonstrate for 12 different fluorophore combinations that it is possible to alter or even inhibit the DNA nanostructure formation—without changing the DNA sequence. Besides its immediate importance for the design of pH-responsive switches and fluorophore labelling, our work presents a strategy to precisely tune the energy landscape of dynamic DNA nanodevices.</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A programmable pAgo nuclease with universal guide and target specificity from the mesophilic bacterium <i>Kurthia massiliensis</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037540729-e7ef2830-797a-4cc1-8dcd-9e5c70e3fdec/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab182</link>
            <description><![CDATA[<p class="para" id="N65541">Argonaute proteins are programmable nucleases that are found in both eukaryotes and prokaryotes and provide defense against invading genetic elements. Although some prokaryotic argonautes (pAgos) were shown to recognize RNA targets <i>in vitro</i>, the majority of studied pAgos have strict specificity toward DNA, which limits their practical use in RNA-centric applications. Here, we describe a unique pAgo nuclease, KmAgo, from the mesophilic bacterium <i>Kurthia massiliensis</i> that can be programmed with either DNA or RNA guides and can precisely cleave both DNA and RNA targets. KmAgo binds 16–20 nt long 5′-phosphorylated guide molecules with no strict specificity for their sequence and is active in a wide range of temperatures. In bacterial cells, KmAgo is loaded with small DNAs with no obvious sequence preferences suggesting that it can uniformly target genomic sequences. Mismatches between the guide and target sequences greatly affect the efficiency and precision of target cleavage, depending on the mismatch position and the nature of the reacting nucleic acids. Target RNA cleavage by KmAgo depends on the formation of secondary structure indicating that KmAgo can be used for structural probing of RNA. These properties of KmAgo open the way for its use for highly specific nucleic acid detection and cleavage.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Corrigendum to article “DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies’’]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037534202-1ca7c7e0-a597-4bcb-a711-1df7704fe520/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab193</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Sequence-dependent cost for Z-form shapes the torsion-driven B–Z transition via close interplay of Z-DNA and DNA bubble]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037514710-8a1bc355-1722-4079-8042-df6a32f984cf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab153</link>
            <description><![CDATA[<p class="para" id="N65541">Despite recent genome-wide investigations of functional DNA elements, the mechanistic details about their actions remain elusive. One intriguing possibility is that DNA sequences with special patterns play biological roles, adopting non-B-DNA conformations. Here we investigated dynamics of thymine-guanine (TG) repeats, microsatellite sequences and recurrently found in promoters, as well as cytosine–guanine (CG) repeats, best-known Z-DNA forming sequence, in the aspect of Z-DNA formation. We measured the energy barriers of the B–Z transition with those repeats and discovered the sequence-dependent penalty for Z-DNA generates distinctive thermodynamic and kinetic features in the torque-induced transition. Due to the higher torsional stress required for Z-form in TG repeats, a bubble could be induced more easily, suppressing Z-DNA induction, but facilitate the B–Z interconversion kinetically at the transition midpoint. Thus, the Z-form by TG repeats has advantages as a <i>torsion buffer</i> and <i>bubble selector</i> while the Z-form by CG repeats likely behaves as <i>torsion absorber</i>. Our statistical physics model supports quantitatively the populations of Z-DNA and reveals the pivotal roles of bubbles in state dynamics. All taken together, a quantitative picture for the transition was deduced within the close interplay among bubbles, plectonemes and Z-DNA.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766037514710-8a1bc355-1722-4079-8042-df6a32f984cf/assets/gkab153gra1.jpg" alt="Dynamic interplay of bubble, supercoil and twisted B-DNA with the Z-DNA state of CG or TG repeats detected by smFRET under various mechanical (force and σ) conditions imposed by magnetic tweezers. TG repeats exhibit higher B–Z transition rates (k) than CG repeats at their respective midpoint σ values."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Dynamic interplay of bubble, supercoil and twisted B-DNA with the Z-DNA state of CG or TG repeats detected by smFRET under various mechanical (force and σ) conditions imposed by magnetic tweezers. TG repeats exhibit higher B–Z transition rates (<i>k</i>) than CG repeats at their respective midpoint σ values.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Androgen and glucocorticoid receptor direct distinct transcriptional programs by receptor-specific and shared DNA binding sites]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037478869-efe3bed6-2644-4fce-9184-0865a4265f1e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab185</link>
            <description><![CDATA[<p class="para" id="N65541">The glucocorticoid (GR) and androgen (AR) receptors execute unique functions <i>in vivo</i>, yet have nearly identical DNA binding specificities. To identify mechanisms that facilitate functional diversification among these transcription factor paralogs, we studied them in an equivalent cellular context. Analysis of chromatin and sequence suggest that divergent binding, and corresponding gene regulation, are driven by different abilities of AR and GR to interact with relatively inaccessible chromatin. Divergent genomic binding patterns can also be the result of subtle differences in DNA binding preference between AR and GR. Furthermore, the sequence composition of large regions (&gt;10 kb) surrounding selectively occupied binding sites differs significantly, indicating a role for the sequence environment in guiding AR and GR to distinct binding sites. The comparison of binding sites that are shared shows that the specificity paradox can also be resolved by differences in the events that occur downstream of receptor binding. Specifically, shared binding sites display receptor-specific enhancer activity, cofactor recruitment and changes in histone modifications. Genomic deletion of shared binding sites demonstrates their contribution to directing receptor-specific gene regulation. Together, these data suggest that differences in genomic occupancy as well as divergence in the events that occur downstream of receptor binding direct functional diversification among transcription factor paralogs.</p>]]></description>
            <pubDate><![CDATA[2021-03-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[What defines a synthetic riboswitch? – Conformational dynamics of ciprofloxacin aptamers with similar binding affinities but varying regulatory potentials]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037435485-c3e84e82-879c-4a79-afcc-3f1be4804d4d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab166</link>
            <description><![CDATA[<p class="para" id="N65541">Among the many <i>in vitro</i>-selected aptamers derived from SELEX protocols, only a small fraction has the potential to be applied for synthetic riboswitch engineering. Here, we present a comparative study of the binding properties of three different aptamers that bind to ciprofloxacin with similar <i>K</i><sub>D</sub> values, yet only two of them can be applied as riboswitches. We used the inherent ligand fluorescence that is quenched upon binding as the reporter signal in fluorescence titration and in time-resolved stopped-flow experiments. Thus, we were able to demonstrate differences in the binding kinetics of regulating and non-regulating aptamers. All aptamers studied underwent a two-step binding mechanism that suggests an initial association step followed by a reorganization of the aptamer to accommodate the ligand. We show that increasing regulatory potential is correlated with a decreasing back-reaction rate of the second binding step, thus resulting in a virtually irreversible last binding step of regulating aptamers. We suggest that a highly favoured structural adaption of the RNA to the ligand during the final binding step is essential for turning an aptamer into a riboswitch. In addition, our results provide an explanation for the fact that so few aptamers with regulating capacity have been found to date. Based on our data, we propose an adjustment of the selection protocol for efficient riboswitch detection.</p>]]></description>
            <pubDate><![CDATA[2021-03-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037415784-13df3637-ed44-48e0-a829-bb7befd3d220/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1272</link>
            <description><![CDATA[<p class="para" id="N65541">Multiple driver genes in individual patient samples may cause resistance to individual drugs in precision medicine. However, current computational methods have not studied how to fill the gap between personalized driver gene identification and combinatorial drug discovery for individual patients. Here, we developed a novel structural network controllability-based personalized driver genes and combinatorial drug identification algorithm (CPGD), aiming to identify combinatorial drugs for an individual patient by targeting personalized driver genes from network controllability perspective. On two benchmark disease datasets (i.e. breast cancer and lung cancer datasets), performance of CPGD is superior to that of other state-of-the-art driver gene-focus methods in terms of discovery rate among prior-known clinical efficacious combinatorial drugs. Especially on breast cancer dataset, CPGD evaluated synergistic effect of pairwise drug combinations by measuring synergistic effect of their corresponding personalized driver gene modules, which are affected by a given targeting personalized driver gene set of drugs. The results showed that CPGD performs better than existing synergistic combinatorial strategies in identifying clinical efficacious paired combinatorial drugs. Furthermore, CPGD enhanced cancer subtyping by computationally providing personalized side effect signatures for individual patients. In addition, CPGD identified 90 drug combinations candidates from SARS-COV2 dataset as potential drug repurposing candidates for recently spreading COVID-19.</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Modeling multi-species RNA modification through multi-task curriculum learning]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037396967-f1cbe967-dd36-4576-be10-4a93e97ef39b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab124</link>
            <description><![CDATA[<p class="para" id="N65541">N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is the most pervasive modification in eukaryotic mRNAs. Numerous biological processes are regulated by this critical post-transcriptional mark, such as gene expression, RNA stability, RNA structure and translation. Recently, various experimental techniques and computational methods have been developed to characterize the transcriptome-wide landscapes of m<sup>6</sup>A modification for understanding its underlying mechanisms and functions in mRNA regulation. However, the experimental techniques are generally costly and time-consuming, while the existing computational models are usually designed only for m<sup>6</sup>A site prediction in a single-species and have significant limitations in accuracy, interpretability and generalizability. Here, we propose a highly interpretable computational framework, called MASS, based on a multi-task curriculum learning strategy to capture m<sup>6</sup>A features across multiple species simultaneously. Extensive computational experiments demonstrate the superior performances of MASS when compared to the state-of-the-art prediction methods. Furthermore, the contextual sequence features of m<sup>6</sup>A captured by MASS can be explained by the known critical binding motifs of the related RNA-binding proteins, which also help elucidate the similarity and difference among m<sup>6</sup>A features across species. In addition, based on the predicted m<sup>6</sup>A profiles, we further delineate the relationships between m<sup>6</sup>A and various properties of gene regulation, including gene expression, RNA stability, translation, RNA structure and histone modification. In summary, MASS may serve as a useful tool for characterizing m<sup>6</sup>A modification and studying its regulatory code. The source code of MASS can be downloaded from https://github.com/mlcb-thu/MASS.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Biological relevance and therapeutic potential of G-quadruplex structures in the human noncoding transcriptome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037247915-01fe9647-a4b0-4580-af0c-3adb4c599a76/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab127</link>
            <description><![CDATA[<p class="para" id="N65541">Noncoding RNAs are functional transcripts that are not translated into proteins. They represent the largest portion of the human transcriptome and have been shown to regulate gene expression networks in both physiological and pathological cell conditions. Research in this field has made remarkable progress in the comprehension of how aberrations in noncoding RNA drive relevant disease-associated phenotypes; however, the biological role and mechanism of action of several noncoding RNAs still need full understanding. Besides fulfilling its function through sequence-based mechanisms, RNA can form complex secondary and tertiary structures which allow non-canonical interactions with proteins and/or other nucleic acids. In this context, the presence of G-quadruplexes in microRNAs and long noncoding RNAs is increasingly being reported. This evidence suggests a role for RNA G-quadruplexes in controlling microRNA biogenesis and mediating noncoding RNA interaction with biological partners, thus ultimately regulating gene expression. Here, we review the state of the art of G-quadruplexes in the noncoding transcriptome, with their structural and functional characterization. In light of the existence and further possible development of G-quadruplex binders that modulate G-quadruplex conformation and protein interactions, we also discuss the therapeutic potential of G-quadruplexes as targets to interfere with disease-associated noncoding RNAs.</p>]]></description>
            <pubDate><![CDATA[2021-03-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MiniCAFE, a CRISPR/Cas9-based compact and potent transcriptional activator, elicits gene expression <i>in vivo</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037239636-84640a7b-5b3b-422c-aa96-4b97a6f90fc9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab174</link>
            <description><![CDATA[<p class="para" id="N65541">CRISPR-mediated gene activation (CRISPRa) is a promising therapeutic gene editing strategy without inducing DNA double-strand breaks (DSBs). However, <i>in vivo</i> implementation of these CRISPRa systems remains a challenge. Here, we report a compact and robust miniCas9 activator (termed miniCAFE) for <i>in vivo</i> activation of endogenous target genes. The system relies on recruitment of an engineered minimal nuclease-null Cas9 from <i>Campylobacter jejuni</i> and potent transcriptional activators to a target locus by a single guide RNA. It enables robust gene activation in human cells even with a single DNA copy and is able to promote lifespan of <i>Caenorhabditis elegans</i> through activation of longevity-regulating genes. As proof-of-concept, delivered within an all-in-one adeno-associated virus (AAV), miniCAFE can activate Fgf21 expression in the liver and regulate energy metabolism in adult mice. Thus, miniCAFE holds great therapeutic potential against human diseases.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766037239636-84640a7b-5b3b-422c-aa96-4b97a6f90fc9/assets/gkab174gra1.jpg" alt="Target transcription activation with CjCas9-based gene activators. Three gene activators, SunTag-dCjCas9/VPR, VPR-dCjCas9, and VPR-CjCas9, are developed. Minimization and optimization of VPR-dCjCas9 leads to creation of MiniCAFE, which is able to activate gene expression and induce corresponding phenotypes in C. elegans, mice and human cells."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Target transcription activation with CjCas9-based gene activators. Three gene activators, SunTag-dCjCas9/VPR, VPR-dCjCas9, and VPR-CjCas9, are developed. Minimization and optimization of VPR-dCjCas9 leads to creation of MiniCAFE, which is able to activate gene expression and induce corresponding phenotypes in C. elegans, mice and human cells.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Local structure of DNA toroids reveals curvature-dependent intermolecular forces]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037224349-62ce0812-b077-4cfb-a543-01983ed31c5d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab197</link>
            <description><![CDATA[<p class="para" id="N65541">In viruses and cells, DNA is closely packed and tightly curved thanks to polyvalent cations inducing an effective attraction between its negatively charged filaments. Our understanding of this effective attraction remains very incomplete, partly because experimental data is limited to bulk measurements on large samples of mostly uncurved DNA helices. Here we use cryo electron microscopy to shed light on the interaction between highly curved helices. We find that the spacing between DNA helices in spermine-induced DNA toroidal condensates depends on their location within the torus, consistent with a mathematical model based on the competition between electrostatic interactions and the bending rigidity of DNA. We use our model to infer the characteristics of the interaction potential, and find that its equilibrium spacing strongly depends on the curvature of the filaments. In addition, the interaction is much softer than previously reported in bulk samples using different salt conditions. Beyond viruses and cells, our characterization of the interactions governing DNA-based dense structures could help develop robust designs in DNA nanotechnologies.</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mutagenic mechanisms of cancer-associated DNA polymerase ϵ alleles]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037165537-5a3f047b-8840-44a0-9307-6883c32d0ef6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab160</link>
            <description><![CDATA[<p class="para" id="N65541">A single amino acid residue change in the exonuclease domain of human DNA polymerase ϵ, P286R, is associated with the development of colorectal cancers, and has been shown to impart a mutator phenotype. The corresponding Pol ϵ allele in the yeast <i>Saccharomyces cerevisiae</i> (<i>pol2-P301R</i>), was found to drive greater mutagenesis than an entirely exonuclease-deficient Pol ϵ (<i>pol2–4</i>), an unexpected phenotype of <i>ultra</i>-mutagenesis. By studying the impact on mutation frequency, type, replication-strand bias, and sequence context, we show that <i>ultra</i>-mutagenesis is commonly observed in yeast cells carrying a range of cancer-associated Pol ϵ exonuclease domain alleles. Similarities between mutations generated by these alleles and those generated in <i>pol2–4</i> cells indicate a shared mechanism of mutagenesis that yields a mutation pattern similar to cancer Signature 14. Comparison of <i>POL2 ultra</i>-mutator with <i>pol2-M644G</i>, a mutant in the polymerase domain decreasing Pol ϵ fidelity, revealed unexpected analogies in the sequence context and strand bias of mutations. Analysis of mutational patterns unique to exonuclease domain mutant cells suggests that backtracking of the polymerase, when the mismatched primer end cannot be accommodated in the proofreading domain, results in the observed insertions and T&gt;A mutations in specific sequence contexts.</p>]]></description>
            <pubDate><![CDATA[2021-03-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ultraviolet-induced RNA:DNA hybrids interfere with chromosomal DNA synthesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037110987-05917772-a057-4b2e-b066-1c34bf3e7053/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab147</link>
            <description><![CDATA[<p class="para" id="N65541">Ultraviolet (UV) induces pyrimidine dimers (PDs) in DNA and replication-dependent fragmentation in chromosomes. The <i>rnhAB</i> mutants in <i>Escherichia coli</i>, accumulating R-loops and single DNA-rNs, are generally resistant to DNA damage, but are surprisingly UV-sensitive, even though they remove PDs normally, suggesting irreparable chromosome lesions. We show here that the RNase H defect does not cause additional chromosome fragmentation after UV, but inhibits DNA synthesis after replication restart. Genetic analysis implies formation of R-loop-anchored transcription elongation complexes (R-loop-aTECs) in UV-irradiated <i>rnhAB</i> mutants, predicting that their chromosomal DNA will accumulate: (i) RNA:DNA hybrids; (ii) a few slow-to-remove PDs. We confirm both features and also find that both, surprisingly, depend on replication restart. Finally, enriching for the UV-induced RNA:DNA hybrids in the <i>rnhAB uvrA</i> mutants also co-enriches for PDs, showing their co-residence in the same structures. We propose that PD-triggered R-loop-aTECs block head-on replication in RNase H-deficient mutants.</p>]]></description>
            <pubDate><![CDATA[2021-03-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural basis for substrate recognition and cleavage by the dimerization-dependent CRISPR–Cas12f nuclease]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037078402-ebc65b42-0c2f-4841-8f9a-1cd93163e294/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab179</link>
            <description><![CDATA[<p class="para" id="N65541">Cas12f, also known as Cas14, is an exceptionally small type V-F CRISPR–Cas nuclease that is roughly half the size of comparable nucleases of this type. To reveal the mechanisms underlying substrate recognition and cleavage, we determined the cryo-EM structures of the Cas12f-sgRNA-target DNA and Cas12f-sgRNA complexes at 3.1 and 3.9 Å, respectively. An asymmetric Cas12f dimer is bound to one sgRNA for recognition and cleavage of dsDNA substrate with a T-rich PAM sequence. Despite its dimerization, Cas12f adopts a conserved activation mechanism among the type V nucleases which requires coordinated conformational changes induced by the formation of the crRNA-target DNA heteroduplex, including the close-to-open transition in the lid motif of the RuvC domain. Only one RuvC domain in the Cas12f dimer is activated by substrate recognition, and the substrate bound to the activated RuvC domain is captured in the structure. Structure-assisted truncated sgRNA, which is less than half the length of the original sgRNA, is still active for target DNA cleavage. Our results expand our understanding of the diverse type V CRISPR–Cas nucleases and facilitate potential genome editing applications using the miniature Cas12f.</p>]]></description>
            <pubDate><![CDATA[2021-03-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Regulation of ex-translational activities is the primary function of the multi-tRNA synthetase complex]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037061181-ba254a38-8832-477b-a943-efab06f856fc/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1183</link>
            <description><![CDATA[<p class="para" id="N65541">During mRNA translation, tRNAs are charged by aminoacyl-tRNA synthetases and subsequently used by ribosomes. A multi-enzyme aminoacyl-tRNA synthetase complex (MSC) has been proposed to increase protein synthesis efficiency by passing charged tRNAs to ribosomes. An alternative function is that the MSC repurposes specific synthetases that are released from the MSC upon cues for functions independent of translation. To explore this, we generated mammalian cells in which arginyl-tRNA synthetase and/or glutaminyl-tRNA synthetase were absent from the MSC. Protein synthesis, under a variety of stress conditions, was unchanged. Most strikingly, levels of charged tRNA<sup>Arg</sup> and tRNA<sup>Gln</sup> remained unchanged and no ribosome pausing was observed at codons for arginine and glutamine. Thus, increasing or regulating protein synthesis efficiency is not dependent on arginyl-tRNA synthetase and glutaminyl-tRNA synthetase in the MSC. Alternatively, and consistent with previously reported ex-translational roles requiring changes in synthetase cellular localizations, our manipulations of the MSC visibly changed localization.</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>SDC</i> mediates DNA methylation-controlled clock pace by interacting with ZTL in <i>Arabidopsis</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766037042736-6e23850f-5fb7-4e5d-b0ec-50511a80f91f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab128</link>
            <description><![CDATA[<p class="para" id="N65541">Molecular bases of eukaryotic circadian clocks mainly rely on transcriptional-translational feedback loops (TTFLs), while epigenetic codes also play critical roles in fine-tuning circadian rhythms. However, unlike histone modification codes that play extensive and well-known roles in the regulation of circadian clocks, whether DNA methylation (5mC) can affect the circadian clock, and the associated underlying molecular mechanisms, remains largely unexplored in many organisms. Here we demonstrate that global genome DNA hypomethylation can significantly lengthen the circadian period of <i>Arabidopsis</i>. Transcriptomic and genetic evidence demonstrate that <i>SUPPRESSOR OF drm1 drm2 cmt3</i> (<i>SDC</i>), encoding an F-box containing protein, is required for the DNA hypomethylation-tuned circadian clock. Moreover, SDC can physically interact with another F-box containing protein ZEITLUPE (ZTL) to diminish its accumulation. Genetic analysis further revealed that <i>ZTL</i> and its substrate <i>TIMING OF CAB EXPRESSION 1</i> (<i>TOC1</i>) likely act downstream of DNA methyltransferases to control circadian rhythm. Together, our findings support the notion that DNA methylation is important to maintain proper circadian pace in <i>Arabidopsis</i>, and further established that <i>SDC</i> links DNA hypomethylation with a proteolytic cascade to assist in tuning the circadian clock.</p>]]></description>
            <pubDate><![CDATA[2021-03-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural and functional studies of SF1B Pif1 from <i>Thermus oshimai</i> reveal dimerization-induced helicase inhibition]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036943578-59b4b09a-9635-496d-9aef-0489047566a0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab188</link>
            <description><![CDATA[<p class="para" id="N65541">Pif1 is an SF1B helicase that is evolutionarily conserved from bacteria to humans and plays multiple roles in maintaining genome stability in both nucleus and mitochondria. Though highly conserved, Pif1 family harbors a large mechanistic diversity. Here, we report crystal structures of <i>Thermus oshimai</i> Pif1 (ToPif1) alone and complexed with partial duplex or single-stranded DNA. In the apo state and in complex with a partial duplex DNA, ToPif1 is monomeric with its domain 2B/loop3 adopting a closed and an open conformation, respectively. When complexed with a single-stranded DNA, ToPif1 forms a stable dimer with domain 2B/loop3 shifting to a more open conformation. Single-molecule and biochemical assays show that domain 2B/loop3 switches repetitively between the closed and open conformations when a ToPif1 monomer unwinds DNA and, in contrast with other typical dimeric SF1A helicases, dimerization has an inhibitory effect on its helicase activity. This mechanism is not general for all Pif1 helicases but illustrates the diversity of regulation mechanisms among different helicases. It also raises the possibility that although dimerization results in activation for SF1A helicases, it may lead to inhibition for some of the other uncharacterized SF1B helicases, an interesting subject warranting further studies.</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RNA helicase-mediated regulation of snoRNP dynamics on pre-ribosomes and rRNA 2′-<i>O</i>-methylation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036922535-b33c1d57-bda8-4cb1-8814-53b340127884/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab159</link>
            <description><![CDATA[<p class="para" id="N65541">RNA helicases play important roles in diverse aspects of RNA metabolism through their functions in remodelling ribonucleoprotein complexes (RNPs), such as pre-ribosomes. Here, we show that the DEAD box helicase Dbp3 is required for efficient processing of the U18 and U24 intron-encoded snoRNAs and 2′-<i>O</i>-methylation of various sites within the 25S ribosomal RNA (rRNA) sequence. Furthermore, numerous box C/D snoRNPs accumulate on pre-ribosomes in the absence of Dbp3. Many snoRNAs guiding Dbp3-dependent rRNA modifications have overlapping pre-rRNA basepairing sites and therefore form mutually exclusive interactions with pre-ribosomes. Analysis of the distribution of these snoRNAs between pre-ribosome-associated and ‘free’ pools demonstrated that many are almost exclusively associated with pre-ribosomal complexes. Our data suggest that retention of such snoRNPs on pre-ribosomes when Dbp3 is lacking may impede rRNA 2′-<i>O</i>-methylation by reducing the recycling efficiency of snoRNPs and by inhibiting snoRNP access to proximal target sites. The observation of substoichiometric rRNA modification at adjacent sites suggests that the snoRNPs guiding such modifications likely interact stochastically rather than hierarchically with their pre-rRNA target sites. Together, our data provide new insights into the dynamics of snoRNPs on pre-ribosomal complexes and the remodelling events occurring during the early stages of ribosome assembly.</p>]]></description>
            <pubDate><![CDATA[2021-03-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Effect of small molecule eRF3 degraders on premature termination codon readthrough]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036882554-45eff6a7-7ec0-4081-9157-df740cb5205e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab194</link>
            <description><![CDATA[<p class="para" id="N65541">Premature termination codon (PTC) readthrough is considered a potential treatment for genetic diseases caused by nonsense mutations. High concentrations of aminoglycosides induce low levels of PTC readthrough but also elicit severe toxicity. Identifying compounds that enhance PTC readthrough by aminoglycosides or reduce their toxicity is a continuing challenge. In humans, a binary complex of eukaryotic release factors 1 (eRF1) and 3 (eRF3a or eRF3b) mediates translation termination. They also participate in the SURF (SMG1-UPF1-eRF1-eRF3) complex assembly involved in nonsense-mediated mRNA decay (NMD). We show that PTC readthrough by aminoglycoside G418 is considerably enhanced by <i>eRF3a</i> and <i>eRF3b</i> siRNAs and cereblon E3 ligase modulators CC-885 and CC-90009, which induce proteasomal degradation of eRF3a and eRF3b. eRF3 degradation also reduces eRF1 levels and upregulates UPF1 and selectively stabilizes <i>TP53</i> transcripts bearing a nonsense mutation over WT, indicating NMD suppression. CC-90009 is considerably less toxic than CC-885 and it enhances PTC readthrough in combination with aminoglycosides in mucopolysaccharidosis type I-Hurler, late infantile neuronal ceroid lipofuscinosis, Duchenne muscular dystrophy and junctional epidermolysis bullosa patient-derived cells with nonsense mutations in the <i>IDUA</i>, <i>TPP1</i>, <i>DMD</i> and <i>COL17A1</i> genes, respectively. Combination of CC-90009 with aminoglycosides such as gentamicin or ELX-02 may have potential for PTC readthrough therapy.</p>]]></description>
            <pubDate><![CDATA[2021-03-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Flexible comparison of batch correction methods for single-cell RNA-seq using BatchBench]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036832471-822b6560-5aae-49c6-8210-4b5d2321fea4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab004</link>
            <description><![CDATA[<p class="para" id="N65541">As the cost of single-cell RNA-seq experiments has decreased, an increasing number of datasets are now available. Combining newly generated and publicly accessible datasets is challenging due to non-biological signals, commonly known as batch effects. Although there are several computational methods available that can remove batch effects, evaluating which method performs best is not straightforward. Here, we present BatchBench (https://github.com/cellgeni/batchbench), a modular and flexible pipeline for comparing batch correction methods for single-cell RNA-seq data. We apply BatchBench to eight methods, highlighting their methodological differences and assess their performance and computational requirements through a compendium of well-studied datasets. This systematic comparison guides users in the choice of batch correction tool, and the pipeline makes it easy to evaluate other datasets.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Rif1 regulates telomere length through conserved HEAT repeats]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036814525-59c724d5-7c1f-4401-8214-db98564373e1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab206</link>
            <description><![CDATA[<p class="para" id="N65541">In budding yeast, Rif1 negatively regulates telomere length, but the mechanism of this regulation has remained elusive. Previous work identified several functional domains of Rif1, but none of these has been shown to mediate telomere length. To define Rif1 domains responsible for telomere regulation, we localized truncations of Rif1 to a single specific telomere and measured telomere length of that telomere compared to bulk telomeres. We found that a domain in the N-terminus containing HEAT repeats, Rif1<sub>177–996</sub>, was sufficient for length regulation when tethered to the telomere. Charged residues in this region were previously proposed to mediate DNA binding. We found that mutation of these residues disrupted telomere length regulation even when Rif1 was tethered to the telomere. Mutation of other conserved residues in this region, which were not predicted to interact with DNA, also disrupted telomere length maintenance, while mutation of conserved residues distal to this region did not. Our data suggest that conserved amino acids in the region from 436 to 577 play a functional role in telomere length regulation, which is separate from their proposed DNA binding function. We propose that the Rif1 HEAT repeats region represents a protein-protein binding interface that mediates telomere length regulation.</p>]]></description>
            <pubDate><![CDATA[2021-03-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Systematic <i>in vitro</i> specificity profiling reveals nicking defects in natural and engineered CRISPR–Cas9 variants]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036807054-cbf18584-f113-4f4d-baca-e744ba108f7e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab163</link>
            <description><![CDATA[<p class="para" id="N65541">Cas9 is an RNA-guided endonuclease in the bacterial CRISPR–Cas immune system and a popular tool for genome editing. The commonly used <i>Streptococcus pyogenes</i> Cas9 (SpCas9) is relatively non-specific and prone to off-target genome editing. Other Cas9 orthologs and engineered variants of SpCas9 have been reported to be more specific. However, previous studies have focused on specificity of double-strand break (DSB) or indel formation, potentially overlooking alternative cleavage activities of these Cas9 variants. In this study, we employed <i>in vitro</i> cleavage assays of target libraries coupled with high-throughput sequencing to systematically compare cleavage activities and specificities of two natural Cas9 variants (SpCas9 and <i>Staphylococcus aureus</i> Cas9) and three engineered SpCas9 variants (SpCas9 HF1, HypaCas9 and HiFi Cas9). We observed that all Cas9s tested could cleave target sequences with up to five mismatches. However, the rate of cleavage of both on-target and off-target sequences varied based on target sequence and Cas9 variant. In addition, SaCas9 and engineered SpCas9 variants nick targets with multiple mismatches but have a defect in generating a DSB, while SpCas9 creates DSBs at these targets. Overall, these differences in cleavage rates and DSB formation may contribute to varied specificities observed in genome editing studies.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ethidium bromide interactions with DNA: an exploration of a classic DNA–ligand complex with unbiased molecular dynamics simulations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036795376-69353d70-7bb9-434f-815b-5075a2e7eb63/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab143</link>
            <description><![CDATA[<p class="para" id="N65541">Visualization of double stranded DNA in gels with the binding of the fluorescent dye ethidium bromide has been a basic experimental technique in any molecular biology laboratory for &gt;40 years. The interaction between ethidium and double stranded DNA has been observed to be an intercalation between base pairs with strong experimental evidence. This presents a unique opportunity for computational chemistry and biomolecular simulation techniques to benchmark and assess their models in order to see if the theory can reproduce experiments and ultimately provide new insights. We present molecular dynamics simulations of the interaction of ethidium with two different double stranded DNA models. The first model system is the classic sequence d(CGCGAATTCGCG)<sub>2</sub> also known as the Drew–Dickerson dodecamer. We found that the ethidium ligand binds mainly stacked on, or intercalated between, the terminal base pairs of the DNA with little to no interaction with the inner base pairs. As the intercalation at the terminal CpG steps is relatively rapid, the resultant DNA unwinding, rigidification, and increased stability of the internal base pair steps inhibits further intercalation. In order to reduce these interactions and to provide a larger groove space, a second 18-mer DNA duplex system with the sequence d(GCATGAACGAACGAACGC) was tested. We computed molecular dynamics simulations for 20 independent replicas with this sequence, each with ∼27 μs of sampling time. Results show several spontaneous intercalation and base-pair eversion events that are consistent with experimental observations. The present work suggests that extended MD simulations with modern DNA force fields and optimized simulation codes are allowing the ability to reproduce unbiased intercalation events that we were not able to previously reach due to limits in computing power and the lack of extensively tested force fields and analysis tools.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766036795376-69353d70-7bb9-434f-815b-5075a2e7eb63/assets/gkab143gra1.jpg" alt="Ethidium intercalation as captured by unbiased molecular dynamics simulations."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Ethidium intercalation as captured by unbiased molecular dynamics simulations.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Computational meta-analysis of ribosomal RNA fragments: potential targets and interaction mechanisms]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036764549-d54377a3-2b7f-4a69-a1a4-cdae2f8c564f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab190</link>
            <description><![CDATA[<p class="para" id="N65541">The most abundant cellular RNA species, ribosomal RNA (rRNA), appears to be a source of massive amounts of non-randomly generated fragments. We found rRNA fragments (rRFs) in immunoprecipitated Argonaute (Ago-IP) complexes in human and mouse cells and in small RNA sequencing datasets. In human Ago1-IP, guanine-rich rRFs were preferentially cut in single-stranded regions of mature rRNAs between pyrimidines and adenosine, and non-randomly paired with cellular transcripts in crosslinked chimeras. Numerous identical rRFs were found in the cytoplasm and nucleus in mouse Ago2-IP. We report specific interaction motifs enriched in rRF-target pairs. Locations of such motifs on rRFs were compatible with the Ago structural features and patterns of the Ago-RNA crosslinking in both species. Strikingly, many of these motifs may bind to double-stranded regions on target RNAs, suggesting a potential pathway for regulating translation by unwinding mRNAs. Occurring on either end of rRFs and matching intronic, untranslated or coding regions in targets, such interaction sites extend the concept of microRNA seed regions. Targeting both borders of certain short introns, rRFs may be involved in their biogenesis or function, facilitated by Ago. Frequently dismissed as noise, rRFs are poised to greatly enrich the known functional spectrum of small RNA regulation.</p>]]></description>
            <pubDate><![CDATA[2021-03-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ADP-ribosylation of RNA and DNA: from <i>in vitro</i> characterization to <i>in vivo</i> function]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036748486-813c75d2-bd64-4940-bb04-215221e21b47/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab136</link>
            <description><![CDATA[<p class="para" id="N65541">The functionality of DNA, RNA and proteins is altered dynamically in response to physiological and pathological cues, partly achieved by their modification. While the modification of proteins with ADP-ribose has been well studied, nucleic acids were only recently identified as substrates for ADP-ribosylation by mammalian enzymes. RNA and DNA can be ADP-ribosylated by specific ADP-ribosyltransferases such as PARP1–3, PARP10 and tRNA 2′-phosphotransferase (TRPT1). Evidence suggests that these enzymes display different preferences towards different oligonucleotides. These reactions are reversed by ADP-ribosylhydrolases of the macrodomain and ARH families, such as MACROD1, TARG1, PARG, ARH1 and ARH3. Most findings derive from <i>in vitro</i> experiments using recombinant components, leaving the relevance of this modification in cells unclear. In this Survey and Summary, we provide an overview of the enzymes that ADP-ribosylate nucleic acids, the reversing hydrolases, and the substrates’ requirements. Drawing on data available for other organisms, such as pierisin1 from cabbage butterflies and the bacterial toxin–antitoxin system DarT–DarG, we discuss possible functions for nucleic acid ADP-ribosylation in mammals. Hypothesized roles for nucleic acid ADP-ribosylation include functions in DNA damage repair, in antiviral immunity or as non-conventional RNA cap. Lastly, we assess various methods potentially suitable for future studies of nucleic acid ADP-ribosylation.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural parameters of palindromic repeats determine the specificity of nuclease attack of secondary structures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036740470-d7611695-8624-4c9a-be8f-85412c847583/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab168</link>
            <description><![CDATA[<p class="para" id="N65541">Palindromic sequences are a potent source of chromosomal instability in many organisms and are implicated in the pathogenesis of human diseases. In this study, we investigate which nucleases are responsible for cleavage of the hairpin and cruciform structures and generation of double-strand breaks at inverted repeats in <i>Saccharomyces cerevisiae</i>. We demonstrate that the involvement of structure-specific nucleases in palindrome fragility depends on the distance between inverted repeats and their transcriptional status. The attack by the Mre11 complex is constrained to hairpins with loops &lt;9 nucleotides. This restriction is alleviated upon RPA depletion, indicating that RPA controls the stability and/or formation of secondary structures otherwise responsible for replication fork stalling and DSB formation. Mus81-Mms4 cleavage of cruciforms occurs at divergently but not convergently transcribed or nontranscribed repeats. Our study also reveals the third pathway for fragility at perfect and quasi-palindromes, which involves cruciform resolution during the G2 phase of the cell cycle.</p>]]></description>
            <pubDate><![CDATA[2021-03-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A novel all-in-one conditional knockout system uncovered an essential role of DDX1 in ribosomal RNA processing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036734495-c1a17313-ad6a-4d84-8157-f6c48d0e4bdf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1296</link>
            <description><![CDATA[<p class="para" id="N65541">Generation of conditional knockout (cKO) and various gene-modified cells is laborious and time-consuming. Here, we established an all-in-one cKO system, which enables highly efficient generation of cKO cells and simultaneous gene modifications, including epitope tagging and reporter gene knock-in. We applied this system to mouse embryonic stem cells (ESCs) and generated RNA helicase <i>Ddx1</i> cKO ESCs. The targeted cells displayed endogenous promoter-driven EGFP and FLAG-tagged DDX1 expression, and they were converted to <i>Ddx1</i> KO via FLP recombinase. We further established TetFE ESCs, which carried a reverse tetracycline transactivator (rtTA) expression cassette and a tetracycline response element (TRE)-regulated FLPERT2 cassette in the <i>Gt(ROSA26)Sor</i> locus for instant and tightly regulated induction of gene KO. By utilizing TetFE <i>Ddx1<sup>F/F</sup></i> ESCs, we isolated highly pure <i>Ddx1<sup>F/F</sup></i> and <i>Ddx1<sup>−</sup><sup>/</sup><sup>−</sup></i> ESCs and found that loss of <i>Ddx1</i> caused rRNA processing defects, thereby activating the ribosome stress–p53 pathway. We also demonstrated cKO of various genes in ESCs and homologous recombination-non-proficient human HT1080 cells. The frequency of cKO clones was remarkably high for both cell types and reached up to 96% when EGFP-positive clones were analyzed. This all-in-one cKO system will be a powerful tool for rapid and precise analyses of gene functions.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Methylation-directed acetylation of histone H3 regulates developmental sensitivity to histone deacetylase inhibition]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036721123-e8e9c606-a8dd-4342-a347-1b7e4ac7d357/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab154</link>
            <description><![CDATA[<p class="para" id="N65541">Hydroxamate-based lysine deacetylase inhibitors (KDACis) are approved for clinical use against certain cancers. However, intrinsic and acquired resistance presents a major problem. Treatment of cells with hydroxamates such as trichostatin A (TSA) leads to rapid preferential acetylation of histone H3 already trimethylated on lysine 4 (H3K4me3), although the importance of this H3K4me3-directed acetylation in the biological consequences of KDACi treatment is not known. We address this utilizing <i>Dictyostelium discoideum</i> strains lacking H3K4me3 due to disruption of the gene encoding the Set1 methyltransferase or mutations in endogenous H3 genes. Loss of H3K4me3 confers resistance to TSA-induced developmental inhibition and delays accumulation of H3K9Ac and H3K14Ac. H3K4me3-directed H3Ac is mediated by Sgf29, a subunit of the SAGA acetyltransferase complex that interacts with H3K4me3 via a tandem tudor domain (TTD). We identify an Sgf29 orthologue in <i>Dictyostelium</i> with a TTD that specifically recognizes the H3K4me3 modification. Disruption of the gene encoding Sgf29 delays accumulation of H3K9Ac and abrogates H3K4me3-directed H3Ac. Either loss or overexpression of Sgf29 confers developmental resistance to TSA. Our results demonstrate that rapid acetylation of H3K4me3 histones regulates developmental sensitivity to TSA. Levels of H3K4me3 or Sgf29 will provide useful biomarkers for sensitivity to this class of chemotherapeutic drug.</p>]]></description>
            <pubDate><![CDATA[2021-03-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>In vivo</i> phage display: identification of organ-specific peptides using deep sequencing and differential profiling across tissues]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036704145-dfaf8283-60d2-40a7-83a6-5275fca33481/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1279</link>
            <description><![CDATA[<p class="para" id="N65541">
<i>In vivo</i> phage display is widely used for identification of organ- or disease-specific homing peptides. However, the current <i>in vivo</i> phage biopanning approaches fail to assess biodistribution of specific peptide phages across tissues during the screen, thus necessitating laborious and time-consuming post-screening validation studies on individual peptide phages. Here, we adopted bioinformatics tools used for RNA sequencing for analysis of high-throughput sequencing (HTS) data to estimate the representation of individual peptides during biopanning <i>in vivo</i>. The data from <i>in vivo</i> phage screen were analyzed using differential binding—relative representation of each peptide in the target organ versus in a panel of control organs. Application of this approach in a model study using low-diversity peptide T7 phage library with spiked-in brain homing phage demonstrated brain-specific differential binding of brain homing phage and resulted in identification of novel lung- and brain-specific homing peptides. Our study provides a broadly applicable approach to streamline <i>in vivo</i> peptide phage biopanning and to increase its reproducibility and success rate.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766036704145-dfaf8283-60d2-40a7-83a6-5275fca33481/assets/gkaa1279gra1.jpg" alt="&#10;In vivo phage display using differential binding approach."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      
<i>In vivo</i> phage display using differential binding approach.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Somatic CAG expansion in Huntington's disease is dependent on the MLH3 endonuclease domain, which can be excluded via splice redirection]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036697529-caebb3b7-42ae-4151-ab7d-24cce7018a65/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab152</link>
            <description><![CDATA[<p class="para" id="N65541">Somatic expansion of the CAG repeat tract that causes Huntington's disease (HD) is thought to contribute to the rate of disease pathogenesis. Therefore, factors influencing repeat expansion are potential therapeutic targets. Genes in the DNA mismatch repair pathway are critical drivers of somatic expansion in HD mouse models. Here, we have tested, using genetic and pharmacological approaches, the role of the endonuclease domain of the mismatch repair protein MLH3 in somatic CAG expansion in HD mice and patient cells. A point mutation in the MLH3 endonuclease domain completely eliminated CAG expansion in the brain and peripheral tissues of a HD knock-in mouse model (<i>Htt</i><sup>Q111</sup>). To test whether the MLH3 endonuclease could be manipulated pharmacologically, we delivered splice switching oligonucleotides in mice to redirect <i>Mlh3</i> splicing to exclude the endonuclease domain. Splice redirection to an isoform lacking the endonuclease domain was associated with reduced CAG expansion. Finally, CAG expansion in HD patient-derived primary fibroblasts was also significantly reduced by redirecting <i>MLH3</i> splicing to the endogenous endonuclease domain-lacking isoform. These data indicate the potential of targeting the MLH3 endonuclease domain to slow somatic CAG repeat expansion in HD, a therapeutic strategy that may be applicable across multiple repeat expansion disorders.</p>]]></description>
            <pubDate><![CDATA[2021-03-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Solid-phase XRN1 reactions for RNA cleavage: application in single-molecule sequencing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036690062-766b93e6-2a0c-445f-8fc3-563a8666db19/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab001</link>
            <description><![CDATA[<p class="para" id="N65541">Modifications in RNA are numerous (∼170) and in higher numbers compared to DNA (∼5) making the ability to sequence an RNA molecule to identify these modifications highly tenuous using next generation sequencing (NGS). The ability to immobilize an exoribonuclease enzyme, such as XRN1, to a solid support while maintaining its activity and capability to cleave both the canonical and modified ribonucleotides from an intact RNA molecule can be a viable approach for single-molecule RNA sequencing. In this study, we report an enzymatic reactor consisting of covalently attached XRN1 to a solid support as the groundwork for a novel RNA exosequencing technique. The covalent attachment of XRN1 to a plastic solid support was achieved using EDC/NHS coupling chemistry. Studies showed that the solid-phase digestion efficiency of model RNAs was 87.6 ± 2.8%, while the XRN1 solution-phase digestion for the same model was 78.3 ± 4.4%. The ability of immobilized XRN1 to digest methylated RNA containing m6A and m5C ribonucleotides was also demonstrated. The processivity and clipping rate of immobilized XRN1 secured using single-molecule fluorescence measurements of a single RNA transcript demonstrated a clipping rate of 26 ± 5 nt s<sup>−1</sup> and a processivity of &gt;10.5 kb at 25°C.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Corrigendum to article “Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation’’]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036685447-f0dbc985-d2d9-4a79-a777-04c5cd27d948/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab222</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-03-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Single-molecule optical mapping of the distribution of DNA phosphorothioate epigenetics]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036653942-1d16d7a0-56d4-40c5-a560-b1a7f27d5893/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab169</link>
            <description><![CDATA[<p class="para" id="N65541">DNA phosphorothioate (PT) modifications, with the nonbridging phosphate oxygen replaced by sulfur, governed by DndABCDE or SspABCD, are widely distributed in prokaryotes and have a highly unusual feature of occupying only a small portion of available consensus sequences in a genome. Despite the presence of plentiful non-PT-protected consensuses, DNA PT modification is still employed as a recognition tag by the restriction cognate, for example, DndFGH or SspE, to discriminate and destroy PT-lacking foreign DNA. This raises a fundamental question about how PT modifications are distributed along DNA molecules to keep the restriction components in check. Here, we present two single-molecule strategies that take advantage of the nucleophilicity of PT in combination with fluorescent markers for optical mapping of both single- and double-stranded PT modifications across individual DNA molecules. Surprisingly, PT profiles vary markedly from molecule to molecule, with different PT locations and spacing distances between PT pairs, even in the presence of DndFGH or SspE. The results revealed unprecedented PT modification features previously obscured by ensemble averaging, providing novel insights into the riddles regarding unusual target selection by PT modification and restriction components.</p>]]></description>
            <pubDate><![CDATA[2021-03-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Corrigendum to article “Micro-homology intermediates: RecA’s transient sampling revealed at the single molecule level’’]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036626072-60126154-56e7-45a4-83b3-dee8740d828e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab220</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-03-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[An RNA-binding protein complex regulates the purine-dependent expression of a nucleobase transporter in trypanosomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036620399-35c3f1d3-58ae-418b-8dfa-53d6be1ccef0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab181</link>
            <description><![CDATA[<p class="para" id="N65541">Post-transcriptional regulation of gene expression is particularly important in trypanosomatid protozoa. RNA-binding proteins (RBPs) regulate mRNA stability and translation, yet information about how RBPs are able to link environmental cues to post-transcriptional control is scarce. In <i>Trypanosoma brucei</i>, we have previously characterized a short RNA stem-loop <i>cis</i>-element (PuRE, <span style="text-decoration: underline">Pu</span>rine <span style="text-decoration: underline">R</span>esponsive <span style="text-decoration: underline">E</span>lement) within the 3′-UTR of the <i>NT8</i> nucleobase transporter mRNA that is necessary and sufficient to confer a strong repression of gene expression in response to purines. In this study, we have identified a protein complex composed of two RNA-binding proteins (PuREBP1 and PuREBP2) that binds to the PuRE <i>in vitro</i> and to <i>NT8</i> mRNA <i>in vivo</i>. Depletion of PuREBP1 by RNA interference results in the upregulation of just <i>NT8</i> and the mRNAs encoding the amino acid transporter AATP6 paralogues. Moreover, we found that the PuREBP1/2 complex is associated with only a handful of mRNAs, and that it is responsible for the observed purine-dependent regulation of NT8 expression.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of <i>GNRH1</i> mRNA in mammalian puberty]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036589437-02b302e0-3715-4ddb-9c6d-f355f269c207/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab155</link>
            <description><![CDATA[<p class="para" id="N65541">The family of Poly(A)-binding proteins (PABPs) regulates the stability and translation of messenger RNAs (mRNAs). Here we reported that the three members of PABPs, including PABPC1, PABPC3 and PABPC4, were identified as novel substrates for MKRN3, whose deletion or loss-of-function mutations were genetically associated with human central precocious puberty (CPP). MKRN3-mediated ubiquitination was found to attenuate the binding of PABPs to the poly(A) tails of mRNA, which led to shortened poly(A) tail-length of <i>GNRH1</i> mRNA and compromised the formation of translation initiation complex (TIC). Recently, we have shown that MKRN3 epigenetically regulates the transcription of <i>GNRH1</i> through conjugating poly-Ub chains onto methyl-DNA bind protein 3 (MBD3). Therefore, MKRN3-mediated ubiquitin signalling could control both transcriptional and post-transcriptional switches of mammalian puberty initiation. While identifying MKRN3 as a novel tissue-specific translational regulator, our work also provided new mechanistic insights into the etiology of MKRN3 dysfunction-associated human CPP.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Crystal structures of influenza nucleoprotein complexed with nucleic acid provide insights into the mechanism of RNA interaction]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036582998-02361f6f-e43e-4892-81cf-c907cff9216e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab203</link>
            <description><![CDATA[<p class="para" id="N65541">The nucleoprotein (NP) of influenza virus is the core component of the ribonucleoprotein (RNP) and performs multiple structural and functional roles. Structures of the influenza A, B and D NP molecules have been solved previously, but structural information on how NP interacts with RNA remains elusive. Here we present the crystal structure of an obligate monomer of H5N1 NP in complex with RNA nucleotides to 2.3 Å, and a C-terminal truncation of this mutant, also in complex with RNA nucleotides, to 3 Å. In both structures, three nucleotides were identified near two positive grooves of NP suggested to be important for RNA binding. Structural evidence supports that conformational changes of flexible loops and the C-terminal tail both play important roles in the binding of RNA. Based on the structure, we propose a mechanism by which NP captures RNA by flexible loops and transfers it onto the positive binding grooves. Binding of RNA by NP is a crucial step for template re-encapsidation during transcription and replication and cRNP formation. Our structures thus provide insights into the molecular virology of the influenza virus.</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RPA2 winged-helix domain facilitates UNG-mediated removal of uracil from ssDNA; implications for repair of mutagenic uracil at the replication fork]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036551707-368a6ff0-6817-408a-91fd-31bbad9e891d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab195</link>
            <description><![CDATA[<p class="para" id="N65541">Uracil occurs at replication forks via misincorporation of deoxyuridine monophosphate (dUMP) or via deamination of existing cytosines, which occurs 2–3 orders of magnitude faster in ssDNA than in dsDNA and is 100% miscoding. Tethering of UNG2 to proliferating cell nuclear antigen (PCNA) allows rapid post-replicative removal of misincorporated uracil, but potential ‘pre-replicative’ removal of deaminated cytosines in ssDNA has been questioned since this could mediate mutagenic translesion synthesis and induction of double-strand breaks. Here, we demonstrate that uracil-DNA glycosylase (UNG), but not SMUG1 efficiently excises uracil from replication protein A (RPA)-coated ssDNA and that this depends on functional interaction between the flexible winged-helix (WH) domain of RPA2 and the N-terminal RPA-binding helix in UNG. This functional interaction is promoted by mono-ubiquitination and diminished by cell-cycle regulated phosphorylations on UNG. Six other human proteins bind the RPA2-WH domain, all of which are involved in DNA repair and replication fork remodelling. Based on this and the recent discovery of the AP site crosslinking protein HMCES, we propose an integrated model in which templated repair of uracil and potentially other mutagenic base lesions in ssDNA at the replication fork, is orchestrated by RPA. The UNG:RPA2-WH interaction may also play a role in adaptive immunity by promoting efficient excision of AID-induced uracils in transcribed immunoglobulin loci.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766036551707-368a6ff0-6817-408a-91fd-31bbad9e891d/assets/gkab195gra1.jpg" alt="The WH-domain of RPA facilitates efficient UNG-mediated excision from RPA-coated ssDNA and may orchestrate error-free templated repair of the resultant AP-site."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      The WH-domain of RPA facilitates efficient UNG-mediated excision from RPA-coated ssDNA and may orchestrate error-free templated repair of the resultant AP-site.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A ProQ/FinO family protein involved in plasmid copy number control favours fitness of bacteria carrying <i>mcr-1</i>-bearing IncI2 plasmids]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036535269-a47d0bf1-5431-43be-b5a4-f21b68cc6652/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab149</link>
            <description><![CDATA[<p class="para" id="N65541">The plasmid-encoded colistin resistance gene <i>mcr-1</i> challenges the use of polymyxins and poses a threat to public health. Although IncI2-type plasmids are the most common vector for spreading the <i>mcr-1</i> gene, the mechanisms by which these plasmids adapt to host bacteria and maintain resistance genes remain unclear. Herein, we investigated the regulatory mechanism for controlling the fitness cost of an IncI2 plasmid carrying <i>mcr-1</i>. A putative ProQ/FinO family protein encoded by the IncI2 plasmid, designated as PcnR (plasmid copy number repressor), balances the <i>mcr-1</i> expression and bacteria fitness by repressing the plasmid copy number. It binds to the first stem-loop structure of the <i>repR</i> mRNA to repress RepA expression, which differs from any other previously reported plasmid replication control mechanism. Plasmid invasion experiments revealed that <i>pcnR</i> is essential for the persistence of the <i>mcr-1-</i>bearing IncI2 plasmid in the bacterial populations. Additionally, single-copy <i>mcr-1</i> gene still exerted a fitness cost to host bacteria, and negatively affected the persistence of the IncI2 plasmid in competitive co-cultures. These findings demonstrate that maintaining <i>mcr-1</i> plasmid at a single copy is essential for its persistence, and explain the significantly reduced prevalence of <i>mcr-1</i> following the ban of colistin as a growth promoter in China.</p>]]></description>
            <pubDate><![CDATA[2021-03-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Iron–sulfur biology invades tRNA modification: the case of U34 sulfuration]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036516994-b225bb7d-35c8-4432-8636-fe22d62363ef/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab138</link>
            <description><![CDATA[<p class="para" id="N65541">Sulfuration of uridine 34 in the anticodon of tRNAs is conserved in the three domains of life, guaranteeing fidelity of protein translation. In eubacteria, it is catalyzed by MnmA-type enzymes, which were previously concluded not to depend on an iron–sulfur [Fe–S] cluster. However, we report here spectroscopic and iron/sulfur analysis, as well as <i>in vitro</i> catalytic assays and site-directed mutagenesis studies unambiguously showing that MnmA from <i>Escherichia coli</i> can bind a [4Fe–4S] cluster, which is essential for sulfuration of U34-tRNA. We propose that the cluster serves to bind and activate hydrosulfide for nucleophilic attack on the adenylated nucleoside. Intriguingly, we found that <i>E. coli</i> cells retain s<sup>2</sup>U34 biosynthesis in the Δ<i>iscUA</i> Δ<i>sufABCDSE</i> strain, lacking functional ISC and SUF [Fe–S] cluster assembly machineries, thus suggesting an original and yet undescribed way of maturation of MnmA. Moreover, we report genetic analysis showing the importance of MnmA for sustaining oxidative stress.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Discovery and engineering of small SlugCas9 with broad targeting range and high specificity and activity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036477085-c527aae7-e275-4fb5-b4fc-9aeaeca77031/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab148</link>
            <description><![CDATA[<p class="para" id="N65541">The compact CRISPR/Cas9 system, which can be delivered with their gRNA and a full-length promoter for expression by a single adeno-associated virus (AAV), is a promising platform for therapeutic applications. We previously identified a compact SauriCas9 that displays high activity and requires a simple NNGG PAM, but the specificity is moderate. Here, we identified three compact Cas9 orthologs, <i>Staphylococcus lugdunensis</i> Cas9 (SlugCas9), <i>Staphylococcus lutrae</i> Cas9 (SlutrCas9) and <i>Staphylococcus haemolyticus</i> Cas9 (ShaCas9), for mammalian genome editing. Of these three Cas9 orthologs, SlugCas9 recognizes a simple NNGG PAM and displays comparable activity to SaCas9. Importantly, we generated a SlugCas9-SaCas9 chimeric nuclease, which has both high specificity and high activity. We finally engineered SlugCas9 with mutations to generate a high-fidelity variant that maintains high specificity without compromising on-target editing efficiency. Our study offers important minimal Cas9 tools that are ideal for both basic research and clinical applications.</p>]]></description>
            <pubDate><![CDATA[2021-03-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Competition between bridged dinucleotides and activated mononucleotides determines the error frequency of nonenzymatic RNA primer extension]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036301949-7c6a51da-9b2d-47a4-8c67-206afaf7d933/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab173</link>
            <description><![CDATA[<p class="para" id="N65541">Nonenzymatic copying of RNA templates with activated nucleotides is a useful model for studying the emergence of heredity at the origin of life. Previous experiments with defined-sequence templates have pointed to the poor fidelity of primer extension as a major problem. Here we examine the origin of mismatches during primer extension on random templates in the simultaneous presence of all four 2-aminoimidazole-activated nucleotides. Using a deep sequencing approach that reports on millions of individual template-product pairs, we are able to examine correct and incorrect polymerization as a function of sequence context. We have previously shown that the predominant pathway for primer extension involves reaction with imidazolium-bridged dinucleotides, which form spontaneously by the reaction of two mononucleotides with each other. We now show that the sequences of correctly paired products reveal patterns that are expected from the bridged dinucleotide mechanism, whereas those associated with mismatches are consistent with direct reaction of the primer with activated mononucleotides. Increasing the ratio of bridged dinucleotides to activated mononucleotides, either by using purified components or by using isocyanide-based activation chemistry, reduces the error frequency. Our results point to testable strategies for the accurate nonenzymatic copying of arbitrary RNA sequences.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766036301949-7c6a51da-9b2d-47a4-8c67-206afaf7d933/assets/gkab173gra1.jpg" alt="Correct nucleotide incorporation in nonenzymatic RNA primer extension can be traced to a bridged dinucleotide mechanism, whereas mismatched incorporations arise from the direct reaction of activated mononucleotides."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Correct nucleotide incorporation in nonenzymatic RNA primer extension can be traced to a bridged dinucleotide mechanism, whereas mismatched incorporations arise from the direct reaction of activated mononucleotides.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Oligomeric quaternary structure of <i>Escherichia coli</i> and <i>Mycobacterium smegmatis</i> Lhr helicases is nucleated by a novel C-terminal domain composed of five winged-helix modules]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036286562-18db5b44-000a-4889-b769-2b04d461587a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab145</link>
            <description><![CDATA[<p class="para" id="N65541">
<i>Mycobacterium smegmatis</i> Lhr (MsmLhr; 1507-aa) is the founder of a novel clade of bacterial helicases. MsmLhr consists of an N-terminal helicase domain (aa 1–856) with a distinctive tertiary structure (Lhr-Core) and a C-terminal domain (Lhr-CTD) of unknown structure. Here, we report that <i>Escherichia coli</i> Lhr (EcoLhr; 1538-aa) is an ATPase, translocase and ATP-dependent helicase. Like MsmLhr, EcoLhr translocates 3′ to 5′ on ssDNA and unwinds secondary structures <i>en route</i>, with RNA:DNA hybrid being preferred versus DNA:DNA duplex. The ATPase and translocase activities of EcoLhr inhere to its 877-aa Core domain. Full-length EcoLhr and MsmLhr have homo-oligomeric quaternary structures in solution, whereas their respective Core domains are monomers. The MsmLhr CTD per se is a homo-oligomer in solution. We employed cryo-EM to solve the structure of the CTD of full-length MsmLhr. The CTD protomer is composed of a series of five winged-helix (WH) modules and a β-barrel module. The CTD adopts a unique homo-tetrameric quaternary structure. A Lhr-CTD subdomain, comprising three tandem WH modules and the β-barrel, is structurally homologous to AlkZ, a bacterial DNA glycosylase that recognizes and excises inter-strand DNA crosslinks. This homology is noteworthy given that Lhr is induced in mycobacteria exposed to the inter-strand crosslinker mitomycin C.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Correction to article “The forkhead transcription factor FOXK2 premarks lineage-specific genes in human embryonic stem cells for activation during differentiation’’]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036140147-ffd93457-a90d-47b0-8490-794ba49072a5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab221</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-03-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Di-phosphorylated BAF shows altered structural dynamics and binding to DNA, but interacts with its nuclear envelope partners]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036118566-213659b0-80fb-49d2-b557-a09d4c3b4831/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab184</link>
            <description><![CDATA[<p class="para" id="N65541">Barrier-to-autointegration factor (BAF), encoded by the <i>BANF1</i> gene, is an abundant and ubiquitously expressed metazoan protein that has multiple functions during the cell cycle. Through its ability to cross-bridge two double-stranded DNA (dsDNA), it favours chromosome compaction, participates in post-mitotic nuclear envelope reassembly and is essential for the repair of large nuclear ruptures. BAF forms a ternary complex with the nuclear envelope proteins lamin A/C and emerin, and its interaction with lamin A/C is defective in patients with recessive accelerated aging syndromes. Phosphorylation of BAF by the vaccinia-related kinase 1 (VRK1) is a key regulator of BAF localization and function. Here, we demonstrate that VRK1 successively phosphorylates BAF on Ser4 and Thr3. The crystal structures of BAF before and after phosphorylation are extremely similar. However, in solution, the extensive flexibility of the N-terminal helix α1 and loop α1α2 in BAF is strongly reduced in di-phosphorylated BAF, due to interactions between the phosphorylated residues and the positively charged C-terminal helix α6. These regions are involved in DNA and lamin A/C binding. Consistently, phosphorylation causes a 5000-fold loss of affinity for dsDNA. However, it does not impair binding to lamin A/C Igfold domain and emerin nucleoplasmic region, which leaves open the question of the regulation of these interactions.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Regulator-dependent temporal dynamics of a restriction-modification system's gene expression upon entering new host cells: single-cell and population studies]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766036061348-eaeafebf-9354-4549-afea-fc834b71104b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab183</link>
            <description><![CDATA[<p class="para" id="N65541">Restriction-modification (R-M) systems represent a first line of defense against invasive DNAs, such as bacteriophage DNAs, and are widespread among bacteria and archaea. By acquiring a Type II R-M system via horizontal gene transfer, the new hosts generally become more resistant to phage infection, through the action of a restriction endonuclease (REase), which cleaves DNA at or near specific sequences. A modification methyltransferase (MTase) serves to protect the host genome against its cognate REase activity. The production of R-M system components upon entering a new host cell must be finely tuned to confer protective methylation before the REase acts, to avoid host genome damage. Some type II R-M systems rely on a third component, the controller (C) protein, which is a transcription factor that regulates the production of REase and/or MTase. Previous studies have suggested C protein effects on the dynamics of expression of an R-M system during its establishment in a new host cell. Here, we directly examine these effects. By fluorescently labelling REase and MTase, we demonstrate that lack of a C protein reduces the delay of REase production, to the point of being simultaneous with, or even preceding, production of the MTase. Single molecule tracking suggests that a REase and a MTase employ different strategies for their target search within host cells, with the MTase spending much more time diffusing in proximity to the nucleoid than does the REase. This difference may partially ameliorate the toxic effects of premature REase expression.</p>]]></description>
            <pubDate><![CDATA[2021-03-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The loopometer: a quantitative <i>in vivo</i> assay for DNA-looping proteins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766035937264-a209fdf3-a820-4019-94db-469646e377f1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1284</link>
            <description><![CDATA[<p class="para" id="N65541">Proteins that can bring together separate DNA sites, either on the same or on different DNA molecules, are critical for a variety of DNA-based processes. However, there are no general and technically simple assays to detect proteins capable of DNA looping <i>in vivo</i> nor to quantitate their <i>in vivo</i> looping efficiency. Here, we develop a quantitative <i>in vivo</i> assay for DNA-looping proteins in <i>Escherichia coli</i> that requires only basic DNA cloning techniques and a LacZ assay. The assay is based on loop assistance, where two binding sites for the candidate looping protein are inserted internally to a pair of operators for the <i>E. coli</i> LacI repressor. DNA looping between the sites shortens the effective distance between the <i>lac</i> operators, increasing LacI looping and strengthening its repression of a <i>lacZ</i> reporter gene. Analysis based on a general model for loop assistance enables quantitation of the strength of looping conferred by the protein and its binding sites. We use this ‘loopometer’ assay to measure DNA looping for a variety of bacterial and phage proteins.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Human METTL18 is a histidine-specific methyltransferase that targets RPL3 and affects ribosome biogenesis and function]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021126690-3c7c1d7b-e526-4bbf-99bb-443e00260158/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab088</link>
            <description><![CDATA[<p class="para" id="N65541">Protein methylation occurs primarily on lysine and arginine, but also on some other residues, such as histidine. METTL18 is the last uncharacterized member of a group of human methyltransferases (MTases) that mainly exert lysine methylation, and here we set out to elucidate its function. We found METTL18 to be a nuclear protein that contains a functional nuclear localization signal and accumulates in nucleoli. Recombinant METTL18 methylated a single protein in nuclear extracts and in isolated ribosomes from <i>METTL18</i> knockout (KO) cells, identified as 60S ribosomal protein L3 (RPL3). We also performed an RPL3 interactomics screen and identified METTL18 as the most significantly enriched MTase. We found that His-245 in RPL3 carries a 3-methylhistidine (3MH; τ-methylhistidine) modification, which was absent in <i>METTL18</i> KO cells. In addition, both recombinant and endogenous METTL18 were found to be automethylated at His-154, thus further corroborating METTL18 as a histidine-specific MTase. Finally, <i>METTL18</i> KO cells displayed altered pre-rRNA processing, decreased polysome formation and codon-specific changes in mRNA translation, indicating that METTL18-mediated methylation of RPL3 is important for optimal ribosome biogenesis and function. In conclusion, we have here established METTL18 as the second human histidine-specific protein MTase, and demonstrated its functional relevance.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A method for characterizing Cas9 variants via a one-million target sequence library of self-targeting sgRNAs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021115653-7dbf398f-b99a-4f0b-a6e7-d86af091e5e9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1220</link>
            <description><![CDATA[<p class="para" id="N65541">Detailed target-selectivity information and experiment-based efficacy prediction tools are primarily available for <i>Streptococcus pyogenes</i> Cas9 (SpCas9). One obstacle to develop such tools is the rarity of accurate data. Here, we report a method termed ‘Self-targeting sgRNA Library Screen’ (SLS) for assaying the activity of Cas9 nucleases in bacteria using random target/sgRNA libraries of self-targeting sgRNAs. Exploiting more than a million different sequences, we demonstrate the use of the method with the SpCas9-HF1 variant to analyse its activity and reveal motifs that influence its target-selectivity. We have also developed an algorithm for predicting the activity of SpCas9-HF1 with an accuracy matching those of existing tools. SLS is a facile alternative to the much more expensive and laborious approaches used currently and has the capability of delivering sufficient amount of data for most of the orthologs and variants of SpCas9.</p>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A novel SHAPE reagent enables the analysis of RNA structure in living cells with unprecedented accuracy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021106020-5566313f-785f-4a61-8b74-504335da2fe5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1255</link>
            <description><![CDATA[<p class="para" id="N65541">Due to the mounting evidence that RNA structure plays a critical role in regulating almost any physiological as well as pathological process, being able to accurately define the folding of RNA molecules within living cells has become a crucial need. We introduce here 2-aminopyridine-3-carboxylic acid imidazolide (2A3), as a general probe for the interrogation of RNA structures <i>in vivo</i>. 2A3 shows moderate improvements with respect to the state-of-the-art selective 2′-hydroxyl acylation analyzed by primer extension (SHAPE) reagent NAI on naked RNA under <i>in vitro</i> conditions, but it significantly outperforms NAI when probing RNA structure <i>in vivo</i>, particularly in bacteria, underlining its increased ability to permeate biological membranes. When used as a restraint to drive RNA structure prediction, data derived by SHAPE-MaP with 2A3 yields more accurate predictions than NAI-derived data. Due to its extreme efficiency and accuracy, we can anticipate that 2A3 will rapidly take over conventional SHAPE reagents for probing RNA structures both <i>in vitro</i> and <i>in vivo</i>.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021096072-4d9ef910-5476-4010-817d-a661d4ca31b4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab110</link>
            <description><![CDATA[<p class="para" id="N65541">DNA repair pathways are essential to maintain the integrity of the genome and prevent cell death and tumourigenesis. Here, we show that the Barrier-to-Autointegration Factor (Banf1) protein has a role in the repair of DNA double-strand breaks. Banf1 is characterized as a nuclear envelope protein and mutations in Banf1 are associated with the severe premature aging syndrome, Néstor–Guillermo Progeria Syndrome. We have previously shown that Banf1 directly regulates the activity of PARP1 in the repair of oxidative DNA lesions. Here, we show that Banf1 also has a role in modulating DNA double-strand break repair through regulation of the DNA-dependent Protein Kinase catalytic subunit, DNA-PKcs. Specifically, we demonstrate that Banf1 relocalizes from the nuclear envelope to sites of DNA double-strand breaks. We also show that Banf1 can bind to and directly inhibit the activity of DNA-PKcs. Supporting this, cellular depletion of Banf1 leads to an increase in non-homologous end-joining and a decrease in homologous recombination, which our data suggest is likely due to unrestrained DNA-PKcs activity. Overall, this study identifies how Banf1 regulates double-strand break repair pathway choice by modulating DNA-PKcs activity to control genome stability within the cell.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mechanism of forkhead transcription factors binding to a novel palindromic DNA site]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021087472-8bcb1c4e-a576-4c8b-b069-4c233d278c8c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab086</link>
            <description><![CDATA[<p class="para" id="N65541">Forkhead transcription factors bind a canonical consensus DNA motif, RYAAAYA (R = A/G, Y = C/T), as a monomer. However, the molecular mechanisms by which forkhead transcription factors bind DNA as a dimer are not well understood. In this study, we show that FOXO1 recognizes a palindromic DNA element DIV2, and mediates transcriptional regulation. The crystal structure of FOXO1/DIV2 reveals that the FOXO1 DNA binding domain (DBD) binds the DIV2 site as a homodimer. The wing1 region of FOXO1 mediates the dimerization, which enhances FOXO1 DNA binding affinity and complex stability. Further biochemical assays show that FOXO3, FOXM1 and FOXI1 also bind the DIV2 site as homodimer, while FOXC2 can only bind this site as a monomer. Our structural, biochemical and bioinformatics analyses not only provide a novel mechanism by which FOXO1 binds DNA as a homodimer, but also shed light on the target selection of forkhead transcription factors.</p>]]></description>
            <pubDate><![CDATA[2021-02-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Defining a novel domain that provides an essential contribution to site-specific interaction of Rep protein with DNA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021078767-e38ef2c6-9a74-47f2-b08e-371770362636/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab113</link>
            <description><![CDATA[<p class="para" id="N65541">An essential feature of replication initiation proteins is their ability to bind to DNA. In this work, we describe a new domain that contributes to a replication initiator sequence-specific interaction with DNA. Applying biochemical assays and structure prediction methods coupled with DNA–protein crosslinking, mass spectrometry, and construction and analysis of mutant proteins, we identified that the replication initiator of the broad host range plasmid RK2, in addition to two winged helix domains, contains a third DNA-binding domain. The phylogenetic analysis revealed that the composition of this unique domain is typical within the described TrfA-like protein family. Both <i>in vitro</i> and <i>in vivo</i> experiments involving the constructed TrfA mutant proteins showed that the newly identified domain is essential for the formation of the protein complex with DNA, contributes to the avidity for interaction with DNA, and the replication activity of the initiator. The analysis of mutant proteins, each containing a single substitution, showed that each of the three domains composing TrfA is essential for the formation of the protein complex with DNA. Furthermore, the new domain, along with the winged helix domains, contributes to the sequence specificity of replication initiator interaction within the plasmid replication origin.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Editorial Expression of Concern on article ‘Functional dissection of the C-terminal domain of type II DNA topoisomerase from the kinetoplastid hemoflagellate <i>Leishmania donovani</i>’]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021075702-ca41b38f-690e-4b31-8ee5-d5d9af690e08/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab171</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Corrigendum to article ‘Hibernation factors directly block ribonucleases from entering the ribosome in response to starvation’]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021072857-2ba3dd74-6e60-41f1-b2da-7ffe4b9ca8e8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab170</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-03-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Analysing the yeast complexome—the Complex Portal rising to the challenge]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021064642-c7c3d79a-fc96-467a-8b83-07db45e87d8e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab077</link>
            <description><![CDATA[<p class="para" id="N65541">The EMBL-EBI Complex Portal is a knowledgebase of macromolecular complexes providing persistent stable identifiers. Entries are linked to literature evidence and provide details of complex membership, function, structure and complex-specific Gene Ontology annotations. Data are freely available and downloadable in HUPO-PSI community standards and missing entries can be requested for curation. In collaboration with <i>Saccharomyces</i> Genome Database and UniProt, the yeast complexome, a compendium of all known heteromeric assemblies from the model organism <i>Saccharomyces cerevisiae</i>, was curated. This expansion of knowledge and scope has led to a 50% increase in curated complexes compared to the previously published dataset, CYC2008. The yeast complexome is used as a reference resource for the analysis of complexes from large-scale experiments. Our analysis showed that genes coding for proteins in complexes tend to have more genetic interactions, are co-expressed with more genes, are more multifunctional, localize more often in the nucleus, and are more often involved in nucleic acid-related metabolic processes and processes where large machineries are the predominant functional drivers. A comparison to genetic interactions showed that about 40% of expanded co-complex pairs also have genetic interactions, suggesting strong functional links between complex members.</p>]]></description>
            <pubDate><![CDATA[2021-03-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The small DUF1127 protein CcaF1 from <i>Rhodobacter sphaeroides</i> is an RNA-binding protein involved in sRNA maturation and RNA turnover]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021055660-fec87348-dc5f-4845-873d-b0df01554a03/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab146</link>
            <description><![CDATA[<p class="para" id="N65541">Many different protein domains are conserved among numerous species, but their function remains obscure. Proteins with DUF1127 domains number &gt;17 000 in current databases, but a biological function has not yet been assigned to any of them. They are mostly found in alpha- and gammaproteobacteria, some of them plant and animal pathogens, symbionts or species used in industrial applications. Bioinformatic analyses revealed similarity of the DUF1127 domain of bacterial proteins to the RNA binding domain of eukaryotic Smaug proteins that are involved in RNA turnover and have a role in development from <i>Drosophila</i> to mammals. This study demonstrates that the 71 amino acid DUF1127 protein CcaF1 from the alphaproteobacterium <i>Rhodobacter sphaeroides</i> participates in maturation of the CcsR sRNAs that are processed from the 3′ UTR of the <i>ccaF</i> mRNA and have a role in the oxidative stress defense. CcaF1 binds to many cellular RNAs of different type, several mRNAs with a function in cysteine / methionine / sulfur metabolism. It affects the stability of the CcsR RNAs and other non-coding RNAs and mRNAs. Thus, the widely distributed DUF1127 domain can mediate RNA-binding, affect stability of its binding partners and consequently modulate the bacterial transcriptome, thereby influencing different physiological processes.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766021055660-fec87348-dc5f-4845-873d-b0df01554a03/assets/gkab146gra1.jpg" alt="CcaF1 protein(red) binds to the ccaF1-ccsR1-4 transcript and together with RNase E contributes to maturation of the CcsR1-4 RNAs. Decreased RNase E activity or excess of CcaF1 impede this maturation. By acting on CcsR maturation CcaF1 contributes to the oxidative stress response. CcaF1 also binds to several other cellular RNAs suggesting its influence also on other physiological processes."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      CcaF1 protein(red) binds to the ccaF1-ccsR1-4 transcript and together with RNase E contributes to maturation of the CcsR1-4 RNAs. Decreased RNase E activity or excess of CcaF1 impede this maturation. By acting on CcsR maturation CcaF1 contributes to the oxidative stress response. CcaF1 also binds to several other cellular RNAs suggesting its influence also on other physiological processes.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021042955-6e0bcbf5-fcfc-44af-b73a-4d187236affa/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab099</link>
            <description><![CDATA[<p class="para" id="N65541">Epstein-Barr virus (EBV), a herpes virus also termed HHV 4 and the first identified human tumor virus, establishes a stable, long-term latent infection in human B cells, its preferred host. Upon induction of EBV’s lytic phase, the latently infected cells turn into a virus factory, a process that is governed by EBV. In the lytic, productive phase, all herpes viruses ensure the efficient induction of all lytic viral genes to produce progeny, but certain of these genes also repress the ensuing antiviral responses of the virally infected host cells, regulate their apoptotic death or control the cellular transcriptome. We now find that EBV causes previously unknown massive and global alterations in the chromatin of its host cell upon induction of the viral lytic phase and prior to the onset of viral DNA replication. The viral initiator protein of the lytic cycle, BZLF1, binds to &gt;10<sup>5</sup> binding sites with different sequence motifs in cellular chromatin in a concentration dependent manner implementing a binary molar switch probably to prevent noise-induced erroneous induction of EBV’s lytic phase. Concomitant with DNA binding of BZLF1, silent chromatin opens locally as shown by ATAC-seq experiments, while previously wide-open cellular chromatin becomes inaccessible on a global scale within hours. While viral transcripts increase drastically, the induction of the lytic phase results in a massive reduction of cellular transcripts and a loss of chromatin-chromatin interactions of cellular promoters with their distal regulatory elements as shown in Capture-C experiments. Our data document that EBV’s lytic cycle induces discrete early processes that disrupt the architecture of host cellular chromatin and repress the cellular epigenome and transcriptome likely supporting the efficient <i>de novo</i> synthesis of this herpes virus.</p>]]></description>
            <pubDate><![CDATA[2021-03-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mechanisms of damage tolerance and repair during DNA replication]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766021000419-4ea814ea-6cad-46a0-be40-0635eeed5e44/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab101</link>
            <description><![CDATA[<p class="para" id="N65541">Accurate duplication of chromosomal DNA is essential for the transmission of genetic information. The DNA replication fork encounters template lesions, physical barriers, transcriptional machinery, and topological barriers that challenge the faithful completion of the replication process. The flexibility of replisomes coupled with tolerance and repair mechanisms counteract these replication fork obstacles. The cell possesses several universal mechanisms that may be activated in response to various replication fork impediments, but it has also evolved ways to counter specific obstacles. In this review, we will discuss these general and specific strategies to counteract different forms of replication associated damage to maintain genomic stability.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Complete minicircle genome of <i>Leptomonas pyrrhocoris</i> reveals sources of its non-canonical mitochondrial RNA editing events]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020991265-0b307402-6ba2-4d68-830c-34aacf648648/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab114</link>
            <description><![CDATA[<p class="para" id="N65541">Uridine insertion/deletion (U-indel) editing of mitochondrial mRNA, unique to the protistan class Kinetoplastea, generates canonical as well as potentially non-productive editing events. While the molecular machinery and the role of the guide (g) RNAs that provide required information for U-indel editing are well understood, little is known about the forces underlying its apparently error-prone nature. Analysis of a gRNA:mRNA pair allows the dissection of editing events in a given position of a given mitochondrial transcript. A complete gRNA dataset, paired with a fully characterized mRNA population that includes non-canonically edited transcripts, would allow such an analysis to be performed globally across the mitochondrial transcriptome. To achieve this, we have assembled 67 minicircles of the insect parasite <i>Leptomonas pyrrhocoris</i>, with each minicircle typically encoding one gRNA located in one of two similar-sized units of different origin. From this relatively narrow set of annotated gRNAs, we have dissected all identified mitochondrial editing events in <i>L. pyrrhocoris</i>, the strains of which dramatically differ in the abundance of individual minicircle classes. Our results support a model in which a multitude of editing events are driven by a limited set of gRNAs, with individual gRNAs possessing an inherent ability to guide canonical and non-canonical editing.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RNA thermoswitches modulate <i>Staphylococcus aureus</i> adaptation to ambient temperatures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020981420-34d1c2da-6569-4bd5-8611-f09c3a3adc6e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab117</link>
            <description><![CDATA[<p class="para" id="N65541">Thermoregulation of virulence genes in bacterial pathogens is essential for environment-to-host transition. However, the mechanisms governing cold adaptation when outside the host remain poorly understood. Here, we found that the production of cold shock proteins CspB and CspC from <i>Staphylococcus aureus</i> is controlled by two paralogous RNA thermoswitches. Through <i>in silico</i> prediction, enzymatic probing and site-directed mutagenesis, we demonstrated that <i>cspB</i> and <i>cspC</i> 5′UTRs adopt alternative RNA structures that shift from one another upon temperature shifts. The open (O) conformation that facilitates mRNA translation is favoured at ambient temperatures (22°C). Conversely, the alternative locked (L) conformation, where the ribosome binding site (RBS) is sequestered in a double-stranded RNA structure, is folded at host-related temperatures (37°C). These structural rearrangements depend on a long RNA hairpin found in the O conformation that sequesters the anti-RBS sequence. Notably, the remaining <i>S. aureus</i> CSP, CspA, may interact with a UUUGUUU motif located in the loop of this long hairpin and favour the folding of the L conformation. This folding represses CspB and CspC production at 37°C. Simultaneous deletion of the <i>cspB/cspC</i> genes or their RNA thermoswitches significantly decreases <i>S. aureus</i> growth rate at ambient temperatures, highlighting the importance of CspB/CspC thermoregulation when <i>S. aureus</i> transitions from the host to the environment.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Gene-specific mutagenesis enables rapid continuous evolution of enzymes <i>in vivo</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020973295-26d993b8-463a-4d1c-b634-df3c14c04d18/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1231</link>
            <description><![CDATA[<p class="para" id="N65541">Various <i>in vivo</i> mutagenesis methods have been developed to facilitate fast and efficient continuous evolution of proteins in cells. However, they either modify the DNA region that does not match the target gene, or suffer from low mutation rates. Here, we report a mutator, eMutaT7 (enhanced MutaT7), with very fast <i>in vivo</i> mutation rate and high gene-specificity in <i>Escherichia coli</i>. eMutaT7, a cytidine deaminase fused to an orthogonal RNA polymerase, can introduce up to ∼4 mutations per 1 kb per day, rivalling the rate in typical <i>in vitro</i> mutagenesis for directed evolution of proteins, and promotes rapid continuous evolution of model proteins for antibiotic resistance and allosteric activation. eMutaT7 provides a very simple and tunable method for continuous directed evolution of proteins, and suggests that the fusion of new DNA-modifying enzymes to the orthogonal RNA polymerase is a promising strategy to explore the expanded sequence space without compromising gene specificity.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766020973295-26d993b8-463a-4d1c-b634-df3c14c04d18/assets/gkaa1231gra1.jpg" alt="eMutaT7: a rapid in vivo mutagenesis method for continuous directed evolution of proteins."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      eMutaT7: a rapid <i>in vivo</i> mutagenesis method for continuous directed evolution of proteins.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A Hi–C data-integrated model elucidates <i>E. coli</i> chromosome’s multiscale organization at various replication stages]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020963692-698832bc-c3d5-4243-a469-40602818f92f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab094</link>
            <description><![CDATA[<p class="para" id="N65541">The chromosome of <i>Escherichia coli</i> is riddled with multi-faceted complexity. The emergence of chromosome conformation capture techniques are providing newer ways to explore chromosome organization. Here we combine a beads-on-a-spring polymer-based framework with recently reported Hi–C data for <i>E. coli</i> chromosome, in rich growth condition, to develop a comprehensive model of its chromosome at 5 kb resolution. The investigation focuses on a range of diverse chromosome architectures of <i>E. coli</i> at various replication states corresponding to a collection of cells, individually present in different stages of cell cycle. The Hi–C data-integrated model captures the self-organization of <i>E. coli</i> chromosome into multiple macrodomains within a ring-like architecture. The model demonstrates that the position of oriC is dependent on architecture and replication state of chromosomes. The distance profiles extracted from the model reconcile fluorescence microscopy and DNA-recombination assay experiments. Investigations into writhe of the chromosome model reveal that it adopts helix-like conformation with no net chirality, earlier hypothesized in experiments. A genome-wide radius of gyration map captures multiple chromosomal interaction domains and identifies the precise locations of rrn operons in the chromosome. We show that a model devoid of Hi–C encoded information would fail to recapitulate most genomic features unique to <i>E. coli</i>.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>De novo</i> 3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020954982-c6de1149-902b-4d85-b92d-87531b2210c6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab119</link>
            <description><![CDATA[<p class="para" id="N65541">The rapid spread of COVID-19 is motivating development of antivirals targeting conserved SARS-CoV-2 molecular machinery. The SARS-CoV-2 genome includes conserved RNA elements that offer potential small-molecule drug targets, but most of their 3D structures have not been experimentally characterized. Here, we provide a compilation of chemical mapping data from our and other labs, secondary structure models, and 3D model ensembles based on Rosetta's FARFAR2 algorithm for SARS-CoV-2 RNA regions including the individual stems SL1-8 in the extended 5′ UTR; the reverse complement of the 5′ UTR SL1-4; the frameshift stimulating element (FSE); and the extended pseudoknot, hypervariable region, and s2m of the 3′ UTR. For eleven of these elements (the stems in SL1–8, reverse complement of SL1–4, FSE, s2m and 3′ UTR pseudoknot), modeling convergence supports the accuracy of predicted low energy states; subsequent cryo-EM characterization of the FSE confirms modeling accuracy. To aid efforts to discover small molecule RNA binders guided by computational models, we provide a second set of similarly prepared models for RNA riboswitches that bind small molecules. Both datasets (‘FARFAR2-SARS-CoV-2’, https://github.com/DasLab/FARFAR2-SARS-CoV-2; and ‘FARFAR2-Apo-Riboswitch’, at https://github.com/DasLab/FARFAR2-Apo-Riboswitch’) include up to 400 models for each RNA element, which may facilitate drug discovery approaches targeting dynamic ensembles of RNA molecules.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766020954982-c6de1149-902b-4d85-b92d-87531b2210c6/assets/gkab119gra1.jpg" alt="&#10;De novo 3D models of SARS-CoV-2 RNA elements and small-molecule-binding RNAs to aid drug discovery."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      
<i>De novo</i> 3D models of SARS-CoV-2 RNA elements and small-molecule-binding RNAs to aid drug discovery.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Targeted-antibacterial-plasmids (TAPs) combining conjugation and CRISPR/Cas systems achieve strain-specific antibacterial activity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020944898-1f93ce3d-bbe5-4035-b217-e2776af55082/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab126</link>
            <description><![CDATA[<p class="para" id="N65541">The global emergence of drug-resistant bacteria leads to the loss of efficacy of our antibiotics arsenal and severely limits the success of currently available treatments. Here, we developed an innovative strategy based on targeted-antibacterial-plasmids (TAPs) that use bacterial conjugation to deliver CRISPR/Cas systems exerting a strain-specific antibacterial activity. TAPs are highly versatile as they can be directed against any specific genomic or plasmid DNA using the custom algorithm (CSTB) that identifies appropriate targeting spacer sequences. We demonstrate the ability of TAPs to induce strain-selective killing by introducing lethal double strand breaks (DSBs) into the targeted genomes. TAPs directed against a plasmid-born carbapenem resistance gene efficiently resensitise the strain to the drug. This work represents an essential step toward the development of an alternative to antibiotic treatments, which could be used for <i>in situ</i> microbiota modification to eradicate targeted resistant and/or pathogenic bacteria without affecting other non-targeted bacterial species.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Staying true to yourself: mechanisms of DNA methylation maintenance in mammals]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020897814-f061fce0-78fe-4159-83dc-c58ad2d4476e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1154</link>
            <description><![CDATA[<p class="para" id="N65541">DNA methylation is essential to development and cellular physiology in mammals. Faulty DNA methylation is frequently observed in human diseases like cancer and neurological disorders. Molecularly, this epigenetic mark is linked to other chromatin modifications and it regulates key genomic processes, including transcription and splicing. Each round of DNA replication generates two hemi-methylated copies of the genome. These must be converted back to symmetrically methylated DNA before the next S-phase, or the mark will fade away; therefore the maintenance of DNA methylation is essential. Mechanistically, the maintenance of this epigenetic modification takes place during and after DNA replication, and occurs within the very dynamic context of chromatin re-assembly. Here, we review recent discoveries and unresolved questions regarding the mechanisms, dynamics and fidelity of DNA methylation maintenance in mammals. We also discuss how it could be regulated in normal development and misregulated in disease.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Anti-CRISPR AcrIF9 functions by inducing the CRISPR–Cas complex to bind DNA non-specifically]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020890717-7e857472-2558-4186-8daf-1230a28e90eb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab092</link>
            <description><![CDATA[<p class="para" id="N65541">Phages and other mobile genetic elements express anti-CRISPR proteins (Acrs) to protect their genomes from destruction by CRISPR–Cas systems. Acrs usually block the ability of CRISPR–Cas systems to bind or cleave their nucleic acid substrates. Here, we investigate an unusual Acr, AcrIF9, that induces a gain-of-function to a type I-F CRISPR–Cas (Csy) complex, causing it to bind strongly to DNA that lacks both a PAM sequence and sequence complementarity. We show that specific and non-specific dsDNA compete for the same site on the Csy:AcrIF9 complex with rapid exchange, but specific ssDNA appears to still bind through complementarity to the CRISPR RNA. Induction of non-specific DNA-binding is a shared property of diverse AcrIF9 homologues. Substitution of a conserved positively charged surface on AcrIF9 abrogated non-specific dsDNA-binding of the Csy:AcrIF9 complex, but specific dsDNA binding was maintained. AcrIF9 mutants with impaired non-specific dsDNA binding activity <i>in vitro</i> displayed a reduced ability to inhibit CRISPR–Cas activity <i>in vivo</i>. We conclude that misdirecting the CRISPR–Cas complex to bind non-specific DNA is a key component of the inhibitory mechanism of AcrIF9. This inhibitory mechanism is distinct from a previously characterized anti-CRISPR, AcrIF1, that sterically blocks DNA-binding, even though AcrIF1and AcrIF9 bind to the same site on the Csy complex.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Microbial single-strand annealing proteins enable CRISPR gene-editing tools with improved knock-in efficiencies and reduced off-target effects]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020841218-5091cc61-c4ca-4531-9b98-9eaaef6c89e0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1264</link>
            <description><![CDATA[<p class="para" id="N65541">Several existing technologies enable short genomic alterations including generating indels and short nucleotide variants, however, engineering more significant genomic changes is more challenging due to reduced efficiency and precision. Here, we developed RecT Editor via Designer-Cas9-Initiated Targeting (REDIT), which leverages phage single-stranded DNA-annealing proteins (SSAP) RecT for mammalian genome engineering. Relative to Cas9-mediated homology-directed repair (HDR), REDIT yielded up to a 5-fold increase of efficiency to insert kilobase-scale exogenous sequences at defined genomic regions. We validated our REDIT approach using different formats and lengths of knock-in templates. We further demonstrated that REDIT tools using Cas9 nickase have efficient gene-editing activities and reduced off-target errors, measured using a combination of targeted sequencing, genome-wide indel, and insertion mapping assays. Our experiments inhibiting repair enzyme activities suggested that REDIT has the potential to overcome limitations of endogenous DNA repair steps. Finally, our REDIT method is applicable across cell types including human stem cells, and is generalizable to different Cas9 enzymes.</p>]]></description>
            <pubDate><![CDATA[2021-02-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Editorial Expression of Concern on article ‘CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions’]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766020836291-5397f0bd-5db9-49b4-a6ef-e3e823eabec8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab172</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Reactive astrocytes in ALS display diminished intron retention]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017175011-fb6cc29a-e5c0-45dc-84e8-e2e4842f5cde/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab115</link>
            <description><![CDATA[<p class="para" id="N65541">Reactive astrocytes are implicated in amyotrophic lateral sclerosis (ALS), although the mechanisms controlling reactive transformation are unknown. We show that decreased intron retention (IR) is common to human-induced pluripotent stem cell (hiPSC)-derived astrocytes carrying ALS-causing mutations in <i>VCP, SOD1</i> and <i>C9orf72</i>. Notably, transcripts with decreased IR and increased expression are overrepresented in reactivity processes including cell adhesion, stress response and immune activation. This was recapitulated in public-datasets for (i) hiPSC-derived astrocytes stimulated with cytokines to undergo reactive transformation and (ii) <i>in vivo</i> astrocytes following selective deletion of TDP-43. We also re-examined public translatome sequencing (TRAP-seq) of astrocytes from a <i>SOD1</i> mouse model, which revealed that transcripts upregulated in translation significantly overlap with transcripts exhibiting decreased IR. Using nucleocytoplasmic fractionation of <i>VCP</i> mutant astrocytes coupled with mRNA sequencing and proteomics, we identify that decreased IR in nuclear transcripts is associated with enhanced nonsense mediated decay and increased cytoplasmic expression of transcripts and proteins regulating reactive transformation. These findings are consistent with a molecular model for reactive transformation in astrocytes whereby poised nuclear reactivity-related IR transcripts are spliced, undergo nuclear-to-cytoplasmic translocation and translation. Our study therefore provides new insights into the molecular regulation of reactive transformation in astrocytes.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766017175011-fb6cc29a-e5c0-45dc-84e8-e2e4842f5cde/assets/gkab115gra1.jpg" alt="Healthy astrocytes (left, blue) have prevalent nuclear intron retention in reactivity transcripts, promoting their nuclear confinement (introns shown as red rectangles). Conversely, ALS astrocytes (right, red) exhibit decreased intron retention in reactivity transcripts, enabling cytoplasmic translocation and translation upon engaging ribosomes, underlying their reactive transformation. A small number of intron retaining transcripts escape to the cytoplasm where they are degraded by nonsense mediated decay (NMD), which is enhanced in ALS astrocytes."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical abstract</div><div class="captionText">                                      Healthy astrocytes (left, blue) have prevalent nuclear intron retention in reactivity transcripts, promoting their nuclear confinement (introns shown as red rectangles). Conversely, ALS astrocytes (right, red) exhibit decreased intron retention in reactivity transcripts, enabling cytoplasmic translocation and translation upon engaging ribosomes, underlying their reactive transformation. A small number of intron retaining transcripts escape to the cytoplasm where they are degraded by nonsense mediated decay (NMD), which is enhanced in ALS astrocytes.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TbSAP is a novel chromatin protein repressing metacyclic variant surface glycoprotein expression sites in bloodstream form <i>Trypanosoma brucei</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017895647-0df24946-c577-4b04-b1e3-973363e981e3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab109</link>
            <description><![CDATA[<p class="para" id="N65541">The African trypanosome <i>Trypanosoma brucei</i> is a unicellular eukaryote, which relies on a protective variant surface glycoprotein (VSG) coat for survival in the mammalian host. A single trypanosome has &gt;2000 <i>VSG</i> genes and pseudogenes of which only one is expressed from one of ∼15 telomeric bloodstream form expression sites (BESs). Infectious metacyclic trypanosomes present within the tsetse fly vector also express <i>VSG</i> from a separate set of telomeric metacyclic ESs (MESs). All MESs are silenced in bloodstream form <i>T. brucei</i>. As very little is known about how this is mediated, we performed a whole genome RNAi library screen to identify MES repressors. This allowed us to identify a novel SAP domain containing DNA binding protein which we called TbSAP. TbSAP is enriched at the nuclear periphery and binds both MESs and BESs. Knockdown of TbSAP in bloodstream form trypanosomes did not result in cells becoming more ‘metacyclic-like'. Instead, there was extensive global upregulation of transcripts including MES <i>VSG</i>s, <i>VSG</i>s within the silent <i>VSG</i> arrays as well as genes immediately downstream of BES promoters. TbSAP therefore appears to be a novel chromatin protein playing an important role in silencing the extensive <i>VSG</i> repertoire of bloodstream form <i>T. brucei</i>.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Streamlining CRISPR spacer-based bacterial host predictions to decipher the viral dark matter]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017392697-61fc6349-3acc-4e0f-a1b4-a2cf85325c8b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab133</link>
            <description><![CDATA[<p class="para" id="N65541">Thousands of new phages have recently been discovered thanks to viral metagenomics. These phages are extremely diverse and their genome sequences often do not resemble any known phages. To appreciate their ecological impact, it is important to determine their bacterial hosts. CRISPR spacers can be used to predict hosts of unknown phages, as spacers represent biological records of past phage–bacteria interactions. However, no guidelines have been established to standardize host prediction based on CRISPR spacers. Additionally, there are no tools that use spacers to perform host predictions on large viral datasets. Here, we developed a set of tools that includes all the necessary steps for predicting the hosts of uncharacterized phages. We created a database of &gt;11 million spacers and a program to execute host predictions on large viral datasets. Our host prediction approach uses biological criteria inspired by how CRISPR–Cas naturally work as adaptive immune systems, which make the results easy to interpret. We evaluated the performance using 9484 phages with known hosts and obtained a recall of 49% and a precision of 69%. We also found that this host prediction method yielded higher performance for phages that infect gut-associated bacteria, suggesting it is well suited for gut-virome characterization.</p>]]></description>
            <pubDate><![CDATA[2021-03-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Frustrated folding of guanine quadruplexes in telomeric DNA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017379003-c711c9ce-f5ad-456b-9bf6-6a1c5da78b62/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab140</link>
            <description><![CDATA[<p class="para" id="N65541">Human chromosomes terminate in long, single-stranded, DNA overhangs of the repetitive sequence (TTAGGG)n. Sets of four adjacent TTAGGG repeats can fold into guanine quadruplexes (GQ), four-stranded structures that are implicated in telomere maintenance and cell immortalization and are targets in cancer therapy. Isolated GQs have been studied in detail, however much less is known about folding in long repeat sequences. Such chains adopt an enormous number of configurations containing various arrangements of GQs and unfolded gaps, leading to a highly frustrated energy landscape. To better understand this phenomenon, we used mutagenesis, thermal melting, and global analysis to determine stability, kinetic, and cooperativity parameters for GQ folding within chains containing 8–12 TTAGGG repeats. We then used these parameters to simulate the folding of 32-repeat chains, more representative of intact telomeres. We found that a combination of folding frustration and negative cooperativity between adjacent GQs increases TTAGGG unfolding by up to 40-fold, providing an abundance of unfolded gaps that are potential binding sites for telomeric proteins. This effect was most pronounced at the chain termini, which could promote telomere extension by telomerase. We conclude that folding frustration is an important and largely overlooked factor controlling the structure of telomeric DNA.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766017379003-c711c9ce-f5ad-456b-9bf6-6a1c5da78b62/assets/gkab140gra1.jpg" alt="Mutagenesis, thermal melts and computational analyses show that folding frustration is a key determinant of guanine quadruplex folding in long telomeric repeat DNA."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Mutagenesis, thermal melts and computational analyses show that folding frustration is a key determinant of guanine quadruplex folding in long telomeric repeat DNA.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Corrigendum to article “A programmable omnipotent Argonaute nuclease from mesophilic bacteria <i>Kurthia massiliensis</i>’’]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017373402-4d3a52b8-c437-459c-9325-881755ece55f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab192</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-03-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Unraveling the interaction between doxorubicin and DNA origami nanostructures for customizable chemotherapeutic drug release]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017354897-2588d048-5f17-404d-b1f0-15197f6dd72a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab097</link>
            <description><![CDATA[<p class="para" id="N65541">Doxorubicin (DOX) is a common drug in cancer chemotherapy, and its high DNA-binding affinity can be harnessed in preparing DOX-loaded DNA nanostructures for targeted delivery and therapeutics. Although DOX has been widely studied, the existing literature of DOX-loaded DNA-carriers remains limited and incoherent. Here, based on an in-depth spectroscopic analysis, we characterize and optimize the DOX loading into different 2D and 3D scaffolded DNA origami nanostructures (DONs). In our experimental conditions, all DONs show similar DOX binding capacities (one DOX molecule per two to three base pairs), and the binding equilibrium is reached within seconds, remarkably faster than previously acknowledged. To characterize drug release profiles, DON degradation and DOX release from the complexes upon DNase I digestion was studied. For the employed DONs, the relative doses (DOX molecules released per unit time) may vary by two orders of magnitude depending on the DON superstructure. In addition, we identify DOX aggregation mechanisms and spectral changes linked to pH, magnesium, and DOX concentration. These features have been largely ignored in experimenting with DNA nanostructures, but are probably the major sources of the incoherence of the experimental results so far. Therefore, we believe this work can act as a guide to tailoring the release profiles and developing better drug delivery systems based on DNA-carriers.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[BRCA1-BARD1 regulates transcription through BRD4 in <i>Xenopus</i> nucleoplasmic extract]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017339399-5c53cad4-e650-4fe7-8be9-d67c55425e72/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab111</link>
            <description><![CDATA[<p class="para" id="N65541">The tumor suppressor BRCA1 is considered a master regulator of genome integrity. Although widely recognized for its DNA repair functions, BRCA1 has also been implicated in various mechanisms of chromatin remodeling and transcription regulation. However, the precise role that BRCA1 plays in these processes has been difficult to establish due to the widespread consequences of its cellular dysfunction. Here, we use nucleoplasmic extract derived from the eggs of <i>Xenopus laevis</i> to investigate the role of BRCA1 in a cell-free transcription system. We report that BRCA1-BARD1 suppresses transcription initiation independent of DNA damage signaling and its established role in histone H2A ubiquitination. BRCA1-BARD1 acts through a histone intermediate, altering acetylation of histone H4K8 and recruitment of the chromatin reader and oncogene regulator BRD4. Together, these results establish a functional relationship between an established (BRCA1) and emerging (BRD4) regulator of genome integrity.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766017339399-5c53cad4-e650-4fe7-8be9-d67c55425e72/assets/gkab111gra1.jpg" alt="BRCA1-BARD1 regulates transcription initiation by limiting recruitment of the chromatin reader BRD4."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      BRCA1-BARD1 regulates transcription initiation by limiting recruitment of the chromatin reader BRD4.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A RanBP2-type zinc finger protein functions in intron splicing in Arabidopsis mitochondria and is involved in the biogenesis of respiratory complex I]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017319232-ef0ecce4-15e5-4a3c-a6db-2c920df8f411/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab066</link>
            <description><![CDATA[<p class="para" id="N65541">The RanBP2 zinc finger (Znf) domain is a prevalent domain that mediates protein interaction and RNA binding. In Arabidopsis, a clade of four RanBP2 Znf-containing proteins, named the Organelle Zinc (OZ) finger family, are known or predicted to be targeted to either the mitochondria or the plastids. Previously we reported that OZ1 is absolutely required for the editing of 14 sites in chloroplasts. We now have investigated the function of OZ2, whose null mutation is embryo lethal. We rescued the null mutant by expressing wild-type <i>OZ2</i> under the control of the seed-specific ABSCISIC ACID-INSENSITIVE3 (ABI3) promoter. Rescued mutant plants exhibit severely delayed development and a distinctive morphological phenotype. Genetic and biochemical analyses demonstrated that OZ2 promotes the splicing of transcripts of several mitochondrial <i>nad</i> genes and <i>rps3</i>. The splicing defect of <i>nad</i> transcripts results in the destabilization of complex I, which in turn affects the respiratory ability of <i>oz2</i> mutants, turning on the alternative respiratory pathway, and impacting the plant development. Protein-protein interaction assays demonstrated binding of OZ2 to several known mitochondrial splicing factors targeting the same splicing events. These findings extend the known functional repertoire of the RanBP2 zinc finger domain in nuclear splicing to include plant organelle splicing.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Spatial coupling between DNA replication and mismatch repair in <i>Caulobacter crescentus</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017299517-9f2d3033-d2db-4998-9d3a-3e4581a98d56/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab112</link>
            <description><![CDATA[<p class="para" id="N65541">The DNA mismatch repair (MMR) process detects and corrects replication errors in organisms ranging from bacteria to humans. In most bacteria, it is initiated by MutS detecting mismatches and MutL nicking the mismatch-containing DNA strand. Here, we show that MMR reduces the appearance of rifampicin resistances more than a 100-fold in the <i>Caulobacter crescentus Alphaproteobacterium</i>. Using fluorescently-tagged and functional MutS and MutL proteins, live cell microscopy experiments showed that MutS is usually associated with the replisome during the whole S-phase of the <i>C. crescentus</i> cell cycle, while MutL molecules may display a more dynamic association with the replisome. Thus, MMR components appear to use a 1D-scanning mode to search for rare mismatches, although the spatial association between MutS and the replisome is dispensible under standard growth conditions. Conversely, the spatial association of MutL with the replisome appears as critical for MMR in <i>C. crescentus</i>, suggesting a model where the β-sliding clamp licences the endonuclease activity of MutL right behind the replication fork where mismatches are generated. The spatial association between MMR and replisome components may also play a role in speeding up MMR and/or in recognizing which strand needs to be repaired in a variety of <i>Alphaproteobacteria</i>.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1766017299517-9f2d3033-d2db-4998-9d3a-3e4581a98d56/assets/gkab112gra1.jpg" alt="In Caulobacter crescentus, MutS is recruited to the replication fork to facilitate detection of replication errors. The MutL endonuclease is licensed by the replisome when MutS detects a mismatch."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      In <i>Caulobacter crescentus</i>, MutS is recruited to the replication fork to facilitate detection of replication errors. The MutL endonuclease is licensed by the replisome when MutS detects a mismatch.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-03-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Disruption of exon-bridging interactions between the minor and major spliceosomes results in alternative splicing around minor introns]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766017232064-5caaff17-efbd-434e-844b-4d029f96d111/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab118</link>
            <description><![CDATA[<p class="para" id="N65541">Vertebrate genomes contain major (&gt;99.5%) and minor (&lt;0.5%) introns that are spliced by the major and minor spliceosomes, respectively. Major intron splicing follows the exon-definition model, whereby major spliceosome components first assemble across exons. However, since most genes with minor introns predominately consist of major introns, formation of exon-definition complexes in these genes would require interaction between the major and minor spliceosomes. Here, we report that minor spliceosome protein U11-59K binds to the major spliceosome U2AF complex, thereby supporting a model in which the minor spliceosome interacts with the major spliceosome across an exon to regulate the splicing of minor introns. Inhibition of minor spliceosome snRNAs and U11-59K disrupted exon-bridging interactions, leading to exon skipping by the major spliceosome. The resulting aberrant isoforms contained a premature stop codon, yet were not subjected to nonsense-mediated decay, but rather bound to polysomes. Importantly, we detected elevated levels of these alternatively spliced transcripts in individuals with minor spliceosome-related diseases such as Roifman syndrome, Lowry–Wood syndrome and early-onset cerebellar ataxia. In all, we report that the minor spliceosome informs splicing by the major spliceosome through exon-definition interactions and show that minor spliceosome inhibition results in aberrant alternative splicing in disease.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Oligomeric complexes formed by Redβ single strand annealing protein in its different DNA bound states]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766011043188-ba4c6eac-4e68-4fde-8675-0c3c0643a3bd/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab125</link>
            <description><![CDATA[<p class="para" id="N65541">Redβ is a single strand annealing protein from bacteriophage λ that binds loosely to ssDNA, not at all to pre-formed dsDNA, but tightly to a duplex intermediate of annealing. As viewed by electron microscopy, Redβ forms oligomeric rings on ssDNA substrate, and helical filaments on the annealed duplex intermediate. However, it is not clear if these are the functional forms of the protein <i>in vivo</i>. We have used size-exclusion chromatography coupled with multi-angle light scattering, analytical ultracentrifugation and native mass spectrometry (nMS) to characterize the size of the oligomers formed by Redβ in its different DNA-bound states. The nMS data, which resolve species with the highest resolution, reveal that Redβ forms an oligomer of 12 subunits in the absence of DNA, complexes ranging from 4 to 14 subunits on 38-mer ssDNA, and a much more distinct and stable complex of 11 subunits on 38-mer annealed duplex. We also measure the concentration of Redβ in cells active for recombination and find it to range from 7 to 27 μM. Collectively, these data provide new insights into the dynamic nature of the complex on ssDNA, and the more stable and defined complex on annealed duplex.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Trypanosome RNAEditing Substrate Binding Complex integrity and function depends on the upstream action of RESC10]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009954888-08f7e48c-c432-40c7-8528-3e99d41e5c8c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab129</link>
            <description><![CDATA[<p class="para" id="N65541">Uridine insertion/deletion editing of mitochondrial mRNAs is a characteristic feature of kinetoplastids, including <i>Trypanosoma brucei</i>. Editing is directed by <i>trans</i>-acting gRNAs and catalyzed by related RNA Editing Core Complexes (RECCs). The non-catalytic RNA <span style="text-decoration: underline">E</span>diting Substrate Binding Complex (RESC) coordinates interactions between RECC, gRNA and mRNA. RESC is a dynamic complex comprising GRBC (Guide RNA Binding Complex) and heterogeneous REMCs (RNA Editing Mediator Complexes). Here, we show that RESC10 is an essential, low abundance, RNA binding protein that exhibits RNase-sensitive and RNase-insensitive interactions with RESC proteins, albeit its minimal <i>in vivo</i> interaction with RESC13. RESC10 RNAi causes extensive RESC disorganization, including disruption of intra-GRBC protein–protein interactions, as well as mRNA depletion from GRBC and accumulation on REMCs. Analysis of mitochondrial RNAs at single nucleotide resolution reveals transcript-specific effects: RESC10 dramatically impacts editing progression in pan-edited RPS12 mRNA, but is critical for editing initiation in mRNAs with internally initiating gRNAs, pointing to distinct initiation mechanisms for these RNA classes. Correlations between sites at which editing pauses in RESC10 depleted cells and those in knockdowns of previously studied RESC proteins suggest that RESC10 acts upstream of these factors and that RESC is particularly important in promoting transitions between uridine insertion and deletion RECCs.</p>]]></description>
            <pubDate><![CDATA[2021-03-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Interrogating accessibility of telomeric sequences with FRET-PAINT: evidence for length-dependent telomere compaction]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009937978-54638633-1f83-47d7-ac6b-9e8c01277c99/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab067</link>
            <description><![CDATA[<p class="para" id="N65541">Single-stranded telomeric overhangs are ∼200 nucleotides long and can form tandem G-quadruplex (GQ) structures, which reduce their accessibility to nucleases and proteins that activate DNA damage response. Whether these tandem GQs further stack to form compact superstructures, which may provide better protection for longer telomeres, is not known. We report single-molecule measurements where the accessibility of 24–144 nucleotide long human telomeric DNA molecules is interrogated by a short PNA molecule that is complementary to a single GGGTTA repeat, as implemented in the FRET-PAINT method. Binding of the PNA strand to available GGGTTA sequences results in discrete FRET bursts which were analyzed in terms of their dwell times, binding frequencies, and topographic distributions. The binding frequencies were greater for binding to intermediate regions of telomeric DNA compared to 3′- or 5′-ends, suggesting these regions are more accessible. Significantly, the binding frequency per telomeric repeat monotonically decreased with increasing telomere length. These results are consistent with telomeres forming more compact structures at longer lengths, reducing accessibility of these critical genomic sites.</p>]]></description>
            <pubDate><![CDATA[2021-03-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A CRISPR-Cas9–integrase complex generates precise DNA fragments for genome integration]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009910465-7709bb64-04b7-41aa-96fc-f8a541c150d8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab123</link>
            <description><![CDATA[<p class="para" id="N65541">CRISPR-Cas9 is an RNA-guided DNA endonuclease involved in bacterial adaptive immunity and widely repurposed for genome editing in human cells, animals and plants. In bacteria, RNA molecules that guide Cas9′s activity derive from foreign DNA fragments that are captured and integrated into the host CRISPR genomic locus by the Cas1-Cas2 CRISPR integrase. How cells generate the specific lengths of DNA required for integrase capture is a central unanswered question of type II-A CRISPR-based adaptive immunity. Here, we show that an integrase supercomplex comprising guide RNA and the proteins Cas1, Cas2, Csn2 and Cas9 generates precisely trimmed 30-base pair DNA molecules required for genome integration. The HNH active site of Cas9 catalyzes exonucleolytic DNA trimming by a mechanism that is independent of the guide RNA sequence. These results show that Cas9 possesses a distinct catalytic capacity for generating immunological memory in prokaryotes.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Methylated HNRNPK acts on RPS19 to regulate ALOX15 synthesis in erythropoiesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009876670-11ecd2fb-271f-4ce0-9855-1ccef34d8806/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab116</link>
            <description><![CDATA[<p class="para" id="N65541">Post-transcriptional control is essential to safeguard structural and metabolic changes in enucleated reticulocytes during their terminal maturation to functional erythrocytes. The timely synthesis of arachidonate 15-lipoxygenase (ALOX15), which initiates mitochondria degradation at the final stage of reticulocyte maturation is regulated by the multifunctional protein HNRNPK. It constitutes a silencing complex at the ALOX15 mRNA 3′ untranslated region that inhibits translation initiation at the AUG by impeding the joining of ribosomal 60S subunits to 40S subunits. To elucidate how HNRNPK interferes with 80S ribosome assembly, three independent screens were applied. They consistently demonstrated a differential interaction of HNRNPK with RPS19, which is localized at the head of the 40S subunit and extends into its functional center. During induced erythroid maturation of K562 cells, decreasing arginine dimethylation of HNRNPK is linked to a reduced interaction with RPS19 <i>in vitro</i> and <i>in vivo</i>. Dimethylation of residues R256, R258 and R268 in HNRNPK affects its interaction with RPS19. In noninduced K562 cells, RPS19 depletion results in the induction of ALOX15 synthesis and mitochondria degradation. Interestingly, residue W52 in RPS19, which is frequently mutated in Diamond-Blackfan Anemia (DBA), participates in specific HNRNPK binding and is an integral part of a putative aromatic cage.</p>]]></description>
            <pubDate><![CDATA[2021-02-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Xenogeneic silencing relies on temperature-dependent phosphorylation of the host H-NS protein in <i>Shewanella</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009867393-9b888ed1-0f69-4b86-8bc2-946344268c8b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab137</link>
            <description><![CDATA[<p class="para" id="N65541">Lateral gene transfer (LGT) plays a key role in shaping the genome evolution and environmental adaptation of bacteria. Xenogeneic silencing is crucial to ensure the safe acquisition of LGT genes into host pre-existing regulatory networks. We previously found that the host nucleoid structuring protein (H-NS) silences prophage CP4So at warm temperatures yet enables this prophage to excise at cold temperatures in <i>Shewanella oneidensis</i>. However, whether H-NS silences other genes and how bacteria modulate H-NS to regulate the expression of genes have not been fully elucidated. In this study, we discovered that the H-NS silences many LGT genes and the xenogeneic silencing of H-NS relies on a temperature-dependent phosphorylation at warm temperatures in <i>S. oneidensis</i>. Specifically, phosphorylation of H-NS at Ser42 is critical for silencing the cold-inducible genes including the excisionase of CP4So prophage, a cold shock protein, and a stress-related chemosensory system. By contrast, nonphosphorylated H-NS derepresses the promoter activity of these genes/operons to enable their expression at cold temperatures. Taken together, our results reveal that the posttranslational modification of H-NS can function as a regulatory switch to control LGT gene expression in host genomes to enable the host bacterium to react and thrive when environmental temperature changes.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Binding site profiles and N-terminal minor groove interactions of the master quorum-sensing regulator LuxR enable flexible control of gene activation and repression]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009779490-f7c11e6c-7953-40c4-8855-b801540e3199/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab150</link>
            <description><![CDATA[<p class="para" id="N65541">LuxR is a TetR family master quorum sensing (QS) regulator activating or repressing expression of hundreds of genes that control collective behaviors in <i>Vibrios</i> with underlying mechanism unknown. To illuminate how this regulator controls expression of various target genes, we applied ChIP-seq and DNase I-seq technologies. <i>Vibrio alginolyticus</i> LuxR controls expression of ∼280 genes that contain either symmetric palindrome (repDNA) or asymmetric (actDNA) binding motifs with different binding profiles. The median number of LuxR binding sites for activated genes are nearly double for that of repressed genes. Crystal structures of LuxR in complex with the respective repDNA and actDNA motifs revealed a new mode of LuxR DNA binding that involves contacts of its N-terminal extension to the minor groove. The N-terminal contacts mediated by Arginine-9 and Arginine-11 differ when LuxR binds to repDNA vs actDNA, leading to higher binding affinity at repressed targets. Moreover, modification of LuxR binding sites, binding profiles, and N-terminal extension have important consequences on QS-regulated phenotypes. These results facilitate fundamental understanding of the high flexibility of mechanisms of LuxR control of gene activation and repression in <i>Vibrio</i> QS, which may facilitate to design QS inhibiting chemicals that interfere with LuxR regulation to effectively control pathogens.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Long-read sequencing and <i>de novo</i> genome assemblies reveal complex chromosome end structures caused by telomere dysfunction at the single nucleotide level]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009693525-edac7c73-1d52-43a8-a723-f38c113d6df4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab141</link>
            <description><![CDATA[<p class="para" id="N65541">Karyotype change and subsequent evolution is triggered by chromosome fusion and rearrangement events, which often occur when telomeres become dysfunctional. Telomeres protect linear chromosome ends from DNA damage responses (DDRs), and telomere dysfunction may result in genome instability. However, the complex chromosome end structures and the other possible consequences of telomere dysfunction have rarely been resolved at the nucleotide level due to the lack of the high-throughput methods needed to analyse these highly repetitive regions. Here we applied long-read sequencing technology to <i>Caenorhabditis elegans</i> survivor lines that emerged after telomere dysfunction. The survivors have preserved traces of DDRs in their genomes and our data revealed that variants generated by telomere dysfunction are accumulated along all chromosomes. The reconstruction of the chromosome end structures through <i>de novo</i> genome assemblies revealed diverse types of telomere damage processing at the nucleotide level. When telomeric repeats were totally eroded by telomere dysfunction, DDRs were mostly terminated by chromosome fusion events. We also partially reconstructed the most complex end structure and its DDR signatures, which would have been accumulated via multiple cell divisions. These finely resolved chromosome end structures suggest possible mechanisms regarding the repair processes after telomere dysfunction, providing insights into chromosome evolution in nature.</p>]]></description>
            <pubDate><![CDATA[2021-03-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DOCK7 protects against replication stress by promoting RPA stability on chromatin]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009657840-f5875c94-99e8-47bd-b865-fd23317547b2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab134</link>
            <description><![CDATA[<p class="para" id="N65541">RPA is a critical factor for DNA replication and replication stress response. Surprisingly, we found that chromatin RPA stability is tightly regulated. We report that the GDP/GTP exchange factor DOCK7 acts as a critical replication stress regulator to promote RPA stability on chromatin. DOCK7 is phosphorylated by ATR and then recruited by MDC1 to the chromatin and replication fork during replication stress. DOCK7-mediated Rac1/Cdc42 activation leads to the activation of PAK1, which subsequently phosphorylates RPA1 at S135 and T180 to stabilize chromatin-loaded RPA1 and ensure proper replication stress response. Moreover, DOCK7 is overexpressed in ovarian cancer and depleting DOCK7 sensitizes cancer cells to camptothecin. Taken together, our results highlight a novel role for DOCK7 in regulation of the replication stress response and highlight potential therapeutic targets to overcome chemoresistance in cancer.</p>]]></description>
            <pubDate><![CDATA[2021-03-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A novel RNA pol II CTD interaction site on the mRNA capping enzyme is essential for its allosteric activation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009391525-6378f0d2-f207-4385-9312-113ddf62e531/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab130</link>
            <description><![CDATA[<p class="para" id="N65541">Recruitment of the mRNA capping enzyme (CE/RNGTT) to the site of transcription is essential for the formation of the 5′ mRNA cap, which in turn ensures efficient transcription, splicing, polyadenylation, nuclear export and translation of mRNA in eukaryotic cells. The CE GTase is recruited and activated by the Serine-5 phosphorylated carboxyl-terminal domain (CTD) of RNA polymerase II. Through the use of molecular dynamics simulations and enhanced sampling techniques, we provide a systematic and detailed characterization of the human CE–CTD interface, describing the effect of the CTD phosphorylation state, length and orientation on this interaction. Our computational analyses identify novel CTD interaction sites on the human CE GTase surface and quantify their relative contributions to CTD binding. We also identify, for the first time, allosteric connections between the CE GTase active site and the CTD binding sites, allowing us to propose a mechanism for allosteric activation. Through binding and activity assays we validate the novel CTD binding sites and show that the CDS2 site is essential for CE GTase activity stimulation. Comparison of the novel sites with cocrystal structures of the CE–CTD complex in different eukaryotic taxa reveals that this interface is considerably more conserved than previous structures have indicated.</p>]]></description>
            <pubDate><![CDATA[2021-03-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Significant non-existence of sequences in genomes and proteomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009368641-6df9e1e7-4b86-4119-bd3c-c0dc04e76e3d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab139</link>
            <description><![CDATA[<p class="para" id="N65541">Minimal absent words (MAWs) are minimal-length oligomers absent from a genome or proteome. Although some artificially synthesized MAWs have deleterious effects, there is still a lack of a strategy for the classification of non-occurring sequences as potentially malicious or benign. In this work, by using Markovian models with multiple-testing correction, we reveal significant absent oligomers, which are statistically expected to exist. This suggests that their absence is due to negative selection. We survey genomes and proteomes covering the diversity of life and find thousands of significant absent sequences. Common significant MAWs are often mono- or dinucleotide tracts, or palindromic. Significant viral MAWs are often restriction sites and may indicate unknown restriction motifs. Surprisingly, significant mammal genome MAWs are often present, but rare, in other mammals, suggesting that they are suppressed but not completely forbidden. Significant human MAWs are frequently present in prokaryotes, suggesting immune function, but rarely present in human viruses, indicating viral mimicry of the host. More than one-fourth of human proteins are one substitution away from containing a significant MAW, with the majority of replacements being predicted harmful. We provide a web-based, interactive database of significant MAWs across genomes and proteomes.</p>]]></description>
            <pubDate><![CDATA[2021-03-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[mTORC1 promotes TOP mRNA translation through site-specific phosphorylation of LARP1]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009312980-774b7381-5ce8-43cd-8d67-07abccc3b71f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1239</link>
            <description><![CDATA[<p class="para" id="N65541">LARP1 is a key repressor of TOP mRNA translation. It binds the m<sup>7</sup>Gppp cap moiety and the adjacent 5′TOP motif of TOP mRNAs, thus impeding the assembly of the eIF4F complex on these transcripts. mTORC1 controls TOP mRNA translation <i>via</i> LARP1, but the details of the mechanism are unclear. Herein we elucidate the mechanism by which mTORC1 controls LARP1’s translation repression activity. We demonstrate that mTORC1 phosphorylates LARP1 <i>in vitro</i> and <i>in vivo</i>, activities that are efficiently inhibited by rapamycin and torin1. We uncover 26 rapamycin-sensitive phospho-serine and -threonine residues on LARP1 that are distributed in 7 clusters. Our data show that phosphorylation of a cluster of residues located proximally to the m<sup>7</sup>Gppp cap-binding DM15 region is particularly sensitive to rapamycin and regulates both the RNA-binding and the translation inhibitory activities of LARP1. Our results unravel a new model of translation control in which the La module (LaMod) and DM15 region of LARP1, both of which can directly interact with TOP mRNA, are differentially regulated: the LaMod remains constitutively bound to PABP (irrespective of the activation status of mTORC1), while the C-terminal DM15 ‘pendular hook’ engages the TOP mRNA 5′-end to repress translation, but only in conditions of mTORC1 inhibition.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[SurVirus: a repeat-aware virus integration caller]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1766009304486-b3a6155e-eacb-422f-bf7a-a0b83d0dc88a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1237</link>
            <description><![CDATA[<p class="para" id="N65541">A significant portion of human cancers are due to viruses integrating into human genomes. Therefore, accurately predicting virus integrations can help uncover the mechanisms that lead to many devastating diseases. Virus integrations can be called by analysing second generation high-throughput sequencing datasets. Unfortunately, existing methods fail to report a significant portion of integrations, while predicting a large number of false positives. We observe that the inaccuracy is caused by incorrect alignment of reads in repetitive regions. False alignments create false positives, while missing alignments create false negatives. This paper proposes SurVirus, an improved virus integration caller that corrects the alignment of reads which are crucial for the discovery of integrations. We use publicly available datasets to show that existing methods predict hundreds of thousands of false positives; SurVirus, on the other hand, is significantly more precise while it also detects many novel integrations previously missed by other tools, most of which are in repetitive regions. We validate a subset of these novel integrations, and find that the majority are correct. Using SurVirus, we find that HPV and HBV integrations are enriched in LINE and Satellite regions which had been overlooked, as well as discover recurrent HBV and HPV breakpoints in human genome-virus fusion transcripts.</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Non-perfectly matching small RNAs can induce stable and heritable epigenetic modifications and can be used as molecular markers to trace the origin and fate of silencing RNAs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765949629448-bbe232a5-ac69-4ca6-a334-6d7c6b8079aa/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab023</link>
            <description><![CDATA[<p class="para" id="N65541">Short non-coding RNA molecules (sRNAs) play a fundamental role in gene regulation and development in higher organisms. They act as molecular postcodes and guide AGO proteins to target nucleic acids. In plants, sRNA-targeted mRNAs are degraded, reducing gene expression. In contrast, sRNA-targeted DNA sequences undergo cytosine methylation referred to as RNA-directed DNA methylation (RdDM). Cytosine methylation can suppress transcription, thus sRNAs are potent regulators of gene expression. sRNA-mediated RdDM is involved in genome stability through transposon silencing, mobile signalling for epigenetic gene control and hybrid vigour. Since cytosine methylation can be passed on to subsequent generations, RdDM contributes to transgenerational inheritance of the epigenome. Using a novel approach, which can differentiate between primary (inducer) and secondary (amplified) sRNAs, we show that initiation of heritable RdDM does not require complete sequence complementarity between the sRNAs and their nuclear target sequences. sRNAs with up to four regularly interspaced mismatches are potent inducers of RdDM, however, the number and disruptive nature of nucleotide polymorphisms negatively correlate with their efficacy. Our findings contribute to understanding how sRNA can directly shape the epigenome and may be used in designing the next generation of RNA silencing constructs.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Prpf31 is essential for the survival and differentiation of retinal progenitor cells by modulating alternative splicing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765949398662-696bc52b-fd9a-487f-9b97-7eb354df9657/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab003</link>
            <description><![CDATA[<p class="para" id="N65541">Dysfunction of splicing factors often result in abnormal cell differentiation and apoptosis, especially in neural tissues. Mutations in pre-mRNAs processing factor 31 (<i>PRPF31</i>) cause autosomal dominant retinitis pigmentosa, a progressive retinal degeneration disease. The transcriptome-wide splicing events specifically regulated by PRPF31 and their biological roles in the development and maintenance of retina are still unclear. Here, we showed that the differentiation and viability of retinal progenitor cells (RPCs) are severely perturbed in <i>prpf31</i> knockout zebrafish when compared with other tissues at an early embryonic stage. At the cellular level, significant mitotic arrest and DNA damage were observed. These defects could be rescued by the wild-type human PRPF31 rather than the disease-associated mutants. Further bioinformatic analysis and experimental verification uncovered that Prpf31 deletion predominantly causes the skipping of exons with a weak 5′ splicing site. Moreover, genes necessary for DNA repair and mitotic progression are most enriched among the differentially spliced events, which may explain the cellular and tissular defects in <i>prpf31</i> mutant retinas. This is the first time that Prpf31 is demonstrated to be essential for the survival and differentiation of RPCs during retinal neurogenesis by specifically modulating the alternative splicing of genes involved in DNA repair and mitosis.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Human pathways in animal models: possibilities and limitations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765949281111-3fdb7e0d-0579-42d8-b957-d305b7bb6868/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab012</link>
            <description><![CDATA[<p class="para" id="N65541">Animal models are crucial for advancing our knowledge about the molecular pathways involved in human diseases. However, it remains unclear to what extent tissue expression of pathways in healthy individuals is conserved between species. In addition, organism-specific information on pathways in animal models is often lacking. Within these limitations, we explore the possibilities that arise from publicly available data for the animal models mouse, rat, and pig. We approximate the animal pathways activity by integrating the human counterparts of curated pathways with tissue expression data from the models. Specifically, we compare whether the animal orthologs of the human genes are expressed in the same tissue. This is complicated by the lower coverage and worse quality of data in rat and pig as compared to mouse. Despite that, from 203 human KEGG pathways and the seven tissues with best experimental coverage, we identify 95 distinct pathways, for which the tissue expression in one animal model agrees better with human than the others. Our systematic pathway-tissue comparison between human and three animal modes points to specific similarities with human and to distinct differences among the animal models, thereby suggesting the most suitable organism for modeling a human pathway or tissue.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765949281111-3fdb7e0d-0579-42d8-b957-d305b7bb6868/assets/gkab012gra1.jpg" alt="Pathway-tissue comparison between human and three animal models."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Pathway-tissue comparison between human and three animal models.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>In vitro</i> selected GUAA tetraloop-binding receptors with structural plasticity and evolvability towards natural RNA structural modules]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765949017427-0cbba233-96bd-4d3b-ace5-1e10fced7083/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab021</link>
            <description><![CDATA[<p class="para" id="N65541">GNRA tetraloop-binding receptor interactions are key components in the macromolecular assembly of a variety of functional RNAs. In nature, there is an apparent bias for GAAA/11nt receptor and GYRA/helix interactions, with the former interaction being thermodynamically more stable than the latter. While past in vitro selections allowed isolation of novel GGAA and GUGA receptors, we report herein an <i>in vitro</i> selection that revealed several novel classes of specific GUAA receptors with binding affinities comparable to those from natural GAAA/11nt interactions. These GUAA receptors have structural homology with double-locked bulge RNA modules naturally occurring in ribosomal RNAs. They display mutational robustness that enables exploration of the sequence/phenotypic space associated to GNRA/receptor interactions through epistasis. Their thermodynamic self-assembly fitness landscape is characterized by a rugged neutral network with possible evolutionary trajectories toward natural GNRA/receptor interactions. High throughput sequencing analysis revealed synergetic mutations located away from the tertiary interactions that positively contribute to assembly fitness. Our study suggests that the repertoire of GNRA/receptor interactions is much larger than initially thought from the analysis of natural stable RNA molecules and also provides clues for their evolution towards natural GNRA/receptors.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RPA complexes in <i>Caenorhabditis elegans</i> meiosis; unique roles in replication, meiotic recombination and apoptosis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948467459-c66237d2-7589-450a-9556-b3a86d7324de/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1293</link>
            <description><![CDATA[<p class="para" id="N65541">Replication Protein A (RPA) is a critical complex that acts in replication and promotes homologous recombination by allowing recombinase recruitment to processed DSB ends. Most organisms possess three RPA subunits (RPA1, RPA2, RPA3) that form a trimeric complex critical for viability. The <i>Caenorhabditis elegans</i> genome encodes RPA-1, RPA-2 and an RPA-2 paralog RPA-4. In our analysis, we determined that RPA-2 is critical for germline replication and normal repair of meiotic DSBs. Interestingly, RPA-1 but not RPA-2 is essential for somatic replication, in contrast to other organisms that require both subunits. Six different hetero- and homodimeric complexes containing permutations of RPA-1, RPA-2 and RPA-4 can be detected in whole animal extracts. Our <i>in vivo</i> studies indicate that RPA-1/4 dimer is less abundant in the nucleus and its formation is inhibited by RPA-2. While RPA-4 does not participate in replication or recombination, we find that RPA-4 inhibits RAD-51 filament formation and promotes apoptosis of a subset of damaged nuclei. Altogether these findings point to sub-functionalization and antagonistic roles of RPA complexes in <i>C. elegans</i>.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Insight into formation propensity of pseudocircular DNA G-hairpins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948317765-20f1f751-641d-4e52-9e23-0b5340ba23a2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab029</link>
            <description><![CDATA[<p class="para" id="N65541">We recently showed that <i>Saccharomyces cerevisiae</i> telomeric DNA can fold into an unprecedented pseudocircular G-hairpin (PGH) structure. However, the formation of PGHs in the context of extended sequences, which is a prerequisite for their function <i>in vivo</i> and their applications in biotechnology, has not been elucidated. Here, we show that despite its ‘circular’ nature, PGHs tolerate single-stranded (ss) protrusions. High-resolution NMR structure of a novel member of PGH family reveals the atomistic details on a junction between ssDNA and PGH unit. Identification of new sequences capable of folding into one of the two forms of PGH helped in defining minimal sequence requirements for their formation. Our time-resolved NMR data indicate a possibility that PGHs fold via a complex kinetic partitioning mechanism and suggests the existence of K<sup>+</sup> ion-dependent PGH folding intermediates. The data not only provide an explanation of cation-type-dependent formation of PGHs, but also explain the unusually large hysteresis between PGH melting and annealing noted in our previous study. Our findings have important implications for DNA biology and nanotechnology. Overrepresentation of sequences able to form PGHs in the evolutionary-conserved regions of the human genome implies their functionally important biological role(s).</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Another layer of complexity in <i>Staphylococcus aureus</i> methionine biosynthesis control: unusual RNase III-driven T-box riboswitch cleavage determines <i>met</i> operon mRNA stability and decay]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948083023-b78f3824-fd1e-428d-b88d-589cfea783d2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1277</link>
            <description><![CDATA[<p class="para" id="N65541">In <i>Staphylococcus aureus, de novo</i> methionine biosynthesis is regulated by a unique hierarchical pathway involving stringent-response controlled CodY repression in combination with a T-box riboswitch and RNA decay. The T-box riboswitch residing in the 5′ untranslated region (<i>met</i> leader RNA) of the <i>S. aureus metICFE-mdh</i> operon controls downstream gene transcription upon interaction with uncharged methionyl-tRNA. <i>met</i> leader and <i>metICFE-mdh</i> (m)RNAs undergo RNase-mediated degradation in a process whose molecular details are poorly understood. Here we determined the secondary structure of the <i>met</i> leader RNA and found the element to harbor, beyond other conserved T-box riboswitch structural features, a terminator helix which is target for RNase III endoribonucleolytic cleavage. As the terminator is a thermodynamically highly stable structure, it also forms posttranscriptionally in <i>met</i> leader/ <i>metICFE-mdh</i> read-through transcripts. Cleavage by RNase III releases the <i>met</i> leader from <i>metICFE-mdh</i> mRNA and initiates RNase J-mediated degradation of the mRNA from the 5′-end. Of note, <i>metICFE-mdh</i> mRNA stability varies over the length of the transcript with a longer lifespan towards the 3′-end. The obtained data suggest that coordinated RNA decay represents another checkpoint in a complex regulatory network that adjusts costly methionine biosynthesis to current metabolic requirements.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765948083023-b78f3824-fd1e-428d-b88d-589cfea783d2/assets/gkaa1277gra1.jpg" alt="The MET-T-box riboswitch, controlling methionine biosynthesis in Staphylococcus aureus, is target of RNase III-mediated cleavage which in turn initiates met operon mRNA decay from the 5′-end involving RNase J."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      The MET-T-box riboswitch, controlling methionine biosynthesis in <i>Staphylococcus aureus</i>, is target of RNase III-mediated cleavage which in turn initiates <i>met</i> operon mRNA decay from the 5′-end involving RNase J.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Small-molecule inhibitors of histone deacetylase improve CRISPR-based adenine base editing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948059563-070974ee-b967-4d4c-a5cb-0a85cd37da19/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab052</link>
            <description><![CDATA[<p class="para" id="N65541">CRISPR-based base editors (BEs) are widely used to induce nucleotide substitutions in living cells and organisms without causing the damaging DNA double-strand breaks and DNA donor templates. Cytosine BEs that induce C:G to T:A conversion and adenine BEs that induce A:T to G:C conversion have been developed. Various attempts have been made to increase the efficiency of both BEs; however, their activities need to be improved for further applications. Here, we describe a fluorescent reporter-based drug screening platform to identify novel chemicals with the goal of improving adenine base editing efficiency. The reporter system revealed that histone deacetylase inhibitors, particularly romidepsin, enhanced base editing efficiencies by up to 4.9-fold by increasing the expression levels of proteins and target accessibility. The results support the use of romidepsin as a viable option to improve base editing efficiency in biomedical research and therapeutic genome engineering.</p>]]></description>
            <pubDate><![CDATA[2021-02-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mechanism of DNA cleavage by the endonuclease SauUSI: a major barrier to horizontal gene transfer and antibiotic resistance in <i>Staphylococcus aureus</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765948031973-b2a61142-b7c3-4fd3-9102-3930ac4eef6f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab042</link>
            <description><![CDATA[<p class="para" id="N65541">Acquisition of foreign DNA by <i>Staphylococcus aureus</i>, including vancomycin resistance genes, is thwarted by the ATP-dependent endonuclease SauUSI. Deciphering the mechanism of action of SauUSI could unravel the reason how it singularly plays a major role in preventing horizontal gene transfer (HGT) in <i>S. aureus</i>. Here, we report a detailed biochemical and structural characterization of SauUSI, which reveals that in the presence of ATP, the enzyme can cleave DNA having a single or multiple target site/s. Remarkably, in the case of multiple target sites, the entire region of DNA flanked by two target sites is shred into smaller fragments by SauUSI. Crystal structure of SauUSI reveals a stable dimer held together by the nuclease domains, which are spatially arranged to hydrolyze the phosphodiester bonds of both strands of the duplex. Thus, the architecture of the dimeric SauUSI facilitates cleavage of either single-site or multi-site DNA. The structure also provides insights into the molecular basis of target recognition by SauUSI. We show that target recognition activates ATP hydrolysis by the helicase-like ATPase domain, which powers active directional movement (translocation) of SauUSI along the DNA. We propose that a pile-up of multiple translocating SauUSI molecules against a stationary SauUSI bound to a target site catalyzes random double-stranded breaks causing shredding of the DNA between two target sites. The extensive and irreparable damage of the foreign DNA by shredding makes SauUSI a potent barrier against HGT.</p>]]></description>
            <pubDate><![CDATA[2021-02-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mobile element warfare via CRISPR and anti-CRISPR in <i>Pseudomonas aeruginosa</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765947827544-11fd700a-184d-4fdc-a1d4-efcfcd6adcb1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab006</link>
            <description><![CDATA[<p class="para" id="N65541">Bacteria deploy multiple defenses to prevent mobile genetic element (MGEs) invasion. CRISPR–Cas immune systems use RNA-guided nucleases to target MGEs, which counter with anti-CRISPR (Acr) proteins. Our understanding of the biology and co-evolutionary dynamics of the common Type I-C CRISPR–Cas subtype has lagged because it lacks an in vivo phage-host model system. Here, we show the anti-phage function of a <i>Pseudomonas aeruginosa</i> Type I-C CRISPR–Cas system encoded on a conjugative pKLC102 island, and its Acr-mediated inhibition by distinct MGEs. Seven genes with anti-Type I-C function (<i>acrIC</i> genes) were identified, many with highly acidic amino acid content, including previously described DNA mimic AcrIF2. Four of the acr genes were broad spectrum, also inhibiting I-E or I-F <i>P. aeruginosa</i> CRISPR–Cas subtypes. Dual inhibition comes at a cost, however, as simultaneous expression of Type I-C and I-F systems renders phages expressing the dual inhibitor AcrIF2 more sensitive to targeting. Mutagenesis of numerous acidic residues in AcrIF2 did not impair anti-I-C or anti-I-F function per se but did exacerbate inhibition defects during competition, suggesting that excess negative charge may buffer DNA mimics against competition. Like AcrIF2, five of the Acr proteins block Cascade from binding DNA, while two function downstream, likely preventing Cas3 recruitment or activity. One such inhibitor, AcrIC3, is found in an ‘anti-Cas3’ cluster within conjugative elements, encoded alongside bona fide Cas3 inhibitors AcrIF3 and AcrIE1. Our findings demonstrate an active battle between an MGE-encoded CRISPR–Cas system and its diverse MGE targets.</p>]]></description>
            <pubDate><![CDATA[2021-02-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MazF toxin causes alterations in <i>Staphylococcus aureus</i> transcriptome, translatome and proteome that underlie bacterial dormancy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765947526741-5dd57a90-fd71-4f6d-97d0-5061858bda9a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1292</link>
            <description><![CDATA[<p class="para" id="N65541">Antibiotic resistance is a serious problem which may be caused by bacterial dormancy. It has been suggested that bacterial toxin–antitoxin systems induce dormancy. We analyzed the genome-wide role of <i>Staphylococcus aureus</i> endoribonuclease toxin MazF using RNA-Seq, Ribo-Seq and quantitative proteomics. We characterized changes in transcriptome, translatome and proteome caused by MazF, and proposed that MazF decreases translation directly by cleaving mRNAs, and indirectly, by decreasing translation factors and by promoting ribosome hibernation. Important pathways affected during the early stage of MazF induction were identified: MazF increases cell wall thickness and decreases cell division; MazF activates SsrA-system which rescues stalled ribosomes, appearing as a result of MazF mRNA cleavage. These pathways may be promising targets for new antibacterial drugs that prevent bacteria dormancy. Finally, we described the overall impact of MazF on <i>S. aureus</i> cell physiology, and propose one of the mechanisms by which MazF might regulate cellular changes leading to dormancy.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765947526741-5dd57a90-fd71-4f6d-97d0-5061858bda9a/assets/gkaa1292gra1.jpg" alt="MazF toxin causes alterations in Staphylococcus aureus transcriptome, translatome and proteome that underlie bacterial dormancy."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      MazF toxin causes alterations in Staphylococcus aureus transcriptome, translatome and proteome that underlie bacterial dormancy.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structure of a reaction intermediate mimic in t<sup>6</sup>A biosynthesis bound in the active site of the TsaBD heterodimer from <i>Escherichia coli</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765947060161-66f5f018-e414-44c7-84f3-2b4657e661b1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab026</link>
            <description><![CDATA[<p class="para" id="N65541">The tRNA modification N6-threonylcarbamoyladenosine (t<sup>6</sup>A) is universally conserved in all organisms. In bacteria, the biosynthesis of t<sup>6</sup>A requires four proteins (TsaBCDE) that catalyze the formation of t<sup>6</sup>A via the unstable intermediate <span style="font-variant: all-small-caps">l</span>-threonylcarbamoyl-adenylate (TC-AMP). While the formation and stability of this intermediate has been studied in detail, the mechanism of its transfer to A37 in tRNA is poorly understood. To investigate this step, the structure of the TsaBD heterodimer from <i>Escherichia coli</i> has been solved bound to a stable phosphonate isosteric mimic of TC-AMP. The phosphonate inhibits t<sup>6</sup>A synthesis <i>in vitro</i> with an IC<sub>50</sub> value of 1.3 μM in the presence of millimolar ATP and L-threonine. The inhibitor binds to TsaBD by coordination to the active site Zn atom via an oxygen atom from both the phosphonate and the carboxylate moieties. The bound conformation of the inhibitor suggests that the catalysis exploits a putative oxyanion hole created by a conserved active site loop of TsaD and that the metal essentially serves as a binding scaffold for the intermediate. The phosphonate bound crystal structure should be useful for the rational design of potent, drug-like small molecule inhibitors as mechanistic probes or potentially novel antibiotics.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>PAUPAR</i> and PAX6 sequentially regulate human embryonic stem cell cortical differentiation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765946995270-edb3b1e2-a811-4fc3-8279-e038e3f5b1e3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab030</link>
            <description><![CDATA[<p class="para" id="N65541">Long noncoding RNAs (lncRNAs) play a wide range of roles in the epigenetic regulation of crucial biological processes, but the functions of lncRNAs in cortical development are poorly understood. Using human embryonic stem cell (hESC)-based 2D neural differentiation approach and 3D cerebral organoid system, we identified that the lncRNA <i>PAUPAR</i>, which is adjacent to <i>PAX6</i>, plays essential roles in cortical differentiation by interacting with PAX6 to regulate the expression of a large number of neural genes. Mechanistic studies showed that <i>PAUPAR</i> confers PAX6 proper binding sites on the target neural genes by directly binding the genomic regions of these genes. Moreover, PAX6 recruits the histone methyltransferase NSD1 through its C-terminal PST enrichment domain, then regulate H3K36 methylation and the expression of target genes. Collectively, our data reveal that the <i>PAUPAR</i>/PAX6/NSD1 complex plays a critical role in the epigenetic regulation of hESC cortical differentiation and highlight the importance of <i>PAUPAR</i> as an intrinsic regulator of cortical differentiation.</p>]]></description>
            <pubDate><![CDATA[2021-02-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A heme•DNAzyme activated by hydrogen peroxide catalytically oxidizes thioethers by direct oxygen atom transfer rather than by a Compound I-like intermediate]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765946969160-2f74b14c-2a37-4c54-bb44-0ba4021f9ffb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab007</link>
            <description><![CDATA[<p class="para" id="N65541">Hemin [Fe(III)-protoporphyrin IX] is known to bind tightly to single-stranded DNA and RNA molecules that fold into G-quadruplexes (GQ). Such complexes are strongly activated for oxidative catalysis. These heme•DNAzymes and ribozymes have found broad utility in bioanalytical and medicinal chemistry and have also been shown to occur within living cells. However, how a GQ is able to activate hemin is poorly understood. Herein, we report fast kinetic measurements (using stopped-flow UV–vis spectrophotometry) to identify the H<sub>2</sub>O<sub>2</sub>-generated activated heme species within a heme•DNAzyme that is active for the oxidation of a thioether substrate, dibenzothiophene (DBT). Singular value decomposition and global fitting analysis was used to analyze the kinetic data, with the results being consistent with the heme•DNAzyme's DBT oxidation being catalyzed by the initial Fe(III)heme–H<sub>2</sub>O<sub>2</sub> complex. Such a complex has been predicted computationally to be a powerful oxidant for thioether substrates. In the heme•DNAzyme, the DNA GQ enhances both the kinetics of formation of the active intermediate as well as the oxidation step of DBT by the active intermediate. We show, using both stopped flow spectrophotometry and EPR measurements, that a classic Compound I is not observable during the catalytic cycle for thioether sulfoxidation.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<span style="font-variant: all-small-caps">CoBold</span>: a method for identifying different functional classes of transient RNA structure features that can impact RNA structure formation <i>in vivo</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944343956-b58c0487-d7cc-4aa0-b5e5-1dd92f5b5697/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa900</link>
            <description><![CDATA[<p class="para" id="N65541">RNA structure formation <i>in vivo</i> happens co-transcriptionally while the transcript is being made. The corresponding co-transcriptional folding pathway typically involves transient RNA structure features that are not part of the final, functional RNA structure. These transient features can play important functional roles of their own and also influence the formation of the final RNA structure <i>in vivo</i>. We here present <span style="font-variant: all-small-caps">CoBold</span>, a computational method for identifying different functional classes of transient RNA structure features that can either aid or hinder the formation of a known reference RNA structure. Our method takes as input either a single RNA or a corresponding multiple-sequence alignment as well as a known reference RNA secondary structure and identifies different classes of transient RNA structure features that could aid or prevent the formation of the given RNA structure. We make <span style="font-variant: all-small-caps">CoBold</span> available via a web-server which includes dedicated data visualisation.</p>]]></description>
            <pubDate><![CDATA[2020-10-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Lamin B1 acetylation slows the G1 to S cell cycle transition through inhibition of DNA repair]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944305467-2681e53b-1501-4229-9537-ea3f4ffdaaf4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab019</link>
            <description><![CDATA[<p class="para" id="N65541">The integrity and regulation of the nuclear lamina is essential for nuclear organization and chromatin stability, with its dysregulation being linked to laminopathy diseases and cancer. Although numerous posttranslational modifications have been identified on lamins, few have been ascribed a regulatory function. Here, we establish that lamin B1 (LMNB1) acetylation at K134 is a molecular toggle that controls nuclear periphery stability, cell cycle progression, and DNA repair. LMNB1 acetylation prevents lamina disruption during herpesvirus type 1 (HSV-1) infection, thereby inhibiting virus production. We also demonstrate the broad impact of this site on laminar processes in uninfected cells. LMNB1 acetylation negatively regulates canonical nonhomologous end joining by impairing the recruitment of 53BP1 to damaged DNA. This defect causes a delay in DNA damage resolution and a persistent activation of the G1/S checkpoint. Altogether, we reveal LMNB1 acetylation as a mechanism for controlling DNA repair pathway choice and stabilizing the nuclear periphery.</p>]]></description>
            <pubDate><![CDATA[2021-02-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structure-based analyses of <i>Salmonella</i> RcsB variants unravel new features of the Rcs regulon]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944290024-8cf0f64c-0368-4a21-997a-973d8a3278d9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab060</link>
            <description><![CDATA[<p class="para" id="N65541">RcsB is a transcriptional regulator that controls expression of numerous genes in enteric bacteria. RcsB accomplishes this role alone or in combination with auxiliary transcriptional factors independently or dependently of phosphorylation. To understand the mechanisms by which RcsB regulates such large number of genes, we performed structural studies as well as <i>in vitro</i> and <i>in vivo</i> functional studies with different RcsB variants. Our structural data reveal that RcsB binds promoters of target genes such as <i>rprA</i> and <i>flhDC</i> in a dimeric active conformation. In this state, the RcsB homodimer docks the DNA-binding domains into the major groove of the DNA, facilitating an initial weak read-out of the target sequence. Interestingly, comparative structural analyses also show that DNA binding may stabilize an active conformation in unphosphorylated RcsB. Furthermore, RNAseq performed in strains expressing wild-type or several RcsB variants provided new insights into the contribution of phosphorylation to gene regulation and assign a potential role of RcsB in controlling iron metabolism. Finally, we delimited the RcsB box for homodimeric active binding to DNA as the sequence TN(G/A)GAN<sub>4</sub>TC(T/C)NA. This RcsB box was found in promoter, intergenic and intragenic regions, facilitating both increased or decreased gene transcription.</p>]]></description>
            <pubDate><![CDATA[2021-02-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The CONJUDOR pipeline for multiplexed knockdown of gene pairs identifies RBBP-5 as a germ cell reprogramming barrier in <i>C. elegans</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944236521-74ab4cd8-1456-4f38-8e3d-c9eb18bff731/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1171</link>
            <description><![CDATA[<p class="para" id="N65541">Multiple gene activities control complex biological processes such as cell fate specification during development and cellular reprogramming. Investigating the manifold gene functions in biological systems requires also simultaneous depletion of two or more gene activities. RNA interference-mediated knockdown (RNAi) is commonly used in <i>Caenorhabditis elegans</i> to assess essential genes, which otherwise lead to lethality or developmental arrest upon full knockout. RNAi application is straightforward by feeding worms with RNAi plasmid-containing bacteria. However, the general approach of mixing bacterial RNAi clones to deplete two genes simultaneously often yields poor results. To address this issue, we developed a bacterial conjugation-mediated double RNAi technique ‘CONJUDOR’. It allows combining RNAi bacteria for robust double RNAi with high-throughput. To demonstrate the power of CONJUDOR for large scale double RNAi screens we conjugated RNAi against the histone chaperone gene <i>lin-53</i> with more than 700 other chromatin factor genes. Thereby, we identified the Set1/MLL methyltransferase complex member RBBP-5 as a novel germ cell reprogramming barrier. Our findings demonstrate that CONJUDOR increases efficiency and versatility of RNAi screens to examine interconnected biological processes in <i>C. elegans</i> with high-throughput.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765944236521-74ab4cd8-1456-4f38-8e3d-c9eb18bff731/assets/gkaa1171gra1.jpg" alt="CONJUDOR adapts bacterial conjugation to combine RNAi plasmids in bacteria for robust knock-down of multiple genes in the nematode C. elegans. CONJUDOR has been used for RNAi screening to deplete multiple gene pairs with high-throughput in order to identify barriers of germ cell reprogramming into GABAergic motor neurons. The Set1/MLL methyltransferase complex member RBBP-5 could be identified using CONJUDOR as a novel barrier for germ cell to neuron reprogramming."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      CONJUDOR adapts bacterial conjugation to combine RNAi plasmids in bacteria for robust knock-down of multiple genes in the nematode <i>C. elegans</i>. CONJUDOR has been used for RNAi screening to deplete multiple gene pairs with high-throughput in order to identify barriers of germ cell reprogramming into GABAergic motor neurons. The Set1/MLL methyltransferase complex member RBBP-5 could be identified using CONJUDOR as a novel barrier for germ cell to neuron reprogramming.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Dynamics of the HD regulatory subdomain of PARP-1; substrate access and allostery in PARP activation and inhibition]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944211218-658f48aa-f5f0-4257-83c9-fd7fed569bcc/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab020</link>
            <description><![CDATA[<p class="para" id="N65541">PARP-1 is a key early responder to DNA damage in eukaryotic cells. An allosteric mechanism links initial sensing of DNA single-strand breaks by PARP-1’s F1 and F2 domains <i>via</i> a process of further domain assembly to activation of the catalytic domain (CAT); synthesis and attachment of poly(ADP-ribose) (PAR) chains to protein sidechains then signals for assembly of DNA repair components. A key component in transmission of the allosteric signal is the HD subdomain of CAT, which alone bridges between the assembled DNA-binding domains and the active site in the ART subdomain of CAT. Here we present a study of isolated CAT domain from human PARP-1, using NMR-based dynamics experiments to analyse WT apo-protein as well as a set of inhibitor complexes (with veliparib, olaparib, talazoparib and EB-47) and point mutants (L713F, L765A and L765F), together with new crystal structures of the free CAT domain and inhibitor complexes. Variations in both dynamics and structures amongst these species point to a model for full-length PARP-1 activation where first DNA binding and then substrate interaction successively destabilise the folded structure of the HD subdomain to the point where its steric blockade of the active site is released and PAR synthesis can proceed.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Repression of a large number of genes requires interplay between homologous recombination and HIRA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944124393-020657f9-9f9a-4f5d-b821-aabde0036583/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab027</link>
            <description><![CDATA[<p class="para" id="N65541">During homologous recombination, Dbl2 protein is required for localisation of Fbh1, an F-box helicase that efficiently dismantles Rad51–DNA filaments. RNA-seq analysis of <i>dbl2Δ</i> transcriptome showed that the <i>dbl2</i> deletion results in upregulation of more than 500 loci in <i>Schizosaccharomyces pombe</i>. Compared with the loci with no change in expression, the misregulated loci in <i>dbl2Δ</i> are closer to long terminal and long tandem repeats. Furthermore, the misregulated loci overlap with antisense transcripts, retrotransposons, meiotic genes and genes located in subtelomeric regions. A comparison of the expression profiles revealed that Dbl2 represses the same type of genes as the HIRA histone chaperone complex. Although <i>dbl2</i> deletion does not alleviate centromeric or telomeric silencing, it suppresses the silencing defect at the outer centromere caused by deletion of <i>hip1</i> and <i>slm9</i> genes encoding subunits of the HIRA complex. Moreover, our analyses revealed that cells lacking <i>dbl2</i> show a slight increase of nucleosomes at transcription start sites and increased levels of methylated histone H3 (H3K9me2) at centromeres, subtelomeres, rDNA regions and long terminal repeats. Finally, we show that other proteins involved in homologous recombination, such as Fbh1, Rad51, Mus81 and Rad54, participate in the same gene repression pathway.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[BACH1 recruits NANOG and histone H3 lysine 4 methyltransferase MLL/SET1 complexes to regulate enhancer–promoter activity and maintains pluripotency]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765944054531-a7d42bfb-352e-4968-a9ff-b374d41e7e4f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab034</link>
            <description><![CDATA[<p class="para" id="N65541">Maintenance of stem-cell identity requires proper regulation of enhancer activity. Both transcription factors OCT4/SOX2/NANOG and histone methyltransferase complexes MLL/SET1 were shown to regulate enhancer activity, but how they are regulated in embryonic stem cells (ESCs) remains further studies. Here, we report a transcription factor BACH1, which directly interacts with OCT4/SOX2/NANOG (OSN) and MLL/SET1 methyltransferase complexes and maintains pluripotency in mouse ESCs (mESCs). BTB domain and bZIP domain of BACH1 are required for these interactions and pluripotency maintenance. Loss of BACH1 reduced the interaction between NANOG and MLL1/SET1 complexes, and decreased their occupancy on chromatin, and further decreased H3 lysine 4 trimethylation (H3K4me3) level on gene promoters and (super-) enhancers, leading to decreased enhancer activity and transcription activity, especially on stemness-related genes. Moreover, BACH1 recruited NANOG through chromatin looping and regulated remote NANOG binding, fine-tuning enhancer–promoter activity and gene expression. Collectively, these observations suggest that BACH1 maintains pluripotency in ESCs by recruiting NANOG and MLL/SET1 complexes to chromatin and maintaining the trimethylated state of H3K4 and enhancer–promoter activity, especially on stemness-related genes.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A native, highly active <i>Tc1/mariner</i> transposon from zebrafish (<i>ZB</i>) offers an efficient genetic manipulation tool for vertebrates]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943977435-68984d42-a362-4323-aa71-ff90942521c3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab045</link>
            <description><![CDATA[<p class="para" id="N65541">New genetic tools and strategies are currently under development to facilitate functional genomics analyses. Here, we describe an active member of the <i>Tc1/mariner</i> transposon superfamily, named <i>ZB</i>, which invaded the zebrafish genome very recently. <i>ZB</i> exhibits high activity in vertebrate cells, in the range of those of the widely used transposons <i>piggyBac</i> (<i>PB</i>), <i>Sleeping Beauty</i> (<i>SB</i>) and <i>Tol2</i>. <i>ZB</i> has a similar structural organization and target site sequence preference to <i>SB</i>, but a different integration profile with respect to genome-wide preference among mammalian functional annotation features. Namely, <i>ZB</i> displays a preference for integration into transcriptional regulatory regions of genes. Accordingly, we demonstrate the utility of <i>ZB</i> for enhancer trapping in zebrafish embryos and in the mouse germline. These results indicate that <i>ZB</i> may be a powerful tool for genetic manipulation in vertebrate model species.</p>]]></description>
            <pubDate><![CDATA[2021-02-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CRISPRidentify: identification of CRISPR arrays using machine learning approach]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943890083-1ebb19ea-a0c4-4b6b-bc31-832bbc825cee/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1158</link>
            <description><![CDATA[<p class="para" id="N65541">CRISPR–Cas are adaptive immune systems that degrade foreign genetic elements in archaea and bacteria. In carrying out their immune functions, CRISPR–Cas systems heavily rely on RNA components. These CRISPR (cr) RNAs are repeat-spacer units that are produced by processing of pre-crRNA, the transcript of CRISPR arrays, and guide Cas protein(s) to the cognate invading nucleic acids, enabling their destruction. Several bioinformatics tools have been developed to detect CRISPR arrays based solely on DNA sequences, but all these tools employ the same strategy of looking for repetitive patterns, which might correspond to CRISPR array repeats. The identified patterns are evaluated using a fixed, built-in scoring function, and arrays exceeding a cut-off value are reported. Here, we instead introduce a data-driven approach that uses machine learning to detect and differentiate true CRISPR arrays from false ones based on several features. Our CRISPR detection tool, CRISPRidentify, performs three steps: detection, feature extraction and classification based on manually curated sets of positive and negative examples of CRISPR arrays. The identified CRISPR arrays are then reported to the user accompanied by detailed annotation. We demonstrate that our approach identifies not only previously detected CRISPR arrays, but also CRISPR array candidates not detected by other tools. Compared to other methods, our tool has a drastically reduced false positive rate. In contrast to the existing tools, our approach not only provides the user with the basic statistics on the identified CRISPR arrays but also produces a certainty score as a practical measure of the likelihood that a given genomic region is a CRISPR array.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A unique arginine cluster in PolDIP2 enhances nucleotide binding and DNA synthesis by PrimPol]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943539325-0fb06d0e-13a7-42b5-b0e0-ba7f35bb358e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab049</link>
            <description><![CDATA[<p class="para" id="N65541">Replication forks often stall at damaged DNA. To overcome these obstructions and complete the DNA duplication in a timely fashion, replication can be restarted downstream of the DNA lesion. In mammalian cells, this repriming of replication can be achieved through the activities of primase and polymerase PrimPol. PrimPol is stimulated in DNA synthesis through interaction with PolDIP2, however the exact mechanism of this PolDIP2-dependent stimulation is still unclear. Here, we show that PrimPol uses a flexible loop to interact with the C-terminal ApaG-like domain of PolDIP2, and that this contact is essential for PrimPol's enhanced processivity. PolDIP2 increases primer-template and dNTP binding affinities of PrimPol, which concomitantly enhances its nucleotide incorporation efficiency. This stimulation is dependent on a unique arginine cluster in PolDIP2. Since the polymerase activity of PrimPol alone is very limited, this mechanism, where the affinity for dNTPs gets increased by PolDIP2 binding, might be critical for the <i>in vivo</i> function of PrimPol in tolerating DNA lesions at physiological nucleotide concentrations.</p>]]></description>
            <pubDate><![CDATA[2021-02-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural determinants of the IRF4/DNA homodimeric complex]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943417874-eb74f298-45de-4c23-8ae7-acb998646f94/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1287</link>
            <description><![CDATA[<p class="para" id="N65541">Interferon regulatory factor 4 (IRF4) is a key transcription factor (TF) in the regulation of immune cells, including B and T cells. It acts by binding DNA as both a homodimer and, in conjunction with other TFs, as a heterodimer. The choice of homo and heterodimeric/ DNA interactions is a critical aspect in the control of the transcriptional program and cell fate outcome. To characterize the nature of this interaction in the homodimeric complex, we have determined the crystal structure of the IRF4/ISRE homodimeric complex. We show that the complex formation is aided by a substantial DNA deformation with co-operative binding achieved exclusively through protein–DNA contact. This markedly contrasts with the heterodimeric form where DNA bound IRF4 is shown to physically interact with PU.1 TF to engage EICE1. We also show that the hotspot residues (Arg98, Cys99 and Asn102) contact both consensus and non-consensus sequences with the L1 loop exhibiting marked flexibility. Additionally, we identified that IRF4<sup>L116R</sup>, a mutant associated with chronic lymphocytic leukemia, binds more robustly to DNA thereby providing a rationale for the observed gain of function. Together, we demonstrate key structural differences between IRF4 homo and heterodimeric complexes, thereby providing molecular insights into IRF4-mediated transcriptional regulation.</p>]]></description>
            <pubDate><![CDATA[2021-02-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Polymer modelling unveils the roles of heterochromatin and nucleolar organizing regions in shaping 3D genome organization in <i>Arabidopsis thaliana</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943372269-0b0c9c48-3266-47ed-9dd0-72a9b31d5df4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1275</link>
            <description><![CDATA[<p class="para" id="N65541">The 3D genome is characterized by a complex organization made of genomic and epigenomic layers with profound implications on gene regulation and cell function. However, the understanding of the fundamental mechanisms driving the crosstalk between nuclear architecture and (epi)genomic information is still lacking. The plant <i>Arabidopsis thaliana</i> is a powerful model organism to address these questions owing to its compact genome for which we have a rich collection of microscopy, chromosome conformation capture (Hi-C) and ChIP-seq experiments. Using polymer modelling, we investigate the roles of nucleolus formation and epigenomics-driven interactions in shaping the 3D genome of <i>A. thaliana</i>. By validation of several predictions with published data, we demonstrate that self-attracting nucleolar organizing regions and repulsive constitutive heterochromatin are major mechanisms to regulate the organization of chromosomes. Simulations also suggest that interphase chromosomes maintain a partial structural memory of the V-shapes, typical of (sub)metacentric chromosomes in anaphase. Additionally, self-attraction between facultative heterochromatin regions facilitates the formation of Polycomb bodies hosting H3K27me3-enriched gene-clusters. Since nucleolus and heterochromatin are highly-conserved in eukaryotic cells, our findings pave the way for a comprehensive characterization of the generic principles that are likely to shape and regulate the 3D genome in many species.</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CK2 kinase-mediated PHF8 phosphorylation controls TopBP1 stability to regulate DNA replication]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943250502-6f4ebb02-484e-4df0-91d2-722c42d75558/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab056</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Dinucleotides as simple models of the base stacking-unstacking component of DNA ‘breathing’ mechanisms]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943210335-1d53e6be-ae0e-420e-a86c-c1c7ac9f8730/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab015</link>
            <description><![CDATA[<p class="para" id="N65541">Regulatory protein access to the DNA duplex ‘interior’ depends on local DNA ‘breathing’ fluctuations, and the most fundamental of these are thermally-driven base stacking-unstacking interactions. The smallest DNA unit that can undergo such transitions is the dinucleotide, whose structural and dynamic properties are dominated by stacking, while the ion condensation, cooperative stacking and inter-base hydrogen-bonding present in duplex DNA are not involved. We use dApdA to study stacking-unstacking at the dinucleotide level because the fluctuations observed are likely to resemble those of larger DNA molecules, but in the absence of constraints introduced by cooperativity are likely to be more pronounced, and thus more accessible to measurement. We study these fluctuations with a combination of Molecular Dynamics simulations on the microsecond timescale and Markov State Model analyses, and validate our results by calculations of circular dichroism (CD) spectra, with results that agree well with the experimental spectra. Our analyses show that the CD spectrum of dApdA is defined by two distinct chiral conformations that correspond, respectively, to a Watson–Crick form and a hybrid form with one base in a Hoogsteen configuration. We find also that ionic structure and water orientation around dApdA play important roles in controlling its breathing fluctuations.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The nascent polypeptide in the 60S subunit determines the Rqc2-dependency of ribosomal quality control]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943148278-d15b3268-9c8b-4be7-a153-104a58ad54b8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab005</link>
            <description><![CDATA[<p class="para" id="N65541">Ribosome stalling at tandem CGA codons or poly(A) sequences activates quality controls for nascent polypeptides including ribosome-associated quality control (RQC) and no-go mRNA decay (NGD). In RQC pathway, Hel2-dependent uS10 ubiquitination and the RQC-trigger (RQT) complex are essential for subunit dissociation, and Ltn1-dependent ubiquitination of peptidyl-tRNA in the 60S subunit requires Rqc2. Here, we report that polytryptophan sequences induce Rqc2-independent RQC. More than 11 consecutive tryptophan residues induced RQC in a manner dependent on Hel2-mediated ribosome ubiquitination and the RQT complex. Polytryptophan sequence-mediated RQC was not coupled with CAT-tailing, and Rqc2 was not required for Ltn1-dependent degradation of the arrest products. Eight consecutive tryptophan residues located at the region proximal to the peptidyl transferase center in the ribosome tunnel inhibited CAT-tailing by tandem CGA codons. Polytryptophan sequences also induced Hel2-mediated canonical RQC-coupled NGD and RQC-uncoupled NGD outside the stalled ribosomes. We propose that poly-tryptophan sequences induce Rqc2-independent RQC, suggesting that CAT-tailing in the 60S subunit could be modulated by the polypeptide in the ribosome exit tunnel.</p>]]></description>
            <pubDate><![CDATA[2021-01-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Hibernation factors directly block ribonucleases from entering the ribosome in response to starvation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943141013-624cfe37-7cb1-42cd-9a43-c54773879400/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab017</link>
            <description><![CDATA[<p class="para" id="N65541">Ribosome hibernation is a universal translation stress response found in bacteria as well as plant plastids. The term was coined almost two decades ago and despite recent insights including detailed cryo-EM structures, the physiological role and underlying molecular mechanism of ribosome hibernation has remained unclear. Here, we demonstrate that <i>Escherichia coli</i> hibernation factors RMF, HPF and RaiA (HFs) concurrently confer ribosome hibernation. In response to carbon starvation and resulting growth arrest, we observe that HFs protect ribosomes at the initial stage of starvation. Consistently, a deletion mutant lacking all three factors (ΔHF) is severely inhibited in regrowth from starvation. ΔHF cells increasingly accumulate 70S ribosomes harbouring fragmented rRNA, while rRNA in wild-type 100S dimers is intact. RNA fragmentation is observed to specifically occur at HF-associated sites in 16S rRNA of assembled 70S ribosomes. Surprisingly, degradation of the 16S rRNA 3′-end is decreased in cells lacking conserved endoribonuclease YbeY and exoribonuclease RNase R suggesting that HFs directly block these ribonucleases from accessing target sites in the ribosome.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Overlapping but distinct: a new model for G-quadruplex biochemical specificity]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765943020846-bd5ab9c1-a7c1-4b1d-bef0-f30e6c79991b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab037</link>
            <description><![CDATA[<p class="para" id="N65541">G-quadruplexes are noncanonical nucleic acid structures formed by stacked guanine tetrads. They are capable of a range of functions and thought to play widespread biological roles. This diversity raises an important question: what determines the biochemical specificity of G-quadruplex structures? The answer is particularly important from the perspective of biological regulation because genomes can contain hundreds of thousands of G-quadruplexes with a range of functions. Here we analyze the specificity of each sequence in a 496-member library of variants of a reference G-quadruplex with respect to five functions. Our analysis shows that the sequence requirements of G-quadruplexes with these functions are different from one another, with some mutations altering biochemical specificity by orders of magnitude. Mutations in tetrads have larger effects than mutations in loops, and changes in specificity are correlated with changes in multimeric state. To complement our biochemical data we determined the solution structure of a monomeric G-quadruplex from the library. The stacked and accessible tetrads rationalize why monomers tend to promote a model peroxidase reaction and generate fluorescence. Our experiments support a model in which the sequence requirements of G-quadruplexes with different functions are overlapping but distinct. This has implications for biological regulation, bioinformatics, and drug design.</p>]]></description>
            <pubDate><![CDATA[2021-02-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Allosteric effects of SSB C-terminal tail on assembly of <i>E. coli</i> RecOR proteins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942962386-9cd8cae3-7bd9-45d1-9599-a5e7809b24e9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1291</link>
            <description><![CDATA[<p class="para" id="N65541">
<i>Escherichia coli</i> RecO is a recombination mediator protein that functions in the RecF pathway of homologous recombination, in concert with RecR, and interacts with <i>E. coli</i> single stranded (ss) DNA binding (SSB) protein via the last 9 amino acids of the C-terminal tails (SSB-Ct). Structures of the <i>E. coli</i> RecR and RecOR complexes are unavailable; however, crystal structures from other organisms show differences in RecR oligomeric state and RecO stoichiometry. We report analytical ultracentrifugation studies of <i>E. coli</i> RecR assembly and its interaction with RecO for a range of solution conditions using both sedimentation velocity and equilibrium approaches. We find that RecR exists in a pH-dependent dimer-tetramer equilibrium that explains the different assembly states reported in previous studies. RecO binds with positive cooperativity to a RecR tetramer, forming both RecR<sub>4</sub>O and RecR<sub>4</sub>O<sub>2</sub> complexes. We find no evidence of a stable RecO complex with RecR dimers. However, binding of RecO to SSB-Ct peptides elicits an allosteric effect, eliminating the positive cooperativity and shifting the equilibrium to favor a RecR<sub>4</sub>O complex. These studies suggest a mechanism for how SSB binding to RecO influences the distribution of RecOR complexes to facilitate loading of RecA onto SSB coated ssDNA to initiate homologous recombination.</p>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[NMR structural study on the self-trimerization of d(GTTAGG) into a dynamic trimolecular G-quadruplex assembly preferentially in Na<sup>+</sup> solution with a moderate K<sup>+</sup> tolerance]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942928258-522c4ebc-aaf6-44c2-8a50-2618ff2482ae/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab028</link>
            <description><![CDATA[<p class="para" id="N65541">Vast G-quadruplexes (GQs) are primarily folded by one, two, or four G-rich oligomers, rarely with an exception. Here, we present the first NMR solution structure of a trimolecular GQ (tri-GQ) that is solely assembled by the self-trimerization of d(GTTAGG), preferentially in Na<sup>+</sup> solution tolerant to an equal amount of K<sup>+</sup> cation. Eight guanines from three asymmetrically folded strands of d(GTTAGG) are organized into a two-tetrad core, which features a broken G-column and two width-irregular grooves. Fast strand exchanges on a timescale of second at 17°C spontaneously occur between folded tri-GQ and unfolded single-strand of d(GTTAGG) that both species coexist in dynamic equilibrium. Thus, this tri-GQ is not just simply a static assembly but rather a dynamic assembly. Moreover, another minor tetra-GQ that has putatively tetrameric (2+2) antiparallel topology becomes noticeable only at an extremely high strand concentration above 18 mM. The major tri-GQ and minor tetra-GQ are considered to be mutually related, and their reversible interconversion pathways are proposed accordingly. The sequence d(GTTAGG) could be regarded as either a reading frame shifted single repeat of human telomeric DNA or a 1.5 repeat of <i>Bombyx mori</i> telomeric DNA. Overall, our findings provide new insight into GQs and expect more functional applications.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural basis of diversity and homodimerization specificity of zinc-finger-associated domains in Drosophila]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942893646-ccb195b7-aaa3-4c2d-8fc0-8e54128c6235/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab061</link>
            <description><![CDATA[<p class="para" id="N65541">In arthropods, zinc finger-associated domains (ZADs) are found at the N-termini of many DNA-binding proteins with tandem arrays of Cys2-His2 zinc fingers (ZAD-C2H2 proteins). ZAD-C2H2 proteins undergo fast evolutionary lineage-specific expansion and functional diversification. Here, we show that all ZADs from <i>Drosophila melanogaster</i> form homodimers, but only certain ZADs with high homology can also heterodimerize. CG2712, for example, is unable to heterodimerize with its paralog, the previously characterized insulator protein Zw5, with which it shares 46% homology. We obtained a crystal structure of CG2712 protein's ZAD domain that, in spite of a low sequence homology, has similar spatial organization with the only known ZAD structure (from Grauzone protein). Steric clashes prevented the formation of heterodimers between Grauzone and CG2712 ZADs. Using detailed structural analysis, site-directed mutagenesis, and molecular dynamics simulations, we demonstrated that rapid evolutionary acquisition of interaction specificity was mediated by the more energy-favorable formation of homodimers in comparison to heterodimers, and that this specificity was achieved by multiple amino acid substitutions resulting in the formation or breaking of stabilizing interactions. We speculate that specific homodimerization of ZAD-C2H2 proteins is important for their architectural role in genome organization.</p>]]></description>
            <pubDate><![CDATA[2021-02-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942872037-453e0ad8-2684-41e5-82b6-a9ec71dfd976/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab032</link>
            <description><![CDATA[<p class="para" id="N65541">Glucocorticoid receptor (GR) is an essential transcription factor (TF), controlling metabolism, development and immune responses. SUMOylation regulates chromatin occupancy and target gene expression of GR in a locus-selective manner, but the mechanism of regulation has remained elusive. Here, we identify the protein network around chromatin-bound GR by using selective isolation of chromatin-associated proteins and show that the network is affected by receptor SUMOylation, with several nuclear receptor coregulators and chromatin modifiers preferring interaction with SUMOylation-deficient GR and proteins implicated in transcriptional repression preferring interaction with SUMOylation-competent GR. This difference is reflected in our chromatin binding, chromatin accessibility and gene expression data, showing that the SUMOylation-deficient GR is more potent in binding and opening chromatin at glucocorticoid-regulated enhancers and inducing expression of target loci. Blockage of SUMOylation by a SUMO-activating enzyme inhibitor (ML-792) phenocopied to a large extent the consequences of GR SUMOylation deficiency on chromatin binding and target gene expression. Our results thus show that SUMOylation modulates the specificity of GR by regulating its chromatin protein network and accessibility at GR-bound enhancers. We speculate that many other SUMOylated TFs utilize a similar regulatory mechanism.</p>]]></description>
            <pubDate><![CDATA[2021-02-01T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Anatomy of noncovalent interactions between the nucleobases or ribose and π-containing amino acids in RNA–protein complexes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942855610-babb50ea-6b7a-4c67-86e5-a6f79bb4204b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab008</link>
            <description><![CDATA[<p class="para" id="N65541">A set of &gt;300 nonredundant high-resolution RNA–protein complexes were rigorously searched for π-contacts between an amino acid side chain (W, H, F, Y, R, E and D) and an RNA nucleobase (denoted π–π interaction) or ribose moiety (denoted sugar–π). The resulting dataset of &gt;1500 RNA–protein π-contacts were visually inspected and classified based on the interaction type, and amino acids and RNA components involved. More than 80% of structures searched contained at least one RNA–protein π-interaction, with π–π contacts making up 59% of the identified interactions. RNA–protein π–π and sugar–π contacts exhibit a range in the RNA and protein components involved, relative monomer orientations and quantum mechanically predicted binding energies. Interestingly, π–π and sugar–π interactions occur more frequently with RNA (4.8 contacts/structure) than DNA (2.6). Moreover, the maximum stability is greater for RNA–protein contacts than DNA–protein interactions. In addition to highlighting distinct differences between RNA and DNA–protein binding, this work has generated the largest dataset of RNA–protein π-interactions to date, thereby underscoring that RNA–protein π-contacts are ubiquitous in nature, and key to the stability and function of RNA–protein complexes.</p>]]></description>
            <pubDate><![CDATA[2021-02-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Oxidative lesions modulate G-quadruplex stability and structure in the human BCL2 promoter]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942590879-40c762c1-c020-4a38-86d3-42bb0e41703d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab057</link>
            <description><![CDATA[<p class="para" id="N65541">Misregulation of <i>BCL2</i> expression has been observed with many diseases and is associated with cellular exposure to reactive oxygen species. A region upstream of the P1 promoter in the human <i>BCL2</i> gene plays a major role in regulating transcription. This G/C-rich region is highly polymorphic and capable of forming G-quadruplex structures. Herein we report that an oxidative event simulated with an 8-oxo-7,8-dihydroguanine (<sup>oxo</sup>G) substitution within a long G-tract results in a reduction of structural polymorphism. Surprisingly, <sup>oxo</sup>G within a 25-nt construct boosts thermal stability of the resulting G-quadruplex. This is achieved by distinct hydrogen bonding properties of <sup>oxo</sup>G, which facilitate formation of an antiparallel basket-type G-quadruplex with a three G-quartet core and a G·<sup>oxo</sup>G·C base triad. While <sup>oxo</sup>G has previously been considered detrimental for G-quadruplex formation, its stabilizing effect within a promoter described in this study suggests a potential novel regulatory role of oxidative stress in general and specifically in <i>BCL2</i> gene transcription.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765942590879-40c762c1-c020-4a38-86d3-42bb0e41703d/assets/gkab057gra1.jpg" alt="&#10;oxoG influences the fold of a G-quadruplex structure within the human BCL2 promoter and enhances the thermal stability of the G4 structure by forming novel structural elements."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      
<sup>oxo</sup>G influences the fold of a G-quadruplex structure within the human BCL2 promoter and enhances the thermal stability of the G4 structure by forming novel structural elements.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-02-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[NOseq: amplicon sequencing evaluation method for RNA m<sup>6</sup>A sites after chemical deamination]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942381808-67b6ea59-957d-40a1-81e6-82ded7e4d52c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1173</link>
            <description><![CDATA[<p class="para" id="N65541">Methods for the detection of m<sup>6</sup>A by RNA-Seq technologies are increasingly sought after. We here present NOseq, a method to detect m<sup>6</sup>A residues in defined amplicons by virtue of their resistance to chemical deamination, effected by nitrous acid. Partial deamination in NOseq affects all exocyclic amino groups present in nucleobases and thus also changes sequence information. The method uses a mapping algorithm specifically adapted to the sequence degeneration caused by deamination events. Thus, m<sup>6</sup>A sites with partial modification levels of ∼50% were detected in defined amplicons, and this threshold can be lowered to ∼10% by combination with m<sup>6</sup>A immunoprecipitation. NOseq faithfully detected known m<sup>6</sup>A sites in human rRNA, and the long non-coding RNA MALAT1, and positively validated several m<sup>6</sup>A candidate sites, drawn from miCLIP data with an m<sup>6</sup>A antibody, in the transcriptome of <i>Drosophila melanogaster</i>. Conceptually related to bisulfite sequencing, NOseq presents a novel amplicon-based sequencing approach for the validation of m<sup>6</sup>A sites in defined sequences.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Alignment free identification of clones in B cell receptor repertoires]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765942194024-70d0f9c7-7b6d-492a-9c9e-4299f563eef9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1160</link>
            <description><![CDATA[<p class="para" id="N65541">Following antigenic challenge, activated B cells rapidly expand and undergo somatic hypermutation, yielding groups of clonally related B cells with diversified immunoglobulin receptors. Inference of clonal relationships based on the receptor sequence is an essential step in many adaptive immune receptor repertoire sequencing studies. These relationships are typically identified by a multi-step process that involves: (i) grouping sequences based on shared V and J gene assignments, and junction lengths and (ii) clustering these sequences using a junction-based distance. However, this approach is sensitive to the initial gene assignments, which are error-prone, and fails to identify clonal relatives whose junction length has changed through accumulation of indels. Through defining a translation-invariant feature space in which we cluster the sequences, we develop an <i>alignment free</i> clonal identification method that does not require gene assignments and is not restricted to a fixed junction length. This <i>alignment free</i> approach has higher sensitivity compared to a typical <i>junction-based distance</i> method without loss of specificity and PPV. While the <i>alignment free</i> procedure identifies clones that are broadly consistent with the <i>junction-based distance</i> method, it also identifies clones with characteristics (multiple V or J gene assignments or junction lengths) that are not detectable with the <i>junction-based distance</i> method.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[NGS-based identification and tracing of microsatellite instability from minute amounts DNA using inter-Alu-PCR]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765941749994-035819c8-bc2c-44ef-ace8-26ed5a94c06c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1175</link>
            <description><![CDATA[<p class="para" id="N65541">Sensitive detection of microsatellite instability (MSI) in tissue or liquid biopsies using next generation sequencing (NGS) has growing prognostic and predictive applications in cancer. However, the complexities of NGS make it cumbersome as compared to established multiplex-PCR detection of MSI. We present a new approach to detect MSI using inter-Alu-PCR followed by targeted NGS, that combines the practical advantages of multiplexed-PCR with the breadth of information provided by NGS. Inter-Alu-PCR employs poly-adenine repeats of variable length present in every Alu element and provides a massively-parallel, rapid approach to capture poly-A-rich genomic fractions within short 80–150bp amplicons generated from adjacent Alu-sequences. A custom-made software analysis tool, MSI-tracer, enables Alu-associated MSI detection from tissue biopsies or MSI-tracing at low-levels in circulating-DNA. MSI-associated indels at somatic-indel frequencies of 0.05–1.5% can be detected depending on the availability of matching normal tissue and the extent of instability. Due to the high Alu copy-number in human genomes, a single inter-Alu-PCR retrieves enough information for identification of MSI-associated-indels from ∼100 pg circulating-DNA, reducing current limits by ∼2-orders of magnitude and equivalent to circulating-DNA obtained from finger-sticks. The combined practical and informational advantages of inter-Alu-PCR make it a powerful tool for identifying tissue-MSI-status or tracing MSI-associated-indels in liquid biopsies.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DNA G-quadruplexes for native mass spectrometry in potassium: a database of validated structures in electrospray-compatible conditions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765941544363-b3f1c301-cf45-4df1-be2c-a6246db8b749/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab039</link>
            <description><![CDATA[<p class="para" id="N65541">G-quadruplex DNA structures have become attractive drug targets, and native mass spectrometry can provide detailed characterization of drug binding stoichiometry and affinity, potentially at high throughput. However, the G-quadruplex DNA polymorphism poses problems for interpreting ligand screening assays. In order to establish standardized MS-based screening assays, we studied 28 sequences with documented NMR structures in (usually ∼100 mM) potassium, and report here their circular dichroism (CD), melting temperature (<i>T</i><sub>m</sub>), NMR spectra and electrospray mass spectra in 1 mM KCl/100 mM trimethylammonium acetate. Based on these results, we make a short-list of sequences that adopt the same structure in the MS assay as reported by NMR, and provide recommendations on using them for MS-based assays. We also built an R-based open-source application to build and consult a database, wherein further sequences can be incorporated in the future. The application handles automatically most of the data processing, and allows generating custom figures and reports. The database is included in the <i>g4dbr</i> package (https://github.com/EricLarG4/g4dbr) and can be explored online (https://ericlarg4.github.io/G4_database.html).</p>]]></description>
            <pubDate><![CDATA[2021-02-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765941349178-4435b0a1-a60e-4cf3-8dda-ed6073e8c928/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab022</link>
            <description><![CDATA[<p class="para" id="N65541">Biomarker-driven trials hold promise for therapeutic development in chronic diseases, such as muscular dystrophy. Myotonic dystrophy type 1 (DM1) involves RNA toxicity, where transcripts containing expanded CUG-repeats (CUG<sup>exp</sup>) accumulate in nuclear foci and sequester splicing factors in the Muscleblind-like (Mbnl) family. Oligonucleotide therapies to mitigate RNA toxicity have emerged but reliable measures of target engagement are needed. Here we examined muscle transcriptomes in mouse models of DM1 and found that CUG<sup>exp</sup> expression or <i>Mbnl</i> gene deletion cause similar dysregulation of alternative splicing. We selected 35 dysregulated exons for further study by targeted RNA sequencing. Across a spectrum of mouse models, the individual splice events and a composite index derived from all events showed a graded response to decrements of Mbnl or increments of CUG<sup>exp</sup>. Antisense oligonucleotides caused prompt reduction of CUG<sup>exp</sup> RNA and parallel correction of the splicing index, followed by subsequent elimination of myotonia. These results suggest that targeted splice sequencing may provide a sensitive and reliable way to assess therapeutic impact in DM1.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Human Rev1 relies on insert-2 to promote selective binding and accurate replication of stabilized G-quadruplex motifs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765941322393-3c779590-4ef5-4701-9ca9-2c10012b9581/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab041</link>
            <description><![CDATA[<p class="para" id="N65541">We previously reported that human Rev1 (hRev1) bound to a parallel-stranded G-quadruplex (G4) from the <i>c-MYC</i> promoter with high affinity. We have extended those results to include other G4 motifs, finding that hRev1 exhibited stronger affinity for parallel-stranded G4 than either anti-parallel or hybrid folds. Amino acids in the αE helix of insert-2 were identified as being important for G4 binding. Mutating E466 and Y470 to alanine selectively perturbed G4 binding affinity. The E466K mutant restored wild-type G4 binding properties. Using a forward mutagenesis assay, we discovered that loss of hRev1 increased G4 mutation frequency &gt;200-fold compared to the control sequence. Base substitutions and deletions occurred around and within the G4 motif. Pyridostatin (PDS) exacerbated this effect, as the mutation frequency increased &gt;700-fold over control and deletions upstream of the G4 site more than doubled. Mutagenic replication of G4 DNA (±PDS) was partially rescued by wild-type and E466K hRev1. The E466A or Y470A mutants failed to suppress the PDS-induced increase in G4 mutation frequency. These findings have implications for the role of insert-2, a motif conserved in vertebrates but not yeast or plants, in Rev1-mediated suppression of mutagenesis during G4 replication.</p>]]></description>
            <pubDate><![CDATA[2021-02-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Site-specific incorporation of 5′-methyl DNA enhances the therapeutic profile of gapmer ASOs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765939442929-a7653efb-395a-4a50-b078-dcb18a4bb426/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab047</link>
            <description><![CDATA[<p class="para" id="N65541">We recently showed that site-specific incorporation of 2′-modifications or neutral linkages in the oligo-deoxynucleotide gap region of toxic phosphorothioate (PS) gapmer ASOs can enhance therapeutic index and safety. In this manuscript, we determined if introducing substitution at the 5′-position of deoxynucleotide monomers in the gap can also enhance therapeutic index. Introducing <i>R</i>- or <i>S</i>-configured 5′-Me DNA at positions 3 and 4 in the oligodeoxynucleotide gap enhanced the therapeutic profile of the modified ASOs suggesting a different positional preference as compared to the 2′-OMe gap modification strategy. The generality of these observations was demonstrated by evaluating <i>R</i>-5′-Me and <i>R</i>-5′-Ethyl DNA modifications in multiple ASOs targeting HDAC2, FXI and Dynamin2 mRNA in the liver. The current work adds to a growing body of evidence that small structural changes can modulate the therapeutic properties of PS ASOs and ushers a new era of chemical optimization with a focus on enhancing the therapeutic profile as opposed to nuclease stability, RNA-affinity and pharmacokinetic properties. The 5′-methyl DNA modified ASOs exhibited excellent safety and antisense activity in mice highlighting the therapeutic potential of this class of nucleic acid analogs for next generation ASO designs.</p>]]></description>
            <pubDate><![CDATA[2021-02-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The metabolite methylglyoxal-mediated gene expression is associated with histone methylglyoxalation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765939245437-f48a98be-2eb6-40a6-86c7-48f79d58011c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab014</link>
            <description><![CDATA[<p class="para" id="N65541">Methylglyoxal (MG) is a byproduct of glycolysis that functions in diverse mammalian developmental processes and diseases and in plant responses to various stresses, including salt stress. However, it is unknown whether MG-regulated gene expression is associated with an epigenetic modification. Here we report that MG methylglyoxalates H3 including H3K4 and increases chromatin accessibility, consistent with the result that H3 methylglyoxalation positively correlates with gene expression. Salt stress also increases H3 methylglyoxalation at salt stress responsive genes correlated to their higher expression. Following exposure to salt stress, salt stress responsive genes were expressed at higher levels in the <i>Arabidopsis glyI2</i> mutant than in wild-type plants, but at lower levels in <i>35S::GLYI2 35S::GLYII4</i> plants, consistent with the higher and lower MG accumulation and H3 methylglyoxalation of target genes in <i>glyI2</i> and <i>35S::GLYI2 35S::GLYII4</i>, respectively. Further, ABI3 and MYC2, regulators of salt stress responsive genes, affect the distribution of H3 methylglyoxalation at salt stress responsive genes. Thus, MG functions as a histone-modifying group associated with gene expression that links glucose metabolism and epigenetic regulation.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Loss of Mediator complex subunit 13 (MED13) promotes resistance to alkylation through cyclin D1 upregulation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907849439-452908ca-6637-45a2-b682-90f714969b41/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1289</link>
            <description><![CDATA[<p class="para" id="N65541">Alkylating drugs are among the most often used chemotherapeutics. While cancer cells frequently develop resistance to alkylation treatments, detailed understanding of mechanisms that lead to the resistance is limited. Here, by using genome-wide CRISPR–Cas9 based screen, we identify transcriptional Mediator complex subunit 13 (MED13) as a novel modulator of alkylation response. The alkylation exposure causes significant MED13 downregulation, while complete loss of MED13 results in reduced apoptosis and resistance to alkylating agents. Transcriptome analysis identified <i>cyclin D1 (CCND1)</i> as one of the highly overexpressed genes in MED13 knock-out (KO) cells, characterized by shorter G1 phase. MED13 is able to bind to <i>CCND1</i> regulatory elements thus influencing the expression. The resistance of MED13 KO cells is directly dependent on the cyclin D1 overexpression, and its down-regulation is sufficient to re-sensitize the cells to alkylating agents. We further demonstrate the therapeutic potential of MED13-mediated response, by applying combinatory treatment with CDK8/19 inhibitor Senexin A. Importantly, the treatment with Senexin A stabilizes MED13, and in combination with alkylating agents significantly reduces viability of cancer cells. In summary, our findings identify novel alkylation stress response mechanism dependent on MED13 and cyclin D1 that can serve as basis for development of innovative therapeutic strategies.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765907849439-452908ca-6637-45a2-b682-90f714969b41/assets/gkaa1289gra1.jpg" alt="Model of MED13 regulated response to alkylation. Created with BioRender.com."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Model of MED13 regulated response to alkylation. Created with BioRender.com.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A comprehensive epigenome atlas reveals DNA methylation regulating skeletal muscle development]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907815831-324d9dd8-6b7a-44a4-907e-31e920846120/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1203</link>
            <description><![CDATA[<p class="para" id="N65541">DNA methylation is important for the epigenetic regulation of gene expression and plays a critical role in mammalian development. However, the dynamic regulation of genome-wide DNA methylation in skeletal muscle development remains largely unknown. Here, we generated the first single-base resolution DNA methylome and transcriptome maps of porcine skeletal muscle across 27 developmental stages. The overall methylation level decreased from the embryo to the adult, which was highly correlated with the downregulated expression of <i>DNMT1</i> and an increase in partially methylated domains. Notably, we identified over 40 000 developmentally differentially methylated CpGs (dDMCs) that reconstitute the developmental trajectory of skeletal muscle and associate with muscle developmental genes and transcription factors (TFs). The dDMCs were significantly under-represented in promoter regulatory regions but strongly enriched as enhancer histone markers and in chromatin-accessible regions. Integrative analysis revealed the negative regulation of both promoter and gene body methylation in genes associated with muscle contraction and insulin signaling during skeletal muscle development. Mechanistically, DNA methylation affected the expression of muscle-related genes by modulating the accessibly of upstream myogenesis TF binding, indicating the involvement of the DNA methylation/<i>SP1</i>/<i>IGF2BP3</i> axis in skeletal myogenesis. Our results highlight the function and regulation of dynamic DNA methylation in skeletal muscle development.</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ecd promotes U5 snRNP maturation and Prp8 stability]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907785842-3e902172-61d6-4393-9015-6bca74c6f333/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1274</link>
            <description><![CDATA[<p class="para" id="N65541">Pre-mRNA splicing catalyzed by the spliceosome represents a critical step in the regulation of gene expression contributing to transcriptome and proteome diversity. The spliceosome consists of five small nuclear ribonucleoprotein particles (snRNPs), the biogenesis of which remains only partially understood. Here we define the evolutionarily conserved protein Ecdysoneless (Ecd) as a critical regulator of U5 snRNP assembly and Prp8 stability. Combining <i>Drosophila</i> genetics with proteomic approaches, we demonstrate the Ecd requirement for the maintenance of adult healthspan and lifespan and identify the Sm ring protein SmD3 as a novel interaction partner of Ecd. We show that the predominant task of Ecd is to deliver Prp8 to the emerging U5 snRNPs in the cytoplasm. <i>Ecd</i> deficiency, on the other hand, leads to reduced Prp8 protein levels and compromised U5 snRNP biogenesis, causing loss of splicing fidelity and transcriptome integrity. Based on our findings, we propose that Ecd chaperones Prp8 to the forming U5 snRNP allowing completion of the cytoplasmic part of the U5 snRNP biogenesis pathway necessary to meet the cellular demand for functional spliceosomes.</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Comparison of loop extrusion and diffusion capture as mitotic chromosome formation pathways in fission yeast]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907758416-196cea0a-d30d-426f-9a47-a14a7fdd5319/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1270</link>
            <description><![CDATA[<p class="para" id="N65541">Underlying higher order chromatin organization are Structural Maintenance of Chromosomes (SMC) complexes, large protein rings that entrap DNA. The molecular mechanism by which SMC complexes organize chromatin is as yet incompletely understood. Two prominent models posit that SMC complexes actively extrude DNA loops (loop extrusion), or that they sequentially entrap two DNAs that come into proximity by Brownian motion (diffusion capture). To explore the implications of these two mechanisms, we perform biophysical simulations of a 3.76 Mb-long chromatin chain, the size of the long <i>Schizosaccharomyces pombe</i> chromosome I left arm. On it, the SMC complex condensin is modeled to perform loop extrusion or diffusion capture. We then compare computational to experimental observations of mitotic chromosome formation. Both loop extrusion and diffusion capture can result in native-like contact probability distributions. In addition, the diffusion capture model more readily recapitulates mitotic chromosome axis shortening and chromatin compaction. Diffusion capture can also explain why mitotic chromatin shows reduced, as well as more anisotropic, movements, features that lack support from loop extrusion. The condensin distribution within mitotic chromosomes, visualized by stochastic optical reconstruction microscopy (STORM), shows clustering predicted from diffusion capture. Our results inform the evaluation of current models of mitotic chromosome formation.</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural insights into the substrate specificity of the endonuclease activity of the influenza virus cap-snatching mechanism]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907743823-7fe8c4c6-98ac-43d8-bc5b-bcb370bbaf04/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1294</link>
            <description><![CDATA[<p class="para" id="N65541">The endonuclease activity within the influenza virus cap-snatching process is a proven therapeutic target. The anti-influenza drug baloxavir is highly effective, but is associated with resistance mutations that threaten its clinical efficacy. The endonuclease resides within the N-terminal domain of the PA subunit (PA<sub>N</sub>) of the influenza RNA dependent RNA polymerase, and we report here complexes of PA<sub>N</sub> with RNA and DNA oligonucleotides to understand its specificity and the structural basis of baloxavir resistance mutations. The RNA and DNA oligonucleotides bind within the substrate binding groove of PA<sub>N</sub> in a similar fashion, explaining the ability of the enzyme to cleave both substrates. The individual nucleotides occupy adjacent conserved pockets that flank the two-metal active site. However, the 2′ OH of the RNA ribose moieties engage in additional interactions that appear to optimize the binding and cleavage efficiency for the natural substrate. The major baloxavir resistance mutation at position 38 is at the core of the substrate binding site, but structural studies and modeling suggest that it maintains the necessary virus fitness via compensating interactions with RNA. These studies will facilitate the development of new influenza therapeutics that spatially match the substrate and are less likely to elicit resistance mutations.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Development of aptamer-based inhibitors for CRISPR/Cas system]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907712193-5714f4b4-1bc7-4724-823d-2494da409818/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa865</link>
            <description><![CDATA[<p class="para" id="N65541">The occurrence of accidental mutations or deletions caused by genome editing with CRISPR/Cas9 system remains a critical unsolved problem of the technology. Blocking excess or prolonged Cas9 activity in cells is considered as one means of solving this problem. Here, we report the development of an inhibitory DNA aptamer against Cas9 by means of in vitro selection (systematic evolution of ligands by exponential enrichment) and subsequent screening with an <i>in vitro</i> cleavage assay. The inhibitory aptamer could bind to Cas9 at low nanomolar affinity and partially form a duplex with CRISPR RNA, contributing to its inhibitory activity. We also demonstrated that improving the inhibitory aptamer with locked nucleic acids efficiently suppressed Cas9-directed genome editing in cells and reduced off-target genome editing. The findings presented here might enable the development of safer and controllable genome editing for biomedical research and gene therapy.</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[UniPath: a uniform approach for pathway and gene-set based analysis of heterogeneity in single-cell epigenome and transcriptome profiles]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907525421-6eb0fb51-972f-40ca-94c0-0081b3e9b101/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab018</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>cola</i>: an R/Bioconductor package for consensus partitioning through a general framework]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907494529-34f236f5-3492-47b2-a228-6b543bccb035/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1146</link>
            <description><![CDATA[<p class="para" id="N65541">Classification of high-throughput genomic data is a powerful method to assign samples to subgroups with specific molecular profiles. Consensus partitioning is the most widely applied approach to reveal subgroups by summarizing a consensus classification from a list of individual classifications generated by repeatedly executing clustering on random subsets of the data. It is able to evaluate the stability of the classification. We implemented a new R/Bioconductor package, <i>cola</i>, that provides a general framework for consensus partitioning. With <i>cola</i>, various parameters and methods can be user-defined and easily integrated into different steps of an analysis, <i>e.g</i>., feature selection, sample classification or defining signatures. <i>cola</i> provides a new method named ATC (<span style="text-decoration: underline">a</span>bility <span style="text-decoration: underline">t</span>o <span style="text-decoration: underline">c</span>orrelate to other rows) to extract features and recommends spherical <i>k</i>-means clustering (skmeans) for subgroup classification. We show that ATC and skmeans have better performance than other commonly used methods by a comprehensive benchmark on public datasets. We also benchmark key parameters in the consensus partitioning procedure, which helps users to select optimal parameter values. Moreover, <i>cola</i> provides rich functionalities to apply multiple partitioning methods in parallel and directly compare their results, as well as rich visualizations. <i>cola</i> can automate the complete analysis and generates a comprehensive HTML report.</p>]]></description>
            <pubDate><![CDATA[2020-12-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Genome-wide integration site detection using Cas9 enriched amplification-free long-range sequencing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907386945-fba3e2c5-9e50-4db2-9344-71b03c9ca125/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1152</link>
            <description><![CDATA[<p class="para" id="N65541">The gene and cell therapy fields are advancing rapidly, with a potential to treat and cure a wide range of diseases, and lentivirus-based gene transfer agents are the vector of choice for many investigators. Early cases of insertional mutagenesis caused by gammaretroviral vectors highlighted that integration site (IS) analysis was a major safety and quality control checkpoint for lentiviral applications. The methods established to detect lentiviral integrations using next-generation sequencing (NGS) are limited by short read length, inadvertent PCR bias, low yield, or lengthy protocols. Here, we describe a new method to sequence IS using Amplification-free Integration Site sequencing (AFIS-Seq). AFIS-Seq is based on amplification-free, Cas9-mediated enrichment of high-molecular-weight chromosomal DNA suitable for long-range Nanopore MinION sequencing. This accessible and low-cost approach generates long reads enabling IS mapping with high certainty within a single day. We demonstrate proof-of-concept by mapping IS of lentiviral vectors in a variety of cell models and report up to 1600-fold enrichment of the signal. This method can be further extended to sequencing of Cas9-mediated integration of genes and to in vivo analysis of IS. AFIS-Seq uses long-read sequencing to facilitate safety evaluation of preclinical lentiviral vector gene therapies by providing IS analysis with improved confidence.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Evidence for multi-copy Mega-NUMT<i>s</i> in the human genome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907303358-4851b97d-2cb8-43a8-834a-902c9fe03494/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1271</link>
            <description><![CDATA[<p class="para" id="N65541">The maternal mode of mitochondrial DNA (mtDNA) inheritance is central to human genetics. Recently, evidence for bi-parental inheritance of mtDNA was claimed for individuals of three pedigrees that suffered mitochondrial disorders. We sequenced mtDNA using both direct Sanger and Massively Parallel Sequencing in several tissues of eleven maternally related and other affiliated healthy individuals of a family pedigree and observed mixed mitotypes in eight individuals. Cells without nuclear DNA, i.e. thrombocytes and hair shafts, only showed the mitotype of haplogroup (hg) V. Skin biopsies were prepared to generate ρ° cells void of mtDNA, sequencing of which resulted in a hg U4c1 mitotype. The position of the Mega-NUMT sequence was determined by fluorescence <i>in situ</i> hybridization and two different quantitative PCR assays were used to determine the number of contributing mtDNA copies. Thus, evidence for the presence of repetitive, full mitogenome Mega-NUMT<i>s</i> matching haplogroup U4c1 in various tissues of eight maternally related individuals was provided. Multi-copy Mega-NUMTs mimic mixtures of mtDNA that cannot be experimentally avoided and thus may appear in diverse fields of mtDNA research and diagnostics. We demonstrate that hair shaft mtDNA sequencing provides a simple but reliable approach to exclude NUMTs as source of misleading results.</p>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[To mock or not: a comprehensive comparison of mock IP and DNA input for ChIP-seq]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907249066-4e6e53d6-9f50-4efe-9061-45312ecc9cea/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1155</link>
            <description><![CDATA[<p class="para" id="N65541">Chromatin immunoprecipitation (IP) followed by sequencing (ChIP-seq) is the gold standard to detect transcription-factor (TF) binding sites in the genome. Its success depends on appropriate controls removing systematic biases. The predominantly used controls, i.e. DNA input, correct for uneven sonication, but not for nonspecific interactions of the IP antibody. Another type of controls, ‘mock’ IP, corrects for both of the issues, but is not widely used because it is considered susceptible to technical noise. The tradeoff between the two control types has not been investigated systematically. Therefore, we generated comparable DNA input and mock IP experiments. Because mock IPs contain only nonspecific interactions, the sites predicted from them using DNA input indicate the spurious-site abundance. This abundance is highly correlated with the ‘genomic activity’ (e.g. chromatin openness). In particular, compared to cell lines, complex samples such as whole organisms have more spurious sites—probably because they contain multiple cell types, resulting in more expressed genes and more open chromatin. Consequently, DNA input and mock IP controls performed similarly for cell lines, whereas for complex samples, mock IP substantially reduced the number of spurious sites. However, DNA input is still informative; thus, we developed a simple framework integrating both controls, improving binding site detection.</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Super-enhancer mediated regulation of adult β-globin gene expression: the role of eRNA and Integrator]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907211354-e48a3b9c-fee7-4c6b-b10f-010a5d0a9995/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab002</link>
            <description><![CDATA[<p class="para" id="N65541">Super-enhancers (SEs) mediate high transcription levels of target genes. Previous studies have shown that SEs recruit transcription complexes and generate enhancer RNAs (eRNAs). We characterized transcription at the human and murine β-globin locus control region (LCR) SE. We found that the human LCR is capable of recruiting transcription complexes independently from linked globin genes in transgenic mice. Furthermore, LCR hypersensitive site 2 (HS2) initiates the formation of bidirectional transcripts in transgenic mice and in the endogenous β-globin gene locus in murine erythroleukemia (MEL) cells. HS2 3′eRNA is relatively unstable and remains in close proximity to the globin gene locus. Reducing the abundance of HS2 3′eRNA leads to a reduction in β-globin gene transcription and compromises RNA polymerase II (Pol II) recruitment at the promoter. The Integrator complex has been shown to terminate eRNA transcription. We demonstrate that Integrator interacts downstream of LCR HS2. Inducible ablation of Integrator function in MEL or differentiating primary human CD34+ cells causes a decrease in expression of the adult β-globin gene and accumulation of Pol II and eRNA at the LCR. The data suggest that transcription complexes are assembled at the LCR and transferred to the globin genes by mechanisms that involve Integrator mediated release of Pol II and eRNA from the LCR.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A programmable omnipotent Argonaute nuclease from mesophilic bacteria <i>Kurthia massiliensis</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907088353-49f2ab30-83c5-4667-a434-76d751e0201d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1278</link>
            <description><![CDATA[<p class="para" id="N65541">Argonaute (Ago) proteins are conserved nucleic acid-guided proteins present in all domains of life. Eukaryotic Argonaute proteins (eAgos) are key players in RNA interference pathways and function as RNA-guided RNA endonucleases at physiological temperatures. Although eAgos are considered to evolve from prokaryotic Argonaute proteins (pAgos), previously studied pAgos were unable to catalyze RNA-guided RNA cleavage at physiological temperatures. Here, we describe a distinctive pAgo from mesophilic bacteria <i>Kurthia massiliensis</i> (KmAgo). KmAgo utilizes DNA guides to cleave single-stranded DNA (ssDNA) and RNA targets with high activity. KmAgo also utilizes RNA guides to cleave ssDNA and RNA targets at moderate temperatures. We show that KmAgo can use 5′ phosphorylated DNA guides as small as 9-mers to cut ssDNA and RNA, like <i>Clostridium butyricum</i> Ago. Small DNA binding confers remarkable thermostability on KmAgo, and we can suppress the guide-independent plasmid processing activity of empty KmAgo by elevating the DNA guide loaded temperature. Moreover, KmAgo performs programmable cleavage of double-stranded DNA and highly structured RNA at 37°C. Therefore, KmAgo can be regarded as a DNA-guided programmable omnipotent nuclease for cleaving most types of nucleic acids efficiently. This study broadens our understanding of Ago proteins and could expand the pAgo-based DNA and RNA manipulation toolbox.</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The complex architecture of p53 binding sites]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907079185-76d79e13-cf59-46a6-b83a-2eecca2d9c6c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1283</link>
            <description><![CDATA[<p class="para" id="N65541">Sequence-specific protein-DNA interactions are at the heart of the response of the tumor-suppressor p53 to numerous physiological and stress-related signals. Large variability has been previously reported in p53 binding to and transactivating from p53 response elements (REs) due, at least in part, to changes in direct (base) and indirect (shape) readouts of p53 REs. Here, we dissect p53 REs to decipher the mechanism by which p53 optimizes this highly regulated variable level of interaction with its DNA binding sites. We show that hemi-specific binding is more prevalent in p53 REs than previously envisioned. We reveal that sequences flanking the REs modulate p53 binding and activity and show that these effects extend to 4–5 bp from the REs. Moreover, we show here that the arrangement of p53 half-sites within its REs, relative to transcription direction, has been fine-tuned by selection pressure to optimize and regulate the response levels from p53 REs. This directionality in the REs arrangement is at least partly encoded in the structural properties of the REs. Furthermore, we show here that in the p21-5′ RE the orientation of the half-sites is such that the effect of the flanking sequences is minimized and we discuss its advantages.</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Bulges in left-handed G-quadruplexes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765907010130-3233db82-258b-4328-9211-13bd74e80f2b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1259</link>
            <description><![CDATA[<p class="para" id="N65541">G-quadruplex (G4) DNA structures with a left-handed backbone progression have unique and conserved structural features. Studies on sequence dependency of the structures revealed the prerequisites and some minimal motifs required for left-handed G4 formation. To extend the boundaries, we explore the adaptability of left-handed G4s towards the existence of bulges. Here we present two X-ray crystal structures and an NMR solution structure of left-handed G4s accommodating one, two and three bulges. Bulges in left-handed G4s show distinct characteristics as compared to those in right-handed G4s. The elucidation of intricate structural details will help in understanding the possible roles and limitations of these unique structures.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A DYRK1B-dependent pathway suppresses rDNA transcription in response to DNA damage]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906891924-f001dd8d-9b31-4bf5-a374-15bea8923392/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1290</link>
            <description><![CDATA[<p class="para" id="N65541">DNA double-strand breaks (DSBs) at ribosomal gene loci trigger inhibition of ribosomal DNA (rDNA) transcription and extensive nucleolar reorganization, including the formation of nucleolar caps where rDNA DSBs engage with canonical DSB signaling and repair factors. While these nucleolar responses underlie maintenance of rDNA stability, the molecular components that drive each of these events remain to be defined. Here we report that full suppression of rRNA synthesis requires the DYRK1B kinase, a nucleolar DSB response that can be uncoupled from ATM-mediated DSB signaling events at the nucleolar periphery. Indeed, by targeting DSBs onto rDNA arrays, we uncovered that chemical inhibition or genetic inactivation of DYRK1B led to sustained nucleolar transcription. Not only does DYRK1B exhibit robust nucleolar accumulation following laser micro-irradiation across cell nuclei, we further showed that DYRK1B is required for rDNA DSB repair and rDNA copy number maintenance, and that DYRK1B-inactivated cells are hypersensitised to DSBs induced at the rDNA arrays. Together, our findings not only identify DYRK1B as a key signaling intermediate that coordinates DSB repair and rDNA transcriptional activities, but also support the idea of specialised DSB responses that operate within the nucleolus to preserve rDNA integrity.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ionic liquids: prospects for nucleic acid handling and delivery]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906645822-753cc2d8-27bc-4c8a-8658-b6ab4f4faa6d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1280</link>
            <description><![CDATA[<p class="para" id="N65541">Operations with nucleic acids are among the main means of studying the mechanisms of gene function and developing novel methods of molecular medicine and gene therapy. These endeavours usually imply the necessity of nucleic acid storage and delivery into eukaryotic cells. In spite of diversity of the existing dedicated techniques, all of them have their limitations. Thus, a recent notion of using ionic liquids in manipulations of nucleic acids has been attracting significant attention lately. Due to their unique physicochemical properties, in particular, their micro-structuring impact and tunability, ionic liquids are currently applied as solvents and stabilizing media in chemical synthesis, electrochemistry, biotechnology, and other areas. Here, we review the current knowledge on interactions between nucleic acids and ionic liquids and discuss potential advantages of applying the latter in delivery of the former into eukaryotic cells.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Atomic resolution of short-range sliding dynamics of thymine DNA glycosylase along DNA minor-groove for lesion recognition]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906615435-2714cb2d-866f-4761-b8ce-286b881eb5b9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1252</link>
            <description><![CDATA[<p class="para" id="N65541">Thymine DNA glycosylase (TDG), as a repair enzyme, plays essential roles in maintaining the genome integrity by correcting several mismatched/damaged nucleobases. TDG acquires an efficient strategy to search for the lesions among a vast number of cognate base pairs. Currently, atomic-level details of how TDG translocates along DNA as it approaches the lesion site and the molecular mechanisms of the interplay between TDG and DNA are still elusive. Here, by constructing the Markov state model based on hundreds of molecular dynamics simulations with an integrated simulation time of ∼25 μs, we reveal the rotation-coupled sliding dynamics of TDG along a 9 bp DNA segment containing one G·T mispair. We find that TDG translocates along DNA at a relatively faster rate when distant from the lesion site, but slows down as it approaches the target, accompanied by deeply penetrating into the minor-groove, opening up the mismatched base pair and significantly sculpturing the DNA shape. Moreover, the electrostatic interactions between TDG and DNA are found to be critical for mediating the TDG translocation. Notably, several uncharacterized TDG residues are identified to take part in regulating the conformational switches of TDG occurred in the site-transfer process, which warrants further experimental validations.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The MRN complex promotes DNA repair by homologous recombination and restrains antigenic variation in African trypanosomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906414975-f1fce29e-264e-4fcc-b4cf-0779397bceab/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1265</link>
            <description><![CDATA[<p class="para" id="N65541">Homologous recombination dominates as the major form of DNA repair in <i>Trypanosoma brucei</i>, and is especially important for recombination of the subtelomeric variant surface glycoprotein during antigenic variation. RAD50, a component of the MRN complex (MRE11, RAD50, NBS1), is central to homologous recombination through facilitating resection and governing the DNA damage response. The function of RAD50 in trypanosomes is untested. Here we report that RAD50 and MRE11 are required for RAD51-dependent homologous recombination and phosphorylation of histone H2A following a DNA double strand break (DSB), but neither MRE11 nor RAD50 substantially influence DSB resection at a chromosome-internal locus. In addition, we reveal intrinsic separation-of-function between <i>T. brucei</i> RAD50 and MRE11, with only RAD50 suppressing DSB repair using donors with short stretches of homology at a subtelomeric locus, and only MRE11 directing DSB resection at the same locus. Finally, we show that loss of either MRE11 or RAD50 causes a greater diversity of expressed VSG variants following DSB repair. We conclude that MRN promotes stringent homologous recombination at subtelomeric loci and restrains antigenic variation.</p>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Insights into synthesis and function of KsgA/Dim1-dependent rRNA modifications in archaea]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906366833-05165be8-7f23-4a03-8eec-6a7a87c7162c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1268</link>
            <description><![CDATA[<p class="para" id="N65541">Ribosomes are intricate molecular machines ensuring proper protein synthesis in every cell. Ribosome biogenesis is a complex process which has been intensively analyzed in bacteria and eukaryotes. In contrast, our understanding of the <i>in vivo</i> archaeal ribosome biogenesis pathway remains less characterized. Here, we have analyzed the <i>in vivo</i> role of the almost universally conserved ribosomal RNA dimethyltransferase KsgA/Dim1 homolog in archaea. Our study reveals that KsgA/Dim1-dependent 16S rRNA dimethylation is dispensable for the cellular growth of phylogenetically distant archaea. However, proteomics and functional analyses suggest that archaeal KsgA/Dim1 and its rRNA modification activity (i) influence the expression of a subset of proteins and (ii) contribute to archaeal cellular fitness and adaptation. In addition, our study reveals an unexpected KsgA/Dim1-dependent variability of rRNA modifications within the archaeal phylum. Combining structure-based functional studies across evolutionary divergent organisms, we provide evidence on how rRNA structure sequence variability (re-)shapes the KsgA/Dim1-dependent rRNA modification status. Finally, our results suggest an uncoupling between the KsgA/Dim1-dependent rRNA modification completion and its release from the nascent small ribosomal subunit. Collectively, our study provides additional understandings into principles of molecular functional adaptation, and further evolutionary and mechanistic insights into an almost universally conserved step of ribosome synthesis.</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ligand-dependent tRNA processing by a rationally designed RNase P riboswitch]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906252488-d30a5e6d-f4b1-4cf2-8f19-758685127cb5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1282</link>
            <description><![CDATA[<p class="para" id="N65541">We describe a synthetic riboswitch element that implements a regulatory principle which directly addresses an essential tRNA maturation step. Constructed using a rational <i>in silico</i> design approach, this riboswitch regulates RNase P-catalyzed tRNA 5′-processing by either sequestering or exposing the single-stranded 5′-leader region of the tRNA precursor in response to a ligand. A single base pair in the 5′-leader defines the regulatory potential of the riboswitch both <i>in vitro</i> and <i>in vivo</i>. Our data provide proof for prior postulates on the importance of the structure of the leader region for tRNA maturation. We demonstrate that computational predictions of ligand-dependent structural rearrangements can address individual maturation steps of stable non-coding RNAs, thus making them amenable as promising target for regulatory devices that can be used as functional building blocks in synthetic biology.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[UniPath: a uniform approach for pathway and gene-set based analysis of heterogeneity in single-cell epigenome and transcriptome profiles]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906227175-4e8de70d-7687-47ba-ab3b-486080ba5b58/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1138</link>
            <description><![CDATA[<p class="para" id="N65541">Recent advances in single-cell open-chromatin and transcriptome profiling have created a challenge of exploring novel applications with a meaningful transformation of read-counts, which often have high variability in noise and drop-out among cells. Here, we introduce UniPath, for representing single-cells using pathway and gene-set enrichment scores by a transformation of their open-chromatin or gene-expression profiles. The robust statistical approach of UniPath provides high accuracy, consistency and scalability in estimating gene-set enrichment scores for every cell. Its framework provides an easy solution for handling variability in drop-out rate, which can sometimes create artefact due to systematic patterns. UniPath provides an alternative approach of dimension reduction of single-cell open-chromatin profiles. UniPath's approach of predicting temporal-order of single-cells using their pathway enrichment scores enables suppression of covariates to achieve correct order of cells. Analysis of mouse cell atlas using our approach yielded surprising, albeit biologically-meaningful co-clustering of cell-types from distant organs. By enabling an unconventional method of exploiting pathway co-occurrence to compare two groups of cells, our approach also proves to be useful in inferring context-specific regulations in cancer cells. Available at https://reggenlab.github.io/UniPathWeb/.</p>]]></description>
            <pubDate><![CDATA[2020-12-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[First insights into the structural features of Ebola virus methyltransferase activities]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906108525-9ba9074c-c270-4dcf-a6e4-8bf71885b2cc/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1276</link>
            <description><![CDATA[<p class="para" id="N65541">The Ebola virus is a deadly human pathogen responsible for several outbreaks in Africa. Its genome encodes the ‘large’ L protein, an essential enzyme that has polymerase, capping and methyltransferase activities. The methyltransferase activity leads to RNA co-transcriptional modifications at the N7 position of the cap structure and at the 2′-O position of the first transcribed nucleotide. Unlike other <i>Mononegavirales</i> viruses, the Ebola virus methyltransferase also catalyses 2′-<i>O</i>-methylation of adenosines located within the RNA sequences. Herein, we report the crystal structure at 1.8 Å resolution of the Ebola virus methyltransferase domain bound to a fragment of a camelid single-chain antibody. We identified structural determinants and key amino acids specifically involved in the internal adenosine-2′-<i>O</i>-methylation from cap-related methylations. These results provide the first high resolution structure of an ebolavirus L protein domain, and the framework to investigate the effects of epitranscriptomic modifications and to design possible antiviral drugs against the <i>Filoviridae</i> family.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Search for translation arrest peptides encoded upstream of genes for components of protein localization pathways]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906101421-c8cd645b-54f7-4c22-891a-d8ae5231a54f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab024</link>
            <description><![CDATA[<p class="para" id="N65541">Regulatory nascent peptides participate in the regulation of cellular functions by the mechanisms involving regulated translation arrest. A class of them in bacteria, called monitoring substrates, feedback-regulates the expression of a specific component of protein localization machinery. Three monitoring substrates, SecM, MifM and VemP have previously been identified. Here, we attempt at identifying additional arrest peptides in bacteria. Our bioinformatic searches over more than 400 bacterial genomic sequences for proteins that have the common characteristic features shared by the known monitoring substrates and subsequent <i>in vitro</i> and <i>in vivo</i> characterization of the highlighted sequences allowed the identification of three arrest peptides termed ApcA, ApdA and ApdP. ApcA and ApdA homologs are conserved among a subset of actinobacteria, whereas ApdP has homologs in a subset of α-proteobacteria. We demonstrate that these arrest peptides, in their ribosome-tethered nascent states, inhibit peptidyl transfer. The elongation arrest occurs at a specific codon near the 3′ end of the coding region, in a manner depending on the amino acid sequence of the nascent chain. Interestingly, the arrest sequences of ApcA, ApdA and ApdP share a sequence R-A-P-G/P that is essential for the elongation arrest.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Multiprotein <i>E. coli</i> SSB–ssDNA complex shows both stable binding and rapid dissociation due to interprotein interactions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906079118-03a9fb73-4e2e-4572-bba9-c23591306283/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1267</link>
            <description><![CDATA[<p class="para" id="N65541">
<i>Escherichia coli</i> SSB (<i>Ec</i>SSB) is a model single-stranded DNA (ssDNA) binding protein critical in genome maintenance. <i>Ec</i>SSB forms homotetramers that wrap ssDNA in multiple conformations to facilitate DNA replication and repair. Here we measure the binding and wrapping of many <i>Ec</i>SSB proteins to a single long ssDNA substrate held at fixed tensions. We show <i>Ec</i>SSB binds in a biphasic manner, where initial wrapping events are followed by unwrapping events as ssDNA-bound protein density passes critical saturation and high free protein concentration increases the fraction of <i>Ec</i>SSBs in less-wrapped conformations. By destabilizing <i>Ec</i>SSB wrapping through increased substrate tension, decreased substrate length, and protein mutation, we also directly observe an unstable bound but unwrapped state in which ∼8 nucleotides of ssDNA are bound by a single domain, which could act as a transition state through which rapid reorganization of the <i>Ec</i>SSB–ssDNA complex occurs. When ssDNA is over-saturated, stimulated dissociation rapidly removes excess <i>Ec</i>SSB, leaving an array of stably-wrapped complexes. These results provide a mechanism through which otherwise stably bound and wrapped <i>Ec</i>SSB tetramers are rapidly removed from ssDNA to allow for DNA maintenance and replication functions, while still fully protecting ssDNA over a wide range of protein concentrations.</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The ATR-WEE1 kinase module inhibits the MAC complex to regulate replication stress response]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906071359-809bf625-e665-4813-afe2-cb7e1884508d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1082</link>
            <description><![CDATA[<p class="para" id="N65541">DNA damage response is a fundamental mechanism to maintain genome stability. The ATR-WEE1 kinase module plays a central role in response to replication stress. Although the ATR-WEE1 pathway has been well studied in yeasts and animals, how ATR-WEE1 functions in plants remains unclear. Through a genetic screen for suppressors of the <i>Arabidopsis atr</i> mutant, we found that loss of function of PRL1, a core subunit of the evolutionarily conserved MAC complex involved in alternative splicing, suppresses the hypersensitivity of <i>atr</i> and <i>wee1</i> to replication stress. Biochemical studies revealed that WEE1 directly interacts with and phosphorylates PRL1 at Serine 145, which promotes PRL1 ubiquitination and subsequent degradation. In line with the genetic and biochemical data, replication stress induces intron retention of cell cycle genes including <i>CYCD1;1</i> and <i>CYCD3;1</i>, which is abolished in <i>wee1</i> but restored in <i>wee1 prl1</i>. Remarkably, co-expressing the coding sequences of <i>CYCD1;1</i> and <i>CYCD3;1</i> partially restores the root length and HU response in <i>wee1 prl1</i>. These data suggested that the ATR-WEE1 module inhibits the MAC complex to regulate replication stress responses. Our study discovered PRL1 or the MAC complex as a key downstream regulator of the ATR-WEE1 module and revealed a novel cell cycle control mechanism.</p>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Crystal structures of the EVE-HNH endonuclease VcaM4I in the presence and absence of DNA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765906050258-90cad546-b937-4b15-a3ed-43830038a94f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1218</link>
            <description><![CDATA[<p class="para" id="N65541">Many modification-dependent restriction endonucleases (MDREs) are fusions of a PUA superfamily modification sensor domain and a nuclease catalytic domain. EVE domains belong to the PUA superfamily, and are present in MDREs in combination with HNH nuclease domains. Here, we present a biochemical characterization of the EVE-HNH endonuclease VcaM4I and crystal structures of the protein alone, with EVE domain bound to either 5mC modified dsDNA or to 5mC/5hmC containing ssDNA. The EVE domain is moderately specific for 5mC/5hmC containing DNA according to EMSA experiments. It flips the modified nucleotide, to accommodate it in a hydrophobic pocket of the enzyme, primarily formed by P24, W82 and Y130 residues. In the crystallized conformation, the EVE domain and linker helix between the two domains block DNA binding to the catalytic domain. Removal of the EVE domain and inter-domain linker, but not of the EVE domain alone converts VcaM4I into a non-specific toxic nuclease. The role of the key residues in the EVE and HNH domains of VcaM4I is confirmed by digestion and restriction assays with the enzyme variants that differ from the wild-type by changes to the base binding pocket or to the catalytic residues.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765906050258-90cad546-b937-4b15-a3ed-43830038a94f/assets/gkaa1218gra1.jpg" alt="Crystal structures of VcaM4I restriction endonuclease provide the first structural description of the EVE domain-modified DNA interaction. Each protomer of the dimeric enzyme is composed of EVE domain responsible for modification detection and HNH domain responsible for DNA cleavage. The EVE domains flip the modified cytosine bases and bind them in dedicated hydrophobic pockets."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Crystal structures of VcaM4I restriction endonuclease provide the first structural description of the EVE domain-modified DNA interaction. Each protomer of the dimeric enzyme is composed of EVE domain responsible for modification detection and HNH domain responsible for DNA cleavage. The EVE domains flip the modified cytosine bases and bind them in dedicated hydrophobic pockets.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Small molecules inhibitors of the heterogeneous ribonuclear protein A18 (hnRNP A18): a regulator of protein translation and an immune checkpoint]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905990354-d37264ae-88cd-47d1-b0ed-d649bc989daf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1254</link>
            <description><![CDATA[<p class="para" id="N65541">We have identified chemical probes that simultaneously inhibit cancer cell progression and an immune checkpoint. Using the computational Site Identification by Ligand Competitive Saturation (SILCS) technology, structural biology and cell-based assays, we identify small molecules that directly and selectively bind to the RNA Recognition Motif (RRM) of hnRNP A18, a regulator of protein translation in cancer cells. hnRNP A18 recognizes a specific RNA signature motif in the 3′UTR of transcripts associated with cancer cell progression (Trx, VEGF, RPA) and, as shown here, a tumor immune checkpoint (CTLA-4). Post-transcriptional regulation of immune checkpoints is a potential therapeutic strategy that remains to be exploited. The probes target hnRNP A18 RRM <i>in vitro</i> and in cells as evaluated by cellular target engagement. As single agents, the probes specifically disrupt hnRNP A18–RNA interactions, downregulate Trx and CTLA-4 protein levels and inhibit proliferation of several cancer cell lines without affecting the viability of normal epithelial cells. These first-in-class chemical probes will greatly facilitate the elucidation of the underexplored biological function of RNA Binding Proteins (RBPs) in cancer cells, including their effects on proliferation and immune checkpoint activation.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A supernumerary designer chromosome for modular <i>in vivo</i> pathway assembly in <i>Saccharomyces cerevisiae</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905953242-e5a25479-749a-4af3-be12-a6c4c2c5bd92/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1167</link>
            <description><![CDATA[<p class="para" id="N65541">The construction of microbial cell factories for sustainable production of chemicals and pharmaceuticals requires extensive genome engineering. Using <i>Saccharomyces cerevisiae</i>, this study proposes synthetic neochromosomes as orthogonal expression platforms for rewiring native cellular processes and implementing new functionalities. Capitalizing the powerful homologous recombination capability of <i>S. cerevisiae</i>, modular neochromosomes of 50 and 100 kb were fully assembled <i>de novo</i> from up to 44 transcriptional-unit-sized fragments in a single transformation. These assemblies were remarkably efficient and faithful to their <i>in silico</i> design. Neochromosomes made of non-coding DNA were stably replicated and segregated irrespective of their size without affecting the physiology of their host. These non-coding neochromosomes were successfully used as landing pad and as exclusive expression platform for the essential glycolytic pathway. This work pushes the limit of DNA assembly in <i>S. cerevisiae</i> and paves the way for <i>de novo</i> designer chromosomes as modular genome engineering platforms in <i>S. cerevisiae</i>.</p>]]></description>
            <pubDate><![CDATA[2021-01-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The solution structures of higher-order human telomere G-quadruplex multimers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905910719-6ce76bf0-1479-41a4-ae0b-6f8803bb8d94/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1285</link>
            <description><![CDATA[<p class="para" id="N65541">Human telomeres contain the repeat DNA sequence 5′-d(TTAGGG), with duplex regions that are several kilobases long terminating in a 3′ single-stranded overhang. The structure of the single-stranded overhang is not known with certainty, with disparate models proposed in the literature. We report here the results of an integrated structural biology approach that combines small-angle X-ray scattering, circular dichroism (CD), analytical ultracentrifugation, size-exclusion column chromatography and molecular dynamics simulations that provide the most detailed characterization to date of the structure of the telomeric overhang. We find that the single-stranded sequences 5′-d(TTAGGG)<sub><i>n</i></sub>, with <i>n</i> = 8, 12 and 16, fold into multimeric structures containing the maximal number (2, 3 and 4, respectively) of contiguous G4 units with no long gaps between units. The G4 units are a mixture of hybrid-1 and hybrid-2 conformers. In the multimeric structures, G4 units interact, at least transiently, at the interfaces between units to produce distinctive CD signatures. Global fitting of our hydrodynamic and scattering data to a worm-like chain (WLC) model indicates that these multimeric G4 structures are semi-flexible, with a persistence length of ∼34 Å. Investigations of its flexibility using MD simulations reveal stacking, unstacking, and coiling movements, which yield unique sites for drug targeting.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Non-B DNA: a major contributor to small- and large-scale variation in nucleotide substitution frequencies across the genome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905892576-fec1f926-678a-437f-b3c3-1e9c98897342/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1269</link>
            <description><![CDATA[<p class="para" id="N65541">Approximately 13% of the human genome can fold into non-canonical (non-B) DNA structures (e.g. G-quadruplexes, Z-DNA, etc.), which have been implicated in vital cellular processes. Non-B DNA also hinders replication, increasing errors and facilitating mutagenesis, yet its contribution to genome-wide variation in mutation rates remains unexplored. Here, we conducted a comprehensive analysis of nucleotide substitution frequencies at non-B DNA loci within noncoding, non-repetitive genome regions, their ±2 kb flanking regions, and 1-Megabase windows, using human-orangutan divergence and human single-nucleotide polymorphisms. Functional data analysis at single-base resolution demonstrated that substitution frequencies are usually elevated at non-B DNA, with patterns specific to each non-B DNA type. Mirror, direct and inverted repeats have higher substitution frequencies in spacers than in repeat arms, whereas G-quadruplexes, particularly stable ones, have higher substitution frequencies in loops than in stems. Several non-B DNA types also affect substitution frequencies in their flanking regions. Finally, non-B DNA explains more variation than any other predictor in multiple regression models for diversity or divergence at 1-Megabase scale. Thus, non-B DNA substantially contributes to variation in substitution frequencies at small and large scales. Our results highlight the role of non-B DNA in germline mutagenesis with implications to evolution and genetic diseases.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765905892576-fec1f926-678a-437f-b3c3-1e9c98897342/assets/gkaa1269gra1.jpg" alt="Guiblet et al. show that loci capable of forming non-canonical (non-B) DNA structures are a major driver of variation in nucleotide substitution levels across the genome. Image credit: Wilfried Guiblet."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Guiblet <i>et al.</i> show that loci capable of forming non-canonical (non-B) DNA structures are a major driver of variation in nucleotide substitution levels across the genome. Image credit: Wilfried Guiblet.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-15T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[tRNA 3′ shortening by LCCR4 as a response to stress in <i>Trypanosoma brucei</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905850484-87293683-8d23-421f-9fb5-2fcaa1680f76/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1261</link>
            <description><![CDATA[<p class="para" id="N65541">Sensing of environmental cues is crucial for cell survival. To adapt to changes in their surroundings cells need to tightly control the repertoire of genes expressed at any time. Regulation of translation is key, especially in organisms in which transcription is hardly controlled, like <i>Trypanosoma brucei</i>. In this study, we describe the shortening of the bulk of the cellular tRNAs during stress at the expense of the conserved 3′ CCA-tail. This tRNA shortening is specific for nutritional stress and renders tRNAs unsuitable substrates for translation. We uncovered the nuclease LCCR4 (Tb927.4.2430), a homologue of the conserved deadenylase Ccr4, as being responsible for tRNA trimming. Once optimal growth conditions are restored tRNAs are rapidly repaired by the trypanosome tRNA nucleotidyltransferase thus rendering the recycled tRNAs amenable for translation. This mechanism represents a fast and efficient way to repress translation during stress, allowing quick reactivation with a low energy input.</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Hydrogen–deuterium exchange reveals a dynamic DNA-binding map of replication protein A]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905805214-c27a2a42-6eec-41ec-9b07-3a5006626a76/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1288</link>
            <description><![CDATA[<p class="para" id="N65541">Replication protein A (RPA) binds to single-stranded DNA (ssDNA) and interacts with over three dozen enzymes and serves as a recruitment hub to coordinate most DNA metabolic processes. RPA binds ssDNA utilizing multiple oligosaccharide/oligonucleotide binding domains and based on their individual DNA binding affinities are classified as high versus low-affinity DNA-binding domains (DBDs). However, recent evidence suggests that the DNA-binding dynamics of DBDs better define their roles. Utilizing hydrogen–deuterium exchange mass spectrometry (HDX-MS), we assessed the ssDNA-driven dynamics of the individual domains of human RPA. As expected, ssDNA binding shows HDX changes in DBDs A, B, C, D and E. However, DBD-A and DBD-B are dynamic and do not show robust DNA-dependent protection. DBD-C displays the most extensive changes in HDX, suggesting a major role in stabilizing RPA on ssDNA. Slower allosteric changes transpire in the protein–protein interaction domains and linker regions, and thus do not directly interact with ssDNA. Within a dynamics-based model for RPA, we propose that DBD-A and -B act as the dynamic half and DBD-C, -D and -E function as the less-dynamic half. Thus, segments of ssDNA buried under the dynamic half are likely more readily accessible to RPA-interacting proteins.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765905805214-c27a2a42-6eec-41ec-9b07-3a5006626a76/assets/gkaa1288gra1.jpg" alt="RPA binds to DNA as two dynamic halves."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical abstract</div><div class="captionText">                                      RPA binds to DNA as two dynamic halves.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Guide-target mismatch effects on dCas9–sgRNA binding activity in living bacterial cells]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905778421-611d9eb1-df50-41e7-ab78-08699c62b99d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1295</link>
            <description><![CDATA[<p class="para" id="N65541">As an effective programmable DNA targeting tool, CRISPR–Cas9 system has been adopted in varieties of biotechnological applications. However, the off-target effects, derived from the tolerance towards guide-target mismatches, are regarded as the major problems in engineering CRISPR systems. To understand this, we constructed two sgRNA libraries carrying saturated single- and double-nucleotide mismatches in living bacteria cells, and profiled the comprehensive landscape of <i>in vivo</i> binding affinity of dCas9 toward DNA target guided by each individual sgRNA with particular mismatches. We observed a synergistic effect in seed, where combinatorial double mutations caused more severe activity loss compared with the two corresponding single mutations. Moreover, we found that a particular mismatch type, dDrG (D = A, T, G), only showed moderate impairment on binding. To quantitatively understand the causal relationship between mismatch and binding behaviour of dCas9, we further established a biophysical model, and found that the thermodynamic properties of base-pairing coupled with strand invasion process, to a large extent, can account for the observed mismatch-activity landscape. Finally, we repurposed this model, together with a convolutional neural network constructed based on the same mechanism, as a predictive tool to guide the rational design of sgRNA in bacterial CRISPR interference.</p>]]></description>
            <pubDate><![CDATA[2021-01-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Pentapeptide repeat protein QnrB1 requires ATP hydrolysis to rejuvenate poisoned gyrase complexes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905771443-a537a12f-6b5d-4790-a323-e91af3410b7c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1266</link>
            <description><![CDATA[<p class="para" id="N65541">DNA gyrase, a type II topoisomerase found predominantly in bacteria, is the target for a variety of ‘poisons’, namely natural product toxins (e.g. albicidin, microcin B17) and clinically important synthetic molecules (e.g. fluoroquinolones). Resistance to both groups can be mediated by pentapeptide repeat proteins (PRPs). Despite long-term studies, the mechanism of action of these protective PRPs is not known. We show that a PRP, QnrB1 provides specific protection against fluoroquinolones, which strictly requires ATP hydrolysis by gyrase. QnrB1 binds to the GyrB protein and stimulates ATPase activity of the isolated N-terminal ATPase domain of GyrB (GyrB43). We probed the QnrB1 binding site using site-specific incorporation of a photoreactive amino acid and mapped the crosslinks to the GyrB43 protein. We propose a model in which QnrB1 binding allosterically promotes dissociation of the fluoroquinolone molecule from the cleavage complex.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765905771443-a537a12f-6b5d-4790-a323-e91af3410b7c/assets/gkaa1266gra1.jpg" alt="Pentapeptide repeat protein QnrB1 requires ATP hydrolysis to rejuvenate poisoned gyrase complexes."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Pentapeptide repeat protein QnrB1 requires ATP hydrolysis to rejuvenate poisoned gyrase complexes.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>Vibrio cholerae</i> FruR facilitates binding of RNA polymerase to the <i>fru</i> promoter in the presence of fructose 1-phosphate]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905765340-78e7417d-6e49-4445-99e1-283e64ee0598/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkab013</link>
            <description><![CDATA[<p class="para" id="N65541">In most bacteria, efficient use of carbohydrates is primarily mediated by the phosphoenolpyruvate (PEP):carbohydrate phosphotransferase system (PTS), which concomitantly phosphorylates the substrates during import. Therefore, transcription of the PTS-encoding genes is precisely regulated by transcriptional regulators, depending on the availability of the substrate. Fructose is transported mainly through the fructose-specific PTS (PTS<sup>Fru</sup>) and simultaneously converted into fructose 1-phosphate (F1P). In Gammaproteobacteria such as <i>Escherichia coli</i> and <i>Pseudomonas putida</i>, transcription of the <i>fru</i> operon encoding two PTS<sup>Fru</sup> components, FruA and FruB, and the 1-phosphofructokinase FruK is repressed by FruR in the absence of the inducer F1P. Here, we show that, contrary to the case in other Gammaproteobacteria, FruR acts as a transcriptional activator of the <i>fru</i> operon and is indispensable for the growth of <i>Vibrio cholerae</i> on fructose. Several lines of evidence suggest that binding of the FruR-F1P complex to an operator which is located between the –35 and –10 promoter elements changes the DNA structure to facilitate RNA polymerase binding to the promoter. We discuss the mechanism by which the highly conserved FruR regulates the expression of its target operon encoding the highly conserved PTS<sup>Fru</sup> and FruK in a completely opposite direction among closely related families of bacteria.</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Parallel reaction pathways accelerate folding of a guanine quadruplex]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905758093-136de822-2da0-4d1d-8c0f-901e628b4e21/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1286</link>
            <description><![CDATA[<p class="para" id="N65541">G-quadruplexes (G4s) are four-stranded, guanine-rich nucleic acid structures that can influence a variety of biological processes such as the transcription and translation of genes and DNA replication. In many cases, a single G4-forming nucleic acid sequence can adopt multiple different folded conformations that interconvert on biologically relevant timescales, entropically stabilizing the folded state. The coexistence of different folded conformations also suggests that there are multiple pathways leading from the unfolded to the folded state ensembles, potentially modulating the folding rate and biological activity. We have developed an experimental method for quantifying the contributions of individual pathways to the folding of conformationally heterogeneous G4s that is based on mutagenesis, thermal hysteresis kinetic experiments and global analysis, and validated our results using photocaged kinetic NMR experiments. We studied the regulatory Pu22 G4 from the c-myc oncogene promoter, which adopts at least four distinct folded isomers. We found that the presence of four parallel pathways leads to a 2.5-fold acceleration in folding; that is, the effective folding rate from the unfolded to folded ensembles is 2.5 times as large as the rate constant for the fastest individual pathway. Since many G4 sequences can adopt many more than four isomers, folding accelerations of more than an order of magnitude are possible via this mechanism.</p>]]></description>
            <pubDate><![CDATA[2021-01-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Parallel monitoring of RNA abundance, localization and compactness with correlative single molecule FISH on LR White embedded samples]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905745938-c7d3a8cf-1ff2-4993-aedb-3a8f17b1b6b8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1142</link>
            <description><![CDATA[<p class="para" id="N65541">Single mRNA molecules are frequently detected by single molecule fluorescence in situ hybridization (smFISH) using branched DNA technology. While providing strong and background-reduced signals, the method is inefficient in detecting mRNAs within dense structures, in monitoring mRNA compactness and in quantifying abundant mRNAs. To overcome these limitations, we have hybridized slices of high pressure frozen, freeze-substituted and LR White embedded cells (LR White smFISH). mRNA detection is physically restricted to the surface of the resin. This enables single molecule detection of RNAs with accuracy comparable to RNA sequencing, irrespective of their abundance, while at the same time providing spatial information on RNA localization that can be complemented with immunofluorescence and electron microscopy, as well as array tomography. Moreover, LR White embedding restricts the number of available probe pair recognition sites for each mRNA to a small subset. As a consequence, differences in signal intensities between RNA populations reflect differences in RNA structures, and we show that the method can be employed to determine mRNA compactness. We apply the method to answer some outstanding questions related to trans-splicing, RNA granules and mitochondrial RNA editing in single-cellular trypanosomes and we show an example of differential gene expression in the metazoan <i>Caenorhabditis elegans</i>.</p>]]></description>
            <pubDate><![CDATA[2020-12-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The forkhead transcription factor FOXK2 premarks lineage-specific genes in human embryonic stem cells for activation during differentiation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905681451-4c778a08-df96-4d1d-9c2e-923b3d716f34/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1281</link>
            <description><![CDATA[<p class="para" id="N65541">Enhancers play important roles in controlling gene expression in a choreographed spatial and temporal manner during development. However, it is unclear how these regulatory regions are established during differentiation. Here we investigated the genome-wide binding profile of the forkhead transcription factor FOXK2 in human embryonic stem cells (ESCs) and downstream cell types. This transcription factor is bound to thousands of regulatory regions in human ESCs, and binding at many sites is maintained as cells differentiate to mesendodermal and neural precursor cell (NPC) types, alongside the emergence of new binding regions. FOXK2 binding is generally associated with active histone marks in any given cell type. Furthermore newly acquired, or retained FOXK2 binding regions show elevated levels of activating histone marks following differentiation to NPCs. In keeping with this association with activating marks, we demonstrate a role for FOXK transcription factors in gene activation during NPC differentiation. FOXK2 occupancy in ESCs is therefore an early mark for delineating the regulatory regions, which become activated in later lineages.</p>]]></description>
            <pubDate><![CDATA[2021-01-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Entropy subspace separation-based clustering for noise reduction (ENCORE) of scRNA-seq data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905383391-9d7b8459-887c-425a-9815-b450ca5c2e39/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1157</link>
            <description><![CDATA[<p class="para" id="N65541">Single-cell RNA sequencing enables us to characterize the cellular heterogeneity in single cell resolution with the help of cell type identification algorithms. However, the noise inherent in single-cell RNA-sequencing data severely disturbs the accuracy of cell clustering, marker identification and visualization. We propose that clustering based on feature density profiles can distinguish informative features from noise. We named such strategy as ‘entropy subspace’ separation and designed a cell clustering algorithm called ENtropy subspace separation-based Clustering for nOise REduction (ENCORE) by integrating the ‘entropy subspace’ separation strategy with a consensus clustering method. We demonstrate that ENCORE performs superiorly on cell clustering and generates high-resolution visualization across 12 standard datasets. More importantly, ENCORE enables identification of group markers with biological significance from a hard-to-separate dataset. With the advantages of effective feature selection, improved clustering, accurate marker identification and high-resolution visualization, we present ENCORE to the community as an important tool for scRNA-seq data analysis to study cellular heterogeneity and discover group markers.</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Micro-homology intermediates: RecA’s transient sampling revealed at the single molecule level]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905180183-6203ae08-2ed0-4580-a107-b23684b5d0bf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1258</link>
            <description><![CDATA[<p class="para" id="N65541">Recombinase A (RecA) is central to homologous recombination. However, despite significant advances, the mechanism with which RecA is able to orchestrate a search for homology remains elusive. DNA nanostructure-augmented high-speed AFM offers the spatial and temporal resolutions required to study the RecA recombination mechanism directly and at the single molecule level. We present the direct <i>in situ</i> observation of RecA-orchestrated alignment of homologous DNA strands to form a stable recombination product within a supporting DNA nanostructure. We show the existence of subtle and short-lived states in the interaction landscape, which suggests that RecA transiently samples micro-homology at the single RecA monomer-level throughout the search for sequence alignment. These transient interactions form the early steps in the search for sequence homology, prior to the formation of stable pairings at &gt;8 nucleotide seeds. The removal of sequence micro-homology results in the loss of the associated transient sampling at that location.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765905180183-6203ae08-2ed0-4580-a107-b23684b5d0bf/assets/gkaa1258gra1.jpg" alt="A schematic diagram depicting the homologous recombination reaction scheme within the DNA origami frame and associated HS-AFM micrographs. Left to right: the layout of the internal suspended DNA molecules (control, NPF and reaction) is shown in reference to an inbuilt polarity marker (black triangle). The RecA NPF (nucleoprotein filament) is formed on the 30 nt ssDNA region of the NPF DNA molecule and is connected into the DNA frame via a UV photocleavable linker (yellow star). Exposure to UV releases the NPF from its tether initiating homologous recombination. This culminates in the formation of a synaptic joint at the region of sequence homology (green) on the reaction DNA. HS-AFM image scale bar = 40 nm."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      A schematic diagram depicting the homologous recombination reaction scheme within the DNA origami frame and associated HS-AFM micrographs. Left to right: the layout of the internal suspended DNA molecules (control, NPF and reaction) is shown in reference to an inbuilt polarity marker (black triangle). The RecA NPF (nucleoprotein filament) is formed on the 30 nt ssDNA region of the NPF DNA molecule and is connected into the DNA frame via a UV photocleavable linker (yellow star). Exposure to UV releases the NPF from its tether initiating homologous recombination. This culminates in the formation of a synaptic joint at the region of sequence homology (green) on the reaction DNA. HS-AFM image scale bar = 40 nm.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Crystal structure of a tick-borne flavivirus RNA-dependent RNA polymerase suggests a host adaptation hotspot in RNA viruses]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765905099801-8e16f7ec-14c0-4a39-b9eb-e13792295e9e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1250</link>
            <description><![CDATA[<p class="para" id="N65541">The RNA-dependent RNA polymerases (RdRPs) encoded by RNA viruses represent a unique class of nucleic acid polymerases. RdRPs are essential in virus life cycle due to their central role in viral genome replication/transcription processes. However, their contribution in host adaption has not been well documented. By solving the RdRP crystal structure of the tick-borne encephalitis virus (TBEV), a tick-borne flavivirus, and comparing the structural and sequence features with mosquito-borne flavivirus RdRPs, we found that a region between RdRP catalytic motifs B and C, namely region B-C, clearly bears host-related diversity. Inter-virus substitutions of region B-C sequence were designed in both TBEV and mosquito-borne Japanese encephalitis virus backbones. While region B-C substitutions only had little or moderate effect on RdRP catalytic activities, virus proliferation was not supported by these substitutions in both virus systems. Importantly, a TBEV replicon-derived viral RNA replication was significantly reduced but not abolished by the substitution, suggesting the involvement of region B-C in viral and/or host processes beyond RdRP catalysis. A systematic structural analysis of region B-C in viral RdRPs further emphasizes its high level of structure and length diversity, providing a basis to further refine its relevance in RNA virus-host interactions in a general context.</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mapping DNA conformations and interactions within the binding cleft of bacteriophage T4 single-stranded DNA binding protein (gp32) at single nucleotide resolution]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765854689437-45271eb7-04c5-4a4d-b4e8-2c22221b5989/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1230</link>
            <description><![CDATA[<p class="para" id="N65541">In this study, we use single-stranded DNA (oligo-dT) lattices that have been position-specifically labeled with monomer or dimer 2-aminopurine (2-AP) probes to map the local interactions of the DNA bases with the nucleic acid binding cleft of gp32, the single-stranded binding (ssb) protein of bacteriophage T4. Three complementary spectroscopic approaches are used to characterize these local interactions of the probes with nearby nucleotide bases and amino acid residues at varying levels of effective protein binding cooperativity, as manipulated by changing lattice length. These include: (i) examining local quenching and enhancing effects on the fluorescence spectra of monomer 2-AP probes at each position within the cleft; (ii) using acrylamide as a dynamic-quenching additive to measure solvent access to monomer 2-AP probes at each ssDNA position; and (iii) employing circular dichroism spectra to characterize changes in exciton coupling within 2-AP dimer probes at specific ssDNA positions within the protein cleft. The results are interpreted in part by what we know about the topology of the binding cleft from crystallographic studies of the DNA binding domain of gp32 and provide additional insights into how gp32 can manipulate the ssDNA chain at various steps of DNA replication and other processes of genome expression.</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Differential activation mechanisms of two isoforms of Gcr1 transcription factor generated from spliced and un-spliced transcripts in <i>Saccharomyces cerevisiae</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765853656928-39334cbb-ac2c-4cb6-b5c5-a851b95848f3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1221</link>
            <description><![CDATA[<p class="para" id="N65541">Gcr1, an important transcription factor for glycolytic genes in <i>Saccharomyces cerevisiae</i>, was recently revealed to have two isoforms, Gcr1<sup>U</sup> and Gcr1<sup>S</sup>, produced from un-spliced and spliced transcripts, respectively. In this study, by generating strains expressing only Gcr1<sup>U</sup> or Gcr1<sup>S</sup> using the CRISPR/Cas9 system, we elucidate differential activation mechanisms of these two isoforms. The Gcr1<sup>U</sup> monomer forms an active complex with its coactivator Gcr2 homodimer, whereas Gcr1<sup>S</sup> acts as a homodimer without Gcr2. The USS domain, 55 residues at the N-terminus existing only in Gcr1<sup>U</sup>, inhibits dimerization of Gcr1<sup>U</sup> and even acts <i>in trans</i> to inhibit Gcr1<sup>S</sup> dimerization. The Gcr1<sup>S</sup> monomer inhibits the metabolic switch from fermentation to respiration by directly binding to the <i>ALD4</i> promoter, which can be restored by overexpression of the <i>ALD4</i> gene, encoding a mitochondrial aldehyde dehydrogenase required for ethanol utilization. Gcr1<sup>U</sup> and Gcr1<sup>S</sup> regulate almost the same target genes, but show unique activities depending on growth phase, suggesting that these isoforms play differential roles through separate activation mechanisms depending on environmental conditions.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765853656928-39334cbb-ac2c-4cb6-b5c5-a851b95848f3/assets/gkaa1221gra1.jpg" alt="Gcr1U and Gcr1S, generated from un-spliced and spliced forms of mRNA, respectively, act as different complexes to activate expression of glycolytic genes."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Gcr1<sup>U</sup> and Gcr1<sup>S</sup>, generated from un-spliced and spliced forms of mRNA, respectively, act as different complexes to activate expression of glycolytic genes.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A pathway for error-free non-homologous end joining of resected meiotic double-strand breaks]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765853181582-561c1f6c-37d9-4ee6-b2dc-ee8100f76d9e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1205</link>
            <description><![CDATA[<p class="para" id="N65541">Programmed DNA double-strand breaks (DSBs) made during meiosis are repaired by recombination with the homologous chromosome to generate, at selected sites, reciprocal crossovers that are critical for the proper separation of homologs in the first meiotic division. Backup repair processes can compensate when the normal meiotic recombination processes are non-functional. We describe a novel backup repair mechanism that occurs when the homologous chromosome is not available in <i>Drosophila melanogaster</i> meiosis. In the presence of a previously described mutation (<i>Mcm5<sup>A7</sup></i>) that disrupts chromosome pairing, DSB repair is initiated by homologous recombination but is completed by non-homologous end joining (NHEJ). Remarkably, this process yields precise repair products. Our results provide support for a recombination intermediate recently proposed in mouse meiosis, in which an oligonucleotide bound to the Spo11 protein that catalyzes DSB formation remains bound after resection. We propose that this oligonucleotide functions as a primer for fill-in synthesis to allow scarless repair by NHEJ. We argue that this is a conserved repair mechanism that is likely to be invoked to overcome occasional challenges in normal meiosis.</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Programmable gene regulation for metabolic engineering using decoy transcription factor binding sites]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765852738711-326e7eac-f0cd-479e-82aa-59eca983d359/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1234</link>
            <description><![CDATA[<p class="para" id="N65541">Transcription factor decoy binding sites are short DNA sequences that can titrate a transcription factor away from its natural binding site, therefore regulating gene expression. In this study, we harness synthetic transcription factor decoy systems to regulate gene expression for metabolic pathways in <i>Escherichia coli</i>. We show that transcription factor decoys can effectively regulate expression of native and heterologous genes. Tunability of the decoy can be engineered via changes in copy number or modifications to the DNA decoy site sequence. Using arginine biosynthesis as a showcase, we observed a 16-fold increase in arginine production when we introduced the decoy system to steer metabolic flux towards increased arginine biosynthesis, with negligible growth differences compared to the wild type strain. The decoy-based production strain retains high genetic integrity; in contrast to a gene knock-out approach where mutations were common, we detected no mutations in the production system using the decoy-based strain. We further show that transcription factor decoys are amenable to multiplexed library screening by demonstrating enhanced tolerance to pinene with a combinatorial decoy library. Our study shows that transcription factor decoy binding sites are a powerful and compact tool for metabolic engineering.</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Effects of codon usage on gene expression are promoter context dependent]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765852016667-f912bbc4-6a48-4540-9118-5b8454efadf6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1253</link>
            <description><![CDATA[<p class="para" id="N65541">Codon usage bias is a universal feature of all genomes. Although codon usage has been shown to regulate mRNA and protein levels by influencing mRNA decay and transcription in eukaryotes, little or no genome-wide correlations between codon usage and mRNA levels are detected in mammalian cells, raising doubt on the significance of codon usage effect on gene expression. Here we show that gene-specific regulation reduces the genome-wide codon usage and mRNA correlations: Constitutively expressed genes exhibit much higher genome-wide correlations than differentially expressed genes from fungi to human cells. Using <i>Drosophila</i> S2 cells as a model system, we showed that the effect of codon usage on mRNA expression level is promoter-dependent. Regions downstream of the core promoters of differentially expressed genes can repress the codon usage effects on mRNA expression. An element in the <i>Hsp70</i> promoter was identified to be necessary and sufficient for this inhibitory effect. The promoter-dependent codon usage effects on mRNA levels are regulated at the transcriptional level through modulation of histone modifications, nucleosome densities and premature termination. Together, our results demonstrate that promoters play a major role in determining whether codon usage influences gene expression and further establish the transcription-dependent codon usage effects on gene expression.</p>]]></description>
            <pubDate><![CDATA[2021-01-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The fission yeast Pin1 peptidyl-prolyl isomerase promotes dissociation of Sty1 MAPK from RNA polymerase II and recruits Ssu72 phosphatase to facilitate oxidative stress induced transcription]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765851638258-5c5a1701-9ae3-4442-b9d3-346db670f31a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1243</link>
            <description><![CDATA[<p class="para" id="N65541">Pin1 is a peptidyl-prolyl isomerase that regulates the structure and function of eukaryotic RNA polymerase II (Pol II) through interaction with the C-terminal domain (CTD) of Rpb1, the largest subunit of Pol II. We demonstrated that this function is important for cellular response to oxidative stress in the fission yeast <i>Schizosaccharomyces pombe</i>. In response to oxidative stress, the Atf1 transcription factor targets Sty1, the mitogen-activated protein kinase (MAPK), to specific stress-responsive promoters. Anchored Sty1 recruits Pol II through direct association with Rpb1-CTD and phosphorylates the reiterated heptad sequence at Serine 5. Pin1 binds phosphorylated CTD to promote dissociation of Sty1 from it, and directly recruits Ssu72 phosphatase to facilitate dephosphorylation of CTD for transcription elongation. In the absence of Pin1, the association of Sty1-Atf1 with Rpb1 persists on stress-responsive promoters failed to generate transcripts of the corresponding genes effectively. The identified characteristic features of the fission yeast Pin1 are conserved in humans. We demonstrated that elevated Pin1 level in cancer cells might help to sustain survival under oxidative stress generated from their altered metabolic pathways. Together, these results suggest a conserved function of Pin1 in cellular response to oxidative stress among eukaryotic cells that might have clinical implication.</p>]]></description>
            <pubDate><![CDATA[2021-01-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[SUMOylation mediates CtIP’s functions in DNA end resection and replication fork protection]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765849237939-715a84dc-d6ac-48c6-a41f-296f0225755f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1232</link>
            <description><![CDATA[<p class="para" id="N65541">Double-strand breaks and stalled replication forks are a significant threat to genomic stability that can lead to chromosomal rearrangements or cell death. The protein CtIP promotes DNA end resection, an early step in homologous recombination repair, and has been found to protect perturbed forks from excessive nucleolytic degradation. However, it remains unknown how CtIP’s function in fork protection is regulated. Here, we show that CtIP recruitment to sites of DNA damage and replication stress is impaired upon global inhibition of SUMOylation. We demonstrate that CtIP is a target for modification by SUMO-2 and that this occurs constitutively during S phase. The modification is dependent on the activities of cyclin-dependent kinases and the PI-3-kinase-related kinase ATR on CtIP’s carboxyl-terminal region, an interaction with the replication factor PCNA, and the E3 SUMO ligase PIAS4. We also identify residue K578 as a key residue that contributes to CtIP SUMOylation. Functionally, a CtIP mutant where K578 is substituted with a non-SUMOylatable arginine residue is defective in promoting DNA end resection, homologous recombination, and in protecting stalled replication forks from excessive nucleolytic degradation. Our results shed further light on the tightly coordinated regulation of CtIP by SUMOylation in the maintenance of genome stability.</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Expansion and re-classification of the extracytoplasmic function (ECF) σ factor family]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765848152741-788f5670-76e2-4ff7-a51d-368bb74367ed/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1229</link>
            <description><![CDATA[<p class="para" id="N65541">Extracytoplasmic function σ factors (ECFs) represent one of the major bacterial signal transduction mechanisms in terms of abundance, diversity and importance, particularly in mediating stress responses. Here, we performed a comprehensive phylogenetic analysis of this protein family by scrutinizing all proteins in the NCBI database. As a result, we identified an average of ∼10 ECFs per bacterial genome and 157 phylogenetic ECF groups that feature a conserved genetic neighborhood and a similar regulation mechanism. Our analysis expands previous classification efforts ∼50-fold, enriches many original ECF groups with previously unclassified proteins and identifies 22 entirely new ECF groups. The ECF groups are hierarchically related to each other and are further composed of subgroups with closely related sequences. This two-tiered classification allows for the accurate prediction of common promoter motifs and the inference of putative regulatory mechanisms across subgroups composing an ECF group. This comprehensive, high-resolution description of the phylogenetic distribution of the ECF family, together with the massive expansion of classified ECF sequences and an openly accessible data repository called ‘ECF Hub’ (https://www.computational.bio.uni-giessen.de/ecfhub), will serve as a powerful hypothesis-generator to guide future research in the field.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Precise and broad scope genome editing based on high-specificity Cas9 nickases]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765847374628-094b7939-d625-4485-947d-823f111bc8b7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1236</link>
            <description><![CDATA[<p class="para" id="N65541">RNA-guided nucleases (RGNs) based on CRISPR systems permit installing short and large edits within eukaryotic genomes. However, precise genome editing is often hindered due to nuclease off-target activities and the multiple-copy character of the vast majority of chromosomal sequences. Dual nicking RGNs and high-specificity RGNs both exhibit low off-target activities. Here, we report that high-specificity Cas9 nucleases are convertible into nicking Cas9<sup>D10A</sup> variants whose precision is superior to that of the commonly used Cas9<sup>D10A</sup> nickase. Dual nicking RGNs based on a selected group of these Cas9<sup>D10A</sup> variants can yield gene knockouts and gene knock-ins at frequencies similar to or higher than those achieved by their conventional counterparts. Moreover, high-specificity dual nicking RGNs are capable of distinguishing highly similar sequences by ‘tiptoeing’ over pre-existing single base-pair polymorphisms. Finally, high-specificity RNA-guided nicking complexes generally preserve genomic integrity, as demonstrated by unbiased genome-wide high-throughput sequencing assays. Thus, in addition to substantially enlarging the Cas9 nickase toolkit, we demonstrate the feasibility in expanding the range and precision of DNA knockout and knock-in procedures. The herein introduced tools and multi-tier high-specificity genome editing strategies might be particularly beneficial whenever predictability and/or safety of genetic manipulations are paramount.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[NOPCHAP1 is a PAQosome cofactor that helps loading NOP58 on RUVBL1/2 during box C/D snoRNP biogenesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765846329871-f165dfe1-aa96-45e7-9779-d23f04f3c6af/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1226</link>
            <description><![CDATA[<p class="para" id="N65541">The PAQosome is a large complex composed of the HSP90/R2TP chaperone and a prefoldin-like module. It promotes the biogenesis of cellular machineries but it is unclear how it discriminates closely related client proteins. Among the main PAQosome clients are C/D snoRNPs and in particular their core protein NOP58. Using NOP58 mutants and proteomic experiments, we identify different assembly intermediates and show that C12ORF45, which we rename NOPCHAP1, acts as a bridge between NOP58 and PAQosome. NOPCHAP1 makes direct physical interactions with the CC-NOP domain of NOP58 and domain II of RUVBL1/2 AAA+ ATPases. Interestingly, NOPCHAP1 interaction with RUVBL1/2 is disrupted upon ATP binding. Moreover, while it robustly binds both yeast and human NOP58, it makes little interactions with NOP56 and PRPF31, two other closely related CC-NOP proteins. Expression of NOP58, but not NOP56 or PRPF31, is decreased in NOPCHAP1 KO cells. We propose that NOPCHAP1 is a client-loading PAQosome cofactor that selects NOP58 to promote box C/D snoRNP assembly.</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural dynamics of double-stranded DNA with epigenome modification]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765840892649-22d262d5-18d0-474d-82a9-f3084ade605c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1210</link>
            <description><![CDATA[<p class="para" id="N65541">Modification of cytosine plays an important role in epigenetic regulation of gene expression and genome stability. Cytosine is converted to 5-methylcytosine (5mC) by DNA methyltransferase; in turn, 5mC may be oxidized to 5-hydroxymethylcytosine (5hmC) by ten-eleven translocation enzyme. The structural flexibility of DNA is known to affect the binding of proteins to methylated DNA. Here, we have carried out a semi-quantitative analysis of the dynamics of double-stranded DNA (dsDNA) containing various epigenetic modifications by combining data from imino <sup>1</sup>H exchange and imino <sup>1</sup>H <i>R</i><sub>1ρ</sub> relaxation dispersion NMR experiments in a complementary way. Using this approach, we characterized the base-opening (<i>k</i><sub>open</sub>) and base-closing (<i>k</i><sub>close</sub>) rates, facilitating a comparison of the base-opening and -closing process of dsDNA containing cytosine in different states of epigenetic modification. A particularly striking result is the increase in the <i>k</i><sub>open</sub> rate of hemi-methylated dsDNA 5mC/C relative to unmodified or fully methylated dsDNA, indicating that the Watson–Crick base pairs undergo selective destabilization in 5mC/C. Collectively, our findings imply that the epigenetic modulation of cytosine dynamics in dsDNA mediates destabilization of the GC Watson–Crick base pair to allow base-flipping in living cells.</p>]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Variable interplay of UV-induced DNA damage and repair at transcription factor binding sites]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765840170700-1c7301ee-1e58-43ac-bee2-e26c62f2ab45/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1219</link>
            <description><![CDATA[<p class="para" id="N65541">An abnormally high rate of UV-light related mutations appears at transcription factor binding sites (TFBS) across melanomas. The binding of transcription factors (TFs) to the DNA impairs the repair of UV-induced lesions and certain TFs have been shown to increase the rate of generation of these lesions at their binding sites. However, the precise contribution of these two elements to the increase in mutation rate at TFBS in these malignant cells is not understood. Here, exploiting nucleotide-resolution data, we computed the rate of formation and repair of UV-lesions within the binding sites of TFs of different families. We observed, at certain dipyrimidine positions within the binding site of TFs in the Tryptophan Cluster family, an increased rate of formation of UV-induced lesions, corroborating previous studies. Nevertheless, across most families of TFs, the observed increased mutation rate within the entire DNA region covered by the protein results from the decreased repair efficiency. While the rate of mutations across all TFBS does not agree with the amount of UV-induced lesions observed immediately after UV exposure, it strongly agrees with that observed after 48 h. This corroborates the determinant role of the impaired repair in the observed increase of mutation rate.</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Partition of tRNA<sup>Gly</sup> isoacceptors between protein and cell-wall peptidoglycan synthesis in <i>Staphylococcus aureus</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765840082324-869c86b0-24fe-4a1e-af59-58dcd36db8a4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1242</link>
            <description><![CDATA[<p class="para" id="N65541">The sequence of tRNAs is submitted to evolutionary constraints imposed by their multiple interactions with aminoacyl-tRNA synthetases, translation elongation factor Tu in complex with GTP (EF-Tu•GTP), and the ribosome, each being essential for accurate and effective decoding of messenger RNAs. In <i>Staphylococcus aureus</i>, an additional constraint is imposed by the participation of tRNA<sup>Gly</sup> isoacceptors in the addition of a pentaglycine side chain to cell-wall peptidoglycan precursors by transferases FmhB, FemA and FemB. Three tRNA<sup>Gly</sup> isoacceptors poorly interacting with EF-Tu•GTP and the ribosome were previously identified. Here, we show that these ‘non-proteogenic’ tRNAs are preferentially recognized by FmhB based on kinetic analyses and on synthesis of stable aminoacyl-tRNA analogues acting as inhibitors. Synthesis of chimeric tRNAs and of helices mimicking the tRNA acceptor arms revealed that this discrimination involves identity determinants exclusively present in the D and T stems and loops of non-proteogenic tRNAs, which belong to an evolutionary lineage only present in the staphylococci. EF-Tu•GTP competitively inhibited FmhB by sequestration of ‘proteogenic’ aminoacyl-tRNAs <i>in vitro</i>. Together, these results indicate that competition for the Gly-tRNA<sup>Gly</sup> pool is restricted by both limited recognition of non-proteogenic tRNAs by EF-Tu•GTP and limited recognition of proteogenic tRNAs by FmhB.</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The <i>MDM2</i> inducible promoter folds into four-tetrad antiparallel G-quadruplexes targetable to fight malignant liposarcoma]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765839979464-4cf52eca-b5c9-47e9-831b-7e6040ef1d82/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1273</link>
            <description><![CDATA[<p class="para" id="N65541">Well-differentiated liposarcoma (WDLPS) is a malignant neoplasia hard to diagnose and treat. Its main molecular signature is amplification of the <i>MDM2-</i>containing genomic region. The <i>MDM2</i> oncogene is the master regulator of p53: its overexpression enhances p53 degradation and inhibits apoptosis, leading to the tumoral phenotype. Here, we show that the <i>MDM2</i> inducible promoter G-rich region folds into stable G-quadruplexes both <i>in vitro</i> and <i>in vivo</i> and it is specifically recognized by cellular helicases. Cell treatment with G-quadruplex-ligands reduces <i>MDM2</i> expression and p53 degradation, thus stimulating cancer cell cycle arrest and apoptosis. Structural characterization of the <i>MDM2</i> G-quadruplex revealed an extraordinarily stable, unique four-tetrad antiparallel dynamic conformation, amenable to selective targeting. These data indicate the feasibility of an out-of-the-box G-quadruplex-targeting approach to defeat WDLPS and all tumours where restoration of wild-type p53 is sought. They also point to G-quadruplex-dependent genomic instability as possible cause of <i>MDM2</i> expansion and WDLPS tumorigenesis.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765839979464-4cf52eca-b5c9-47e9-831b-7e6040ef1d82/assets/gkaa1273gra1.jpg" alt="Scheme representing how G4-ligand-induced stabilization of MDM2 P2 promoter G4 leads to accumulation of p53 and hnRNP-K proteins, resulting in stimulation of apoptosis and cell cycle arrest."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Scheme representing how G4-ligand-induced stabilization of MDM2 P2 promoter G4 leads to accumulation of p53 and hnRNP-K proteins, resulting in stimulation of apoptosis and cell cycle arrest.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2021-01-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[
<i>Pseudomonas putida</i> MPE, a manganese-dependent endonuclease of the binuclear metallophosphoesterase superfamily, incises single-strand DNA in two orientations to yield a mixture of 3′-PO<sub>4</sub> and 3′-OH termini]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765839531617-a74b7fd7-2838-46ef-96d8-1b1f3c67080e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1214</link>
            <description><![CDATA[<p class="para" id="N65541">
<i>Pseudomonas putida</i> MPE exemplifies a novel clade of manganese-dependent single-strand DNA endonuclease within the binuclear metallophosphoesterase superfamily. MPE is encoded within a widely conserved DNA repair operon. Via structure-guided mutagenesis, we identify His113 and His81 as essential for DNA nuclease activity, albeit inessential for hydrolysis of bis-<i>p</i>-nitrophenylphosphate. We propose that His113 contacts the scissile phosphodiester and serves as a general acid catalyst to expel the OH leaving group of the product strand. We find that MPE cleaves the 3′ and 5′ single-strands of tailed duplex DNAs and that MPE can sense and incise duplexes at sites of short mismatch bulges and opposite a nick. We show that MPE is an ambidextrous phosphodiesterase capable of hydrolyzing the ssDNA backbone in either orientation to generate a mixture of 3′-OH and 3′-PO<sub>4</sub> cleavage products. The directionality of phosphodiester hydrolysis is dictated by the orientation of the water nucleophile <i>vis-à-vis</i> the OH leaving group, which must be near apical for the reaction to proceed. We propose that the MPE active site and metal-bound water nucleophile are invariant and the enzyme can bind the ssDNA productively in opposite orientations.</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Targeting alternative splicing by RNAi: from the differential impact on splice variants to triggering artificial pre-mRNA splicing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765839081559-2b10c1d4-4ef3-409d-b035-ec21fd378745/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1260</link>
            <description><![CDATA[<p class="para" id="N65541">Alternative splicing generates multiple transcript and protein isoforms from a single gene and controls transcript intracellular localization and stability by coupling to mRNA export and nonsense-mediated mRNA decay (NMD). RNA interference (RNAi) is a potent mechanism to modulate gene expression. However, its interactions with alternative splicing are poorly understood. We used artificial microRNAs (amiRNAs, also termed shRNAmiR) to knockdown all splice variants of selected target genes in <i>Arabidopsis thaliana</i>. We found that splice variants, which vary by their protein-coding capacity, subcellular localization and sensitivity to NMD, are affected differentially by an amiRNA, although all of them contain the target site. Particular transcript isoforms escape amiRNA-mediated degradation due to their nuclear localization. The nuclear and NMD-sensitive isoforms mask RNAi action in alternatively spliced genes. Interestingly, Arabidopsis <i>SPL</i> genes, which undergo alternative splicing and are targets of miR156, are regulated in the same manner. Moreover, similar results were obtained in mammalian cells using siRNAs, indicating cross-kingdom conservation of these interactions among RNAi and splicing isoforms. Furthermore, we report that amiRNA can trigger artificial alternative splicing, thus expanding the RNAi functional repertoire. Our findings unveil novel interactions between different post-transcriptional processes in defining transcript fates and regulating gene expression.</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Terminal deoxynucleotidyl transferase-mediated formation of protein binding polynucleotides]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765838072959-3641a13a-0ab1-49e1-9629-c7de7530ea03/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1263</link>
            <description><![CDATA[<p class="para" id="N65541">Terminal deoxynucleotidyl transferase (TdT) enzyme plays an integral part in the V(D)J recombination, allowing for the huge diversity in expression of immunoglobulins and T-cell receptors within lymphocytes, through their unique ability to incorporate single nucleotides into oligonucleotides without the need of a template. The role played by TdT in lymphocytes precursors found in early vertebrates is not known. In this paper, we demonstrated a new screening method that utilises TdT to form libraries of variable sized (vsDNA) libraries of polynucleotides that displayed binding towards protein targets. The extent of binding and size distribution of each vsDNA library towards their respective protein target can be controlled through the alteration of different reaction conditions such as time of reaction, nucleotide ratio and initiator concentration raising the possibility for the rational design of aptamers prior to screening. The new approach, allows for the screening of aptamers based on size as well as sequence in a single round, which minimises PCR bias. We converted the protein bound sequences to dsDNA using rapid amplification of variable ends assays (RAVE) and sequenced them using next generation sequencing. The resultant aptamers demonstrated low nanomolar binding and high selectivity towards their respective targets.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Intestinal differentiation involves cleavage of histone H3 N-terminal tails by multiple proteases]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765838036279-853b4d68-cd59-4ee9-96f8-afc9c1bdb3ee/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1228</link>
            <description><![CDATA[<p class="para" id="N65541">The proteolytic cleavage of histone tails, also termed histone clipping, has been described as a mechanism for permanent removal of post-translational modifications (PTMs) from histone proteins. Such activity has been ascribed to ensure regulatory function in key cellular processes such as differentiation, senescence and transcriptional control, for which different histone-specific proteases have been described. However, all these studies were exclusively performed using cell lines cultured <i>in vitro</i> and no clear evidence that histone clipping is regulated <i>in vivo</i> has been reported. Here we show that histone H3 N-terminal tails undergo extensive cleavage in the differentiated cells of the villi in mouse intestinal epithelium. Combining biochemical methods, 3D organoid cultures and <i>in vivo</i> approaches, we demonstrate that intestinal H3 clipping is the result of multiple proteolytic activities. We identified Trypsins and Cathepsin L as specific H3 tail proteases active in small intestinal differentiated cells and showed that their proteolytic activity is differentially affected by the PTM pattern of histone H3 tails. Together, our findings provide <i>in vivo</i> evidence of H3 tail proteolysis in mammalian tissues, directly linking H3 clipping to cell differentiation.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Customized optical mapping by CRISPR–Cas9 mediated DNA labeling with multiple sgRNAs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765836900343-d67e3df6-0e9a-45e0-a8b5-a9b65c86b973/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1088</link>
            <description><![CDATA[<p class="para" id="N65541">Whole-genome mapping technologies have been developed as a complementary tool to provide scaffolds for genome assembly and structural variation analysis (<a href="#B1">1</a>,<a href="#B2">2</a>). We recently introduced a novel DNA labeling strategy based on a CRISPR–Cas9 genome editing system, which can target any 20bp sequences. The labeling strategy is specifically useful in targeting repetitive sequences, and sequences not accessible to other labeling methods. In this report, we present customized mapping strategies that extend the applications of CRISPR–Cas9 DNA labeling. We first design a CRISPR–Cas9 labeling strategy to interrogate and differentiate the single allele differences in NGG protospacer adjacent motifs (PAM sequence). Combined with sequence motif labeling, we can pinpoint the single-base differences in highly conserved sequences. In the second strategy, we design mapping patterns across a genome by selecting sets of specific single-guide RNAs (sgRNAs) for labeling multiple loci of a genomic region or a whole genome. By developing and optimizing a single tube synthesis of multiple sgRNAs, we demonstrate the utility of CRISPR–Cas9 mapping with 162 sgRNAs targeting the 2Mb <i>Haemophilus influenzae</i> chromosome. These CRISPR–Cas9 mapping approaches could be particularly useful for applications in defining long-distance haplotypes and pinpointing the breakpoints in large structural variants in complex genomes and microbial mixtures.</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Dynamics and competition of CRISPR–Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765836822753-71972aec-44b6-404a-943f-59a8653f29c5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1251</link>
            <description><![CDATA[<p class="para" id="N65541">Investigations of CRISPR gene knockout editing profiles have contributed to enhanced precision of editing outcomes. However, for homology-directed repair (HDR) in particular, the editing dynamics and patterns in clinically relevant cells, such as human iPSCs and primary T cells, are poorly understood. Here, we explore the editing dynamics and DNA repair profiles after the delivery of Cas9-guide RNA ribonucleoprotein (RNP) with or without the adeno-associated virus serotype 6 (AAV6) as HDR donors in four cell types. We show that editing profiles have distinct differences among cell lines. We also reveal the kinetics of HDR mediated by the AAV6 donor template. Quantification of T<sub>50</sub> (time to reach half of the maximum editing frequency) indicates that short indels (especially +A/T) occur faster than longer (&gt;2 bp) deletions, while the kinetics of HDR falls between NHEJ (non-homologous end-joining) and MMEJ (microhomology-mediated end-joining). As such, AAV6-mediated HDR effectively outcompetes the longer MMEJ-mediated deletions but not NHEJ-mediated indels. Notably, a combination of small molecular compounds M3814 and Trichostatin A (TSA), which potently inhibits predominant NHEJ repairs, leads to a 3-fold increase in HDR efficiency.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Determinants of adenine-mutagenesis in diversity-generating retroelements]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765835395097-2af5f9f8-eb4e-436c-864d-bd8e6dfb7c70/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1240</link>
            <description><![CDATA[<p class="para" id="N65541">Diversity-generating retroelements (DGRs) vary protein sequences to the greatest extent known in the natural world. These elements are encoded by constituents of the human microbiome and the microbial ‘dark matter’. Variation occurs through adenine-mutagenesis, in which genetic information in RNA is reverse transcribed faithfully to cDNA for all template bases but adenine. We investigated the determinants of adenine-mutagenesis in the prototypical <i>Bordetella</i> bacteriophage DGR through an <i>in vitro</i> system composed of the reverse transcriptase bRT, Avd protein, and a specific RNA. We found that the catalytic efficiency for correct incorporation during reverse transcription by the bRT-Avd complex was strikingly low for all template bases, with the lowest occurring for adenine. Misincorporation across a template adenine was only somewhat lower in efficiency than correct incorporation. We found that the C6, but not the N1 or C2, purine substituent was a key determinant of adenine-mutagenesis. bRT-Avd was insensitive to the C6 amine of adenine but recognized the C6 carbonyl of guanine. We also identified two bRT amino acids predicted to nonspecifically contact incoming dNTPs, R74 and I181, as promoters of adenine-mutagenesis. Our results suggest that the overall low catalytic efficiency of bRT-Avd is intimately tied to its ability to carry out adenine-mutagenesis.</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The nucleoid-associated protein IHF acts as a ‘transcriptional domainin’ protein coordinating the bacterial virulence traits with global transcription]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765835182442-5006ebba-9965-4b2f-a38e-60f44597ceb0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1227</link>
            <description><![CDATA[<p class="para" id="N65541">Bacterial pathogenic growth requires a swift coordination of pathogenicity function with various kinds of environmental stress encountered in the course of host infection. Among the factors critical for bacterial adaptation are changes of DNA topology and binding effects of nucleoid-associated proteins transducing the environmental signals to the chromosome and coordinating the global transcriptional response to stress. In this study, we use the model phytopathogen <i>Dickeya dadantii</i> to analyse the organisation of transcription by the nucleoid-associated heterodimeric protein IHF. We inactivated the IHFα subunit of IHF thus precluding the IHFαβ heterodimer formation and determined both phenotypic effects of <i>ihfA</i> mutation on <i>D. dadantii</i> virulence and the transcriptional response under various conditions of growth. We show that <i>ihfA</i> mutation reorganises the genomic expression by modulating the distribution of chromosomal DNA supercoils at different length scales, thus affecting many virulence genes involved in both symptomatic and asymptomatic phases of infection, including those required for pectin catabolism. Altogether, we propose that IHF heterodimer is a ‘transcriptional domainin’ protein, the lack of which impairs the spatiotemporal organisation of transcriptional stress-response domains harbouring various virulence traits, thus abrogating the pathogenicity of <i>D. dadantii</i>.</p>]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Splicing at the phase-separated nuclear speckle interface: a model]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765835123224-5077edf5-9f62-4b5e-9184-197d898dcb08/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1209</link>
            <description><![CDATA[<p class="para" id="N65541">Phase-separated membraneless bodies play important roles in nucleic acid biology. While current models for the roles of phase separation largely focus on the compartmentalization of constituent proteins, we reason that other properties of phase separation may play functional roles. Specifically, we propose that interfaces of phase-separated membraneless bodies could have functional roles in spatially organizing biochemical reactions. Here we propose such a model for the nuclear speckle, a membraneless body implicated in RNA splicing. In our model, sequence-dependent RNA positioning along the nuclear speckle interface coordinates RNA splicing. Our model asserts that exons are preferentially sequestered into nuclear speckles through binding by SR proteins, while introns are excluded through binding by nucleoplasmic hnRNP proteins. As a result, splice sites at exon-intron boundaries are preferentially positioned at nuclear speckle interfaces. This positioning exposes splice sites to interface-localized spliceosomes, enabling the subsequent splicing reaction. Our model provides a simple mechanism that seamlessly explains much of the complex logic of splicing. This logic includes experimental results such as the antagonistic duality between splicing factors, the position dependence of splicing sequence motifs, and the collective contribution of many motifs to splicing decisions. Similar functional roles for phase-separated interfaces may exist for other membraneless bodies.</p>]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Sequence- and structure-specific cytosine-5 mRNA methylation by NSUN6]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765835053433-413b7559-61a2-4a2d-ad3b-62ff3a34a629/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1193</link>
            <description><![CDATA[<p class="para" id="N65541">The highly abundant N6-methyladenosine (m<sup>6</sup>A) RNA modification affects most aspects of mRNA function, yet the precise function of the rarer 5-methylcytidine (m<sup>5</sup>C) remains largely unknown. Here, we map m<sup>5</sup>C in the human transcriptome using methylation-dependent individual-nucleotide resolution cross-linking and immunoprecipitation (miCLIP) combined with RNA bisulfite sequencing. We identify NSUN6 as a methyltransferase with strong substrate specificity towards mRNA. NSUN6 primarily targeted three prime untranslated regions (3′UTR) at the consensus sequence motif CTCCA, located in loops of hairpin structures. Knockout and rescue experiments revealed enhanced mRNA and translation levels when NSUN6-targeted mRNAs were methylated. Ribosome profiling further demonstrated that NSUN6-specific methylation correlated with translation termination. While NSUN6 was dispensable for mouse embryonic development, it was down-regulated in human tumours and high expression of NSUN6 indicated better patient outcome of certain cancer types. In summary, our study identifies NSUN6 as a methyltransferase targeting mRNA, potentially as part of a quality control mechanism involved in translation termination fidelity.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765834839874-171e3f68-5fbe-4c95-bf79-6ee46b408de3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1235</link>
            <description><![CDATA[<p class="para" id="N65541">Antisense oligonucleotides (ASOs) have emerged as a new class of drugs to treat a wide range of diseases, including neurological indications. Spinraza, an ASO that modulates splicing of <i>SMN2</i> RNA, has shown profound disease modifying effects in Spinal Muscular Atrophy (SMA) patients, energizing efforts to develop ASOs for other neurological diseases. While SMA specifically affects spinal motor neurons, other neurological diseases affect different central nervous system (CNS) regions, neuronal and non-neuronal cells. Therefore, it is important to characterize ASO distribution and activity in all major CNS structures and cell types to have a better understanding of which neurological diseases are amenable to ASO therapy. Here we present for the first time the atlas of ASO distribution and activity in the CNS of mice, rats, and non-human primates (NHP), species commonly used in preclinical therapeutic development. Following central administration of an ASO to rodents, we observe widespread distribution and target RNA reduction throughout the CNS in neurons, oligodendrocytes, astrocytes and microglia. This is also the case in NHP, despite a larger CNS volume and more complex neuroarchitecture. Our results demonstrate that ASO drugs are well suited for treating a wide range of neurological diseases for which no effective treatments are available.</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Decoding the epitranscriptional landscape from native RNA sequences]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765834540189-27a77f27-c16d-41c9-b1c9-c17828968f26/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa620</link>
            <description><![CDATA[<p class="para" id="N65541">Traditional epitranscriptomics relies on capturing a single RNA modification by antibody or chemical treatment, combined with short-read sequencing to identify its transcriptomic location. This approach is labor-intensive and may introduce experimental artifacts. Direct sequencing of native RNA using Oxford Nanopore Technologies (ONT) can allow for directly detecting the RNA base modifications, although these modifications might appear as sequencing errors. The percent Error of Specific Bases (%ESB) was higher for native RNA than unmodified RNA, which enabled the detection of ribonucleotide modification sites. Based on the %ESB differences, we developed a bioinformatic tool, epitranscriptional landscape inferring from glitches of ONT signals (ELIGOS), that is based on various types of synthetic modified RNA and applied to rRNA and mRNA. ELIGOS is able to accurately predict known classes of RNA methylation sites (AUC &gt; 0.93) in rRNAs from <i>Escherichia</i><i>coli</i>, yeast, and human cells, using either unmodified <i>in vitro</i> transcription RNA or a background error model, which mimics the systematic error of direct RNA sequencing as the reference. The well-known DRACH/RRACH motif was localized and identified, consistent with previous studies, using differential analysis of ELIGOS to study the impact of RNA m<sup>6</sup>A methyltransferase by comparing wild type and knockouts in yeast and mouse cells. Lastly, the DRACH motif could also be identified in the mRNA of three human cell lines. The mRNA modification identified by ELIGOS is at the level of individual base resolution. In summary, we have developed a bioinformatic software package to uncover native RNA modifications.</p>]]></description>
            <pubDate><![CDATA[2020-07-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A deafness-associated tRNA mutation caused pleiotropic effects on the m<sup>1</sup>G37 modification, processing, stability and aminoacylation of tRNA<sup>Ile</sup> and mitochondrial translation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765833201424-c735afee-4a92-4445-8ab8-cf18f304073b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1225</link>
            <description><![CDATA[<p class="para" id="N65541">Defects in the posttranscriptional modifications of mitochondrial tRNAs have been linked to human diseases, but their pathophysiology remains elusive. In this report, we investigated the molecular mechanism underlying a deafness-associated tRNA<sup>Ile</sup> 4295A&gt;G mutation affecting a highly conserved adenosine at position 37, 3′ adjacent to the tRNA’s anticodon. Primer extension and methylation activity assays revealed that the m.4295A&gt;G mutation introduced a tRNA methyltransferase 5 (TRMT5)-catalyzed m<sup>1</sup>G37 modification of tRNA<sup>Ile</sup>. Molecular dynamics simulations suggested that the m.4295A&gt;G mutation affected tRNA<sup>Ile</sup> structure and function, supported by increased melting temperature, conformational changes and instability of mutated tRNA. An <i>in vitro</i> processing experiment revealed that the m.4295A&gt;G mutation reduced the 5′ end processing efficiency of tRNA<sup>Ile</sup> precursors, catalyzed by RNase P. We demonstrated that cybrid cell lines carrying the m.4295A&gt;G mutation exhibited significant alterations in aminoacylation and steady-state levels of tRNA<sup>Ile</sup>. The aberrant tRNA metabolism resulted in the impairment of mitochondrial translation, respiratory deficiency, decreasing membrane potentials and ATP production, increasing production of reactive oxygen species and promoting autophagy. These demonstrated the pleiotropic effects of m.4295A&gt;G mutation on tRNA<sup>Ile</sup> and mitochondrial functions. Our findings highlighted the essential role of deficient posttranscriptional modifications in the structure and function of tRNA and their pathogenic consequence of deafness.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Factors that mold the nuclear landscape of HIV-1 integration]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765824654370-384f382c-a329-4c3c-be55-1a6e1c26ea50/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1207</link>
            <description><![CDATA[<p class="para" id="N65541">The integration of retroviral reverse transcripts into the chromatin of the cells that they infect is required for virus replication. Retroviral integration has far-reaching consequences, from perpetuating deadly human diseases to molding metazoan evolution. The lentivirus human immunodeficiency virus 1 (HIV-1), which is the causative agent of the AIDS pandemic, efficiently infects interphase cells due to the active nuclear import of its preintegration complex (PIC). To enable integration, the PIC must navigate the densely-packed nuclear environment where the genome is organized into different chromatin states of varying accessibility in accordance with cellular needs. The HIV-1 capsid protein interacts with specific host factors to facilitate PIC nuclear import, while additional interactions of viral integrase, the enzyme responsible for viral DNA integration, with cellular nuclear proteins and nucleobases guide integration to specific chromosomal sites. HIV-1 integration favors transcriptionally active chromatin such as speckle-associated domains and disfavors heterochromatin including lamina-associated domains. In this review, we describe virus-host interactions that facilitate HIV-1 PIC nuclear import and integration site targeting, highlighting commonalities among factors that participate in both of these steps. We moreover discuss how the nuclear landscape influences HIV-1 integration site selection as well as the establishment of active versus latent virus infection.</p>]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765823386294-f90662b6-8f89-401e-8226-891cc25ba674/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1122</link>
            <description><![CDATA[<p class="para" id="N65541">Results of massive parallel sequencing-by-synthesis vary depending on the sequencing approach. CoolMPS™ is a new sequencing chemistry that incorporates bases by labeled antibodies. To evaluate the performance, we sequenced 240 human non-coding RNA samples (dementia patients and controls) with and without CoolMPS. The Q30 value as indicator of the per base sequencing quality increased from 91.8 to 94%. The higher quality was reached across the whole read length. Likewise, the percentage of reads mapping to the human genome increased from 84.9 to 86.2%. For both technologies, we computed similar distributions between different RNA classes (miRNA, piRNA, tRNA, snoRNA and yRNA) and within the classes. While standard sequencing-by-synthesis allowed to recover more annotated miRNAs, CoolMPS yielded more novel miRNAs. The correlation between the two methods was 0.97. Evaluating the diagnostic performance, we observed lower minimal <i>P</i>-values for CoolMPS (adjusted <i>P</i>-value of 0.0006 versus 0.0004) and larger effect sizes (Cohen's d of 0.878 versus 0.9). Validating 19 miRNAs resulted in a correlation of 0.852 between CoolMPS and reverse transcriptase-quantitative polymerase chain reaction. Comparison to data generated with Illumina technology confirmed a known shift in the overall RNA composition. With CoolMPS we evaluated a novel sequencing-by-synthesis technology showing high performance for the analysis of non-coding RNAs.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Molecular underpinnings of ssDNA specificity by Rep HUH-endonucleases and implications for HUH-tag multiplexing and engineering]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822892231-db3a3c2f-6dac-44f5-be92-e6a40c36cae8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1248</link>
            <description><![CDATA[<p class="para" id="N65541">Replication initiator proteins (Reps) from the HUH-endonuclease superfamily process specific single-stranded DNA (ssDNA) sequences to initiate rolling circle/hairpin replication in viruses, such as crop ravaging geminiviruses and human disease causing parvoviruses. In biotechnology contexts, Reps are the basis for HUH-tag bioconjugation and a critical adeno-associated virus genome integration tool. We solved the first co-crystal structures of Reps complexed to ssDNA, revealing a key motif for conferring sequence specificity and for anchoring a bent DNA architecture. In combination, we developed a deep sequencing cleavage assay, termed HUH-seq, to interrogate subtleties in Rep specificity and demonstrate how differences can be exploited for multiplexed HUH-tagging. Together, our insights allowed engineering of only four amino acids in a Rep chimera to predictably alter sequence specificity. These results have important implications for modulating viral infections, developing Rep-based genomic integration tools, and enabling massively parallel HUH-tag barcoding and bioconjugation applications.</p>]]></description>
            <pubDate><![CDATA[2021-01-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Chromatin regulatory dynamics of early human small intestinal development using a directed differentiation model]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822591449-18c2e9d8-ecf7-43d0-b053-ed084a0fb1c5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1204</link>
            <description><![CDATA[<p class="para" id="N65541">The establishment of the small intestinal (SI) lineage during human embryogenesis ensures functional integrity of the intestine after birth. The chromatin dynamics that drive SI lineage formation and regional patterning in humans are essentially unknown. To fill this knowledge void, we apply a cutting-edge genomic technology to a state-of-the-art human model of early SI development. Specifically, we leverage chromatin run-on sequencing (ChRO-seq) to define the landscape of active promoters, enhancers and gene bodies across distinct stages of directed differentiation of human pluripotent stem cells into SI spheroids with regional specification. Through comprehensive ChRO-seq analysis we identify candidate stage-specific chromatin activity states, novel markers and enhancer hotspots during the directed differentiation. Moreover, we propose a detailed transcriptional network associated with SI lineage formation or regional patterning. Our ChRO-seq analyses uncover a previously undescribed pattern of enhancer activity and transcription at HOX gene loci underlying SI regional patterning. We also validated this unique HOX dynamics by the analysis of single cell RNA-seq data from human fetal SI. Overall, the results lead to a new proposed working model for the regulatory underpinnings of human SI development, thereby adding a novel dimension to the literature that has relied almost exclusively on non-human models.</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mechanism of efficient double-strand break repair by a long non-coding RNA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822562147-bf2ddf7b-040d-404d-bf44-0e0781e0b7af/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1233</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-12-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A ubiquitin switch controls autocatalytic inactivation of the DNA–protein crosslink repair protease SPRTN]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822221285-1ff89d5b-39d3-4eb1-a8f4-ba7c3ac78c8f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1224</link>
            <description><![CDATA[<p class="para" id="N65541">Repair of covalent DNA–protein crosslinks (DPCs) by the metalloprotease SPRTN prevents genome instability, premature aging and carcinogenesis. SPRTN is specifically activated by DNA structures containing single- and double-stranded features, but degrades the protein components of DPCs promiscuously and independent of amino acid sequence. This lack of specificity is useful to target diverse protein adducts, however, it requires tight control in return, in order to prohibit uncontrolled proteolysis of chromatin proteins. Here, we discover the components and principles of a ubiquitin switch, which negatively regulates SPRTN. We demonstrate that monoubiquitylation is induced in an E3 ligase-independent manner and, in contrast to previous assumptions, does not control chromatin access of the enzyme. Data obtained in cells and <i>in vitro</i> reveal that monoubiquitylation induces inactivation of the enzyme by triggering autocatalytic cleavage <i>in trans</i> while also priming SPRTN for proteasomal degradation <i>in cis</i>. Finally, we show that the deubiquitylating enzyme USP7 antagonizes this negative control of SPRTN in the presence of DPCs.</p>]]></description>
            <pubDate><![CDATA[2020-12-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural interpretation of the effects of threo-nucleotides on nonenzymatic template-directed polymerization]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765822146316-1ac0d90c-c72e-4694-80bd-c67adc1dc241/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1215</link>
            <description><![CDATA[<p class="para" id="N65541">The prebiotic synthesis of ribonucleotides is likely to have been accompanied by the synthesis of noncanonical nucleotides including the threo-nucleotide building blocks of TNA. Here, we examine the ability of activated threo-nucleotides to participate in nonenzymatic template-directed polymerization. We find that primer extension by multiple sequential threo-nucleotide monomers is strongly disfavored relative to ribo-nucleotides. Kinetic, NMR and crystallographic studies suggest that this is due in part to the slow formation of the imidazolium-bridged TNA dinucleotide intermediate in primer extension, and in part because of the greater distance between the attacking RNA primer 3′-hydroxyl and the phosphate of the incoming threo-nucleotide intermediate. Even a single activated threo-nucleotide in the presence of an activated downstream RNA oligonucleotide is added to the primer 10-fold more slowly than an activated ribonucleotide. In contrast, a single activated threo-nucleotide at the end of an RNA primer or in an RNA template results in only a modest decrease in the rate of primer extension, consistent with the minor and local structural distortions revealed by crystal structures. Our results are consistent with a model in which heterogeneous primordial oligonucleotides would, through cycles of replication, have given rise to increasingly homogeneous RNA strands.</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[IncC helper dependent plasmid-like replication of Salmonella Genomic Island 1]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765821999184-6c581102-f7ab-44c5-9fb6-ade760a96678/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1257</link>
            <description><![CDATA[<p class="para" id="N65541">The <i>Salmonella</i> genomic island 1 (SGI1) and its variants are mobilized by IncA and IncC conjugative plasmids. SGI1-family elements and their helper plasmids are effective transporters of multidrug resistance determinants. SGI1 exploits the transfer apparatus of the helper plasmid and hijacks its activator complex, AcaCD, to trigger the expression of several SGI1 genes. In this way, SGI1 times its excision from the chromosome to the helper entry and expresses mating pore components that enhance SGI1 transfer. The SGI1-encoded T4SS components and the FlhDC-family activator proved to be interchangeable with their IncC-encoded homologs, indicating multiple interactions between SGI1 and its helpers. As a new aspect of this crosstalk, we report here the helper-induced replication of SGI1, which requires both activators, AcaCD and FlhDC<sub>SGI1</sub>, and significantly increases the stability of SGI1 when coexists with the helper plasmid. We have identified the <i>oriV</i><sub>SGI1</sub> and shown that <i>S004-repA</i> operon encodes for a translationally coupled leader protein and an IncN2/N3-related RepA that are expressed under the control of the AcaCD-responsive promoter P<i><sub>S004</sub></i>. This replicon transiently maintains SGI1 as a 4–8-copy plasmid, not only stabilizing the island but also contributing to the fast displacement of the helper plasmid.</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Translation elongation rate varies among organs and decreases with age]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765821524139-915fe38e-dfad-4475-8155-ef5b81915f6c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1103</link>
            <description><![CDATA[<p class="para" id="N65541">There has been a surge of interest towards targeting protein synthesis to treat diseases and extend lifespan. Despite the progress, few options are available to assess translation in live animals, as their complexity limits the repertoire of experimental tools to monitor and manipulate processes within organs and individual cells. It this study, we developed a labeling-free method for measuring organ- and cell-type-specific translation elongation rates <i>in vivo</i>. It is based on time-resolved delivery of translation initiation and elongation inhibitors in live animals followed by ribosome profiling. It also reports translation initiation sites in an organ-specific manner. Using this method, we found that the elongation rates differ more than 50% among mouse organs and determined them to be 6.8, 5.0 and 4.3 amino acids per second for liver, kidney, and skeletal muscle, respectively. We further found that the elongation rate is reduced by 20% between young adulthood and mid-life. Thus, translation, a major metabolic process in cells, is tightly regulated at the level of elongation of nascent polypeptide chains.</p>]]></description>
            <pubDate><![CDATA[2020-12-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A fast and robust iterative genome-editing method based on a Rock-Paper-Scissors strategy]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820670741-b6671e45-c9ec-4b62-b9f2-cc1d40885780/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1141</link>
            <description><![CDATA[<p class="para" id="N65541">The production of optimized strains of a specific phenotype requires the construction and testing of a large number of genome modifications and combinations thereof. Most bacterial iterative genome-editing methods include essential steps to eliminate selection markers, or to cure plasmids. Additionally, the presence of escapers leads to time-consuming separate single clone picking and subsequent cultivation steps. Herein, we report a genome-editing method based on a Rock-Paper-Scissors (RPS) strategy. Each of three constructed sgRNA plasmids can cure, or be cured by, the other two plasmids in the system; plasmids from a previous round of editing can be cured while the current round of editing takes place. Due to the enhanced curing efficiency and embedded double check mechanism, separate steps for plasmid curing or confirmation are not necessary, and only two times of cultivation are needed per genome-editing round. This method was successfully demonstrated in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> with both gene deletions and replacements. To the best of our knowledge, this is the fastest and most robust iterative genome-editing method, with the least times of cultivation decreasing the possibilities of spontaneous genome mutations.</p>]]></description>
            <pubDate><![CDATA[2020-12-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CoolMPS for robust sequencing of single-nuclear RNAs captured by droplet-based method]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820665254-f23bf339-1624-447d-bf4d-67146ff45095/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1127</link>
            <description><![CDATA[<p class="para" id="N65541">Massively-parallel single-cell and single-nucleus RNA sequencing (scRNA-seq, snRNA-seq) requires extensive sequencing to achieve proper per-cell coverage, making sequencing resources and availability of sequencers critical factors for conducting deep transcriptional profiling. CoolMPS is a novel sequencing-by-synthesis approach that relies on nucleotide labeling by re-usable antibodies, but whether it is applicable to snRNA-seq has not been tested. Here, we use a low-cost and off-the-shelf protocol to chemically convert libraries generated with the widely-used Chromium 10X technology to be sequenceable with CoolMPS technology. To assess the quality and performance of converted libraries sequenced with CoolMPS, we generated a snRNA-seq dataset from the hippocampus of young and old mice. Native libraries were sequenced on an Illumina Novaseq and libraries that were converted to be compatible with CoolMPS were sequenced on a DNBSEQ-400RS. CoolMPS-derived data faithfully replicated key characteristics of the native library dataset, including correct estimation of ambient RNA-contamination, detection of captured cells, cell clustering results, spatial marker gene expression, inter- and intra-replicate differences and gene expression changes during aging. In conclusion, our results show that CoolMPS provides a viable alternative to standard sequencing of RNA from droplet-based libraries.</p>]]></description>
            <pubDate><![CDATA[2020-12-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Arabidopsis mTERF9 protein promotes chloroplast ribosomal assembly and translation by establishing ribonucleoprotein interactions <i>in vivo</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820190001-a77c4a3b-769f-4767-9977-ce3886ca06b1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1244</link>
            <description><![CDATA[<p class="para" id="N65541">The mitochondrial transcription termination factor proteins are nuclear-encoded nucleic acid binders defined by degenerate tandem helical-repeats of ∼30 amino acids. They are found in metazoans and plants where they localize in organelles. In higher plants, the mTERF family comprises ∼30 members and several of these have been linked to plant development and response to abiotic stress. However, knowledge of the molecular basis underlying these physiological effects is scarce. We show that the Arabidopsis mTERF9 protein promotes the accumulation of the <i>16S</i> and <i>23S</i> rRNAs in chloroplasts, and interacts predominantly with the <i>16S</i> rRNA <i>in vivo</i> and <i>in vitro</i>. Furthermore, mTERF9 is found in large complexes containing ribosomes and polysomes in chloroplasts. The comprehensive analysis of mTERF9 <i>in vivo</i> protein interactome identified many subunits of the 70S ribosome whose assembly is compromised in the null <i>mterf9</i> mutant, putative ribosome biogenesis factors and CPN60 chaperonins. Protein interaction assays in yeast revealed that mTERF9 directly interact with these proteins. Our data demonstrate that mTERF9 integrates protein-protein and protein-RNA interactions to promote chloroplast ribosomal assembly and translation. Besides extending our knowledge of mTERF functional repertoire in plants, these findings provide an important insight into the chloroplast ribosome biogenesis.</p>]]></description>
            <pubDate><![CDATA[2021-01-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A hotspot for enhancing insulin receptor activation revealed by a conformation-specific allosteric aptamer]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820178252-b92937eb-1b13-444f-a875-149f002550d2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1247</link>
            <description><![CDATA[<p class="para" id="N65541">Aptamers are single-stranded oligonucleotides that bind to a specific target with high affinity, and are widely applied in biomedical diagnostics and drug development. However, the use of aptamers has largely been limited to simple binders or inhibitors that interfere with the function of a target protein. Here, we show that an aptamer can also act as a positive allosteric modulator that enhances the activation of a receptor by stabilizing the binding of a ligand to that receptor. We developed an aptamer, named IR-A43, which binds to the insulin receptor, and confirmed that IR-A43 and insulin bind to the insulin receptor with mutual positive cooperativity. IR-A43 alone is inactive, but, in the presence of insulin, it potentiates autophosphorylation and downstream signaling of the insulin receptor. By using the species-specific activity of IR-A43 at the human insulin receptor, we demonstrate that residue Q272 in the cysteine-rich domain is directly involved in the insulin-enhancing activity of IR-A43. Therefore, we propose that the region containing residue Q272 is a hotspot that can be used to enhance insulin receptor activation. Moreover, our study implies that aptamers are promising reagents for the development of allosteric modulators that discriminate a specific conformation of a target receptor.</p>]]></description>
            <pubDate><![CDATA[2021-01-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Catalytically inactive Cas9 impairs DNA replication fork progression to induce focal genomic instability]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765820156697-65ed64a2-2c10-4280-9ebe-389e611f7ecc/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1241</link>
            <description><![CDATA[<p class="para" id="N65541">Catalytically inactive Cas9 (dCas9) has become an increasingly popular tool for targeted gene activation/inactivation, live-cell imaging, and base editing. While dCas9 was reported to induce base substitutions and indels, it has not been associated with structural variations. Here, we show that dCas9 impedes replication fork progression to destabilize tandem repeats in budding yeast. When targeted to the <i>CUP1</i> array comprising ∼16 repeat units, dCas9 induced its contraction in most cells, especially in the presence of nicotinamide. Replication intermediate analysis demonstrated replication fork stalling in the vicinity of dCas9-bound sites. Genetic analysis indicated that while destabilization is counteracted by the replisome progression complex components Ctf4 and Mrc1 and the accessory helicase Rrm3, it involves single-strand annealing by the recombination proteins Rad52 and Rad59. Although dCas9-mediated replication fork stalling is a potential risk in conventional applications, it may serve as a novel tool for both mechanistic studies and manipulation of genomic instability.</p>]]></description>
            <pubDate><![CDATA[2021-01-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Dynamics of TRF1 organizing a single human telomere]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765819760503-37a3dc10-a1a8-4f33-b751-0f60eadf1172/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1222</link>
            <description><![CDATA[<p class="para" id="N65541">Chromosome stability is primarily determined by telomere length. TRF1 is the core subunit of shelterin that plays a critical role in telomere organization and replication. However, the dynamics of TRF1 in scenarios of telomere-processing activities remain elusive. Using single-molecule magnetic tweezers, we here investigated the dynamics of TRF1 upon organizing a human telomere and the protein-DNA interactions at a moving telomeric fork. We first developed a method to obtain telomeres from human cells for directly measuring the telomere length by single-molecule force spectroscopy. Next, we examined the compaction and decompaction of a telomere by TRF1 dimers. TRF1 dissociates from a compacted telomere with heterogenous loops in ∼20 s. We also found a negative correlation between the number of telomeric loops and loop sizes. We further characterized the dynamics of TRF1 at a telomeric DNA fork. With binding energies of 11 <i>k</i><sub>B</sub><i>T</i>, TRF1 can modulate the forward and backward steps of DNA fork movements by 2–9 s at a critical force of <i>F</i><sub>1/2</sub>, temporarily maintaining the telomeric fork open. Our results shed light on the mechanisms of how TRF1 organizes human telomeres and facilitates the efficient replication of telomeric DNA. Our work will help future research on the chemical biology of telomeres and shelterin-targeted drug discovery.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765819760503-37a3dc10-a1a8-4f33-b751-0f60eadf1172/assets/gkaa1222gra1.jpg" alt="We use single-molecule magnetic tweezers to precisely measure the absolute length of single human telomeres and reveal the dynamics of TRF1 upon organizing a telomere."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      We use single-molecule magnetic tweezers to precisely measure the absolute length of single human telomeres and reveal the dynamics of TRF1 upon organizing a telomere.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A pan-cancer atlas of somatic mutations in miRNA biogenesis genes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765818501962-4414f9da-ac1f-4d17-b163-f769f87cac57/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1223</link>
            <description><![CDATA[<p class="para" id="N65541">It is a well-known and intensively studied phenomenon that the levels of many miRNAs are differentiated in cancer. miRNA biogenesis and functional expression are complex processes orchestrated by many proteins cumulatively called miRNA biogenesis proteins. To characterize cancer somatic mutations in the miRNA biogenesis genes and investigate their potential impact on the levels of miRNAs, we analyzed whole-exome sequencing datasets of over 10 000 cancer/normal sample pairs deposited within the TCGA repository. We identified and characterized over 3600 somatic mutations in 29 miRNA biogenesis genes and showed that some of the genes are overmutated in specific cancers and/or have recurrent hotspot mutations (e.g. <i>SMAD4</i> in PAAD, COAD and READ; <i>DICER1</i> in UCEC; <i>PRKRA</i> in OV and <i>LIN28B</i> in SKCM). We identified a list of miRNAs whose level is affected by particular types of mutations in either <i>SMAD4</i>, <i>SMAD2</i> or <i>DICER1</i> and showed that hotspot mutations in the RNase domains in DICER1 not only decrease the level of 5p-miRNAs but also increase the level of 3p-miRNAs, including many well-known cancer-related miRNAs. We also showed an association of the mutations with patient survival. Eventually, we created an atlas/compendium of miRNA biogenesis alterations providing a useful resource for different aspects of biomedical research.</p>]]></description>
            <pubDate><![CDATA[2021-01-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Chromatin structure restricts origin utilization when quiescent cells re-enter the cell cycle]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765818494702-5bec1b95-656c-47b8-ae84-303e462f2f4e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1148</link>
            <description><![CDATA[<p class="para" id="N65541">Quiescent cells reside in G0 phase, which is characterized by the absence of cell growth and proliferation. These cells remain viable and re-enter the cell cycle when prompted by appropriate signals. Using a budding yeast model of cellular quiescence, we investigated the program that initiated DNA replication when these G0 cells resumed growth. Quiescent cells contained very low levels of replication initiation factors, and their entry into S phase was delayed until these factors were re-synthesized. A longer S phase in these cells correlated with the activation of fewer origins of replication compared to G1 cells. The chromatin structure around inactive origins in G0 cells showed increased H3 occupancy and decreased nucleosome positioning compared to the same origins in G1 cells, inhibiting the origin binding of the Mcm4 subunit of the MCM licensing factor. Thus, quiescent yeast cells are under-licensed during their re-entry into S phase.</p>]]></description>
            <pubDate><![CDATA[2020-12-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A simplified strategy for titrating gene expression reveals new relationships between genotype, environment, and bacterial growth]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762851235-c026e902-c6d1-4dca-8ee9-0f084f7855b7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1073</link>
            <description><![CDATA[<p class="para" id="N65541">A lack of high-throughput techniques for making titrated, gene-specific changes in expression limits our understanding of the relationship between gene expression and cell phenotype. Here, we present a generalizable approach for quantifying growth rate as a function of titrated changes in gene expression level. The approach works by performing CRISPRi with a series of mutated single guide RNAs (sgRNAs) that modulate gene expression. To evaluate sgRNA mutation strategies, we constructed a library of 5927 sgRNAs targeting 88 genes in <i>Escherichia coli</i> MG1655 and measured the effects on growth rate. We found that a compounding mutational strategy, through which mutations are incrementally added to the sgRNA, presented a straightforward way to generate a monotonic and gradated relationship between mutation number and growth rate effect. We also implemented molecular barcoding to detect and correct for mutations that ‘escape’ the CRISPRi targeting machinery; this strategy unmasked deleterious growth rate effects obscured by the standard approach of ignoring escapers. Finally, we performed controlled environmental variations and observed that many gene-by-environment interactions go completely undetected at the limit of maximum knockdown, but instead manifest at intermediate expression perturbation strengths. Overall, our work provides an experimental platform for quantifying the phenotypic response to gene expression variation.</p>]]></description>
            <pubDate><![CDATA[2020-11-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Deploying MMEJ using MENdel in precision gene editing applications for gene therapy and functional genomics]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762837627-448596c8-6392-4080-8681-133f67b54a60/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1156</link>
            <description><![CDATA[<p class="para" id="N65541">Gene-editing experiments commonly elicit the error-prone non-homologous end joining for DNA double-strand break (DSB) repair. Microhomology-mediated end joining (MMEJ) can generate more predictable outcomes for functional genomic and somatic therapeutic applications. We compared three DSB repair prediction algorithms – MENTHU, inDelphi, and Lindel – in identifying MMEJ-repaired, homogeneous genotypes (PreMAs) in an independent dataset of 5,885 distinct Cas9-mediated mouse embryonic stem cell DSB repair events. MENTHU correctly identified 46% of all PreMAs available, a ∼2- and ∼60-fold sensitivity increase compared to inDelphi and Lindel, respectively. In contrast, only Lindel correctly predicted predominant single-base insertions. We report the new algorithm MENdel, a combination of MENTHU and Lindel, that achieves the most predictive coverage of homogeneous out-of-frame mutations in this large dataset. We then estimated the frequency of Cas9-targetable homogeneous frameshift-inducing DSBs in vertebrate coding regions for gene discovery using MENdel. 47 out of 54 genes (87%) contained at least one early frameshift-inducing DSB and 49 out of 54 (91%) did so when also considering Cas12a-mediated deletions. We suggest that the use of MENdel helps researchers use MMEJ at scale for reverse genetics screenings and with sufficient intra-gene density rates to be viable for nearly all loss-of-function based gene editing therapeutic applications.</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Water spines and networks in G-quadruplex structures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762761650-e6c3ee45-c954-43dd-81e8-c43f6bd97aef/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1177</link>
            <description><![CDATA[<p class="para" id="N65541">Quadruplex DNAs can fold into a variety of distinct topologies, depending in part on loop types and orientations of individual strands, as shown by high-resolution crystal and NMR structures. Crystal structures also show associated water molecules. We report here on an analysis of the hydration arrangements around selected folded quadruplex DNAs, which has revealed several prominent features that re-occur in related structures. Many of the primary-sphere water molecules are found in the grooves and loop regions of these structures. At least one groove in anti-parallel and hybrid quadruplex structures is long and narrow and contains an extensive spine of linked primary-sphere water molecules. This spine is analogous to but fundamentally distinct from the well-characterized spine observed in the minor groove of A/T-rich duplex DNA, in that every water molecule in the continuous quadruplex spines makes a direct hydrogen bond contact with groove atoms, principally phosphate oxygen atoms lining groove walls and guanine base nitrogen atoms on the groove floor. By contrast, parallel quadruplexes do not have extended grooves, but primary-sphere water molecules still cluster in them and are especially associated with the loops, helping to stabilize loop conformations.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762754566-8f56931f-9776-4d05-b8c6-54319db97932/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1015</link>
            <description><![CDATA[<p class="para" id="N65541">Understanding the functional impact of cancer somatic mutations represents a critical knowledge gap for implementing precision oncology. It has been increasingly appreciated that the interaction profile mediated by a genomic mutation provides a fundamental link between genotype and phenotype. However, specific effects on biological signaling networks for the majority of mutations are largely unknown by experimental approaches. To resolve this challenge, we developed e-MutPath (edgetic Mutation-mediated Pathway perturbations), a network-based computational method to identify candidate ‘edgetic’ mutations that perturb functional pathways. e-MutPath identifies informative paths that could be used to distinguish disease risk factors from neutral elements and to stratify disease subtypes with clinical relevance. The predicted targets are enriched in cancer vulnerability genes, known drug targets but depleted for proteins associated with side effects, demonstrating the power of network-based strategies to investigate the functional impact and perturbation profiles of genomic mutations. Together, e-MutPath represents a robust computational tool to systematically assign functions to genetic mutations, especially in the context of their specific pathway perturbation effect.</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TonEBP recognizes R-loops and initiates m6A RNA methylation for R-loop resolution]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762706204-59f36ce0-a0a4-49ba-be56-aa3e2bcf828f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1162</link>
            <description><![CDATA[<p class="para" id="N65541">R-loops are three-stranded, RNA–DNA hybrid, nucleic acid structures produced due to inappropriate processing of newly transcribed RNA or transcription-replication collision (TRC). Although R-loops are important for many cellular processes, their accumulation causes genomic instability and malignant diseases, so these structures are tightly regulated. It was recently reported that R-loop accumulation is resolved by methyltransferase-like 3 (METTL3)-mediated m6A RNA methylation under physiological conditions. However, it remains unclear how R-loops in the genome are recognized and induce resolution signals. Here, we demonstrate that tonicity-responsive enhancer binding protein (TonEBP) recognizes R-loops generated by DNA damaging agents such as ultraviolet (UV) or camptothecin (CPT). Single-molecule imaging and biochemical assays reveal that TonEBP preferentially binds a R-loop via both 3D collision and 1D diffusion along DNA <i>in vitro</i>. In addition, we find that TonEBP recruits METTL3 to R-loops through the Rel homology domain (RHD) for m6A RNA methylation. We also show that TonEBP recruits RNaseH1 to R-loops through a METTL3 interaction. Consistent with this, TonEBP or METTL3 depletion increases R-loops and reduces cell survival in the presence of UV or CPT. Collectively, our results reveal an R-loop resolution pathway by TonEBP and m6A RNA methylation by METTL3 and provide new insights into R-loop resolution processes.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural basis of sequestration of the anti-Shine-Dalgarno sequence in the Bacteroidetes ribosome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762694837-feada39a-2015-4639-b266-10f00df9b5e2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1195</link>
            <description><![CDATA[<p class="para" id="N65541">Genomic studies have indicated that certain bacterial lineages such as the Bacteroidetes lack Shine-Dalgarno (SD) sequences, and yet with few exceptions ribosomes of these organisms carry the canonical anti-SD (ASD) sequence. Here, we show that ribosomes purified from <i>Flavobacterium johnsoniae</i>, a representative of the Bacteroidetes, fail to recognize the SD sequence of mRNA <i>in vitro</i>. A cryo-electron microscopy structure of the complete 70S ribosome from <i>F. johnsoniae</i> at 2.8 Å resolution reveals that the ASD is sequestered by ribosomal proteins bS21, bS18 and bS6, explaining the basis of ASD inhibition. The structure also uncovers a novel ribosomal protein—bL38. Remarkably, in <i>F. johnsoniae</i> and many other Flavobacteriia, the gene encoding bS21 contains a strong SD, unlike virtually all other genes. A subset of Flavobacteriia have an alternative ASD, and in these organisms the fully complementary sequence lies upstream of the bS21 gene, indicative of natural covariation. In other Bacteroidetes classes, strong SDs are frequently found upstream of the genes for bS21 and/or bS18. We propose that these SDs are used as regulatory elements, enabling bS21 and bS18 to translationally control their own production.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765762694837-feada39a-2015-4639-b266-10f00df9b5e2/assets/gkaa1195gra1.jpg" alt="In most bacteria, start codon selection is guided by the Shine Dalgarno (SD) sequence. Bacteroidetes fail to recognize the SD sequence of mRNA. However, these bacteria retain the canonical anti-Shine-Dalgarno (ASD) sequence. The cryo-electron microscopy structure of the 70S ribosome from Flavobacterium johnsoniae, a representative of the Bacteroidetes reveals that the ASD is sequestered by ribosomal proteins bS21, bS18 and bS6, explaining the basis of ASD inhibition."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      In most bacteria, start codon selection is guided by the Shine Dalgarno (SD) sequence. Bacteroidetes fail to recognize the SD sequence of mRNA. However, these bacteria retain the canonical anti-Shine-Dalgarno (ASD) sequence. The cryo-electron microscopy structure of the 70S ribosome from Flavobacterium johnsoniae, a representative of the Bacteroidetes reveals that the ASD is sequestered by ribosomal proteins bS21, bS18 and bS6, explaining the basis of ASD inhibition.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Single-molecule visualization of human RECQ5 interactions with single-stranded DNA recombination intermediates]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762678995-719d4827-d123-4897-acab-0bec756847c7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1184</link>
            <description><![CDATA[<p class="para" id="N65541">RECQ5 is one of five RecQ helicases found in humans and is thought to participate in homologous DNA recombination by acting as a negative regulator of the recombinase protein RAD51. Here, we use kinetic and single molecule imaging methods to monitor RECQ5 behavior on various nucleoprotein complexes. Our data demonstrate that RECQ5 can act as an ATP-dependent single-stranded DNA (ssDNA) motor protein and can translocate on ssDNA that is bound by replication protein A (RPA). RECQ5 can also translocate on RAD51-coated ssDNA and readily dismantles RAD51–ssDNA filaments. RECQ5 interacts with RAD51 through protein–protein contacts, and disruption of this interface through a RECQ5–F666A mutation reduces translocation velocity by ∼50%. However, RECQ5 readily removes the ATP hydrolysis-deficient mutant RAD51–K133R from ssDNA, suggesting that filament disruption is not coupled to the RAD51 ATP hydrolysis cycle. RECQ5 also readily removes RAD51–I287T, a RAD51 mutant with enhanced ssDNA-binding activity, from ssDNA. Surprisingly, RECQ5 can bind to double-stranded DNA (dsDNA), but it is unable to translocate. Similarly, RECQ5 cannot dismantle RAD51-bound heteroduplex joint molecules. Our results suggest that the roles of RECQ5 in genome maintenance may be regulated in part at the level of substrate specificity.</p>]]></description>
            <pubDate><![CDATA[2020-12-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Predicting regulatory variants using a dense epigenomic mapped CNN model elucidated the molecular basis of trait-tissue associations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762672510-95683339-0ee6-476b-8f39-f53d4b32b985/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1137</link>
            <description><![CDATA[<p class="para" id="N65541">Assessing the causal tissues of human complex diseases is important for the prioritization of trait-associated genetic variants. Yet, the biological underpinnings of trait-associated variants are extremely difficult to infer due to statistical noise in genome-wide association studies (GWAS), and because &gt;90% of genetic variants from GWAS are located in non-coding regions. Here, we collected the largest human epigenomic map from ENCODE and Roadmap consortia and implemented a deep-learning-based convolutional neural network (CNN) model to predict the regulatory roles of genetic variants across a comprehensive list of epigenomic modifications. Our model, called DeepFun, was built on DNA accessibility maps, histone modification marks, and transcription factors. DeepFun can systematically assess the impact of non-coding variants in the most functional elements with tissue or cell-type specificity, even for rare variants or de novo mutations. By applying this model, we prioritized trait-associated loci for 51 publicly-available GWAS studies. We demonstrated that CNN-based analyses on dense and high-resolution epigenomic annotations can refine important GWAS associations in order to identify regulatory loci from background signals, which yield novel insights for better understanding the molecular basis of human complex disease. We anticipate our approaches will become routine in GWAS downstream analysis and non-coding variant evaluation.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The mTOR regulated RNA-binding protein LARP1 requires PABPC1 for guided mRNA interaction]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762665073-3e824b8d-eabd-4bfd-bda1-0260dfedb500/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1189</link>
            <description><![CDATA[<p class="para" id="N65541">The mammalian target of rapamycin (mTOR) is a critical regulator of cell growth, integrating multiple signalling cues and pathways. Key among the downstream activities of mTOR is the control of the protein synthesis machinery. This is achieved, in part, <i>via</i> the co-ordinated regulation of mRNAs that contain a terminal oligopyrimidine tract (TOP) at their 5′ends, although the mechanisms by which this occurs downstream of mTOR signalling are still unclear. We used RNA-binding protein (RBP) capture to identify changes in the protein-RNA interaction landscape following mTOR inhibition. Upon mTOR inhibition, the binding of LARP1 to a number of mRNAs, including TOP-containing mRNAs, increased. Importantly, non-TOP-containing mRNAs bound by LARP1 are in a translationally-repressed state, even under control conditions. The mRNA interactome of the LARP1-associated protein PABPC1 was found to have a high degree of overlap with that of LARP1 and our data show that PABPC1 is required for the association of LARP1 with its specific mRNA targets. Finally, we demonstrate that mRNAs, including those encoding proteins critical for cell growth and survival, are translationally repressed when bound by both LARP1 and PABPC1.</p>]]></description>
            <pubDate><![CDATA[2020-12-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The proto-Nucleic Acid Builder: a software tool for constructing nucleic acid analogs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762638300-3878fac3-231b-4e39-846d-18c2a8e40386/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1159</link>
            <description><![CDATA[<p class="para" id="N65541">The helical structures of DNA and RNA were originally revealed by experimental data. Likewise, the development of programs for modeling these natural polymers was guided by known structures. These nucleic acid polymers represent only two members of a potentially vast class of polymers with similar structural features, but that differ from DNA and RNA in the backbone or nucleobases. Xeno nucleic acids (XNAs) incorporate alternative backbones that affect the conformational, chemical, and thermodynamic properties of XNAs. Given the vast chemical space of possible XNAs, computational modeling of alternative nucleic acids can accelerate the search for plausible nucleic acid analogs and guide their rational design. Additionally, a tool for the modeling of nucleic acids could help reveal what nucleic acid polymers may have existed before RNA in the early evolution of life. To aid the development of novel XNA polymers and the search for possible pre-RNA candidates, this article presents the proto-Nucleic Acid Builder (https://github.com/GT-NucleicAcids/pnab), an open-source program for modeling nucleic acid analogs with alternative backbones and nucleobases. The torsion-driven conformation search procedure implemented here predicts structures with good accuracy compared to experimental structures, and correctly demonstrates the correlation between the helical structure and the backbone conformation in DNA and RNA.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765762638300-3878fac3-231b-4e39-846d-18c2a8e40386/assets/gkaa1159gra1.jpg" alt="An artistic rendering of the proto-Nucleic Acid builder."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      An artistic rendering of the proto-Nucleic Acid builder.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Histones participate in base excision repair of 8-oxodGuo by transiently cross-linking with active repair intermediates in nucleosome core particles]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762632826-7ad43270-6507-4085-a2f0-9a4a3d095c53/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1153</link>
            <description><![CDATA[<p class="para" id="N65541">8-Oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodGuo) is a biomarker of oxidative DNA damage and can be repaired by hOGG1 and APE1 via the base excision repair (BER) pathway. In this work, we studied coordinated BER of 8-oxodGuo by hOGG1 and APE1 in nucleosome core particles and found that histones transiently formed DNA-protein cross-links (DPCs) with active repair intermediates such as 3′-phospho-α,β-unsaturated aldehyde (PUA) and 5′-deoxyribosephosphate (dRP). The effects of histone participation could be beneficial or deleterious to the BER process, depending on the circumstances. In the absence of APE1, histones enhanced the AP lyase activity of hOGG1 by cross-linking with 3′-PUA. However, the formed histone-PUA DPCs hampered the subsequent repair process. In the presence of APE1, both the AP lyase activity of hOGG1 and the formation of histone-PUA DPCs were suppressed. In this case, histones could catalyse removal of the 5′-dRP by transiently cross-linking with the active intermediate. That is, histones promoted the repair by acting as 5′-dRP lyases. Our findings demonstrate that histones participate in multiple steps of 8-oxodGuo repair in nucleosome core particles, highlighting the diverse roles that histones may play during DNA repair in eukaryotic cells.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DNA damage alters nuclear mechanics through chromatin reorganization]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762626815-e76a24ee-b39c-41be-b562-c8cc3dea27a3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1202</link>
            <description><![CDATA[<p class="para" id="N65541">DNA double-strand breaks drive genomic instability. However, it remains unknown how these processes may affect the biomechanical properties of the nucleus and what role nuclear mechanics play in DNA damage and repair efficiency. Here, we have used Atomic Force Microscopy to investigate nuclear mechanical changes, arising from externally induced DNA damage. We found that nuclear stiffness is significantly reduced after cisplatin treatment, as a consequence of DNA damage signalling. This softening was linked to global chromatin decondensation, which improves molecular diffusion within the organelle. We propose that this can increase recruitment for repair factors. Interestingly, we also found that reduction of nuclear tension, through cytoskeletal relaxation, has a protective role to the cell and reduces accumulation of DNA damage. Overall, these changes protect against further genomic instability and promote DNA repair. We propose that these processes may underpin the development of drug resistance.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MiR-CLIP reveals <i>iso</i>-miR selective regulation in the miR-124 targetome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762620331-95c8927c-4426-46bd-a156-b11e36df822a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1117</link>
            <description><![CDATA[<p class="para" id="N65541">Many microRNAs regulate gene expression via atypical mechanisms, which are difficult to discern using native cross-linking methods. To ascertain the scope of non-canonical miRNA targeting, methods are needed that identify all targets of a given miRNA. We designed a new class of miR-CLIP probe, whereby psoralen is conjugated to the 3p arm of a pre-microRNA to capture targetomes of miR-124 and miR-132 in HEK293T cells. Processing of pre-miR-124 yields miR-124 and a 5′-extended isoform, <i>iso</i>-miR-124. Using miR-CLIP, we identified overlapping targetomes from both isoforms. From a set of 16 targets, 13 were differently inhibited at mRNA/protein levels by the isoforms. Moreover, delivery of pre-miR-124 into cells repressed these targets more strongly than individual treatments with miR-124 and <i>iso</i>-miR-124, suggesting that isomirs from one pre-miRNA may function synergistically. By mining the miR-CLIP targetome, we identified nine G-bulged target-sites that are regulated at the protein level by miR-124 but not isomiR-124. Using structural data, we propose a model involving AGO2 helix-7 that suggests why only miR-124 can engage these sites. In summary, access to the miR-124 targetome via miR-CLIP revealed for the first time how heterogeneous processing of miRNAs combined with non-canonical targeting mechanisms expand the regulatory range of a miRNA.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Reconstitution of mammalian mitochondrial translation system capable of correct initiation and long polypeptide synthesis from leaderless mRNA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762614179-f0a33fc0-ecea-4992-a857-edce39158857/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1165</link>
            <description><![CDATA[<p class="para" id="N65541">Mammalian mitochondria have their own dedicated protein synthesis system, which produces 13 essential subunits of the oxidative phosphorylation complexes. We have reconstituted an <i>in vitro</i> translation system from mammalian mitochondria, utilizing purified recombinant mitochondrial translation factors, 55S ribosomes from pig liver mitochondria, and a tRNA mixture from either <i>Escherichia coli</i> or yeast. The system is capable of translating leaderless mRNAs encoding model proteins (DHFR and nanoLuciferase) or some mtDNA-encoded proteins. We show that a leaderless mRNA, encoding nanoLuciferase, is faithfully initiated without the need for any auxiliary factors other than IF-2mt and IF-3mt. We found that the ribosome-dependent GTPase activities of both the translocase EF-G1mt and the recycling factor EF-G2mt are insensitive to fusidic acid (FA), the translation inhibitor that targets bacterial EF-G homologs, and consequently the system is resistant to FA. Moreover, we demonstrate that a polyproline sequence in the protein causes 55S mitochondrial ribosome stalling, yielding ribosome nascent chain complexes. Analyses of the effects of the Mg concentration on the polyproline-mediated ribosome stalling suggested the unique regulation of peptide elongation by the mitoribosome. This system will be useful for analyzing the mechanism of translation initiation, and the interactions between the nascent peptide chain and the mitochondrial ribosome.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A network-based comparative framework to study conservation and divergence of proteomes in plant phylogenies]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762586828-7060bdd1-024e-421e-ad83-6c227b860383/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1041</link>
            <description><![CDATA[<p class="para" id="N65541">Comparative functional genomics offers a powerful approach to study species evolution. To date, the majority of these studies have focused on the transcriptome in mammalian and yeast phylogenies. Here, we present a novel multi-species proteomic dataset and a computational pipeline to systematically compare the protein levels across multiple plant species. Globally we find that protein levels diverge according to phylogenetic distance but is more constrained than the mRNA level. Module-level comparative analysis of groups of proteins shows that proteins that are more highly expressed tend to be more conserved. To interpret the evolutionary patterns of conservation and divergence, we develop a novel network-based integrative analysis pipeline that combines publicly available transcriptomic datasets to define co-expression modules. Our analysis pipeline can be used to relate the changes in protein levels to different species-specific phenotypic traits. We present a case study with the rhizobia-legume symbiosis process that supports the role of autophagy in this symbiotic association.</p>]]></description>
            <pubDate><![CDATA[2020-11-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Pseudouridine-mediated translation control of mRNA by methionine aminoacyl tRNA synthetase]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762567714-40d9d6f6-80ae-471a-9376-d11034720285/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1178</link>
            <description><![CDATA[<p class="para" id="N65541">Modification of nucleotides within an mRNA emerges as a key path for gene expression regulation. Pseudouridine is one of the most common RNA modifications; however, only a few mRNA modifiers have been identified to date, and no one mRNA pseudouridine reader is known. Here, we applied a novel genome-wide approach to identify mRNA regions that are bound by yeast methionine aminoacyl tRNA<sup>Met</sup> synthetase (MetRS). We found a clear enrichment to regions that were previously described to contain pseudouridine (Ψ). Follow-up <i>in vitro</i> and <i>in vivo</i> analyses on a prime target (position 1074 within <i>YEF3</i> mRNA) demonstrated the importance of pseudouridine for MetRS binding. Furthermore, polysomal and protein analyses revealed that Ψ1074 mediates translation. Modification of this site occurs presumably by Pus6, a pseudouridine synthetase known to modify MetRS cognate tRNA. Consistently, the deletion of Pus6 leads to a decrease in MetRS association with both tRNA<sup>Met</sup> and <i>YEF3</i> mRNA. Furthermore, while global protein synthesis decreases in <i>pus6Δ</i>, translation of <i>YEF3</i> increases. Together, our data imply that Pus6 ‘writes’ modifications on tRNA and mRNA, and both types of RNAs are ‘read’ by MetRS for translation regulation purposes. This represents a novel integrated path for writing and reading modifications on both tRNA and mRNA, which may lead to coordination between global and gene-specific translational responses.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765762567714-40d9d6f6-80ae-471a-9376-d11034720285/assets/gkaa1178gra1.jpg" alt="Pseudouridylation by Pus6 enhances MetRS binding of tRNA and mRNA, to confer global and gene-specific translation regulation, respectively."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Pseudouridylation by Pus6 enhances MetRS binding of tRNA and mRNA, to confer global and gene-specific translation regulation, respectively.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The fragility of a structurally diverse duplication block triggers recurrent genomic amplification]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762552600-192f38cf-357b-45d9-9d47-83cb9b06f700/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1136</link>
            <description><![CDATA[<p class="para" id="N65541">The human genome contains hundreds of large, structurally diverse blocks that are insufficiently represented in the reference genome and are thus not amenable to genomic analyses. Structural diversity in the human population suggests that these blocks are unstable in the germline; however, whether or not these blocks are also unstable in the cancer genome remains elusive. Here we report that the 500 kb block called KRTAP_region_1 (<i>KRTAP-1</i>) on 17q12–21 recurrently demarcates the amplicon of the <i>ERBB2</i> (HER2) oncogene in breast tumors. <i>KRTAP-1</i> carries numerous tandemly-duplicated segments that exhibit diversity within the human population. We evaluated the fragility of the block by cytogenetically measuring the distances between the flanking regions and found that spontaneous distance outliers (i.e DNA breaks) appear more frequently at <i>KRTAP-1</i> than at the representative common fragile site (CFS) FRA16D. Unlike CFSs, <i>KRTAP-1</i> is not sensitive to aphidicolin. The exonuclease activity of DNA repair protein Mre11 protects <i>KRTAP-1</i> from breaks, whereas CtIP does not. Breaks at <i>KRTAP-1</i> lead to the palindromic duplication of the <i>ERBB2</i> locus and trigger Breakage-Fusion-Bridge cycles. Our results indicate that an insufficiently investigated area of the human genome is fragile and could play a crucial role in cancer genome evolution.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Characterization of the first tetrameric transcription factor of the GntR superfamily with allosteric regulation from the bacterial pathogen <i>Agrobacterium fabrum</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762535813-bf4254d7-98fe-41f1-94a4-ea16b8ca22ab/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1181</link>
            <description><![CDATA[<p class="para" id="N65541">A species-specific region, denoted SpG8-1b allowing hydroxycinnamic acids (HCAs) degradation is important for the transition between the two lifestyles (rhizospheric versus pathogenic) of the plant pathogen <i>Agrobacterium fabrum</i>. Indeed, HCAs can be either used as trophic resources and/or as induced-virulence molecules. The SpG8-1b region is regulated by two transcriptional regulators, namely, HcaR (Atu1422) and Atu1419. In contrast to HcaR, Atu1419 remains so far uncharacterized. The high-resolution crystal structures of two fortuitous citrate complexes, two DNA complexes and the apoform revealed that the tetrameric Atu1419 transcriptional regulator belongs to the VanR group of Pfam PF07729 subfamily of the large GntR superfamily. Until now, GntR regulators were described as dimers. Here, we showed that Atu1419 represses three genes of the HCAs catabolic pathway. We characterized both the effector and DNA binding sites and identified key nucleotides in the target palindrome. From promoter activity measurement using defective gene mutants, structural analysis and gel-shift assays, we propose N5,N10-methylenetetrahydrofolate as the effector molecule, which is not a direct product/substrate of the HCA degradation pathway. The Zn<i><sup>2+</sup></i> ion present in the effector domain has both a structural and regulatory role. Overall, our work shed light on the allosteric mechanism of transcription employed by this GntR repressor.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The transcriptional repressors VAL1 and VAL2 recruit PRC2 for genome-wide Polycomb silencing in <i>Arabidopsis</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762427410-6f64cace-5c2d-4e8e-80fd-a276c653fb6d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1129</link>
            <description><![CDATA[<p class="para" id="N65541">The Polycomb repressive complex 2 (PRC2) catalyzes histone H3 Lys27 trimethylation (H3K27me3) to repress gene transcription in multicellular eukaryotes. Despite its importance in gene silencing and cellular differentiation, how PRC2 is recruited to target loci is still not fully understood. Here, we report genome-wide evidence for the recruitment of PRC2 by the transcriptional repressors VIVIPAROUS1/ABI3-LIKE1 (VAL1) and VAL2 in <i>Arabidopsis thaliana</i>. We show that the <i>val1 val2</i> double mutant possesses somatic embryonic phenotypes and a transcriptome strikingly similar to those of the <i>swn clf</i> double mutant, which lacks the PRC2 catalytic subunits SWINGER (SWN) and CURLY LEAF (CLF). We further show that VAL1 and VAL2 physically interact with SWN and CLF <i>in vivo</i>. Genome-wide binding profiling demonstrated that they colocalize with SWN and CLF at PRC2 target loci. Loss of VAL1/2 significantly reduces SWN and CLF enrichment at PRC2 target loci and leads to a genome-wide redistribution of H3K27me3 that strongly affects transcription. Finally, we provide evidence that the VAL1/VAL2–RY regulatory system is largely independent of previously identified modules for Polycomb silencing in plants. Together, our work demonstrates an extensive genome-wide interaction between VAL1/2 and PRC2 and provides mechanistic insights into the establishment of Polycomb silencing in plants.</p>]]></description>
            <pubDate><![CDATA[2020-12-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[G-Quadruplex loops regulate PARP-1 enzymatic activation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762361338-b38042fa-87d7-465e-b403-3868be075ef0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1172</link>
            <description><![CDATA[<p class="para" id="N65541">G-Quadruplexes are non-B form DNA structures present at regulatory regions in the genome, such as promoters of proto-oncogenes and telomeres. The prominence in such sites suggests G-quadruplexes serve an important regulatory role in the cell. Indeed, oxidized G-quadruplexes found at regulatory sites are regarded as epigenetic elements and are associated with an interlinking of DNA repair and transcription. PARP-1 binds damaged DNA and non-B form DNA, where it covalently modifies repair enzymes or chromatin-associated proteins respectively with poly(ADP-ribose) (PAR). PAR serves as a signal in regulation of transcription, chromatin remodeling, and DNA repair. PARP-1 is known to bind G-quadruplexes with stimulation of enzymatic activity. We show that PARP-1 binds several G-quadruplex structures with nanomolar affinities, but only a subset promote PARP-1 activity. The G-quadruplex forming sequence found in the proto-oncogene c-KIT promoter stimulates enzymatic activity of PARP-1. The loop-forming characteristics of the c-KIT G-quadruplex sequence regulate PARP-1 catalytic activity, whereas eliminating these loop features reduces PARP-1 activity. Oxidized G-quadruplexes that have been suggested to form unique, looped structures stimulate PARP-1 activity. Our results support a functional interaction between PARP-1 and G-quadruplexes. PARP-1 enzymatic activation by G-quadruplexes is dependent on the loop features and the presence of oxidative damage.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Heritable pattern of oxidized DNA base repair coincides with pre-targeting of repair complexes to open chromatin]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762353824-f1e80034-1caf-4d59-a39d-fc8c417962c6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1120</link>
            <description><![CDATA[<p class="para" id="N65541">Human genome stability requires efficient repair of oxidized bases, which is initiated via damage recognition and excision by NEIL1 and other base excision repair (BER) pathway DNA glycosylases (DGs). However, the biological mechanisms underlying detection of damaged bases among the million-fold excess of undamaged bases remain enigmatic. Indeed, mutation rates vary greatly within individual genomes, and lesion recognition by purified DGs in the chromatin context is inefficient. Employing super-resolution microscopy and co-immunoprecipitation assays, we find that acetylated NEIL1 (AcNEIL1), but not its non-acetylated form, is predominantly localized in the nucleus in association with epigenetic marks of uncondensed chromatin. Furthermore, chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) revealed non-random AcNEIL1 binding near transcription start sites of weakly transcribed genes and along highly transcribed chromatin domains. Bioinformatic analyses revealed a striking correspondence between AcNEIL1 occupancy along the genome and mutation rates, with AcNEIL1-occupied sites exhibiting fewer mutations compared to AcNEIL1-free domains, both in cancer genomes and in population variation. Intriguingly, from the evolutionarily conserved unstructured domain that targets NEIL1 to open chromatin, its damage surveillance of highly oxidation-susceptible sites to preserve essential gene function and to limit instability and cancer likely originated ∼500 million years ago during the buildup of free atmospheric oxygen.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765762353824-f1e80034-1caf-4d59-a39d-fc8c417962c6/assets/gkaa1120gra1.jpg" alt="DNA glycosylase NEIL1 has acquired a 3-Lys acetylation center in eutherians, which upon acetylation confers stabilization to the enzyme on chromatin, thereby enabling efficient protection against oxidative DNA damage."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      DNA glycosylase NEIL1 has acquired a 3-Lys acetylation center in eutherians, which upon acetylation confers stabilization to the enzyme on chromatin, thereby enabling efficient protection against oxidative DNA damage.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The nature of the modification at position 37 of tRNA<sup>Phe</sup> correlates with acquired taxol resistance]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762298978-5d4a4229-5d7a-4a1e-becc-9ea237dead1d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1164</link>
            <description><![CDATA[<p class="para" id="N65541">Acquired drug resistance is a major obstacle in cancer therapy. Recent studies revealed that reprogramming of tRNA modifications modulates cancer survival in response to chemotherapy. However, dynamic changes in tRNA modification were not elucidated. In this study, comparative analysis of the human cancer cell lines and their taxol resistant strains based on tRNA mapping was performed by using UHPLC–MS/MS. It was observed for the first time in all three cell lines that 4-demethylwyosine (imG-14) substitutes for hydroxywybutosine (OHyW) due to tRNA-wybutosine synthesizing enzyme-2 (TYW2) downregulation and becomes the predominant modification at the 37<sup>th</sup> position of tRNA<sup>phe</sup> in the taxol-resistant strains. Further analysis indicated that the increase in imG-14 levels is caused by downregulation of TYW2. The time courses of the increase in imG-14 and downregulation of TYW2 are consistent with each other as well as consistent with the time course of the development of taxol-resistance. Knockdown of TYW2 in HeLa cells caused both an accumulation of imG-14 and reduction in taxol potency. Taken together, low expression of TYW2 enzyme promotes the cancer survival and resistance to taxol therapy, implying a novel mechanism for taxol resistance. Reduction of imG-14 deposition offers an underlying rationale to overcome taxol resistance in cancer chemotherapy.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Systematic evaluation of the effects of genetic variants on PIWI-interacting RNA expression across 33 cancer types]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762295153-072ceee4-5eb8-4922-a776-11664c5092c1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1190</link>
            <description><![CDATA[<p class="para" id="N65541">PIWI-interacting RNAs (piRNAs) are an emerging class of non-coding RNAs involved in tumorigenesis. Expression quantitative trait locus (eQTL) analysis has been demonstrated to help reveal the genetic mechanism of single nucleotide polymorphisms (SNPs) in cancer etiology. However, there are no databases that have been constructed to provide an eQTL analysis between SNPs and piRNA expression. In this study, we collected genotyping and piRNA expression data for 10 997 samples across 33 cancer types from The Cancer Genome Atlas (TCGA). Using linear regression <i>cis</i>-eQTL analysis with adjustment of appropriate covariates, we identified millions of SNP-piRNA pairs in tumor (76 924 831) and normal (24 431 061) tissues. Further, we performed differential expression and survival analyses, and linked the eQTLs to genome-wide association study (GWAS) data to comprehensively decipher the functional roles of identified cis-piRNA eQTLs. Finally, we developed a user-friendly database, piRNA-eQTL (http://njmu-edu.cn:3838/piRNA-eQTL/), to help users query, browse and download corresponding eQTL results. In summary, piRNA-eQTL could serve as an important resource to assist the research community in understanding the roles of genetic variants and piRNAs in the development of cancers.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[An atypical BRCT–BRCT interaction with the XRCC1 scaffold protein compacts human DNA Ligase IIIα within a flexible DNA repair complex]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762288797-7e049e67-73bc-4e1b-ad98-93e4f4c30e9f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1188</link>
            <description><![CDATA[<p class="para" id="N65541">The XRCC1–DNA ligase IIIα complex (XL) is critical for DNA single-strand break repair, a key target for PARP inhibitors in cancer cells deficient in homologous recombination. Here, we combined biophysical approaches to gain insights into the shape and conformational flexibility of the XL as well as XRCC1 and DNA ligase IIIα (LigIIIα) alone. Structurally-guided mutational analyses based on the crystal structure of the human BRCT–BRCT heterodimer identified the network of salt bridges that together with the N-terminal extension of the XRCC1 C-terminal BRCT domain constitute the XL molecular interface. Coupling size exclusion chromatography with small angle X-ray scattering and multiangle light scattering (SEC-SAXS–MALS), we determined that the XL is more compact than either XRCC1 or LigIIIα, both of which form transient homodimers and are highly disordered. The reduced disorder and flexibility allowed us to build models of XL particles visualized by negative stain electron microscopy that predict close spatial organization between the LigIIIα catalytic core and both BRCT domains of XRCC1. Together our results identify an atypical BRCT–BRCT interaction as the stable nucleating core of the XL that links the flexible nick sensing and catalytic domains of LigIIIα to other protein partners of the flexible XRCC1 scaffold.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765762288797-7e049e67-73bc-4e1b-ad98-93e4f4c30e9f/assets/gkaa1188gra1.jpg" alt="Integrative modeling from EM and SAXS with atomic resolution domain structures reveals the functional compaction of the XRCC1-DNA ligase IIIα complex that extends beyond the interacting C-terminal BRCT–BRCT domains to the catalytic region of DNA ligase IIIα."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Integrative modeling from EM and SAXS with atomic resolution domain structures reveals the functional compaction of the XRCC1-DNA ligase IIIα complex that extends beyond the interacting C-terminal BRCT–BRCT domains to the catalytic region of DNA ligase IIIα.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Human GTPBP5 is involved in the late stage of mitoribosome large subunit assembly]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762282916-2d29da27-3ac1-40da-9ced-e5efcc7a7953/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1131</link>
            <description><![CDATA[<p class="para" id="N65541">Human mitoribosomes are macromolecular complexes essential for translation of 11 mitochondrial mRNAs. The large and the small mitoribosomal subunits undergo a multistep maturation process that requires the involvement of several factors. Among these factors, GTP-binding proteins (GTPBPs) play an important role as GTP hydrolysis can provide energy throughout the assembly stages. In bacteria, many GTPBPs are needed for the maturation of ribosome subunits and, of particular interest for this study, ObgE has been shown to assist in the 50S subunit assembly. Here, we characterize the role of a related human Obg-family member, GTPBP5. We show that GTPBP5 interacts specifically with the large mitoribosomal subunit (mt-LSU) proteins and several late-stage mitoribosome assembly factors, including MTERF4:NSUN4 complex, MRM2 methyltransferase, MALSU1 and MTG1. Interestingly, we find that interaction of GTPBP5 with the mt-LSU is compromised in the presence of a non-hydrolysable analogue of GTP, implying a different mechanism of action of this protein in contrast to that of other Obg-family GTPBPs. GTPBP5 ablation leads to severe impairment in the oxidative phosphorylation system, concurrent with a decrease in mitochondrial translation and reduced monosome formation. Overall, our data indicate an important role of GTPBP5 in mitochondrial function and suggest its involvement in the late-stage of mt-LSU maturation.</p>]]></description>
            <pubDate><![CDATA[2020-12-07T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Validation of human microRNA target pathways enables evaluation of target prediction tools]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762259865-33d6dc80-01af-4aaf-a01e-b4735c5edc79/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1161</link>
            <description><![CDATA[<p class="para" id="N65541">MicroRNAs are regulators of gene expression. A wide-spread, yet not validated, assumption is that the targetome of miRNAs is non-randomly distributed across the transcriptome and that targets share functional pathways. We developed a computational and experimental strategy termed high-throughput miRNA interaction reporter assay (HiTmIR) to facilitate the validation of target pathways. First, targets and target pathways are predicted and prioritized by computational means to increase the specificity and positive predictive value. Second, the novel webtool miRTaH facilitates guided designs of reporter assay constructs at scale. Third, automated and standardized reporter assays are performed. We evaluated HiTmIR using miR-34a-5p, for which TNF- and TGFB-signaling, and Parkinson's Disease (PD)-related categories were identified and repeated the pipeline for miR-7-5p. HiTmIR validated 58.9% of the target genes for miR-34a-5p and 46.7% for miR-7-5p. We confirmed the targeting by measuring the endogenous protein levels of targets in a neuronal cell model. The standardized positive and negative targets are collected in the new miRATBase database, representing a resource for training, or benchmarking new target predictors. Applied to 88 target predictors with different confidence scores, TargetScan 7.2 and miRanda outperformed other tools. Our experiments demonstrate the efficiency of HiTmIR and provide evidence for an orchestrated miRNA-gene targeting.</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A skipping rope translocation mechanism in a widespread family of DNA repair helicases]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762253658-0d940087-1a34-4a73-89d8-5876e42f8e25/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1174</link>
            <description><![CDATA[<p class="para" id="N65541">Mitomycin repair factor A represents a family of DNA helicases that harbor a domain of unknown function (DUF1998) and support repair of mitomycin C-induced DNA damage by presently unknown molecular mechanisms. We determined crystal structures of <i>Bacillus subtilis</i> Mitomycin repair factor A alone and in complex with an ATP analog and/or DNA and conducted structure-informed functional analyses. Our results reveal a unique set of auxiliary domains appended to a dual-RecA domain core. Upon DNA binding, a Zn<sup>2+</sup>-binding domain, encompassing the domain of unknown function, acts like a drum that rolls out a canopy of helicase-associated domains, entrapping the substrate and tautening an inter-domain linker across the loading strand. Quantification of DNA binding, stimulated ATPase and helicase activities in the wild type and mutant enzyme variants in conjunction with the mode of coordination of the ATP analog suggest that Mitomycin repair factor A employs similar ATPase-driven conformational changes to translocate on DNA, with the linker ratcheting through the nucleotides like a ‘skipping rope’. The electrostatic surface topology outlines a likely path for the displaced DNA strand. Our results reveal unique molecular mechanisms in a widespread family of DNA repair helicases linked to bacterial antibiotics resistance.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765762253658-0d940087-1a34-4a73-89d8-5876e42f8e25/assets/gkaa1174gra1.jpg" alt="Crystal structures of the DUF1998 DNA helicase, MrfA, were determined in the apo, DNA-bound and DNA/AMPPNP-bound forms, and translocase/helicase mechanisms were interrogated by structure-informed mutational analyses in vitro."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Crystal structures of the DUF1998 DNA helicase, MrfA, were determined in the apo, DNA-bound and DNA/AMPPNP-bound forms, and translocase/helicase mechanisms were interrogated by structure-informed mutational analyses <i>in vitro</i>.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Optimized design of antisense oligomers for targeted rRNA depletion]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762240527-35880281-9301-4653-9572-8e301325617e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1072</link>
            <description><![CDATA[<p class="para" id="N65541">RNA sequencing (RNA-seq) is extensively used to quantify gene expression transcriptome-wide. Although often paired with polyadenylate (poly(A)) selection to enrich for messenger RNA (mRNA), many applications require alternate approaches to counteract the high proportion of ribosomal RNA (rRNA) in total RNA. Recently, digestion using RNaseH and antisense DNA oligomers tiling target rRNAs has emerged as an alternative to commercial rRNA depletion kits. Here, we present a streamlined, more economical RNaseH-mediated rRNA depletion with substantially lower up-front costs, using shorter antisense oligos only sparsely tiled along the target RNA in a 5-min digestion reaction. We introduce a novel Web tool, Oligo-ASST, that simplifies oligo design to target regions with optimal thermodynamic properties, and additionally can generate compact, common oligo pools that simultaneously target divergent RNAs, e.g. across different species. We demonstrate the efficacy of these strategies by generating rRNA-depletion oligos for <i>Xenopus laevis</i> and for zebrafish, which expresses two distinct versions of rRNAs during embryogenesis. The resulting RNA-seq libraries reduce rRNA to &lt;5% of aligned reads, on par with poly(A) selection, and also reveal expression of many non-adenylated RNA species. Oligo-ASST is freely available at https://mtleelab.pitt.edu/oligo to design antisense oligos for any taxon or to target any abundant RNA for depletion.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765762240527-35880281-9301-4653-9572-8e301325617e/assets/gkaa1072gra1.jpg" alt="Oligo-ASST designs optimized antisense oligo sets to target RNAs for depletion."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Oligo-ASST designs optimized antisense oligo sets to target RNAs for depletion.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[High-resolution visualization and quantification of nucleic acid–based therapeutics in cells and tissues using Nanoscale secondary ion mass spectrometry (NanoSIMS)]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762231584-c700bf2d-0cc1-42af-a1eb-7741f33d4976/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1112</link>
            <description><![CDATA[<p class="para" id="N65541">Nucleic acid therapeutics (NATs) have proven useful in promoting the degradation of specific transcripts, modifying gene expression, and regulating mRNA splicing. In each situation, efficient delivery of nucleic acids to cells, tissues and intracellular compartments is crucial—both for optimizing efficacy and reducing side effects. Despite successes in NATs, our understanding of their cellular uptake and distribution in tissues is limited. Current methods have yielded insights into distribution of NATs within cells and tissues, but the sensitivity and resolution of these approaches are limited. Here, we show that nanoscale secondary ion mass spectrometry (NanoSIMS) imaging can be used to define the distribution of 5-bromo-2′-deoxythymidine (5-BrdT) modified antisense oligonucleotides (ASO) in cells and tissues with high sensitivity and spatial resolution. This approach makes it possible to define ASO uptake and distribution in different subcellular compartments and to quantify the impact of targeting ligands designed to promote ASO uptake by cells. Our studies showed that phosphorothioate ASOs are associated with filopodia and the inner nuclear membrane in cultured cells, and also revealed substantial cellular and subcellular heterogeneity of ASO uptake in mouse tissues. NanoSIMS imaging represents a significant advance in visualizing uptake and distribution of NATs; this approach will be useful in optimizing efficacy and delivery of NATs for treating human disease.</p>]]></description>
            <pubDate><![CDATA[2020-12-04T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Functional analysis reveals G/U pairs critical for replication and trafficking of an infectious non-coding viroid RNA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762216972-2788e9fb-098f-4d3c-8db3-255dfc59c264/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1211</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Strand antagonism in RNAi: an explanation of differences in potency between intracellularly expressed siRNA and shRNA]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762214314-376cdb78-0840-4265-ac7c-ac8b122cff58/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1217</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ribosome association primes the stringent factor Rel for tRNA-dependent locking in the A-site and activation of (p)ppGpp synthesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762196408-9efd14b4-a0f1-49f9-941c-a8d1ce83e8b9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1187</link>
            <description><![CDATA[<p class="para" id="N65541">In the Gram-positive Firmicute bacterium <i>Bacillus subtilis</i>, amino acid starvation induces synthesis of the alarmone (p)ppGpp by the RelA/SpoT Homolog factor Rel. This bifunctional enzyme is capable of both synthesizing and hydrolysing (p)ppGpp. To detect amino acid deficiency, Rel monitors the aminoacylation status of the ribosomal A-site tRNA by directly inspecting the tRNA’s CCA end. Here we dissect the molecular mechanism of <i>B. subtilis</i> Rel. Off the ribosome, Rel predominantly assumes a ‘closed’ conformation with dominant (p)ppGpp hydrolysis activity. This state does not specifically select deacylated tRNA since the interaction is only moderately affected by tRNA aminoacylation. Once bound to the vacant ribosomal A-site, Rel assumes an ‘open’ conformation, which primes its TGS and Helical domains for specific recognition and stabilization of cognate deacylated tRNA on the ribosome. The tRNA locks Rel on the ribosome in a hyperactivated state that processively synthesises (p)ppGpp while the hydrolysis is suppressed. In stark contrast to non-specific tRNA interactions off the ribosome, tRNA-dependent Rel locking on the ribosome and activation of (p)ppGpp synthesis are highly specific and completely abrogated by tRNA aminoacylation. Binding pppGpp to a dedicated allosteric site located in the N-terminal catalytic domain region of the enzyme further enhances its synthetase activity.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The versatile interactome of chloroplast ribosomes revealed by affinity purification mass spectrometry]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762190112-c7a3315e-368f-4da3-a22a-d403c55933cb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1192</link>
            <description><![CDATA[<p class="para" id="N65541">In plant cells, chloroplast gene expression is predominantly controlled through post-transcriptional regulation. Such fine-tuning is vital for precisely orchestrating protein complex assembly as for the photosynthesis machinery and for quickly responding to environmental changes. While regulation of chloroplast protein synthesis is of central importance, little is known about the degree and nature of the regulatory network, mainly due to challenges associated with the specific isolation of transient ribosome interactors. Here, we established a ribosome affinity purification method, which enabled us to broadly uncover putative ribosome-associated proteins in chloroplasts. Endogenously tagging of a protein of the large or small subunit revealed not only interactors of the holo complex, but also preferential interactors of the two subunits. This includes known canonical regulatory proteins as well as several new proteins belonging to the categories of protein and RNA regulation, photosystem biogenesis, redox control and metabolism. The sensitivity of the here applied screen was validated for various transiently interacting proteins. We further provided evidence for the existence of a ribosome-associated N<sup>α</sup>-acetyltransferase in chloroplasts and its ability to acetylate substrate proteins at their N-terminus. The broad set of ribosome interactors underscores the potential to regulate chloroplast gene expression on the level of protein synthesis.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural basis for inhibition of the type I-F CRISPR–Cas surveillance complex by AcrIF4, AcrIF7 and AcrIF14]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762184508-a602b95d-e7df-4533-a36b-00ac293e9906/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1199</link>
            <description><![CDATA[<p class="para" id="N65541">CRISPR–Cas systems are adaptive immune systems in bacteria and archaea to defend against mobile genetic elements (MGEs) and have been repurposed as genome editing tools. Anti-CRISPR (Acr) proteins are produced by MGEs to counteract CRISPR–Cas systems and can be used to regulate genome editing by CRISPR techniques. Here, we report the cryo-EM structures of three type I-F Acr proteins, AcrIF4, AcrIF7 and AcrIF14, bound to the type I-F CRISPR–Cas surveillance complex (the Csy complex) from <i>Pseudomonas aeruginosa</i>. AcrIF4 binds to an unprecedented site on the C-terminal helical bundle of Cas8f subunit, precluding conformational changes required for activation of the Csy complex. AcrIF7 mimics the PAM duplex of target DNA and is bound to the N-terminal DNA vise of Cas8f. Two copies of AcrIF14 bind to the thumb domains of Cas7.4f and Cas7.6f, preventing hybridization between target DNA and the crRNA. Our results reveal structural detail of three AcrIF proteins, each binding to a different site on the Csy complex for inhibiting degradation of MGEs.</p>]]></description>
            <pubDate><![CDATA[2020-12-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Identification of lysine isobutyrylation as a new histone modification mark]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762172446-bacc23c8-7593-4a04-b459-ffa859fe5b17/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1176</link>
            <description><![CDATA[<p class="para" id="N65541">Short-chain acylations of lysine residues in eukaryotic proteins are recognized as essential posttranslational chemical modifications (PTMs) that regulate cellular processes from transcription, cell cycle, metabolism, to signal transduction. Lysine butyrylation was initially discovered as a normal straight chain butyrylation (Knbu). Here we report its structural isomer, branched chain butyrylation, i.e. lysine isobutyrylation (Kibu), existing as a new PTM on nuclear histones. Uniquely, isobutyryl-CoA is derived from valine catabolism and branched chain fatty acid oxidation which is distinct from the metabolism of <i>n</i>-butyryl-CoA. Several histone acetyltransferases were found to possess lysine isobutyryltransferase activity <i>in vitro</i>, especially p300 and HAT1. Transfection and western blot experiments showed that p300 regulated histone isobutyrylation levels in the cell. We resolved the X-ray crystal structures of HAT1 in complex with isobutyryl-CoA that gleaned an atomic level insight into HAT-catalyzed isobutyrylation. RNA-Seq profiling revealed that isobutyrate greatly affected the expression of genes associated with many pivotal biological pathways. Together, our findings identify Kibu as a novel chemical modification mark in histones and suggest its extensive role in regulating epigenetics and cellular physiology.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Flanking sequence preference modulates <i>de novo</i> DNA methylation in the mouse genome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762133158-6d8d5a78-7cbf-4ea8-bc41-43dbf26a38e0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1168</link>
            <description><![CDATA[<p class="para" id="N65541">Mammalian <i>de novo</i> DNA methyltransferases (DNMT) are responsible for the establishment of cell-type-specific DNA methylation in healthy and diseased tissues. Through genome-wide analysis of <i>de novo</i> methylation activity in murine stem cells we uncover that DNMT3A prefers to methylate CpGs followed by cytosines or thymines, while DNMT3B predominantly methylates CpGs followed by guanines or adenines. These signatures are further observed at non-CpG sites, resembling methylation context observed in specialised cell types, including neurons and oocytes. We further show that these preferences result from structural differences in the catalytic domains of the two <i>de novo</i> DNMTs and are not a consequence of differential recruitment to the genome. Molecular dynamics simulations suggest that, in case of human DNMT3A, the preference is due to favourable polar interactions between the flexible Arg836 side chain and the guanine that base-pairs with the cytosine following the CpG. By exchanging arginine to a lysine, the corresponding side chain in DNMT3B, the sequence preference is reversed, confirming the requirement for arginine at this position. This context-dependent enzymatic activity provides additional insights into the complex regulation of DNA methylation patterns.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762038988-785e360a-ca9a-4095-8863-1092ca55face/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1201</link>
            <description><![CDATA[<p class="para" id="N65541">Many APOBEC cytidine deaminase members are known to induce ‘off-target’ cytidine deaminations in 5′TC motifs in genomic DNA that contribute to cancer evolution. In this report, we characterized APOBEC1, which is a possible cancer related APOBEC since APOBEC1 mRNA is highly expressed in certain types of tumors, such as lung adenocarcinoma. We found a low level of APOBEC1-induced DNA damage, as measured by γH2AX foci, in genomic DNA of a lung cancer cell line that correlated to its inability to compete <i>in vitro</i> with replication protein A (RPA) for ssDNA. This suggests that RPA can act as a defense against off-target deamination for some APOBEC enzymes. Overall, the data support the model that the ability of an APOBEC to compete with RPA can better predict genomic damage than combined analysis of mRNA expression levels in tumors and analysis of mutation signatures.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765762038988-785e360a-ca9a-4095-8863-1092ca55face/assets/gkaa1201gra1.jpg" alt="Depending on whether DNA replication is slowed or normal APOBECs must cycle through an excess of single-stranded (ss)DNA or compete with RPA to catalyze cytosine to uracil deaminations (C→U)."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Depending on whether DNA replication is slowed or normal APOBECs must cycle through an excess of single-stranded (ss)DNA or compete with RPA to catalyze cytosine to uracil deaminations (C→U).</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Histone methyltransferase ATX1 dynamically regulates fiber secondary cell wall biosynthesis in <i>Arabidopsis</i> inflorescence stem]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762032558-bf5184c6-ea0a-4ad1-aa4a-d2c0638fed4d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1191</link>
            <description><![CDATA[<p class="para" id="N65541">Secondary wall thickening in the sclerenchyma cells is strictly controlled by a complex network of transcription factors in vascular plants. However, little is known about the epigenetic mechanism regulating secondary wall biosynthesis. In this study, we identified that <i>ARABIDOPSIS HOMOLOG of TRITHORAX1</i> (<i>ATX1</i>), a H3K4-histone methyltransferase, mediates the regulation of fiber cell wall development in inflorescence stems of <i>Arabidopsis thaliana</i>. Genome-wide analysis revealed that the up-regulation of genes involved in secondary wall formation during stem development is largely coordinated by increasing level of H3K4 tri-methylation. Among all histone methyltransferases for H3K4me3 in <i>Arabidopsis</i>, <i>ATX1</i> is markedly increased during the inflorescence stem development and loss-of-function mutant <i>atx1</i> was impaired in secondary wall thickening in interfascicular fibers. Genetic analysis showed that ATX1 positively regulates secondary wall deposition through activating the expression of secondary wall NAC master switch genes, <i>SECONDARY WALL-ASSOCIATED NAC DOMAIN PROTEIN1</i> (<i>SND1</i>) and <i>NAC SECONDARY WALL THICKENING PROMOTING FACTOR1</i> (<i>NST1</i>). We further identified that ATX1 directly binds the loci of <i>SND1</i> and <i>NST1</i>, and activates their expression by increasing H3K4me3 levels at these loci. Taken together, our results reveal that ATX1 plays a key role in the regulation of secondary wall biosynthesis in interfascicular fibers during inflorescence stem development of <i>Arabidopsis</i>.</p>]]></description>
            <pubDate><![CDATA[2020-12-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Histone benzoylation serves as an epigenetic mark for DPF and YEATS family proteins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762026768-605c2843-0f11-4783-a94e-e80426f9ef71/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1130</link>
            <description><![CDATA[<p class="para" id="N65541">Histone modifications and their functional readout serve as an important mechanism for gene regulation. Lysine benzoylation (Kbz) on histones is a recently identified acylation mark associated with active transcription. However, it remains to be explored whether putative readers exist to recognize this epigenetic mark. Here, our systematic binding studies demonstrated that the DPF and YEATS, but not the Bromodomain family members, are readers for histone Kbz. Co-crystal structural analyses revealed a ‘hydrophobic encapsulation’ and a ‘tip-sensor’ mechanism for Kbz readout by DPF and YEATS, respectively. Moreover, the DPF and YEATS family members display subtle yet unique features to create somewhat flexible engagements of different acylation marks. For instance, YEATS2 but not the other YEATS proteins exhibits best preference for Kbz than lysine acetylation and crotonylation due to its wider ‘tip-sensor’ pocket. The levels of histone benzoylation in cultured cells or in mice are upregulated upon sodium benzoate treatment, highlighting its dynamic regulation. In summary, our work identifies the first readers for histone Kbz and reveals the molecular basis underlying Kbz recognition, thus paving the way for further functional dissections of histone benzoylation.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural basis for the substrate specificity and catalytic features of pseudouridine kinase from <i>Arabidopsis thaliana</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762021483-588383e0-b478-426a-be2f-8a0e2a3a03bd/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1144</link>
            <description><![CDATA[<p class="para" id="N65541">RNA modifications can regulate the stability of RNAs, mRNA–protein interactions, and translation efficiency. Pseudouridine is a prevalent RNA modification, and its metabolic fate after RNA turnover was recently characterized in eukaryotes, in the plant <i>Arabidopsis thaliana</i>. Here, we present structural and biochemical analyses of PSEUDOURIDINE KINASE from Arabidopsis (AtPUKI), the enzyme catalyzing the first step in pseudouridine degradation. AtPUKI, a member of the PfkB family of carbohydrate kinases, is a homodimeric α/β protein with a protruding small β-strand domain, which serves simultaneously as dimerization interface and dynamic substrate specificity determinant. AtPUKI has a unique nucleoside binding site specifying the binding of pseudourine, in particular at the nucleobase, by multiple hydrophilic interactions, of which one is mediated by a loop from the small β-strand domain of the adjacent monomer. Conformational transition of the dimerized small β-strand domains containing active site residues is required for substrate specificity. These dynamic features explain the higher catalytic efficiency for pseudouridine over uridine. Both substrates bind well (similar <i>K</i><sub>m</sub>), but only pseudouridine is turned over efficiently. Our studies provide an example for structural and functional divergence in the PfkB family and highlight how AtPUKI avoids futile uridine phosphorylation which <i>in vivo</i> would disturb pyrimidine homeostasis.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ribosome profiling reveals ribosome stalling on tryptophan codons and ribosome queuing upon oxidative stress in fission yeast]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765762015226-30e75a1f-5e6f-4a25-ba3d-95b203989586/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1180</link>
            <description><![CDATA[<p class="para" id="N65541">Translational control is essential in response to stress. We investigated the translational programmes launched by the fission yeast <i>Schizosaccharomyces pombe</i> upon five environmental stresses. We also explored the contribution of defence pathways to these programmes: The Integrated Stress Response (ISR), which regulates translation initiation, and the stress-response MAPK pathway. We performed ribosome profiling of cells subjected to each stress, in wild type cells and in cells with the defence pathways inactivated. The transcription factor Fil1, a functional homologue of the yeast Gcn4 and the mammalian Atf4 proteins, was translationally upregulated and required for the response to most stresses. Moreover, many mRNAs encoding proteins required for ribosome biogenesis were translationally downregulated. Thus, several stresses trigger a universal translational response, including reduced ribosome production and a Fil1-mediated transcriptional programme. Surprisingly, ribosomes stalled on tryptophan codons upon oxidative stress, likely due to a decrease in charged tRNA-Tryptophan. Stalling caused ribosome accumulation upstream of tryptophan codons (ribosome queuing/collisions), demonstrating that stalled ribosomes affect translation elongation by other ribosomes. Consistently, tryptophan codon stalling led to reduced translation elongation and contributed to the ISR-mediated inhibition of initiation. We show that different stresses elicit common and specific translational responses, revealing a novel role in Tryptophan-tRNA availability.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TENET: gene network reconstruction using transfer entropy reveals key regulatory factors from single cell transcriptomic data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761950726-f6c0249d-159b-4d08-be26-0c8cb23c0c7a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1014</link>
            <description><![CDATA[<p class="para" id="N65541">Accurate prediction of gene regulatory rules is important towards understanding of cellular processes. Existing computational algorithms devised for bulk transcriptomics typically require a large number of time points to infer gene regulatory networks (GRNs), are applicable for a small number of genes and fail to detect potential causal relationships effectively. Here, we propose a novel approach ‘TENET’ to reconstruct GRNs from single cell RNA sequencing (scRNAseq) datasets. Employing transfer entropy (TE) to measure the amount of causal relationships between genes, TENET predicts large-scale gene regulatory cascades/relationships from scRNAseq data. TENET showed better performance than other GRN reconstructors, in identifying key regulators from public datasets. Specifically from scRNAseq, TENET identified key transcriptional factors in embryonic stem cells (ESCs) and during direct cardiomyocytes reprogramming, where other predictors failed. We further demonstrate that known target genes have significantly higher TE values, and TENET predicted higher TE genes were more influenced by the perturbation of their regulator. Using TENET, we identified and validated that Nme2 is a culture condition specific stem cell factor. These results indicate that TENET is uniquely capable of identifying key regulators from scRNAseq data.</p>]]></description>
            <pubDate><![CDATA[2020-11-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Structural basis for guide RNA trimming by RNase D ribonuclease in <i>Trypanosoma brucei</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761944041-3e6b3c58-ae8d-43f1-95d2-6b85389110cd/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1197</link>
            <description><![CDATA[<p class="para" id="N65541">Infection with kinetoplastid parasites, including <i>Trypanosoma brucei</i> (<i>T. brucei</i>), <i>Trypanosoma cruzi</i> (<i>T. cruzi</i>) and <i>Leishmania</i> can cause serious disease in humans. Like other kinetoplastid species, mRNAs of these disease-causing parasites must undergo posttranscriptional editing in order to be functional. mRNA editing is directed by gRNAs, a large group of small RNAs. Similar to mRNAs, gRNAs are also precisely regulated. In <i>T. brucei</i>, overexpression of RNase D ribonuclease (<i>Tb</i>RND) leads to substantial reduction in the total gRNA population and subsequent inhibition of mRNA editing. However, the mechanisms regulating gRNA binding and cleavage by <i>Tb</i>RND are not well defined. Here, we report a thorough structural study of <i>Tb</i>RND. Besides Apo- and NMP-bound structures, we also solved one <i>Tb</i>RND structure in complexed with single-stranded RNA. In combination with mutagenesis and <i>in vitro</i> cleavage assays, our structures indicated that <i>Tb</i>RND follows the conserved two-cation-assisted mechanism in catalysis. <i>Tb</i>RND is a unique RND member, as it contains a ZFD domain at its C-terminus. In addition to <i>T. brucei</i>, our studies also advanced our understanding on the potential gRNA degradation pathway in <i>T. cruzi</i>, <i>Leishmania</i>, as well for as other disease-associated parasites expressing ZFD-containing RNDs.</p>]]></description>
            <pubDate><![CDATA[2020-12-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[A functional connection between translation elongation and protein folding at the ribosome exit tunnel in <i>Saccharomyces cerevisiae</i>]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761919680-0b59caa5-f08d-4150-9b23-4d46adbc7750/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1200</link>
            <description><![CDATA[<p class="para" id="N65541">Proteostasis needs to be tightly controlled to meet the cellular demand for correctly <i>de novo</i> folded proteins and to avoid protein aggregation. While a coupling between translation rate and co-translational folding, likely involving an interplay between the ribosome and its associated chaperones, clearly appears to exist, the underlying mechanisms and the contribution of ribosomal proteins remain to be explored. The ribosomal protein uL3 contains a long internal loop whose tip region is in close proximity to the ribosomal peptidyl transferase center. Intriguingly, the <i>rpl3</i>[W255C] allele, in which the residue making the closest contact to this catalytic site is mutated, affects diverse aspects of ribosome biogenesis and function. Here, we have uncovered, by performing a synthetic lethal screen with this allele, an unexpected link between translation and the folding of nascent proteins by the ribosome-associated Ssb-RAC chaperone system. Our results reveal that uL3 and Ssb-RAC cooperate to prevent 80S ribosomes from piling up within the 5′ region of mRNAs early on during translation elongation. Together, our study provides compelling <i>in vivo</i> evidence for a functional connection between peptide bond formation at the peptidyl transferase center and chaperone-assisted <i>de novo</i> folding of nascent polypeptides at the solvent-side of the peptide exit tunnel.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Multiple competing RNA structures dynamically control alternative splicing in the human ATE1 gene]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761855756-f00e5dc8-b438-482a-9df8-3f88a12b2b13/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1208</link>
            <description><![CDATA[<p class="para" id="N65541">The mammalian <i>Ate1</i> gene encodes an arginyl transferase enzyme with tumor suppressor function that depends on the inclusion of one of the two mutually exclusive exons (MXE), exons 7a and 7b. We report that the molecular mechanism underlying MXE splicing in <i>Ate1</i> involves five conserved regulatory intronic elements R1–R5, of which R1 and R4 compete for base pairing with R3, while R2 and R5 form an ultra-long-range RNA structure spanning 30 Kb. In minigenes, single and double mutations that disrupt base pairings in R1R3 and R3R4 lead to the loss of MXE splicing, while compensatory triple mutations that restore RNA structure revert splicing to that of the wild type. In the endogenous <i>Ate1</i> pre-mRNA, blocking the competing base pairings by LNA/DNA mixmers complementary to R3 leads to the loss of MXE splicing, while the disruption of R2R5 interaction changes the ratio of MXE. That is, <i>Ate1</i> splicing is controlled by two independent, dynamically interacting, and functionally distinct RNA structure modules. Exon 7a becomes more included in response to RNA Pol II slowdown, however it fails to do so when the ultra-long-range R2R5 interaction is disrupted, indicating that exon 7a/7b ratio depends on co-transcriptional RNA folding. In sum, these results demonstrate that splicing is coordinated both in time and in space over very long distances, and that the interaction of these components is mediated by RNA structure.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Genome-wide investigation of the dynamic changes of epigenome modifications after global DNA methylation editing]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761849610-670a6ba5-e9f1-4791-918c-769e65ba3a44/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1169</link>
            <description><![CDATA[<p class="para" id="N65541">Chromatin properties are regulated by complex networks of epigenome modifications. Currently, it is unclear how these modifications interact and if they control downstream effects such as gene expression. We employed promiscuous chromatin binding of a zinc finger fused catalytic domain of DNMT3A to introduce DNA methylation in HEK293 cells at many CpG islands (CGIs) and systematically investigated the dynamics of the introduced DNA methylation and the consequent changes of the epigenome network. We observed efficient methylation at thousands of CGIs, but it was unstable at about 90% of them, highlighting the power of genome-wide molecular processes that protect CGIs against DNA methylation. Partially stable methylation was observed at about 1000 CGIs, which showed enrichment in H3K27me3. Globally, the introduced DNA methylation strongly correlated with a decrease in gene expression indicating a direct effect. Similarly, global but transient reductions in H3K4me3 and H3K27ac were observed after DNA methylation but no changes were found for H3K9me3 and H3K36me3. Our data provide a global and time-resolved view on the network of epigenome modifications, their connections with DNA methylation and the responses triggered by artificial DNA methylation revealing a direct repressive effect of DNA methylation in CGIs on H3K4me3, histone acetylation, and gene expression.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Basic mechanisms and kinetics of pause-interspersed transcript elongation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761809375-b3a5acd0-dfd4-4772-a46e-36c5dff96a51/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1182</link>
            <description><![CDATA[<p class="para" id="N65541">RNA polymerase pausing during elongation is an important mechanism in the regulation of gene expression. Pausing along DNA templates is thought to be induced by distinct signals encoded in the nucleic acid sequence and halt elongation complexes to allow time for necessary co-transcriptional events. Pausing signals have been classified as those producing short-lived elemental, long-lived backtracked, or hairpin-stabilized pauses. In recent years, structural microbiology and single-molecule studies have significantly advanced our understanding of the paused states, but the dynamics of these states are still uncertain, although several models have been proposed to explain the experimentally observed pausing behaviors. This review summarizes present knowledge about the paused states, discusses key discrepancies among the kinetic models and their basic assumptions, and highlights the importance and challenges in constructing theoretical models that may further our biochemical understanding of transcriptional pausing.</p>]]></description>
            <pubDate><![CDATA[2020-12-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[G-quadruplex–R-loop interactions and the mechanism of anticancer G-quadruplex binders]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761793218-85617013-5780-42dd-8390-b8cd6eebb2d2/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1206</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Asymmetron: a toolkit for the identification of strand asymmetry patterns in biological sequences]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765761782226-91a9f59a-fe9d-45d4-adcc-025ad8a8cab5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1052</link>
            <description><![CDATA[<p class="para" id="N65541">DNA strand asymmetries can have a major effect on several biological functions, including replication, transcription and transcription factor binding. As such, DNA strand asymmetries and mutational strand bias can provide information about biological function. However, a versatile tool to explore this does not exist. Here, we present Asymmetron, a user-friendly computational tool that performs statistical analysis and visualizations for the evaluation of strand asymmetries. Asymmetron takes as input DNA features provided with strand annotation and outputs strand asymmetries for consecutive occurrences of a single DNA feature or between pairs of features. We illustrate the use of Asymmetron by identifying transcriptional and replicative strand asymmetries of germline structural variant breakpoints. We also show that the orientation of the binding sites of 45% of human transcription factors analyzed have a significant DNA strand bias in transcribed regions, that is also corroborated in ChIP-seq analyses, and is likely associated with transcription. In summary, we provide a novel tool to assess DNA strand asymmetries and show how it can be used to derive new insights across a variety of biological disciplines.</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[StreptomeDB 3.0: an updated compendium of streptomycetes natural products]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765741441869-e74f2f81-6379-4439-a9d5-51507910a1a4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa868</link>
            <description><![CDATA[<p class="para" id="N65541">Antimicrobial resistance is an emerging global health threat necessitating the rapid development of novel antimicrobials. Remarkably, the vast majority of currently available antibiotics are natural products (NPs) isolated from streptomycetes, soil-dwelling bacteria of the genus <i>Streptomyces</i>. However, there is still a huge reservoir of streptomycetes NPs which remains pharmaceutically untapped and a compendium thereof could serve as a source of inspiration for the rational design of novel antibiotics. Initially released in 2012, StreptomeDB (http://www.pharmbioinf.uni-freiburg.de/streptomedb) is the first and only public online database that enables the interactive phylogenetic exploration of streptomycetes and their isolated or mutasynthesized NPs. In this third release, there are substantial improvements over its forerunners, especially in terms of data content. For instance, about 2500 unique NPs were newly annotated through manual curation of about 1300 PubMed-indexed articles, published in the last five years since the second release. To increase interoperability, StreptomeDB entries were hyperlinked to several spectral, (bio)chemical and chemical vendor databases, and also to a genome-based NP prediction server. Moreover, predicted pharmacokinetic and toxicity profiles were added. Lastly, some recent real-world use cases of StreptomeDB are highlighted, to illustrate its applicability in life sciences.</p>]]></description>
            <pubDate><![CDATA[2020-10-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PheLiGe: an interactive database of billions of human genotype–phenotype associations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765741398253-35ef7a0c-fce0-4239-a619-4e8fadaf2710/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1086</link>
            <description><![CDATA[<p class="para" id="N65541">Genome-wide association studies have provided a vast array of publicly available SNP × phenotype association results. However, they are often in disparate repositories and formats, making downstream analyses difficult and time consuming. PheLiGe (https://phelige.com) is a database that provides easy access to such results via a web interface. The underlying database currently stores &gt;75 billion genotype–phenotype associations from 7347 genome-wide and 1.2 million region-wide (e.g. <i>cis</i>-eQTL) association scans. The web interface allows for investigation of regional genotype-phenotype associations across many phenotypes, giving insights into the biological function affected by the variant in question. Furthermore, PheLiGe can compare regional patterns of association between different traits. This analysis can ascertain whether a co-association is due to pleiotropy or linkage. Moreover, comparison of association patterns for a complex trait of interest and gene expression and protein levels can implicate causal genes.</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[BRENDA, the ELIXIR core data resource in 2021: new developments and updates]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765741355937-2dcba8cd-bf11-487b-8215-1803c3dc019f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1025</link>
            <description><![CDATA[<p class="para" id="N65541">The BRENDA enzyme database (https://www.brenda-enzymes.org), established in 1987, has evolved into the main collection of functional enzyme and metabolism data. In 2018, BRENDA was selected as an ELIXIR Core Data Resource. BRENDA provides reliable data, continuous curation and updates of classified enzymes, and the integration of newly discovered enzymes. The main part contains &gt;5 million data for ∼90 000 enzymes from ∼13 000 organisms, manually extracted from ∼157 000 primary literature references, combined with information of text and data mining, data integration, and prediction algorithms. Supplements comprise disease-related data, protein sequences, 3D structures, genome annotations, ligand information, taxonomic, bibliographic, and kinetic data. BRENDA offers an easy access to enzyme information from quick to advanced searches, text- and structured-based queries for enzyme-ligand interactions, word maps, and visualization of enzyme data. The BRENDA Pathway Maps are completely revised and updated for an enhanced interactive and intuitive usability. The new design of the Enzyme Summary Page provides an improved access to each individual enzyme. A new protein structure 3D viewer was integrated. The prediction of the intracellular localization of eukaryotic enzymes has been implemented. The new EnzymeDetector combines BRENDA enzyme annotations with protein and genome databases for the detection of eukaryotic and prokaryotic enzymes.</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Mouse Genome Database (MGD): Knowledgebase for mouse–human comparative biology]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765741326283-88bd7f1b-f6b7-47e9-94b0-9dbf0674b832/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1083</link>
            <description><![CDATA[<p class="para" id="N65541">The Mouse Genome Database (MGD; http://www.informatics.jax.org) is the community model organism knowledgebase for the laboratory mouse, a widely used animal model for comparative studies of the genetic and genomic basis for human health and disease. MGD is the authoritative source for biological reference data related to mouse genes, gene functions, phenotypes and mouse models of human disease. MGD is the primary source for official gene, allele, and mouse strain nomenclature based on the guidelines set by the International Committee on Standardized Nomenclature for Mice. MGD’s biocuration scientists curate information from the biomedical literature and from large and small datasets contributed directly by investigators. In this report we describe significant enhancements to the content and interfaces at MGD, including (i) improvements in the Multi Genome Viewer for exploring the genomes of multiple mouse strains, (ii) inclusion of many more mouse strains and new mouse strain pages with extended query options and (iii) integration of extensive data about mouse strain variants. We also describe improvements to the efficiency of literature curation processes and the implementation of an information portal focused on mouse models and genes for the study of COVID-19.</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The international glycan repository GlyTouCan version 3.0]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765741158667-c6c9c8bf-8612-41bc-99a4-1a9d9f56d704/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa947</link>
            <description><![CDATA[<p class="para" id="N65541">Glycans serve important roles in signaling events and cell-cell communication, and they are recognized by lectins, viruses and bacteria, playing a variety of roles in many biological processes. However, there was no system to organize the plethora of glycan-related data in the literature. Thus GlyTouCan (https://glytoucan.org) was developed as the international glycan repository, allowing researchers to assign accession numbers to glycans. This also aided in the integration of glycan data across various databases. GlyTouCan assigns accession numbers to glycans which are defined as sets of monosaccharides, which may or may not be characterized with linkage information. GlyTouCan was developed to be able to recognize any level of ambiguity in glycans and uniquely assign accession numbers to each of them, regardless of the input text format. In this manuscript, we describe the latest update to GlyTouCan in version 3.0, its usage, and plans for future development.</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[OrthoDB in 2020: evolutionary and functional annotations of orthologs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765741014290-f30fa868-b957-4f69-a112-88c681c0ec4f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1009</link>
            <description><![CDATA[<p class="para" id="N65541">OrthoDB provides evolutionary and functional annotations of orthologs, inferred for a vast number of available organisms. OrthoDB is leading in the coverage and genomic diversity sampling of Eukaryotes, Prokaryotes and Viruses, and the sampling of Bacteria is further set to increase three-fold. The user interface has been enhanced in response to the massive growth in data. OrthoDB provides three views on the data: (i) a list of orthologous groups related to a user query, which are now arranged to visualize their hierarchical relations, (ii) a detailed view of an orthologous group, now featuring a Sankey diagram to facilitate navigation between the levels of orthology, from more finely-resolved to more general groups of orthologs, as well as an arrangement of orthologs into an interactive organism taxonomy structure, and (iii) we added a gene-centric view, showing the gene functional annotations and the pair-wise orthologs in example species. The OrthoDB standalone software for delineation of orthologs, Orthologer, is freely available. Online BUSCO assessments and mapping to OrthoDB of user-uploaded data enable interactive exploration of related annotations and generation of comparative charts. OrthoDB strives to predict orthologs from the broadest coverage of species, as well as to extensively collate available functional annotations, and to compute evolutionary annotations such as evolutionary rate and phyletic profile. OrthoDB data can be assessed via SPARQL RDF, REST API, downloaded or browsed online from https://orthodb.org.</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CMNPD: a comprehensive marine natural products database towards facilitating drug discovery from the ocean]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765741009145-07110853-45fa-4385-8eda-25287e12c5e5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa763</link>
            <description><![CDATA[<p class="para" id="N65541">Marine organisms are expected to be an important source of inspiration for drug discovery after terrestrial plants and microorganisms. Despite the remarkable progress in the field of marine natural products (MNPs) chemistry, there are only a few open access databases dedicated to MNPs research. To meet the growing demand for mining and sharing for MNPs-related data resources, we developed CMNPD, a comprehensive marine natural products database based on manually curated data. CMNPD currently contains more than 31 000 chemical entities with various physicochemical and pharmacokinetic properties, standardized biological activity data, systematic taxonomy and geographical distribution of source organisms, and detailed literature citations. It is an integrated platform for structure dereplication (assessment of novelty) of (marine) natural products, discovery of lead compounds, data mining of structure-activity relationships and investigation of chemical ecology. Access is available through a user-friendly web interface at https://www.cmnpd.org. We are committed to providing a free data sharing platform for not only professional MNPs researchers but also the broader scientific community to facilitate drug discovery from the ocean.</p>]]></description>
            <pubDate><![CDATA[2020-09-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DrugCentral 2021 supports drug discovery and repositioning]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740831987-f69848e8-b27b-4710-8fca-333f6a06f6e5/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa997</link>
            <description><![CDATA[<p class="para" id="N65541">DrugCentral is a public resource (http://drugcentral.org) that serves the scientific community by providing up-to-date drug information, as described in previous papers. The current release includes 109 newly approved (October 2018 through March 2020) active pharmaceutical ingredients in the US, Europe, Japan and other countries; and two molecular entities (e.g. mefuparib) of interest for COVID19. New additions include a set of pharmacokinetic properties for ∼1000 drugs, and a sex-based separation of side effects, processed from FAERS (FDA Adverse Event Reporting System); as well as a drug repositioning prioritization scheme based on the market availability and intellectual property rights forFDA approved drugs. In the context of the COVID19 pandemic, we also incorporated REDIAL-2020, a machine learning platform that estimates anti-SARS-CoV-2 activities, as well as the ‘drugs in news’ feature offers a brief enumeration of the most interesting drugs at the present moment. The full database dump and data files are available for download from the DrugCentral web portal.</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RASP: an atlas of transcriptome-wide RNA secondary structure probing data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740825666-09dc18d0-15bd-4b23-9de3-4b2843208e97/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa880</link>
            <description><![CDATA[<p class="para" id="N65541">RNA molecules fold into complex structures that are important across many biological processes. Recent technological developments have enabled transcriptome-wide probing of RNA secondary structure using nucleases and chemical modifiers. These approaches have been widely applied to capture RNA secondary structure in many studies, but gathering and presenting such data from very different technologies in a comprehensive and accessible way has been challenging. Existing RNA structure probing databases usually focus on low-throughput or very specific datasets. Here, we present a comprehensive RNA structure probing database called RASP (<b>R</b>NA <b>A</b>tlas of <b>S</b>tructure <b>P</b>robing) by collecting 161 deduplicated transcriptome-wide RNA secondary structure probing datasets from 38 papers. RASP covers 18 species across animals, plants, bacteria, fungi, and also viruses, and categorizes 18 experimental methods including DMS-seq, SHAPE-Seq, SHAPE-MaP, and icSHAPE, etc. Specially, RASP curates the up-to-date datasets of several RNA secondary structure probing studies for the RNA genome of SARS-CoV-2, the RNA virus that caused the on-going COVID-19 pandemic. RASP also provides a user-friendly interface to query, browse, and visualize RNA structure profiles, offering a shortcut to accessing RNA secondary structures grounded in experimental data. The database is freely available at http://rasp.zhanglab.net.</p>]]></description>
            <pubDate><![CDATA[2020-10-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GreenPhylDB v5: a comparative pangenomic database for plant genomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740767946-1711a242-b0e0-464e-87ea-57274ea22542/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1068</link>
            <description><![CDATA[<p class="para" id="N65541">Comparative genomics is the analysis of genomic relationships among different species and serves as a significant base for evolutionary and functional genomic studies. GreenPhylDB (https://www.greenphyl.org) is a database designed to facilitate the exploration of gene families and homologous relationships among plant genomes, including staple crops critically important for global food security. GreenPhylDB is available since 2007, after the release of the <i>Arabidopsis thaliana</i> and <i>Oryza sativa</i> genomes and has undergone multiple releases. With the number of plant genomes currently available, it becomes challenging to select a single reference for comparative genomics studies but there is still a lack of databases taking advantage several genomes by species for orthology detection. GreenPhylDBv5 introduces the concept of comparative pangenomics by harnessing multiple genome sequences by species. We created 19 pangenes and processed them with other species still relying on one genome. In total, 46 plant species were considered to build gene families and predict their homologous relationships through phylogenetic-based analyses. In addition, since the previous publication, we rejuvenated the website and included a new set of original tools including protein-domain combination, tree topologies searches and a section for users to store their own results in order to support community curation efforts.</p>]]></description>
            <pubDate><![CDATA[2020-11-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Rfam 14: expanded coverage of metagenomic, viral and microRNA families]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740700991-cc799198-6c00-4d2d-8fa9-72eeaed5ee56/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1047</link>
            <description><![CDATA[<p class="para" id="N65541">Rfam is a database of RNA families where each of the 3444 families is represented by a multiple sequence alignment of known RNA sequences and a covariance model that can be used to search for additional members of the family. Recent developments have involved expert collaborations to improve the quality and coverage of Rfam data, focusing on microRNAs, viral and bacterial RNAs. We have completed the first phase of synchronising microRNA families in Rfam and miRBase, creating 356 new Rfam families and updating 40. We established a procedure for comprehensive annotation of viral RNA families starting with <i>Flavivirus</i> and <i>Coronaviridae</i> RNAs. We have also increased the coverage of bacterial and metagenome-based RNA families from the ZWD database. These developments have enabled a significant growth of the database, with the addition of 759 new families in Rfam 14. To facilitate further community contribution to Rfam, expert users are now able to build and submit new families using the newly developed Rfam Cloud family curation system. New Rfam website features include a new sequence similarity search powered by RNAcentral, as well as search and visualisation of families with pseudoknots. Rfam is freely available at https://rfam.org.</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DDBJ update: streamlining submission and access of human data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740611856-06aeaf7d-f64f-4bab-898f-8a6fe8e16931/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa982</link>
            <description><![CDATA[<p class="para" id="N65541">The Bioinformation and DDBJ Center (DDBJ Center, https://www.ddbj.nig.ac.jp) provides databases that capture, preserve and disseminate diverse biological data to support research in the life sciences. This center collects nucleotide sequences with annotations, raw sequencing data, and alignment information from high-throughput sequencing platforms, and study and sample information, in collaboration with the National Center for Biotechnology Information (NCBI) and the European Bioinformatics Institute (EBI). This collaborative framework is known as the International Nucleotide Sequence Database Collaboration (INSDC). In collaboration with the National Bioscience Database Center (NBDC), the DDBJ Center also provides a controlled-access database, the Japanese Genotype–phenotype Archive (JGA), which archives and distributes human genotype and phenotype data, requiring authorized access. The NBDC formulates guidelines and policies for sharing human data and reviews data submission and use applications. To streamline all of the processes at NBDC and JGA, we have integrated the two systems by introducing a unified login platform with a group structure in September 2020. In addition to the public databases, the DDBJ Center provides a computer resource, the NIG supercomputer, for domestic researchers to analyze large-scale genomic data. This report describes updates to the services of the DDBJ Center, focusing on the NBDC and JGA system enhancements.</p>]]></description>
            <pubDate><![CDATA[2020-11-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MeDAS: a Metazoan Developmental Alternative Splicing database]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740539667-0e398349-7326-4859-b947-4fda87d0aa52/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa886</link>
            <description><![CDATA[<p class="para" id="N65541">Alternative splicing is widespread throughout eukaryotic genomes and greatly increases transcriptomic diversity. Many alternative isoforms have functional roles in developmental processes and are precisely temporally regulated. To facilitate the study of alternative splicing in a developmental context, we created MeDAS, a Metazoan Developmental Alternative Splicing database. MeDAS is an added-value resource that re-analyses publicly archived RNA-seq libraries to provide quantitative data on alternative splicing events as they vary across the time course of development. It has broad temporal and taxonomic scope and is intended to assist the user in identifying trends in alternative splicing throughout development. To create MeDAS, we re-analysed a curated set of 2232 Illumina polyA+ RNA-seq libraries that chart detailed time courses of embryonic and post-natal development across 18 species with a taxonomic range spanning the major metazoan lineages from <i>Caenorhabditis elegans</i> to human. MeDAS is freely available at https://das.chenlulab.com both as raw data tables and as an interactive browser allowing searches by species, tissue, or genomic feature (gene, transcript or exon ID and sequence). Results will provide details on alternative splicing events identified for the queried feature and can be visualised at the gene-, transcript- and exon-level as time courses of expression and inclusion levels, respectively.</p>]]></description>
            <pubDate><![CDATA[2020-10-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[VIPERdb v3.0: a structure-based data analytics platform for viral capsids]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740525192-2eddd228-fe46-45ac-a66f-d3910bdc3b0a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1096</link>
            <description><![CDATA[<p class="para" id="N65541">VIrus Particle ExploreR data base (VIPERdb) (http://viperdb.scripps.edu) is a curated repository of virus capsid structures and a database of structure-derived data along with various virus specific information. VIPERdb has been continuously improved for over 20 years and contains a number of virus structure analysis tools. The release of VIPERdb v3.0 contains new structure-based data analytics tools like Multiple Structure-based and Sequence Alignment (MSSA) to identify hot-spot residues within a selected group of structures and an anomaly detection application to analyze and curate the structure-derived data within individual virus families. At the time of this writing, there are 931 virus structures from 62 different virus families in the database. Significantly, the new release also contains a standalone database called ‘Virus World database’ (VWdb) that comprises all the characterized viruses (∼181 000) known to date, gathered from ICTVdb and NCBI, and their capsid protein sequences, organized according to their virus taxonomy with links to known structures in VIPERdb and PDB. Moreover, the new release of VIPERdb includes a service-oriented data engine to handle all the data access requests and provides an interface for futuristic data analytics using machine leaning applications.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740486800-a4fcd12d-3735-40c5-88af-4b626e4f9936/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1022</link>
            <description><![CDATA[<p class="para" id="N65541">The National Genomics Data Center (NGDC), part of the China National Center for Bioinformation (CNCB), provides a suite of database resources to support worldwide research activities in both academia and industry. With the explosive growth of multi-omics data, CNCB-NGDC is continually expanding, updating and enriching its core database resources through big data deposition, integration and translation. In the past year, considerable efforts have been devoted to 2019nCoVR, a newly established resource providing a global landscape of SARS-CoV-2 genomic sequences, variants, and haplotypes, as well as Aging Atlas, BrainBase, GTDB (Glycosyltransferases Database), LncExpDB, and TransCirc (Translation potential for circular RNAs). Meanwhile, a series of resources have been updated and improved, including BioProject, BioSample, GWH (Genome Warehouse), GVM (Genome Variation Map), GEN (Gene Expression Nebulas) as well as several biodiversity and plant resources. Particularly, BIG Search, a scalable, one-stop, cross-database search engine, has been significantly updated by providing easy access to a large number of internal and external biological resources from CNCB-NGDC, our partners, EBI and NCBI. All of these resources along with their services are publicly accessible at https://bigd.big.ac.cn.</p>]]></description>
            <pubDate><![CDATA[2020-11-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740478659-2bd8716f-53bd-4580-936a-3b2606386e29/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa917</link>
            <description><![CDATA[<p class="para" id="N65541">Essential genes refer to genes that are required by an organism to survive under specific conditions. Studies of the minimal-gene-set for bacteria have elucidated fundamental cellular processes that sustain life. The past five years have seen a significant progress in identifying human essential genes, primarily due to the successful use of CRISPR/Cas9 in various types of human cells. DEG 15, a new release of the Database of Essential Genes (www.essentialgene.org), has provided major advancements, compared to DEG 10. Specifically, the number of eukaryotic essential genes has increased by more than fourfold, and that of prokaryotic ones has more than doubled. Of note, the human essential-gene number has increased by more than tenfold. Moreover, we have developed built-in analysis modules by which users can perform various analyses, such as essential-gene distributions between bacterial leading and lagging strands, sub-cellular localization distribution, enrichment analysis of gene ontology and KEGG pathways, and generation of Venn diagrams to compare and contrast gene sets between experiments. Additionally, the database offers customizable BLAST tools for performing species- and experiment-specific BLAST searches. Therefore, DEG comprehensively harbors updated human-curated essential-gene records among prokaryotes and eukaryotes with built-in tools to enhance essential-gene analysis.</p>]]></description>
            <pubDate><![CDATA[2020-10-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[iCSDB: an integrated database of CRISPR screens]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740441572-c8c5a9c4-6b9e-4bfa-be3f-d3b6b3b11af1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa989</link>
            <description><![CDATA[<p class="para" id="N65541">High-throughput screening based on CRISPR-Cas9 libraries has become an attractive and powerful technique to identify target genes for functional studies. However, accessibility of public data is limited due to the lack of user-friendly utilities and up-to-date resources covering experiments from third parties. Here, we describe iCSDB, an integrated database of CRISPR screening experiments using human cell lines. We compiled two major sources of CRISPR-Cas9 screening: the DepMap portal and BioGRID ORCS. DepMap portal itself is an integrated database that includes three large-scale projects of CRISPR screening. We additionally aggregated CRISPR screens from BioGRID ORCS that is a collection of screening results from PubMed articles. Currently, iCSDB contains 1375 genome-wide screens across 976 human cell lines, covering 28 tissues and 70 cancer types. Importantly, the batch effects from different CRISPR libraries were removed and the screening scores were converted into a single metric to estimate the knockout efficiency. Clinical and molecular information were also integrated to help users to select cell lines of interest readily. Furthermore, we have implemented various interactive tools and viewers to facilitate users to choose, examine and compare the screen results both at the gene and guide RNA levels. iCSDB is available at https://www.kobic.re.kr/icsdb/.</p>]]></description>
            <pubDate><![CDATA[2020-11-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[FlyBase: updates to the <i>Drosophila melanogaster</i> knowledge base]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740397511-b4b0e084-e838-41a2-892b-e810783a8cb7/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1026</link>
            <description><![CDATA[<p class="para" id="N65541">FlyBase (flybase.org) is an essential online database for researchers using <i>Drosophila melanogaster</i> as a model organism, facilitating access to a diverse array of information that includes genetic, molecular, genomic and reagent resources. Here, we describe the introduction of several new features at FlyBase, including Pathway Reports, paralog information, disease models based on orthology, customizable tables within reports and overview displays (‘ribbons’) of expression and disease data. We also describe a variety of recent important updates, including incorporation of a developmental proteome, upgrades to the GAL4 search tab, additional Experimental Tool Reports, migration to JBrowse for genome browsing and improvements to batch queries/downloads and the Fast-Track Your Paper tool.</p>]]></description>
            <pubDate><![CDATA[2020-11-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[AcrHub: an integrative hub for investigating, predicting and mapping anti-CRISPR proteins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740376409-71636662-9b8e-43b4-ba9c-62874ec6c071/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa951</link>
            <description><![CDATA[<p class="para" id="N65541">Anti-CRISPR (Acr) proteins naturally inhibit CRISPR-Cas adaptive immune systems across bacterial and archaeal domains of life. This emerging field has caused a paradigm shift in the way we think about the CRISPR-Cas system, and promises a number of useful applications from gene editing to phage therapy. As the number of verified and predicted Acrs rapidly expands, few online resources have been developed to deal with this wealth of information. To overcome this shortcoming, we developed AcrHub, an integrative database to provide an all-in-one solution for investigating, predicting and mapping Acr proteins. AcrHub catalogs 339 non-redundant experimentally validated Acrs and over 70 000 predicted Acrs extracted from genome sequence data from a diverse range of prokaryotic organisms and their viruses. It integrates state-of-the-art predictors to predict potential Acrs, and incorporates three analytical modules: similarity analysis, phylogenetic analysis and homology network analysis, to analyze their relationships with known Acrs. By interconnecting all modules as a platform, AcrHub presents enriched and in-depth analysis of known and potential Acrs and therefore provides new and exciting insights into the future of Acr discovery and validation. AcrHub is freely available at http://pacrispr.erc.monash.edu/AcrHub/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765740376409-71636662-9b8e-43b4-ba9c-62874ec6c071/assets/gkaa951gra1.jpg" alt="AcrHub: an integrative hub for investigating, predicting and mapping anti-CRISPR proteins."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      AcrHub: an integrative hub for investigating, predicting and mapping anti-CRISPR proteins.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[FANTOM enters 20th year: expansion of transcriptomic atlases and functional annotation of non-coding RNAs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740362021-b5a53e86-954f-41ec-9a13-9943955ba769/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1054</link>
            <description><![CDATA[<p class="para" id="N65541">The Functional ANnoTation Of the Mammalian genome (FANTOM) Consortium has continued to provide extensive resources in the pursuit of understanding the transcriptome, and transcriptional regulation, of mammalian genomes for the last 20 years. To share these resources with the research community, the FANTOM web-interfaces and databases are being regularly updated, enhanced and expanded with new data types. In recent years, the FANTOM Consortium's efforts have been mainly focused on creating new non-coding RNA datasets and resources. The existing FANTOM5 human and mouse miRNA atlas was supplemented with rat, dog, and chicken datasets. The sixth (latest) edition of the FANTOM project was launched to assess the function of human long non-coding RNAs (lncRNAs). From its creation until 2020, FANTOM6 has contributed to the research community a large dataset generated from the knock-down of 285 lncRNAs in human dermal fibroblasts; this is followed with extensive expression profiling and cellular phenotyping. Other updates to the FANTOM resource includes the reprocessing of the miRNA and promoter atlases of human, mouse and chicken with the latest reference genome assemblies. To facilitate the use and accessibility of all above resources we further enhanced FANTOM data viewers and web interfaces. The updated FANTOM web resource is publicly available at https://fantom.gsc.riken.jp/.</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[WikiPathways: connecting communities]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740348624-e215afb1-7110-48f6-95d2-0202e8109daf/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1024</link>
            <description><![CDATA[<p class="para" id="N65541">WikiPathways (https://www.wikipathways.org) is a biological pathway database known for its collaborative nature and open science approaches. With the core idea of the scientific community developing and curating biological knowledge in pathway models, WikiPathways lowers all barriers for accessing and using its content. Increasingly more content creators, initiatives, projects and tools have started using WikiPathways. Central in this growth and increased use of WikiPathways are the various communities that focus on particular subsets of molecular pathways such as for rare diseases and lipid metabolism. Knowledge from published pathway figures helps prioritize pathway development, using optical character and named entity recognition. We show the growth of WikiPathways over the last three years, highlight the new communities and collaborations of pathway authors and curators, and describe various technologies to connect to external resources and initiatives. The road toward a sustainable, community-driven pathway database goes through integration with other resources such as Wikidata and allowing more use, curation and redistribution of WikiPathways content.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765740348624-e215afb1-7110-48f6-95d2-0202e8109daf/assets/gkaa1024gra1.jpg" alt="WikiPathways enables research communities to collaborate on molecular pathway curation to create reusable, machine-readable pathway models. The pathway collections are freely available and integrated with many analysis tools and resources."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      WikiPathways enables research communities to collaborate on molecular pathway curation to create reusable, machine-readable pathway models. The pathway collections are freely available and integrated with many analysis tools and resources.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[m<sup>6</sup>A-Atlas: a comprehensive knowledgebase for unraveling the <i>N</i><sup>6</sup>-methyladenosine (m<sup>6</sup>A) epitranscriptome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740342935-f20640df-9ea4-4dbb-bcde-f6dff61be481/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa692</link>
            <description><![CDATA[<p class="para" id="N65541">
<i>N</i>
<sup>6</sup>-Methyladenosine (m<sup>6</sup>A) is the most prevalent RNA modification on mRNAs and lncRNAs. It plays a pivotal role during various biological processes and disease pathogenesis. We present here a comprehensive knowledgebase, m<sup>6</sup>A-Atlas, for unraveling the m<sup>6</sup>A epitranscriptome. Compared to existing databases, m<sup>6</sup>A-Atlas features a high-confidence collection of 442 162 reliable m<sup>6</sup>A sites identified from seven base-resolution technologies and the quantitative (rather than binary) epitranscriptome profiles estimated from 1363 high-throughput sequencing samples. It also offers novel features, such as; the conservation of m<sup>6</sup>A sites among seven vertebrate species (including human, mouse and chimp), the m<sup>6</sup>A epitranscriptomes of 10 virus species (including HIV, KSHV and DENV), the putative biological functions of individual m<sup>6</sup>A sites predicted from epitranscriptome data, and the potential pathogenesis of m<sup>6</sup>A sites inferred from disease-associated genetic mutations that can directly destroy m<sup>6</sup>A directing sequence motifs. A user-friendly graphical user interface was constructed to support the query, visualization and sharing of the m<sup>6</sup>A epitranscriptomes annotated with sites specifying their interaction with post-transcriptional machinery (RBP-binding, microRNA interaction and splicing sites) and interactively display the landscape of multiple RNA modifications. These resources provide fresh opportunities for unraveling the m<sup>6</sup>A epitranscriptomes. m<sup>6</sup>A-Atlas is freely accessible at: www.xjtlu.edu.cn/biologicalsciences/atlas.</p>]]></description>
            <pubDate><![CDATA[2020-08-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[KEGG: integrating viruses and cellular organisms]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740250651-4813e5ff-6059-4a95-b89a-a5a5bd518d21/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa970</link>
            <description><![CDATA[<p class="para" id="N65541">KEGG (https://www.kegg.jp/) is a manually curated resource integrating eighteen databases categorized into systems, genomic, chemical and health information. It also provides KEGG mapping tools, which enable understanding of cellular and organism-level functions from genome sequences and other molecular datasets. KEGG mapping is a predictive method of reconstructing molecular network systems from molecular building blocks based on the concept of functional orthologs. Since the introduction of the KEGG NETWORK database, various diseases have been associated with network variants, which are perturbed molecular networks caused by human gene variants, viruses, other pathogens and environmental factors. The network variation maps are created as aligned sets of related networks showing, for example, how different viruses inhibit or activate specific cellular signaling pathways. The KEGG pathway maps are now integrated with network variation maps in the NETWORK database, as well as with conserved functional units of KEGG modules and reaction modules in the MODULE database. The KO database for functional orthologs continues to be improved and virus KOs are being expanded for better understanding of virus-cell interactions and for enabling prediction of viral perturbations.</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740191574-be8a3a74-08a1-4db1-a410-5a8ff3b75b3c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1006</link>
            <description><![CDATA[<p class="para" id="N65541">An updated Lnc2Cancer 3.0 (http://www.bio-bigdata.net/lnc2cancer or http://bio-bigdata.hrbmu.edu.cn/lnc2cancer) database, which includes comprehensive data on experimentally supported long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) associated with human cancers. In addition, web tools for analyzing lncRNA expression by high-throughput RNA sequencing (RNA-seq) and single-cell RNA-seq (scRNA-seq) are described. Lnc2Cancer 3.0 was updated with several new features, including (i) Increased cancer-associated lncRNA entries over the previous version. The current release includes 9254 lncRNA-cancer associations, with 2659 lncRNAs and 216 cancer subtypes. (ii) Newly adding 1049 experimentally supported circRNA-cancer associations, with 743 circRNAs and 70 cancer subtypes. (iii) Experimentally supported regulatory mechanisms of cancer-related lncRNAs and circRNAs, involving microRNAs, transcription factors (TF), genetic variants, methylation and enhancers were included. (iv) Appending experimentally supported biological functions of cancer-related lncRNAs and circRNAs including cell growth, apoptosis, autophagy, epithelial mesenchymal transformation (EMT), immunity and coding ability. (v) Experimentally supported clinical relevance of cancer-related lncRNAs and circRNAs in metastasis, recurrence, circulation, drug resistance, and prognosis was included. Additionally, two flexible online tools, including RNA-seq and scRNA-seq web tools, were developed to enable fast and customizable analysis and visualization of lncRNAs in cancers. Lnc2Cancer 3.0 is a valuable resource for elucidating the associations between lncRNA, circRNA and cancer.</p>]]></description>
            <pubDate><![CDATA[2020-11-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[HeRA: an atlas of enhancer RNAs across human tissues]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740159797-c79dbdc4-4d18-4589-b42d-ade8134fb633/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa940</link>
            <description><![CDATA[<p class="para" id="N65541">Enhancer RNA (eRNA) is a type of long non-coding RNA transcribed from DNA enhancer regions. Despite critical roles of eRNA in gene regulation, the expression landscape of eRNAs in normal human tissue remains unexplored. Using numerous samples from the Genotype-Tissue Expression project, we characterized 45 411 detectable eRNAs and identified tens of thousands of associations between eRNAs and traits, including gender, race, and age. We constructed a co-expression network to identify millions of putative eRNA regulators and target genes across different tissues. We further constructed a user-friendly data portal, <span style="text-decoration: underline">H</span>uman <span style="text-decoration: underline">e</span>nhancer <span style="text-decoration: underline">R</span>NA <span style="text-decoration: underline">A</span>tlas (HeRA, https://hanlab.uth.edu/HeRA/). In HeRA, users can search, browse, and download the eRNA expression profile, trait-related eRNAs, and eRNA co-expression network by searching the eRNA ID, gene symbol, and genomic region in one or multiple tissues. HeRA is the first data portal to characterize eRNAs from 9577 samples across 54 human tissues and facilitates functional and mechanistic investigations of eRNAs.</p>]]></description>
            <pubDate><![CDATA[2020-10-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[KinaseMD: kinase mutations and drug response database]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740132726-4d4d167c-5bad-4821-9258-a575c283082d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa945</link>
            <description><![CDATA[<p class="para" id="N65541">Mutations in kinases are abundant and critical to study signaling pathways and regulatory roles in human disease, especially in cancer. Somatic mutations in kinase genes can affect drug treatment, both sensitivity and resistance, to clinically used kinase inhibitors. Here, we present a newly constructed database, KinaseMD (<b>kinase m</b>utations and <b>d</b>rug response), to structurally and functionally annotate kinase mutations. KinaseMD integrates 679 374 somatic mutations, 251 522 network-rewiring events, and 390 460 drug response records curated from various sources for 547 kinases. We uniquely annotate the mutations and kinase inhibitor response in four types of protein substructures (gatekeeper, A-loop, G-loop and αC-helix) that are linked to kinase inhibitor resistance in literature. In addition, we annotate functional mutations that may rewire kinase regulatory network and report four phosphorylation signals (gain, loss, up-regulation and down-regulation). Overall, KinaseMD provides the most updated information on mutations, unique annotations of drug response especially drug resistance and functional sites of kinases. KinaseMD is accessible at https://bioinfo.uth.edu/kmd/, having functions for searching, browsing and downloading data. To our knowledge, there has been no systematic annotation of these structural mutations linking to kinase inhibitor response. In summary, KinaseMD is a centralized database for kinase mutations and drug response.</p>]]></description>
            <pubDate><![CDATA[2020-11-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Datanator: an integrated database of molecular data for quantitatively modeling cellular behavior]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740075128-44c26fea-132f-4d93-8918-6eaf3abcc8f0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1008</link>
            <description><![CDATA[<p class="para" id="N65541">Integrative research about multiple biochemical subsystems has significant potential to help advance biology, bioengineering and medicine. However, it is difficult to obtain the diverse data needed for integrative research. To facilitate biochemical research, we developed Datanator (https://datanator.info), an integrated database and set of tools for finding <i>clouds</i> of multiple types of molecular data about specific molecules and reactions in specific organisms and environments, as well as data about chemically-similar molecules and reactions in phylogenetically-similar organisms in similar environments. Currently, Datanator includes metabolite concentrations, RNA modifications and half-lives, protein abundances and modifications, and reaction rate constants about a broad range of organisms. Going forward, we aim to launch a community initiative to curate additional data. Datanator also provides tools for filtering, visualizing and exporting these data clouds. We believe that Datanator can facilitate a wide range of research from integrative mechanistic models, such as whole-cell models, to comparative data-driven analyses of multiple organisms.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765740075128-44c26fea-132f-4d93-8918-6eaf3abcc8f0/assets/gkaa1008gra1.jpg" alt="Datanator (https://datanator.info) is an integrated database of molecular data. To help investigators find relevant data for research even in the absence of direct measurements, Datanator includes tools for assembling &quot;clouds&quot; of measurements centered on a specific molecule or reaction in a particular organism that encompass measurements of similar molecules and reactions in similar organisms. Datanator is ideal for integrative and comparative analysis and modeling."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Datanator (https://datanator.info) is an integrated database of molecular data. To help investigators find relevant data for research even in the absence of direct measurements, Datanator includes tools for assembling "clouds" of measurements centered on a specific molecule or reaction in a particular organism that encompass measurements of similar molecules and reactions in similar organisms. Datanator is ideal for integrative and comparative analysis and modeling.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MobiDB: intrinsically disordered proteins in 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765740015420-47cf02b4-c311-4e01-9e8a-10ad91bfb571/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1058</link>
            <description><![CDATA[<p class="para" id="N65541">The MobiDB database (URL: https://mobidb.org/) provides predictions and annotations for intrinsically disordered proteins. Here, we report recent developments implemented in MobiDB version 4, regarding the database format, with novel types of annotations and an improved update process. The new website includes a re-designed user interface, a more effective search engine and advanced API for programmatic access. The new database schema gives more flexibility for the users, as well as simplifying the maintenance and updates. In addition, the new entry page provides more visualisation tools including customizable feature viewer and graphs of the residue contact maps. MobiDB v4 annotates the binding modes of disordered proteins, whether they undergo disorder-to-order transitions or remain disordered in the bound state. In addition, disordered regions undergoing liquid-liquid phase separation or post-translational modifications are defined. The integrated information is presented in a simplified interface, which enables faster searches and allows large customized datasets to be downloaded in TSV, Fasta or JSON formats. An alternative advanced interface allows users to drill deeper into features of interest. A new statistics page provides information at database and proteome levels. The new MobiDB version presents state-of-the-art knowledge on disordered proteins and improves data accessibility for both computational and experimental users.</p>]]></description>
            <pubDate><![CDATA[2020-11-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Animal-APAdb: a comprehensive animal alternative polyadenylation database]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739980054-4b88d68d-1383-40eb-a4c7-1d2e57fe5c16/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa778</link>
            <description><![CDATA[<p class="para" id="N65541">Alternative polyadenylation (APA) is an important post-transcriptional regulatory mechanism that recognizes different polyadenylation signals on transcripts, resulting in transcripts with different lengths of 3′ untranslated regions and thereby influencing a series of biological processes. Recent studies have highlighted the important roles of APA in human. However, APA profiles in other animals have not been fully recognized, and there is no database that provides comprehensive APA information for other animals except human. Here, by using the RNA sequencing data collected from public databases, we systematically characterized the APA profiles in 9244 samples of 18 species. In total, we identified 342 952 APA events with a median of 17 020 per species using the DaPars2 algorithm, and 315 691 APA events with a median of 17 953 per species using the QAPA algorithm in these 18 species, respectively. In addition, we predicted the polyadenylation sites (PAS) and motifs near PAS of these species. We further developed Animal-APAdb, a user-friendly database (http://gong_lab.hzau.edu.cn/Animal-APAdb/) for data searching, browsing and downloading. With comprehensive information of APA events in different tissues of different species, Animal-APAdb may greatly facilitate the exploration of animal APA patterns and novel mechanisms, gene expression regulation and APA evolution across tissues and species.</p>]]></description>
            <pubDate><![CDATA[2020-09-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The UCSC Genome Browser database: 2021 update]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739973171-a6481bd2-41f3-4115-9ae9-f962ffe7bd8c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1070</link>
            <description><![CDATA[<p class="para" id="N65541">For more than two decades, the UCSC Genome Browser database (https://genome.ucsc.edu) has provided high-quality genomics data visualization and genome annotations to the research community. As the field of genomics grows and more data become available, new modes of display are required to accommodate new technologies. New features released this past year include a Hi-C heatmap display, a phased family trio display for VCF files, and various track visualization improvements. Striving to keep data up-to-date, new updates to gene annotations include GENCODE Genes, NCBI RefSeq Genes, and Ensembl Genes. New data tracks added for human and mouse genomes include the ENCODE registry of candidate cis-regulatory elements, promoters from the Eukaryotic Promoter Database, and NCBI RefSeq Select and Matched Annotation from NCBI and EMBL-EBI (MANE). Within weeks of learning about the outbreak of coronavirus, UCSC released a genome browser, with detailed annotation tracks, for the SARS-CoV-2 RNA reference assembly.</p>]]></description>
            <pubDate><![CDATA[2020-11-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PROMISCUOUS 2.0: a resource for drug-repositioning]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739930034-a11fcbef-98e7-464c-8f22-07965ccb897e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1061</link>
            <description><![CDATA[<p class="para" id="N65541">The development of new drugs for diseases is a time-consuming, costly and risky process. In recent years, many drugs could be approved for other indications. This repurposing process allows to effectively reduce development costs, time and, ultimately, save patients’ lives. During the ongoing COVID-19 pandemic, drug repositioning has gained widespread attention as a fast opportunity to find potential treatments against the newly emerging disease. In order to expand this field to researchers with varying levels of experience, we made an effort to open it to all users (meaning novices as well as experts in cheminformatics) by significantly improving the entry-level user experience. The browsing functionality can be used as a global entry point to collect further information with regards to small molecules (∼1 million), side-effects (∼110 000) or drug-target interactions (∼3 million). The drug-repositioning tab for small molecules will also suggest possible drug-repositioning opportunities to the user by using structural similarity measurements for small molecules using two different approaches. Additionally, using information from the Promiscuous 2.0 Database, lists of candidate drugs for given indications were precomputed, including a section dedicated to potential treatments for COVID-19. All the information is interconnected by a dynamic network-based visualization to identify new indications for available compounds. Promiscuous 2.0 is unique in its functionality and is publicly available at http://bioinformatics.charite.de/promiscuous2.</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Aging Atlas: a multi-omics database for aging biology]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739906612-8d707836-fbd8-4a1f-89af-8a6f3f7a1aa4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa894</link>
            <description><![CDATA[<p class="para" id="N65541">Organismal aging is driven by interconnected molecular changes encompassing internal and extracellular factors. Combinational analysis of high-throughput ‘multi-omics’ datasets (gathering information from genomics, epigenomics, transcriptomics, proteomics, metabolomics and pharmacogenomics), at either populational or single-cell levels, can provide a multi-dimensional, integrated profile of the heterogeneous aging process with unprecedented throughput and detail. These new strategies allow for the exploration of the molecular profile and regulatory status of gene expression during aging, and in turn, facilitate the development of new aging interventions. With a continually growing volume of valuable aging-related data, it is necessary to establish an open and integrated database to support a wide spectrum of aging research. The Aging Atlas database aims to provide a wide range of life science researchers with valuable resources that allow access to a large-scale of gene expression and regulation datasets created by various high-throughput omics technologies. The current implementation includes five modules: transcriptomics (RNA-seq), single-cell transcriptomics (scRNA-seq), epigenomics (ChIP-seq), proteomics (protein–protein interaction), and pharmacogenomics (geroprotective compounds). Aging Atlas provides user-friendly functionalities to explore age-related changes in gene expression, as well as raw data download services. Aging Atlas is freely available at https://bigd.big.ac.cn/aging/index.</p>]]></description>
            <pubDate><![CDATA[2020-10-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RMVar: an updated database of functional variants involved in RNA modifications]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739901852-0025c90e-3c66-4c8e-b094-bbfe71352c8f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa811</link>
            <description><![CDATA[<p class="para" id="N65541">Distinguishing the few disease-related variants from a massive number of passenger variants is a major challenge. Variants affecting RNA modifications that play critical roles in many aspects of RNA metabolism have recently been linked to many human diseases, such as cancers. Evaluating the effect of genetic variants on RNA modifications will provide a new perspective for understanding the pathogenic mechanism of human diseases. Previously, we developed a database called ‘m6AVar’ to host variants associated with m<sup>6</sup>A, one of the most prevalent RNA modifications in eukaryotes. To host all RNA modification (RM)-associated variants, here we present an updated version of m6AVar renamed RMVar (http://rmvar.renlab.org). In this update, RMVar contains 1 678 126 RM-associated variants for 9 kinds of RNA modifications, namely m<sup>6</sup>A, m<sup>6</sup>Am, m<sup>1</sup>A, pseudouridine, m<sup>5</sup>C, m<sup>5</sup>U, 2′-O-Me, A-to-I and m<sup>7</sup>G, at three confidence levels. Moreover, RBP binding regions, miRNA targets, splicing events and circRNAs were integrated to assist investigations of the effects of RM-associated variants on posttranscriptional regulation. In addition, disease-related information was integrated from ClinVar and other genome-wide association studies (GWAS) to investigate the relationship between RM-associated variants and diseases. We expect that RMVar may boost further functional studies on genetic variants affecting RNA modifications.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765739901852-0025c90e-3c66-4c8e-b094-bbfe71352c8f/assets/gkaa811gra1.jpg" alt="RMVar: an updated database of functional variants involved in RNA modifications."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      RMVar: an updated database of functional variants involved in RNA modifications.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[IDDB: a comprehensive resource featuring genes, variants and characteristics associated with infertility]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739897338-188483d2-443e-4bd8-b5e6-2bad1606844e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa753</link>
            <description><![CDATA[<p class="para" id="N65541">Infertility is a complex multifactorial disease that affects up to 10% of couples across the world. However, many mechanisms of infertility remain unclear due to the lack of studies based on systematic knowledge, leading to ineffective treatment and/or transmission of genetic defects to offspring. Here, we developed an infertility disease database to provide a comprehensive resource featuring various factors involved in infertility. Features in the current IDDB version were manually curated as follows: (i) a total of 307 infertility-associated genes in human and 1348 genes associated with reproductive disorder in 9 model organisms; (ii) a total of 202 chromosomal abnormalities leading to human infertility, including aneuploidies and structural variants; and (iii) a total of 2078 pathogenic variants from infertility patients’ samples across 60 different diseases causing infertility. Additionally, the characteristics of clinically diagnosed infertility patients (i.e. causative variants, laboratory indexes and clinical manifestations) were collected. To the best of our knowledge, the IDDB is the first infertility database serving as a systematic resource for biologists to decipher infertility mechanisms and for clinicians to achieve better diagnosis/treatment of patients from disease phenotype to genetic factors. The IDDB is freely available at http://mdl.shsmu.edu.cn/IDDB/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765739897338-188483d2-443e-4bd8-b5e6-2bad1606844e/assets/gkaa753gra1.jpg" alt="The major components of Infertility Disease Database and their combinations."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      The major components of Infertility Disease Database and their combinations.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-09-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[dbGuide: a database of functionally validated guide RNAs for genome editing in human and mouse cells]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739886291-acf794f4-6751-4427-affe-706c203b3e5d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa848</link>
            <description><![CDATA[<p class="para" id="N65541">With the technology's accessibility and ease of use, CRISPR has been employed widely in many different organisms and experimental settings. As a result, thousands of publications have used CRISPR to make specific genetic perturbations, establishing in itself a resource of validated guide RNA sequences. While numerous computational tools to assist in the design and identification of candidate guide RNAs exist, these are still just at best predictions and generally, researchers inevitably will test multiple sequences for functional activity. Here, we present <i>dbGuide</i> (https://sgrnascorer.cancer.gov/dbguide), a database of functionally validated guide RNA sequences for CRISPR/Cas9-based knockout in human and mouse. Our database not only contains computationally determined candidate guide RNA sequences, but of even greater value, over 4000 sequences which have been functionally validated either through direct amplicon sequencing or manual curation of literature from over 1000 publications. Finally, our established framework will allow for continual addition of newly published and experimentally validated guide RNA sequences for CRISPR/Cas9-based knockout as well as incorporation of sequences from different gene editing systems, additional species and other types of site-specific functionalities such as base editing, gene activation, repression and epigenetic modification.</p>]]></description>
            <pubDate><![CDATA[2020-10-13T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GRNdb: decoding the gene regulatory networks in diverse human and mouse conditions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739822202-dae95753-a6e8-4d0f-adf8-f342de1b6047/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa995</link>
            <description><![CDATA[<p class="para" id="N65541">Gene regulatory networks (GRNs) formed by transcription factors (TFs) and their downstream target genes play essential roles in gene expression regulation. Moreover, GRNs can be dynamic changing across different conditions, which are crucial for understanding the underlying mechanisms of disease pathogenesis. However, no existing database provides comprehensive GRN information for various human and mouse normal tissues and diseases at the single-cell level. Based on the known TF-target relationships and the large-scale single-cell RNA-seq data collected from public databases as well as the bulk data of The Cancer Genome Atlas and the Genotype-Tissue Expression project, we systematically predicted the GRNs of 184 different physiological and pathological conditions of human and mouse involving &gt;633 000 cells and &gt;27 700 bulk samples. We further developed GRNdb, a freely accessible and user-friendly database (http://www.grndb.com/) for searching, comparing, browsing, visualizing, and downloading the predicted information of 77 746 GRNs, 19 687 841 TF-target pairs, and related binding motifs at single-cell/bulk resolution. GRNdb also allows users to explore the gene expression profile, correlations, and the associations between expression levels and the patient survival of diverse cancers. Overall, GRNdb provides a valuable and timely resource to the scientific community to elucidate the functions and mechanisms of gene expression regulation in various conditions.</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Plant-ImputeDB: an integrated multiple plant reference panel database for genotype imputation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739790253-11f7d0a7-2e2f-45cc-9b35-4a054a5b0453/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa953</link>
            <description><![CDATA[<p class="para" id="N65541">Genotype imputation is a process that estimates missing genotypes in terms of the haplotypes and genotypes in a reference panel. It can effectively increase the density of single nucleotide polymorphisms (SNPs), boost the power to identify genetic association and promote the combination of genetic studies. However, there has been a lack of high-quality reference panels for most plants, which greatly hinders the application of genotype imputation. Here, we developed Plant-ImputeDB (http://gong_lab.hzau.edu.cn/Plant_imputeDB/), a comprehensive database with reference panels of 12 plant species for online genotype imputation, SNP and block search and free download. By integrating genotype data and whole-genome resequencing data of plants from various studies and databases, the current Plant-ImputeDB provides high-quality reference panels of 12 plant species, including ∼69.9 million SNPs from 34 244 samples. It also provides an easy-to-use online tool with the option of two popular tools specifically designed for genotype imputation. In addition, Plant-ImputeDB accepts submissions of different types of genomic variations, and provides free and open access to all publicly available data in support of related research worldwide. In general, Plant-ImputeDB may serve as an important resource for plant genotype imputation and greatly facilitate the research on plant genetic research.</p>]]></description>
            <pubDate><![CDATA[2020-11-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[INTEDE: interactome of drug-metabolizing enzymes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739685351-047936ff-9375-47ec-83cf-fde4160c731c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa755</link>
            <description><![CDATA[<p class="para" id="N65541">Drug-metabolizing enzymes (DMEs) are critical determinant of drug safety and efficacy, and the interactome of DMEs has attracted extensive attention. There are 3 major interaction types in an interactome: microbiome–DME interaction (MICBIO), xenobiotics–DME interaction (XEOTIC) and host protein–DME interaction (HOSPPI). The interaction data of each type are essential for drug metabolism, and the collective consideration of multiple types has implication for the future practice of precision medicine. However, no database was designed to systematically provide the data of all types of DME interactions. Here, a database of the Interactome of Drug-Metabolizing Enzymes (INTEDE) was therefore constructed to offer these interaction data. First, 1047 unique DMEs (448 host and 599 microbial) were confirmed, for the first time, using their metabolizing drugs. Second, for these newly confirmed DMEs, all types of their interactions (3359 MICBIOs between 225 microbial species and 185 DMEs; 47 778 XEOTICs between 4150 xenobiotics and 501 DMEs; 7849 HOSPPIs between 565 human proteins and 566 DMEs) were comprehensively collected and then provided, which enabled the crosstalk analysis among multiple types. Because of the huge amount of accumulated data, the INTEDE made it possible to generalize key features for revealing disease etiology and optimizing clinical treatment. INTEDE is freely accessible at: https://idrblab.org/intede/</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765739685351-047936ff-9375-47ec-83cf-fde4160c731c/assets/gkaa755gra1.jpg" alt="The Interactome Database of Drug-Metabolizing Enzyme (INTEDE) provides the comprehensive interactome data from three perspectives for both human and microbial drug-metabolizing enzymes."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      The Interactome Database of Drug-Metabolizing Enzyme (INTEDE) provides the comprehensive interactome data from three perspectives for both human and microbial drug-metabolizing enzymes.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RJunBase: a database of RNA splice junctions in human normal and cancerous tissues]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739616010-e1313cc8-676b-4c44-b6ae-923b63924c8f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1056</link>
            <description><![CDATA[<p class="para" id="N65541">Splicing is an essential step of RNA processing for multi-exon genes, in which introns are removed from a precursor RNA, thereby producing mature RNAs containing splice junctions. Here, we develope the RJunBase (www.RJunBase.org), a web-accessible database of three types of RNA splice junctions (linear, back-splice, and fusion junctions) that are derived from RNA-seq data of non-cancerous and cancerous tissues. The RJunBase aims to integrate and characterize all RNA splice junctions of both healthy or pathological human cells and tissues. This new database facilitates the visualization of the gene-level splicing pattern and the junction-level expression profile, as well as the demonstration of unannotated and tumor-specific junctions. The first release of RJunBase contains 682 017 linear junctions, 225 949 back-splice junctions and 34 733 fusion junctions across 18 084 non-cancerous and 11 540 cancerous samples. RJunBase can aid researchers in discovering new splicing-associated targets and provide insights into the identification and assessment of potential neoepitopes for cancer treatment.</p>]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[OGEE v3: Online GEne Essentiality database with increased coverage of organisms and human cell lines]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739604025-1c879f6d-1ad5-45d8-ae3c-d40039ebf05b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa884</link>
            <description><![CDATA[<p class="para" id="N65541">OGEE is an Online GEne Essentiality database. Gene essentiality is not a static and binary property, rather a context-dependent and evolvable property in all forms of life. In OGEE we collect not only experimentally tested essential and non-essential genes, but also associated gene properties that contributes to gene essentiality. We tagged conditionally essential genes that show variable essentiality statuses across datasets to highlight complex interplays between gene functions and environmental/experimental perturbations. OGEE v3 contains gene essentiality datasets for 91 species; almost doubled from 48 species in previous version. To accommodate recent advances on human cancer essential genes (as known as tumor dependency genes) that could serve as targets for cancer treatment and/or drug development, we expanded the collection of human essential genes from 16 cell lines in previous to 581. These human cancer cell lines were tested with high-throughput experiments such as CRISPR-Cas9 and RNAi; in total, 150 of which were tested by both techniques. We also included factors known to contribute to gene essentiality for these cell lines, such as genomic mutation, methylation and gene expression, along with extensive graphical visualizations for ease of understanding of these factors. OGEE v3 can be accessible freely at https://v3.ogee.info.</p>]]></description>
            <pubDate><![CDATA[2020-10-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PK-DB: pharmacokinetics database for individualized and stratified computational modeling]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739568853-6d51a36f-37e5-4943-9103-4d2aa100a738/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa990</link>
            <description><![CDATA[<p class="para" id="N65541">A multitude of pharmacokinetics studies have been published. However, due to the lack of an open database, pharmacokinetics data, as well as the corresponding meta-information, have been difficult to access. We present PK-DB (https://pk-db.com), an open database for pharmacokinetics information from clinical trials. PK-DB provides curated information on (i) characteristics of studied patient cohorts and subjects (e.g. age, bodyweight, smoking status, genetic variants); (ii) applied interventions (e.g. dosing, substance, route of application); (iii) pharmacokinetic parameters (e.g. clearance, half-life, area under the curve) and (iv) measured pharmacokinetic time-courses. Key features are the representation of experimental errors, the normalization of measurement units, annotation of information to biological ontologies, calculation of pharmacokinetic parameters from concentration-time profiles, a workflow for collaborative data curation, strong validation rules on the data, computational access via a REST API as well as human access via a web interface. PK-DB enables meta-analysis based on data from multiple studies and data integration with computational models. A special focus lies on meta-data relevant for individualized and stratified computational modeling with methods like physiologically based pharmacokinetic (PBPK), pharmacokinetic/pharmacodynamic (PK/PD), or population pharmacokinetic (pop PK) modeling.</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MolluscDB: an integrated functional and evolutionary genomics database for the hyper-diverse animal phylum Mollusca]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739550298-b4e187ca-4f31-4633-83dd-5615b1ba7bba/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa918</link>
            <description><![CDATA[<p class="para" id="N65541">Mollusca represents the second largest animal phylum but remains poorly explored from a genomic perspective. While the recent increase in genomic resources holds great promise for a deep understanding of molluscan biology and evolution, access and utilization of these resources still pose a challenge. Here, we present the first comprehensive molluscan genomics database, MolluscDB (http://mgbase.qnlm.ac), which compiles and integrates current molluscan genomic/transcriptomic resources and provides convenient tools for multi-level integrative and comparative genomic analyses. MolluscDB enables a systematic view of genomic information from various aspects, such as genome assembly statistics, genome phylogenies, fossil records, gene information, expression profiles, gene families, transcription factors, transposable elements and mitogenome organization information. Moreover, MolluscDB offers valuable customized datasets or resources, such as gene coexpression networks across various developmental stages and adult tissues/organs, core gene repertoires inferred for major molluscan lineages, and macrosynteny analysis for chromosomal evolution. MolluscDB presents an integrative and comprehensive genomics platform that will allow the molluscan community to cope with ever-growing genomic resources and will expedite new scientific discoveries for understanding molluscan biology and evolution.</p>]]></description>
            <pubDate><![CDATA[2020-10-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GIMICA: host genetic and immune factors shaping human microbiota]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739544736-3a948232-4501-4bf5-ae9e-c7514b052c24/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa851</link>
            <description><![CDATA[<p class="para" id="N65541">Besides the environmental factors having tremendous impacts on the composition of microbial community, the host factors have recently gained extensive attentions on their roles in shaping human microbiota. There are two major types of host factors: host genetic factors (HGFs) and host immune factors (HIFs). These factors of each type are essential for defining the chemical and physical landscapes inhabited by microbiota, and the collective consideration of both types have great implication to serve comprehensive health management. However, no database was available to provide the comprehensive factors of both types. Herein, a database entitled ‘Host <span style="text-decoration: underline">G</span>enetic and <span style="text-decoration: underline">I</span>mmune Factors Shaping Human <span style="text-decoration: underline">Mic</span>robiot<span style="text-decoration: underline">a</span> (GIMICA)’ was constructed. Based on the 4257 microbes confirmed to inhabit nine sites of human body, 2851 HGFs (1368 single nucleotide polymorphisms (SNPs), 186 copy number variations (CNVs), and 1297 non-coding ribonucleic acids (RNAs)) modulating the expression of 370 microbes were collected, and 549 HIFs (126 lymphocytes and phagocytes, 387 immune proteins, and 36 immune pathways) regulating the abundance of 455 microbes were also provided. All in all, GIMICA enabled the collective consideration not only between different types of host factor but also between the host and environmental ones, which is freely accessible without login requirement at: https://idrblab.org/gimica/</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765739544736-3a948232-4501-4bf5-ae9e-c7514b052c24/assets/gkaa851gra1.jpg" alt="GIMICA is unique in: (i) providing both host genetic and immune factors shaping human microbiota and (ii) enabling collective consideration not only among various host factors but also between the host and environmental ones."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      GIMICA is unique in: (i) providing both host genetic and immune factors shaping human microbiota and (ii) enabling collective consideration not only among various host factors but also between the host and environmental ones.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[NONCODEV6: an updated database dedicated to long non-coding RNA annotation in both animals and plants]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739485091-b5ed246f-900c-4a1c-9204-a839d52157d0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1046</link>
            <description><![CDATA[<p class="para" id="N65541">NONCODE (http://www.noncode.org/) is a comprehensive database of collection and annotation of noncoding RNAs, especially long non-coding RNAs (lncRNAs) in animals. NONCODEV6 is dedicated to providing the full scope of lncRNAs across plants and animals. The number of lncRNAs in NONCODEV6 has increased from 548 640 to 644 510 since the last update in 2017. The number of human lncRNAs has increased from 172 216 to 173 112. The number of mouse lncRNAs increased from 131 697 to 131 974. The number of plant lncRNAs is 94 697. The relationship between lncRNAs in human and cancer were updated with transcriptome sequencing profiles. Three important new features were also introduced in NONCODEV6: (i) updated human lncRNA-disease relationships, especially cancer; (ii) lncRNA annotations with tissue expression profiles and predicted function in five common plants; iii) lncRNAs conservation annotation at transcript level for 23 plant species. NONCODEV6 is accessible through http://www.noncode.org/.</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739431085-218c363e-0032-496e-be2e-c1d77e68d77b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1063</link>
            <description><![CDATA[<p class="para" id="N65541">Pharmacotranscriptomics has become a powerful approach for evaluating the therapeutic efficacy of drugs and discovering new drug targets. Recently, studies of traditional Chinese medicine (TCM) have increasingly turned to high-throughput transcriptomic screens for molecular effects of herbs/ingredients. And numerous studies have examined gene targets for herbs/ingredients, and link herbs/ingredients to various modern diseases. However, there is currently no systematic database organizing these data for TCM. Therefore, we built <b>HERB</b>, a <b><span style="text-decoration: underline">h</span></b>igh-throughput <b><span style="text-decoration: underline">e</span></b>xperiment- and <b><span style="text-decoration: underline">r</span></b>eference-guided data<b><span style="text-decoration: underline">b</span></b>ase of TCM, with its Chinese name as BenCaoZuJian. We re-analyzed 6164 gene expression profiles from 1037 high-throughput experiments evaluating TCM herbs/ingredients, and generated connections between TCM herbs/ingredients and 2837 modern drugs by mapping the comprehensive pharmacotranscriptomics dataset in HERB to CMap, the largest such dataset for modern drugs. Moreover, we manually curated 1241 gene targets and 494 modern diseases for 473 herbs/ingredients from 1966 references published recently, and cross-referenced this novel information to databases containing such data for drugs. Together with database mining and statistical inference, we linked 12 933 targets and 28 212 diseases to 7263 herbs and 49 258 ingredients and provided six pairwise relationships among them in HERB. In summary, HERB will intensively support the modernization of TCM and guide rational modern drug discovery efforts. And it is accessible through http://herb.ac.cn/.</p>]]></description>
            <pubDate><![CDATA[2020-12-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MitImpact 3: modeling the residue interaction network of the Respiratory Chain subunits]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739348503-fca4d9d1-57d6-40c4-b68b-df5e6e2551d6/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1032</link>
            <description><![CDATA[<p class="para" id="N65541">Numerous lines of evidence have shown that the interaction between the nuclear and mitochondrial genomes ensures the efficient functioning of the OXPHOS complexes, with substantial implications in bioenergetics, adaptation, and disease. Their interaction is a fascinating and complex trait of the eukaryotic cell that MitImpact explores with its third major release. MitImpact expands its collection of genomic, clinical, and functional annotations of all non-synonymous substitutions of the human mitochondrial genome with new information on putative Compensated Pathogenic Deviations and co-varying amino acid sites of the Respiratory Chain subunits. It further provides evidence of energetic and structural residue compensation by techniques of molecular dynamics simulation. MitImpact is freely accessible at http://mitimpact.css-mendel.it.</p>]]></description>
            <pubDate><![CDATA[2020-12-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MNDR v3.0: mammal ncRNA–disease repository with increased coverage and annotation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739308713-24930ae4-af46-423e-8598-18452a41c575/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa707</link>
            <description><![CDATA[<p class="para" id="N65541">Many studies have indicated that non-coding RNA (ncRNA) dysfunction is closely related to numerous diseases. Recently, accumulated ncRNA–disease associations have made related databases insufficient to meet the demands of biomedical research. The constant updating of ncRNA–disease resources has become essential. Here, we have updated the mammal ncRNA–disease repository (MNDR, http://www.rna-society.org/mndr/) to version 3.0, containing more than one million entries, four-fold increment in data compared to the previous version. Experimental and predicted circRNA–disease associations have been integrated, increasing the number of categories of ncRNAs to five, and the number of mammalian species to 11. Moreover, ncRNA–disease related drug annotations and associations, as well as ncRNA subcellular localizations and interactions, were added. In addition, three ncRNA–disease (miRNA/lncRNA/circRNA) prediction tools were provided, and the website was also optimized, making it more practical and user-friendly. In summary, MNDR v3.0 will be a valuable resource for the investigation of disease mechanisms and clinical treatment strategies.</p>]]></description>
            <pubDate><![CDATA[2020-08-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The antiSMASH database version 3: increased taxonomic coverage and new query features for modular enzymes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739296880-a22ea3c0-bf4a-4397-9c7b-d363b8d0ca11/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa978</link>
            <description><![CDATA[<p class="para" id="N65541">Microorganisms produce natural products that are frequently used in the development of antibacterial, antiviral, and anticancer drugs, pesticides, herbicides, or fungicides. In recent years, genome mining has evolved into a prominent method to access this potential. antiSMASH is one of the most popular tools for this task. Here, we present version 3 of the antiSMASH database, providing a means to access and query precomputed antiSMASH-5.2-detected biosynthetic gene clusters from representative, publicly available, high-quality microbial genomes via an interactive graphical user interface. In version 3, the database contains 147 517 high quality BGC regions from 388 archaeal, 25 236 bacterial and 177 fungal genomes and is available at https://antismash-db.secondarymetabolites.org/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765739296880-a22ea3c0-bf4a-4397-9c7b-d363b8d0ca11/assets/gkaa978gra1.jpg" alt="The antiSMASH database was updated to version 3, now containing 147 517 secondary/specialized metabolite biosynthetic gene clusters (BGCs) originating from 25 236 bacterial, 388 archaeal and 177 fungal genomes. The database provides interactive access to the detailed annotation of each BGC that was generated with the most recent version of antiSMASH (v5.2)."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      The antiSMASH database was updated to version 3, now containing 147 517 secondary/specialized metabolite biosynthetic gene clusters (BGCs) originating from 25 236 bacterial, 388 archaeal and 177 fungal genomes. The database provides interactive access to the detailed annotation of each BGC that was generated with the most recent version of antiSMASH (v5.2).</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[jMorp updates in 2020: large enhancement of multi-omics data resources on the general Japanese population]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739258554-bd23256e-03cc-4c79-9e3f-6508e2a256a8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1034</link>
            <description><![CDATA[<p class="para" id="N65541">In the Tohoku Medical Megabank project, genome and omics analyses of participants in two cohort studies were performed. A part of the data is available at the Japanese Multi Omics Reference Panel (jMorp; https://jmorp.megabank.tohoku.ac.jp) as a web-based database, as reported in our previous manuscript published in <i>Nucleic Acid Research</i> in 2018. At that time, jMorp mainly consisted of metabolome data; however, now genome, methylome, and transcriptome data have been integrated in addition to the enhancement of the number of samples for the metabolome data. For genomic data, jMorp provides a Japanese reference sequence obtained using <i>de novo</i> assembly of sequences from three Japanese individuals and allele frequencies obtained using whole-genome sequencing of 8,380 Japanese individuals. In addition, the omics data include methylome and transcriptome data from ∼300 samples and distribution of concentrations of more than 755 metabolites obtained using high-throughput nuclear magnetic resonance and high-sensitivity mass spectrometry. In summary, jMorp now provides four different kinds of omics data (genome, methylome, transcriptome, and metabolome), with a user-friendly web interface. This will be a useful scientific data resource on the general population for the discovery of disease biomarkers and personalized disease prevention and early diagnosis.</p>]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Cyanorak v2.1: a scalable information system dedicated to the visualization and expert curation of marine and brackish picocyanobacteria genomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739253009-06830789-7270-45c1-9018-3024021c24ba/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa958</link>
            <description><![CDATA[<p class="para" id="N65541">Cyanorak v2.1 (http://www.sb-roscoff.fr/cyanorak) is an information system dedicated to visualizing, comparing and curating the genomes of <i>Prochlorococcus</i>, <i>Synechococcus</i> and <i>Cyanobium</i>, the most abundant photosynthetic microorganisms on Earth. The database encompasses sequences from 97 genomes, covering most of the wide genetic diversity known so far within these groups, and which were split into 25,834 clusters of likely orthologous groups (CLOGs). The user interface gives access to genomic characteristics, accession numbers as well as an interactive map showing strain isolation sites. The main entry to the database is through search for a term (gene name, product, etc.), resulting in a list of CLOGs and individual genes. Each CLOG benefits from a rich functional annotation including EggNOG, EC/K numbers, GO terms, TIGR Roles, custom-designed Cyanorak Roles as well as several protein motif predictions. Cyanorak also displays a phyletic profile, indicating the genotype and pigment type for each CLOG, and a genome viewer (Jbrowse) to visualize additional data on each genome such as predicted operons, genomic islands or transcriptomic data, when available. This information system also includes a BLAST search tool, comparative genomic context as well as various data export options. Altogether, Cyanorak v2.1 constitutes an invaluable, scalable tool for comparative genomics of ecologically relevant marine microorganisms.</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ATACdb: a comprehensive human chromatin accessibility database]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739231057-bf00a877-a514-4019-8ff0-d7e681a3beab/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa943</link>
            <description><![CDATA[<p class="para" id="N65541">Accessible chromatin is a highly informative structural feature for identifying regulatory elements, which provides a large amount of information about transcriptional activity and gene regulatory mechanisms. Human ATAC-seq datasets are accumulating rapidly, prompting an urgent need to comprehensively collect and effectively process these data. We developed a comprehensive human chromatin accessibility database (ATACdb, http://www.licpathway.net/ATACdb), with the aim of providing a large amount of publicly available resources on human chromatin accessibility data, and to annotate and illustrate potential roles in a tissue/cell type-specific manner. The current version of ATACdb documented a total of 52 078 883 regions from over 1400 ATAC-seq samples. These samples have been manually curated from over 2200 chromatin accessibility samples from NCBI GEO/SRA. To make these datasets more accessible to the research community, ATACdb provides a quality assurance process including four quality control (QC) metrics. ATACdb provides detailed (epi)genetic annotations in chromatin accessibility regions, including super-enhancers, typical enhancers, transcription factors (TFs), common single-nucleotide polymorphisms (SNPs), risk SNPs, eQTLs, LD SNPs, methylations, chromatin interactions and TADs. Especially, ATACdb provides accurate inference of TF footprints within chromatin accessibility regions. ATACdb is a powerful platform that provides the most comprehensive accessible chromatin data, QC, TF footprint and various other annotations.</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MASI: microbiota—active substance interactions database]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739193463-0f859d55-4c1c-4d8d-aafb-93384d3ce860/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa924</link>
            <description><![CDATA[<p class="para" id="N65541">Xenobiotic and host active substances interact with gut microbiota to influence human health and therapeutics. Dietary, pharmaceutical, herbal and environmental substances are modified by microbiota with altered bioavailabilities, bioactivities and toxic effects. Xenobiotics also affect microbiota with health implications. Knowledge of these microbiota and active substance interactions is important for understanding microbiota-regulated functions and therapeutics. Established microbiota databases provide useful information about the microbiota-disease associations, diet and drug interventions, and microbiota modulation of drugs. However, there is insufficient information on the active substances modified by microbiota and the abundance of gut bacteria in humans. Only ∼7% drugs are covered by the established databases. To complement these databases, we developed MASI, Microbiota—Active Substance Interactions database, for providing the information about the microbiota alteration of various substances, substance alteration of microbiota, and the abundance of gut bacteria in humans. These include 1,051 pharmaceutical, 103 dietary, 119 herbal, 46 probiotic, 142 environmental substances interacting with 806 microbiota species linked to 56 diseases and 784 microbiota–disease associations. MASI covers 11 215 bacteria-pharmaceutical, 914 bacteria-herbal, 309 bacteria-dietary, 753 bacteria-environmental substance interactions and the abundance profiles of 259 bacteria species in 3465 patients and 5334 healthy individuals. MASI is freely accessible at http://www.aiddlab.com/MASI.</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Peryton: a manual collection of experimentally supported microbe-disease associations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765739130693-ae6e05e3-0ed5-4d21-9424-d6e5a3fde073/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa902</link>
            <description><![CDATA[<p class="para" id="N65541">We present <i>Peryton</i> (https://dianalab.e-ce.uth.gr/peryton/), a database of experimentally supported microbe-disease associations. Its first version constitutes a novel resource hosting more than 7900 entries linking 43 diseases with 1396 microorganisms. <i>Peryton's</i> content is exclusively sustained by manual curation of biomedical articles. Diseases and microorganisms are provided in a systematic, standardized manner using reference resources to create database dictionaries. Information about the experimental design, study cohorts and the applied high- or low-throughput techniques is meticulously annotated and catered to users. Several functionalities are provided to enhance user experience and enable ingenious use of <i>Peryton</i>. One or more microorganisms and/or diseases can be queried at the same time. Advanced filtering options and direct text-based filtering of results enable refinement of returned information and the conducting of tailored queries suitable to different research questions. <i>Peryton</i> also provides interactive visualizations to effectively capture different aspects of its content and results can be directly downloaded for local storage and downstream analyses. <i>Peryton</i> will serve as a valuable source, enabling scientists of microbe-related disease fields to form novel hypotheses but, equally importantly, to assist in cross-validation of findings.</p>]]></description>
            <pubDate><![CDATA[2020-10-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MethHC 2.0: information repository of DNA methylation and gene expression in human cancer]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765738992900-4666978d-c49b-4d55-83ea-69c13f4cc1bc/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1104</link>
            <description><![CDATA[<p class="para" id="N65541">DNA methylation is an important epigenetic regulator in gene expression and has several roles in cancer and disease progression. MethHC version 2.0 (MethHC 2.0) is an integrated and web-based resource focusing on the aberrant methylomes of human diseases, specifically cancer. This paper presents an updated implementation of MethHC 2.0 by incorporating additional DNA methylomes and transcriptomes from several public repositories, including 33 human cancers, over 50 118 microarray and RNA sequencing data from TCGA and GEO, and accumulating up to 3586 manually curated data from &gt;7000 collected published literature with experimental evidence. MethHC 2.0 has also been equipped with enhanced data annotation functionality and a user-friendly web interface for data presentation, search, and visualization. Provided features include clinical-pathological data, mutation and copy number variation, multiplicity of information (gene regions, enhancer regions, and CGI regions), and circulating tumor DNA methylation profiles, available for research such as biomarker panel design, cancer comparison, diagnosis, prognosis, therapy study and identifying potential epigenetic biomarkers. MethHC 2.0 is now available at http://awi.cuhk.edu.cn/∼MethHC.</p>]]></description>
            <pubDate><![CDATA[2020-12-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PhycoCosm, a comparative algal genomics resource]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765738987679-d9903658-1d89-491b-87a8-faef9803f02e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa898</link>
            <description><![CDATA[<p class="para" id="N65541">Algae are a diverse, polyphyletic group of photosynthetic eukaryotes spanning nearly all eukaryotic lineages of life and collectively responsible for ∼50% of photosynthesis on Earth. Sequenced algal genomes, critical to understanding their complex biology, are growing in number and require efficient tools for analysis. PhycoCosm (https://phycocosm.jgi.doe.gov) is an algal multi-omics portal, developed by the US Department of Energy Joint Genome Institute to support analysis and distribution of algal genome sequences and other ‘omics’ data. PhycoCosm provides integration of genome sequence and annotation for &gt;100 algal genomes with available multi-omics data and interactive web-based tools to enable algal research in bioenergy and the environment, encouraging community engagement and data exchange, and fostering new sequencing projects that will further these research goals.</p>]]></description>
            <pubDate><![CDATA[2020-10-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[OpenProt 2021: deeper functional annotation of the coding potential of eukaryotic genomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765738982746-9c6ca6da-c4aa-4516-b68f-f6665332aeb1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1036</link>
            <description><![CDATA[<p class="para" id="N65541">OpenProt (www.openprot.org) is the first proteogenomic resource supporting a polycistronic annotation model for eukaryotic genomes. It provides a deeper annotation of open reading frames (ORFs) while mining experimental data for supporting evidence using cutting-edge algorithms. This update presents the major improvements since the initial release of OpenProt. All species support recent NCBI RefSeq and Ensembl annotations, with changes in annotations being reported in OpenProt. Using the 131 ribosome profiling datasets re-analysed by OpenProt to date, non-AUG initiation starts are reported alongside a confidence score of the initiating codon. From the 177 mass spectrometry datasets re-analysed by OpenProt to date, the unicity of the detected peptides is controlled at each implementation. Furthermore, to guide the users, detectability statistics and protein relationships (isoforms) are now reported for each protein. Finally, to foster access to deeper ORF annotation independently of one’s bioinformatics skills or computational resources, OpenProt now offers a data analysis platform. Users can submit their dataset for analysis and receive the results from the analysis by OpenProt. All data on OpenProt are freely available and downloadable for each species, the release-based format ensuring a continuous access to the data. Thus, OpenProt enables a more comprehensive annotation of eukaryotic genomes and fosters functional proteomic discoveries.</p>]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RNAcentral 2021: secondary structure integration, improved sequence search and new member databases]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765738976019-f26f43ef-8b7d-486f-bbd3-5d5983b86588/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa921</link>
            <description><![CDATA[<p class="para" id="N65541">RNAcentral is a comprehensive database of non-coding RNA (ncRNA) sequences that provides a single access point to 44 RNA resources and &gt;18 million ncRNA sequences from a wide range of organisms and RNA types. RNAcentral now also includes secondary (2D) structure information for &gt;13 million sequences, making RNAcentral the world’s largest RNA 2D structure database. The 2D diagrams are displayed using R2DT, a new 2D structure visualization method that uses consistent, reproducible and recognizable layouts for related RNAs. The sequence similarity search has been updated with a faster interface featuring facets for filtering search results by RNA type, organism, source database or any keyword. This sequence search tool is available as a reusable web component, and has been integrated into several RNAcentral member databases, including Rfam, miRBase and snoDB. To allow for a more fine-grained assignment of RNA types and subtypes, all RNAcentral sequences have been annotated with Sequence Ontology terms. The RNAcentral database continues to grow and provide a central data resource for the RNA community. RNAcentral is freely available at https://rnacentral.org.</p>]]></description>
            <pubDate><![CDATA[2020-10-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[crisprSQL: a novel database platform for CRISPR/Cas off-target cleavage assays]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610422100-4ed0ff1e-0ed8-41a4-add8-ab3bd08e54df/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa885</link>
            <description><![CDATA[<p class="para" id="N65541">With ongoing development of the CRISPR/Cas programmable nuclease system, applications in the area of <i>in vivo</i> therapeutic gene editing are increasingly within reach. However, non-negligible off-target effects remain a major concern for clinical applications. Even though a multitude of off-target cleavage datasets have been published, a comprehensive, transparent overview tool has not yet been established. Here, we present crisprSQL (http://www.crisprsql.com), an interactive and bioinformatically enhanced collection of CRISPR/Cas9 off-target cleavage studies aimed at enriching the fields of cleavage profiling, gene editing safety analysis and transcriptomics. The current version of crisprSQL contains cleavage data from 144 guide RNAs on 25,632 guide-target pairs from human and rodent cell lines, with interaction-specific references to epigenetic markers and gene names. The first curated database of this standard, it promises to enhance safety quantification research, inform experiment design and fuel development of computational off-target prediction algorithms.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765610422100-4ed0ff1e-0ed8-41a4-add8-ab3bd08e54df/assets/gkaa885gra1.jpg" alt="Overview of the crisprSQL database. Cleavage and epigenetics data (left) are joined together and supplemented by attributes calculated from their properties (top). This forms the crisprSQL database, which has an online user interface supporting data browsing, export and upload of new studies (right)."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Overview of the crisprSQL database. Cleavage and epigenetics data (left) are joined together and supplemented by attributes calculated from their properties (top). This forms the crisprSQL database, which has an online user interface supporting data browsing, export and upload of new studies (right).</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LncSEA: a platform for long non-coding RNA related sets and enrichment analysis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610375866-8e1fa084-ee59-4b0f-8473-f4e510039c55/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa806</link>
            <description><![CDATA[<p class="para" id="N65541">Long non-coding RNAs (lncRNAs) have been proven to play important roles in transcriptional processes and various biological functions. Establishing a comprehensive collection of human lncRNA sets is urgent work at present. Using reference lncRNA sets, enrichment analyses will be useful for analyzing lncRNA lists of interest submitted by users. Therefore, we developed a human lncRNA sets database, called LncSEA, which aimed to document a large number of available resources for human lncRNA sets and provide annotation and enrichment analyses for lncRNAs. LncSEA supports &gt;40 000 lncRNA reference sets across 18 categories and 66 sub-categories, and covers over 50 000 lncRNAs. We not only collected lncRNA sets based on downstream regulatory data sources, but also identified a large number of lncRNA sets regulated by upstream transcription factors (TFs) and DNA regulatory elements by integrating TF ChIP-seq, DNase-seq, ATAC-seq and H3K27ac ChIP-seq data. Importantly, LncSEA provides annotation and enrichment analyses of lncRNA sets associated with upstream regulators and downstream targets. In summary, LncSEA is a powerful platform that provides a variety of types of lncRNA sets for users, and supports lncRNA annotations and enrichment analyses. The LncSEA database is freely accessible at http://bio.liclab.net/LncSEA/index.php.</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[canSAR: update to the cancer translational research and drug discovery knowledgebase]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610371258-1bcf18c3-9792-4a6b-b919-cf76c1df1a99/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1059</link>
            <description><![CDATA[<p class="para" id="N65541">canSAR (http://cansar.icr.ac.uk) is the largest, public, freely available, integrative translational research and drug discovery knowledgebase for oncology. canSAR integrates vast multidisciplinary data from across genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and more. It also provides unique data, curation and annotation and crucially, AI-informed target assessment for drug discovery. canSAR is widely used internationally by academia and industry. Here we describe significant developments and enhancements to the data, web interface and infrastructure of canSAR in the form of the new implementation of the system: canSAR<i>black</i>. We demonstrate new functionality in aiding translation hypothesis generation and experimental design, and show how canSAR can be adapted and utilised outside oncology.</p>]]></description>
            <pubDate><![CDATA[2020-11-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[REDIportal: millions of novel A-to-I RNA editing events from thousands of RNAseq experiments]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610307533-7ddd1c4a-0ae7-4e99-a8d0-6df6383c5049/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa916</link>
            <description><![CDATA[<p class="para" id="N65541">RNA editing is a relevant epitranscriptome phenomenon able to increase the transcriptome and proteome diversity of eukaryotic organisms. ADAR mediated RNA editing is widespread in humans in which millions of A-to-I changes modify thousands of primary transcripts. RNA editing has pivotal roles in the regulation of gene expression or modulation of the innate immune response or functioning of several neurotransmitter receptors. Massive transcriptome sequencing has fostered the research in this field. Nonetheless, different aspects of the RNA editing biology are still unknown and need to be elucidated. To support the study of A-to-I RNA editing we have updated our REDIportal catalogue raising its content to about 16 millions of events detected in 9642 human RNAseq samples from the GTEx project by using a dedicated pipeline based on the HPC version of the REDItools software. REDIportal now allows searches at sample level, provides overviews of RNA editing profiles per each RNAseq experiment, implements a Gene View module to look at individual events in their genic context and hosts the CLAIRE database. Starting from this novel version, REDIportal will start collecting non-human RNA editing changes for comparative genomics investigations. The database is freely available at http://srv00.recas.ba.infn.it/atlas/index.html.</p>]]></description>
            <pubDate><![CDATA[2020-10-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[miRNASNP-v3: a comprehensive database for SNPs and disease-related variations in miRNAs and miRNA targets]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610303771-24572ff6-7072-4468-a72a-6f82b832b33e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa783</link>
            <description><![CDATA[<p class="para" id="N65541">MicroRNAs (miRNAs) related single-nucleotide variations (SNVs), including single-nucleotide polymorphisms (SNPs) and disease-related variations (DRVs) in miRNAs and miRNA-target binding sites, can affect miRNA functions and/or biogenesis, thus to impact on phenotypes. miRNASNP is a widely used database for miRNA-related SNPs and their effects. Here, we updated it to miRNASNP-v3 (http://bioinfo.life.hust.edu.cn/miRNASNP/) with tremendous number of SNVs and new features, especially the DRVs data. We analyzed the effects of 7 161 741 SNPs and 505 417 DRVs on 1897 pre-miRNAs (2630 mature miRNAs) and 3′UTRs of 18 152 genes. miRNASNP-v3 provides a one-stop resource for miRNA-related SNVs research with the following functions: (i) explore associations between miRNA-related SNPs/DRVs and diseases; (ii) browse the effects of SNPs/DRVs on miRNA-target binding; (iii) functional enrichment analysis of miRNA target gain/loss caused by SNPs/DRVs; (iv) investigate correlations between drug sensitivity and miRNA expression; (v) inquire expression profiles of miRNAs and their targets in cancers; (vi) browse the effects of SNPs/DRVs on pre-miRNA secondary structure changes; and (vii) predict the effects of user-defined variations on miRNA-target binding or pre-miRNA secondary structure. miRNASNP-v3 is a valuable and long-term supported resource in functional variation screening and miRNA function studies.</p>]]></description>
            <pubDate><![CDATA[2020-09-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[HRT Atlas v1.0 database: redefining human and mouse housekeeping genes and candidate reference transcripts by mining massive RNA-seq datasets]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610290670-0da88ee0-0fcf-48a9-9fc5-3f946cad4b68/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa609</link>
            <description><![CDATA[<p class="para" id="N65541">Housekeeping (HK) genes are constitutively expressed genes that are required for the maintenance of basic cellular functions. Despite their importance in the calibration of gene expression, as well as the understanding of many genomic and evolutionary features, important discrepancies have been observed in studies that previously identified these genes. Here, we present Housekeeping and Reference Transcript Atlas (HRT Atlas v1.0, www.housekeeping.unicamp.br) a web-based database which addresses some of the previously observed limitations in the identification of these genes, and offers a more accurate database of human and mouse HK genes and transcripts. The database was generated by mining massive human and mouse RNA-seq data sets, including 11 281 and 507 high-quality RNA-seq samples from 52 human non-disease tissues/cells and 14 healthy tissues/cells of C57BL/6 wild type mouse, respectively. User can visualize the expression and download lists of 2158 human HK transcripts from 2176 HK genes and 3024 mouse HK transcripts from 3277 mouse HK genes. HRT Atlas also offers the most stable and suitable tissue selective candidate reference transcripts for normalization of qPCR experiments. Specific primers and predicted modifiers of gene expression for some of these HK transcripts are also proposed. HRT Atlas has also been integrated with a regulatory elements resource from Epiregio server.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765610290670-0da88ee0-0fcf-48a9-9fc5-3f946cad4b68/assets/gkaa609gra1.jpg" alt="The workflow of database generation and web-tool implementation are shown. After downloading and identification of HK genes and transcripts using a specific algorithm, transcripts of genes with unknown pseudogenes were used to select suitable candidate reference transcripts. Some candidate reference transcript-specific primers were designed. The web-based tool was developed using Shiny package and encapsulated into docker image for deployment."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      The workflow of database generation and web-tool implementation are shown. After downloading and identification of HK genes and transcripts using a specific algorithm, transcripts of genes with unknown pseudogenes were used to select suitable candidate reference transcripts. Some candidate reference transcript-specific primers were designed. The web-based tool was developed using Shiny package and encapsulated into docker image for deployment.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-07-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Bgee suite: integrated curated expression atlas and comparative transcriptomics in animals]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610255022-32a1a5a5-2962-4fc6-99cf-82d9d7475b4b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa793</link>
            <description><![CDATA[<p class="para" id="N65541">Bgee is a database to retrieve and compare gene expression patterns in multiple animal species, produced by integrating multiple data types (RNA-Seq, Affymetrix, in situ hybridization, and EST data). It is based exclusively on curated healthy wild-type expression data (e.g., no gene knock-out, no treatment, no disease), to provide a comparable reference of normal gene expression. Curation includes very large datasets such as GTEx (re-annotation of samples as ‘healthy’ or not) as well as many small ones. Data are integrated and made comparable between species thanks to consistent data annotation and processing, and to calls of presence/absence of expression, along with expression scores. As a result, Bgee is capable of detecting the conditions of expression of any single gene, accommodating any data type and species. Bgee provides several tools for analyses, allowing, e.g., automated comparisons of gene expression patterns within and between species, retrieval of the prefered conditions of expression of any gene, or enrichment analyses of conditions with expression of sets of genes. Bgee release 14.1 includes 29 animal species, and is available at https://bgee.org/ and through its Bioconductor R package BgeeDB.</p>]]></description>
            <pubDate><![CDATA[2020-10-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[HumanMetagenomeDB: a public repository of curated and standardized metadata for human metagenomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610227224-9b78032e-c77c-4bf3-bfd8-6be8585e6684/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1031</link>
            <description><![CDATA[<p class="para" id="N65541">Metagenomics became a standard strategy to comprehend the functional potential of microbial communities, including the human microbiome. Currently, the number of metagenomes in public repositories is increasing exponentially. The Sequence Read Archive (SRA) and the MG-RAST are the two main repositories for metagenomic data. These databases allow scientists to reanalyze samples and explore new hypotheses. However, mining samples from them can be a limiting factor, since the metadata available in these repositories is often misannotated, misleading, and decentralized, creating an overly complex environment for sample reanalysis. The main goal of the HumanMetagenomeDB is to simplify the identification and use of public human metagenomes of interest. HumanMetagenomeDB version 1.0 contains metadata of 69 822 metagenomes. We standardized 203 attributes, based on standardized ontologies, describing host characteristics (e.g. sex, age and body mass index), diagnosis information (e.g. cancer, Crohn's disease and Parkinson), location (e.g. country, longitude and latitude), sampling site (e.g. gut, lung and skin) and sequencing attributes (e.g. sequencing platform, average length and sequence quality). Further, HumanMetagenomeDB version 1.0 metagenomes encompass 58 countries, 9 main sample sites (i.e. body parts), 58 diagnoses and multiple ages, ranging from just born to 91 years old. The HumanMetagenomeDB is publicly available at https://webapp.ufz.de/hmgdb/.</p>]]></description>
            <pubDate><![CDATA[2020-11-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610211924-cf4ae0f7-7c5f-46f3-83cc-d302cf814523/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1011</link>
            <description><![CDATA[<p class="para" id="N65541">The mammalian mitochondrial proteome is under dual genomic control, with 99% of proteins encoded by the nuclear genome and 13 originating from the mitochondrial DNA (mtDNA). We previously developed MitoCarta, a catalogue of over 1000 genes encoding the mammalian mitochondrial proteome. This catalogue was compiled using a Bayesian integration of multiple sequence features and experimental datasets, notably protein mass spectrometry of mitochondria isolated from fourteen murine tissues. Here, we introduce MitoCarta3.0. Beginning with the MitoCarta2.0 inventory, we performed manual review to remove 100 genes and introduce 78 additional genes, arriving at an updated inventory of 1136 human genes. We now include manually curated annotations of sub-mitochondrial localization (matrix, inner membrane, intermembrane space, outer membrane) as well as assignment to 149 hierarchical ‘MitoPathways’ spanning seven broad functional categories relevant to mitochondria. MitoCarta3.0, including sub-mitochondrial localization and MitoPathway annotations, is freely available at http://www.broadinstitute.org/mitocarta and should serve as a continued community resource for mitochondrial biology and medicine.</p>]]></description>
            <pubDate><![CDATA[2020-11-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MoonProt 3.0: an update of the moonlighting proteins database]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610208202-aba37c73-370d-45a3-9f42-d09984ac0e39/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1101</link>
            <description><![CDATA[<p class="para" id="N65541">MoonProt 3.0 (http://moonlightingproteins.org) is an updated open-access database storing expert-curated annotations for moonlighting proteins. Moonlighting proteins have two or more physiologically relevant distinct biochemical or biophysical functions performed by a single polypeptide chain. Here, we describe an expansion in the database since our previous report in the Database Issue of Nucleic Acids Research in 2018. For this release, the number of proteins annotated has been expanded to over 500 proteins and dozens of protein annotations have been updated with additional information, including more structures in the Protein Data Bank, compared with version 2.0. The new entries include more examples from humans, plants and archaea, more proteins involved in disease and proteins with different combinations of functions. More kinds of information about the proteins and the species in which they have multiple functions has been added, including CATH and SCOP classification of structure, known and predicted disorder, predicted transmembrane helices, type of organism, relationship of the protein to disease, and relationship of organism to cause of disease.</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GENCODE 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610195762-a35e1146-f31a-4d3d-a00d-d7c0eb834cb8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1087</link>
            <description><![CDATA[<p class="para" id="N65541">The GENCODE project annotates human and mouse genes and transcripts supported by experimental data with high accuracy, providing a foundational resource that supports genome biology and clinical genomics. GENCODE annotation processes make use of primary data and bioinformatic tools and analysis generated both within the consortium and externally to support the creation of transcript structures and the determination of their function. Here, we present improvements to our annotation infrastructure, bioinformatics tools, and analysis, and the advances they support in the annotation of the human and mouse genomes including: the completion of first pass manual annotation for the mouse reference genome; targeted improvements to the annotation of genes associated with SARS-CoV-2 infection; collaborative projects to achieve convergence across reference annotation databases for the annotation of human and mouse protein-coding genes; and the first GENCODE manually supervised automated annotation of lncRNAs. Our annotation is accessible via Ensembl, the UCSC Genome Browser and https://www.gencodegenes.org.</p>]]></description>
            <pubDate><![CDATA[2020-12-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610188814-cf50180a-949c-4902-ad34-b98778ad48c3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1038</link>
            <description><![CDATA[<p class="para" id="N65541">The Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB), the US data center for the global PDB archive and a founding member of the Worldwide Protein Data Bank partnership, serves tens of thousands of data depositors in the Americas and Oceania and makes 3D macromolecular structure data available at no charge and without restrictions to millions of RCSB.org users around the world, including &gt;660 000 educators, students and members of the curious public using PDB101.RCSB.org. PDB data depositors include structural biologists using macromolecular crystallography, nuclear magnetic resonance spectroscopy, 3D electron microscopy and micro-electron diffraction. PDB data consumers accessing our web portals include researchers, educators and students studying fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. During the past 2 years, the research-focused RCSB PDB web portal (RCSB.org) has undergone a complete redesign, enabling improved searching with full Boolean operator logic and more facile access to PDB data integrated with &gt;40 external biodata resources. New features and resources are described in detail using examples that showcase recently released structures of SARS-CoV-2 proteins and host cell proteins relevant to understanding and addressing the COVID-19 global pandemic.</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[SilencerDB: a comprehensive database of silencers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610142577-051bba41-4c3e-4f0f-81dc-7ca343842485/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa839</link>
            <description><![CDATA[<p class="para" id="N65541">Gene regulatory elements, including promoters, enhancers, silencers, etc., control transcriptional programs in a spatiotemporal manner. Though these elements are known to be able to induce either positive or negative transcriptional control, the community has been mostly studying enhancers which amplify transcription initiation, with less emphasis given to silencers which repress gene expression. To facilitate the study of silencers and the investigation of their potential roles in transcriptional control, we developed SilencerDB (http://health.tsinghua.edu.cn/silencerdb/), a comprehensive database of silencers by manually curating silencers from 2300 published articles. The current version, SilencerDB 1.0, contains (1) 33 060 validated silencers from experimental methods, and (ii) 5 045 547 predicted silencers from state-of-the-art machine learning methods. The functionality of SilencerDB includes (a) standardized categorization of silencers in a tree-structured class hierarchy based on species, organ, tissue and cell line and (b) comprehensive annotations of silencers with the nearest gene and potential regulatory genes. SilencerDB, to the best of our knowledge, is the first comprehensive database at this scale dedicated to silencers, with reliable annotations and user-friendly interactive database features. We believe this database has the potential to enable advanced understanding of silencers in regulatory mechanisms and to empower researchers to devise diverse applications of silencers in disease development.</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[VARAdb: a comprehensive variation annotation database for human]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610111778-dcc838fd-16e7-492a-ad84-79d93f94cd18/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa922</link>
            <description><![CDATA[<p class="para" id="N65541">With the study of human diseases and biological processes increasing, a large number of non-coding variants have been identified and facilitated. The rapid accumulation of genetic and epigenomic information has resulted in an urgent need to collect and process data to explore the regulation of non-coding variants. Here, we developed a comprehensive variation annotation database for human (VARAdb, http://www.licpathway.net/VARAdb/), which specifically considers non-coding variants. VARAdb provides annotation information for 577,283,813 variations and novel variants, prioritizes variations based on scores using nine annotation categories, and supports pathway downstream analysis. Importantly, VARAdb integrates a large amount of genetic and epigenomic data into five annotation sections, which include ‘Variation information’, ‘Regulatory information’, ‘Related genes’, ‘Chromatin accessibility’ and ‘Chromatin interaction’. The detailed annotation information consists of motif changes, risk SNPs, LD SNPs, eQTLs, clinical variant-drug-gene pairs, sequence conservation, somatic mutations, enhancers, super enhancers, promoters, transcription factors, chromatin states, histone modifications, chromatin accessibility regions and chromatin interactions. This database is a user-friendly interface to query, browse and visualize variations and related annotation information. VARAdb is a useful resource for selecting potential functional variations and interpreting their effects on human diseases and biological processes.</p>]]></description>
            <pubDate><![CDATA[2020-10-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610097728-15731f9b-869e-401d-83cd-2997c6612370/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa840</link>
            <description><![CDATA[<p class="para" id="N65541">Open Targets Genetics (https://genetics.opentargets.org) is an open-access integrative resource that aggregates human GWAS and functional genomics data including gene expression, protein abundance, chromatin interaction and conformation data from a wide range of cell types and tissues to make robust connections between GWAS-associated loci, variants and likely causal genes. This enables systematic identification and prioritisation of likely causal variants and genes across all published trait-associated loci. In this paper, we describe the public resources we aggregate, the technology and analyses we use, and the functionality that the portal offers. Open Targets Genetics can be searched by variant, gene or study/phenotype. It offers tools that enable users to prioritise causal variants and genes at disease-associated loci and access systematic cross-disease and disease-molecular trait colocalization analysis across 92 cell types and tissues including the eQTL Catalogue. Data visualizations such as Manhattan-like plots, regional plots, credible sets overlap between studies and PheWAS plots enable users to explore GWAS signals in depth. The integrated data is made available through the web portal, for bulk download and via a GraphQL API, and the software is open source. Applications of this integrated data include identification of novel targets for drug discovery and drug repurposing.</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[KLIFS: an overhaul after the first 5 years of supporting kinase research]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610088118-f365c2ce-423d-456d-8d4b-fac8f5a8949d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa895</link>
            <description><![CDATA[<p class="para" id="N65541">Kinases are a prime target of drug development efforts with &gt;60 drug approvals in the past two decades. Due to the research into this protein family, a wealth of data has been accumulated that keeps on growing. KLIFS—Kinase–Ligand Interaction Fingerprints and Structures—is a structural database focusing on how kinase inhibitors interact with their targets. The aim of KLIFS is to support (structure-based) kinase research through the systematic collection, annotation, and processing of kinase structures. Now, 5 years after releasing the initial KLIFS website, the database has undergone a complete overhaul with a new website, new logo, and new functionalities. In this article, we start by looking back at how KLIFS has been used by the research community, followed by a description of the renewed KLIFS, and conclude with showcasing the functionalities of KLIFS. Major changes include the integration of approved drugs and inhibitors in clinical trials, extension of the coverage to atypical kinases, and a RESTful API for programmatic access. KLIFS is available at the new domain https://klifs.net.</p>]]></description>
            <pubDate><![CDATA[2020-10-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GPCRdb in 2021: integrating GPCR sequence, structure and function]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610051912-b6f4497e-643f-423f-aefc-80698068acbe/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1080</link>
            <description><![CDATA[<p class="para" id="N65541">G protein-coupled receptors (GPCRs) form both the largest family of membrane proteins and drug targets, mediating the action of one-third of medicines. The GPCR database, GPCRdb serves &gt;4 000 researchers every month and offers reference data, analysis of own or literature data, experiment design and dissemination of published datasets. Here, we describe new and updated GPCRdb resources with a particular focus on integration of sequence, structure and function. GPCRdb contains all human non-olfactory GPCRs (and &gt;27 000 orthologs), G-proteins and arrestins. It includes over 2 000 drug and in-trial agents and nearly 200 000 ligands with activity and availability data. GPCRdb annotates all published GPCR structures (updated monthly), which are also offered in a refined version (with re-modeled missing/distorted regions and reverted mutations) and provides structure models of all human non-olfactory receptors in inactive, intermediate and active states. Mutagenesis data in the GPCRdb spans natural genetic variants, GPCR-G protein interfaces, ligand sites and thermostabilising mutations. A new sequence signature tool for identification of functional residue determinants has been added and two data driven tools to design ligand site mutations and constructs for structure determination have been updated extending their coverage of receptors and modifications. The GPCRdb is available at https://gpcrdb.org.</p>]]></description>
            <pubDate><![CDATA[2020-12-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PubChem in 2021: new data content and improved web interfaces]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610047183-cca649f1-14bb-4994-8716-975daa829e27/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa971</link>
            <description><![CDATA[<p class="para" id="N65541">PubChem (https://pubchem.ncbi.nlm.nih.gov) is a popular chemical information resource that serves the scientific community as well as the general public, with millions of unique users per month. In the past two years, PubChem made substantial improvements. Data from more than 100 new data sources were added to PubChem, including chemical-literature links from Thieme Chemistry, chemical and physical property links from SpringerMaterials, and patent links from the World Intellectual Properties Organization (WIPO). PubChem's homepage and individual record pages were updated to help users find desired information faster. This update involved a data model change for the data objects used by these pages as well as by programmatic users. Several new services were introduced, including the PubChem Periodic Table and Element pages, Pathway pages, and Knowledge panels. Additionally, in response to the coronavirus disease 2019 (COVID-19) outbreak, PubChem created a special data collection that contains PubChem data related to COVID-19 and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[gcType: a high-quality type strain genome database for microbial phylogenetic and functional research]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610040372-d5e5abf9-e647-4ddf-b0b6-f0a58261b8b3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa957</link>
            <description><![CDATA[<p class="para" id="N65541">Taxonomic and functional research of microorganisms has increasingly relied upon genome-based data and methods. As the depository of the Global Catalogue of Microorganisms (GCM) 10K prokaryotic type strain sequencing project, Global Catalogue of Type Strain (gcType) has published 1049 type strain genomes sequenced by the GCM 10K project which are preserved in global culture collections with a valid published status. Additionally, the information provided through gcType includes &gt;12 000 publicly available type strain genome sequences from GenBank incorporated using quality control criteria and standard data annotation pipelines to form a high-quality reference database. This database integrates type strain sequences with their phenotypic information to facilitate phenotypic and genotypic analyses. Multiple formats of cross-genome searches and interactive interfaces have allowed extensive exploration of the database's resources. In this study, we describe web-based data analysis pipelines for genomic analyses and genome-based taxonomy, which could serve as a one-stop platform for the identification of prokaryotic species. The number of type strain genomes that are published will continue to increase as the GCM 10K project increases its collaboration with culture collections worldwide. Data of this project is shared with the International Nucleotide Sequence Database Collaboration. Access to gcType is free at http://gctype.wdcm.org/.</p>]]></description>
            <pubDate><![CDATA[2020-10-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ThermoMutDB: a thermodynamic database for missense mutations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610035939-38ef19f9-212d-4432-acf8-7b82a4e2bf0e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa925</link>
            <description><![CDATA[<p class="para" id="N65541">Proteins are intricate, dynamic structures, and small changes in their amino acid sequences can lead to large effects on their folding, stability and dynamics. To facilitate the further development and evaluation of methods to predict these changes, we have developed ThermoMutDB, a manually curated database containing &gt;14,669 experimental data of thermodynamic parameters for wild type and mutant proteins. This represents an increase of 83% in unique mutations over previous databases and includes thermodynamic information on 204 new proteins. During manual curation we have also corrected annotation errors in previously curated entries. Associated with each entry, we have included information on the unfolding Gibbs free energy and melting temperature change, and have associated entries with available experimental structural information. ThermoMutDB supports users to contribute to new data points and programmatic access to the database via a RESTful API. ThermoMutDB is freely available at: http://biosig.unimelb.edu.au/thermomutdb.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765610035939-38ef19f9-212d-4432-acf8-7b82a4e2bf0e/assets/gkaa925gra1.jpg" alt="ThermoMutDB is an online resource associating effects of missense mutations on protein thermodynamics."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      ThermoMutDB is an online resource associating effects of missense mutations on protein thermodynamics.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Human Phenotype Ontology in 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610019914-76affff9-255a-411c-baf2-3a58299300c8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1043</link>
            <description><![CDATA[<p class="para" id="N65541">The Human Phenotype Ontology (HPO, https://hpo.jax.org) was launched in 2008 to provide a comprehensive logical standard to describe and computationally analyze phenotypic abnormalities found in human disease. The HPO is now a worldwide standard for phenotype exchange. The HPO has grown steadily since its inception due to considerable contributions from clinical experts and researchers from a diverse range of disciplines. Here, we present recent major extensions of the HPO for neurology, nephrology, immunology, pulmonology, newborn screening, and other areas. For example, the seizure subontology now reflects the International League Against Epilepsy (ILAE) guidelines and these enhancements have already shown clinical validity. We present new efforts to harmonize computational definitions of phenotypic abnormalities across the HPO and multiple phenotype ontologies used for animal models of disease. These efforts will benefit software such as Exomiser by improving the accuracy and scope of cross-species phenotype matching. The computational modeling strategy used by the HPO to define disease entities and phenotypic features and distinguish between them is explained in detail.We also report on recent efforts to translate the HPO into indigenous languages. Finally, we summarize recent advances in the use of HPO in electronic health record systems.</p>]]></description>
            <pubDate><![CDATA[2020-12-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[AtMAD: <i>Arabidopsis thaliana</i> multi-omics association database]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765610010109-7150d2c2-3218-4868-9ea5-1887c98b8c40/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1042</link>
            <description><![CDATA[<p class="para" id="N65541">Integration analysis of multi-omics data provides a comprehensive landscape for understanding biological systems and mechanisms. The abundance of high-quality multi-omics data (genomics, transcriptomics, methylomics and phenomics) for the model organism <i>Arabidopsis thaliana</i> enables scientists to study the genetic mechanism of many biological processes. However, no resource is available to provide comprehensive and systematic multi-omics associations for Arabidopsis. Here, we developed an <i>Arabidopsis thaliana</i> Multi-omics Association Database (AtMAD, http://www.megabionet.org/atmad), a public repository for large-scale measurements of associations between genome, transcriptome, methylome, pathway and phenotype in Arabidopsis, designed for facilitating identification of eQTL, emQTL, Pathway-mQTL, Phenotype-pathway, GWAS, TWAS and EWAS. Candidate variants/methylations/genes were identified in AtMAD for specific phenotypes or biological processes, many of them are supported by experimental evidence. Based on the multi-omics association strategy, we have identified 11 796 <i>cis</i>-eQTLs and 10 119 <i>trans</i>-eQTLs. Among them, 68 837 environment-eQTL associations and 149 622 GWAS-eQTL associations were identified and stored in AtMAD. For expression–methylation quantitative trait loci (emQTL), we identified 265 776 emQTLs and 122 344 pathway-mQTLs. For TWAS and EWAS, we obtained 62 754 significant phenotype-gene associations and 3 993 379 significant phenotype-methylation associations, respectively. Overall, the multi-omics associated network in AtMAD will provide new insights into exploring biological mechanisms of plants at multi-omics levels.</p>]]></description>
            <pubDate><![CDATA[2020-11-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ViruSurf: an integrated database to investigate viral sequences]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609999557-358d7fb6-ad6b-4dc9-965a-b7db8a64f0d3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa846</link>
            <description><![CDATA[<p class="para" id="N65541">ViruSurf, available at http://gmql.eu/virusurf/, is a large public database of viral sequences and integrated and curated metadata from heterogeneous sources (RefSeq, GenBank, COG-UK and NMDC); it also exposes computed nucleotide and amino acid variants, called from original sequences. A GISAID-specific ViruSurf database, available at http://gmql.eu/virusurf_gisaid/, offers a subset of these functionalities. Given the current pandemic outbreak, SARS-CoV-2 data are collected from the four sources; but ViruSurf contains other virus species harmful to humans, including SARS-CoV, MERS-CoV, Ebola and Dengue. The database is centered on sequences, described from their biological, technological and organizational dimensions. In addition, the analytical dimension characterizes the sequence in terms of its annotations and variants. The web interface enables expressing complex search queries in a simple way; arbitrary search queries can freely combine conditions on attributes from the four dimensions, extracting the resulting sequences. Several example queries on the database confirm and possibly improve results from recent research papers; results can be recomputed over time and upon selected populations. Effective search over large and curated sequence data may enable faster responses to future threats that could arise from new viruses.</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Nucleome Data Bank: web-based resources to simulate and analyze the three-dimensional genome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609994748-d83bbac7-ca33-4353-9f28-f50c2452047d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa818</link>
            <description><![CDATA[<p class="para" id="N65541">We introduce the Nucleome Data Bank (NDB), a web-based platform to simulate and analyze the three-dimensional (3D) organization of genomes. The NDB enables physics-based simulation of chromosomal structural dynamics through the MEGABASE + MiChroM computational pipeline. The input of the pipeline consists of epigenetic information sourced from the Encode database; the output consists of the trajectories of chromosomal motions that accurately predict Hi-C and fluorescence <i>in</i><i>situ</i> hybridization data, as well as multiple observations of chromosomal dynamics <i>in vivo</i>. As an intermediate step, users can also generate chromosomal sub-compartment annotations directly from the same epigenetic input, without the use of any DNA–DNA proximity ligation data. Additionally, the NDB freely hosts both experimental and computational structural genomics data. Besides being able to perform their own genome simulations and download the hosted data, users can also analyze and visualize the same data through custom-designed web-based tools. In particular, the one-dimensional genetic and epigenetic data can be overlaid onto accurate 3D structures of chromosomes, to study the spatial distribution of genetic and epigenetic features. The NDB aims to be a shared resource to biologists, biophysicists and all genome scientists. The NDB is available at https://ndb.rice.edu.</p>]]></description>
            <pubDate><![CDATA[2020-10-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Pfam: The protein families database in 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609980507-8d13f41c-e93c-415f-817c-3b6bb2aa933e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa913</link>
            <description><![CDATA[<p class="para" id="N65541">The Pfam database is a widely used resource for classifying protein sequences into families and domains. Since Pfam was last described in this journal, over 350 new families have been added in Pfam 33.1 and numerous improvements have been made to existing entries. To facilitate research on COVID-19, we have revised the Pfam entries that cover the SARS-CoV-2 proteome, and built new entries for regions that were not covered by Pfam. We have reintroduced Pfam-B which provides an automatically generated supplement to Pfam and contains 136 730 novel clusters of sequences that are not yet matched by a Pfam family. The new Pfam-B is based on a clustering by the MMseqs2 software. We have compared all of the regions in the RepeatsDB to those in Pfam and have started to use the results to build and refine Pfam repeat families. Pfam is freely available for browsing and download at http://pfam.xfam.org/.</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609976563-df99495a-ce68-41e4-81dd-6ec749a272a9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa882</link>
            <description><![CDATA[<p class="para" id="N65541">CRISPR genetic screens in cancer cell models are a powerful tool to elucidate oncogenic mechanisms and to identify promising therapeutic targets. The Project Score database (https://score.depmap.sanger.ac.uk/) uses genome-wide CRISPR–Cas9 dropout screening data in hundreds of highly annotated cancer cell models to identify genes required for cell fitness and prioritize novel oncology targets. The Project Score database currently allows users to investigate the fitness effect of 18 009 genes tested across 323 cancer cell models. Through interactive interfaces, users can investigate data by selecting a specific gene, cancer cell model or tissue type, as well as browsing all gene fitness scores. Additionally, users can identify and rank candidate drug targets based on an established oncology target prioritization pipeline, incorporating genetic biomarkers and clinical datasets for each target, and including suitability for drug development based on pharmaceutical tractability. Data are freely available and downloadable. To enhance analyses, links to other key resources including Open Targets, COSMIC, the Cell Model Passports, UniProt and the Genomics of Drug Sensitivity in Cancer are provided. The Project Score database is a valuable new tool for investigating genetic dependencies in cancer cells and the identification of candidate oncology targets.</p>]]></description>
            <pubDate><![CDATA[2020-10-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609942177-e892a964-0f59-4b6d-a02d-be94c309832f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1074</link>
            <description><![CDATA[<p class="para" id="N65541">Cellular life depends on a complex web of functional associations between biomolecules. Among these associations, protein–protein interactions are particularly important due to their versatility, specificity and adaptability. The STRING database aims to integrate all known and predicted associations between proteins, including both physical interactions as well as functional associations. To achieve this, STRING collects and scores evidence from a number of sources: (i) automated text mining of the scientific literature, (ii) databases of interaction experiments and annotated complexes/pathways, (iii) computational interaction predictions from co-expression and from conserved genomic context and (iv) systematic transfers of interaction evidence from one organism to another. STRING aims for wide coverage; the upcoming version 11.5 of the resource will contain more than 14 000 organisms. In this update paper, we describe changes to the text-mining system, a new scoring-mode for physical interactions, as well as extensive user interface features for customizing, extending and sharing protein networks. In addition, we describe how to query STRING with genome-wide, experimental data, including the automated detection of enriched functionalities and potential biases in the user's query data. The STRING resource is available online, at https://string-db.org/.</p>]]></description>
            <pubDate><![CDATA[2020-11-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CoV3D: a database of high resolution coronavirus protein structures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609929609-36764464-ac2b-4e49-a465-5eb37a91dcf3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa731</link>
            <description><![CDATA[<p class="para" id="N65541">SARS-CoV-2, the etiologic agent of COVID-19, exemplifies the general threat to global health posed by coronaviruses. The urgent need for effective vaccines and therapies is leading to a rapid rise in the number of high resolution structures of SARS-CoV-2 proteins that collectively reveal a map of virus vulnerabilities. To assist structure-based design of vaccines and therapeutics against SARS-CoV-2 and other coronaviruses, we have developed CoV3D, a database and resource for coronavirus protein structures, which is updated on a weekly basis. CoV3D provides users with comprehensive sets of structures of coronavirus proteins and their complexes with antibodies, receptors, and small molecules. Integrated molecular viewers allow users to visualize structures of the spike glycoprotein, which is the major target of neutralizing antibodies and vaccine design efforts, as well as sets of spike-antibody complexes, spike sequence variability, and known polymorphisms. In order to aid structure-based design and analysis of the spike glycoprotein, CoV3D permits visualization and download of spike structures with modeled N-glycosylation at known glycan sites, and contains structure-based classification of spike conformations, generated by unsupervised clustering. CoV3D can serve the research community as a centralized reference and resource for spike and other coronavirus protein structures, and is available at: https://cov3d.ibbr.umd.edu.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765609929609-36764464-ac2b-4e49-a465-5eb37a91dcf3/assets/gkaa731gra1.jpg" alt="CoV3D: a database of high resolution coronavirus protein structures."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      CoV3D: a database of high resolution coronavirus protein structures.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-09-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609920874-6b487f90-d94f-4ed2-8cc7-ae4e01e8f788/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1033</link>
            <description><![CDATA[<p class="para" id="N65541">The prevalence of neutral mutations in cancer cell population impedes the distinguishing of cancer-causing driver mutations from passenger mutations. To systematically prioritize the oncogenic ability of somatic mutations and cancer genes, we constructed a useful platform, OncoVar (https://oncovar.org/), which employed published bioinformatics algorithms and incorporated known driver events to identify driver mutations and driver genes. We identified 20 162 cancer driver mutations, 814 driver genes and 2360 pathogenic pathways with high-confidence by reanalyzing 10 769 exomes from 33 cancer types in The Cancer Genome Atlas (TCGA) and 1942 genomes from 18 cancer types in International Cancer Genome Consortium (ICGC). OncoVar provides four points of view, ‘Mutation’, ‘Gene’, ‘Pathway’ and ‘Cancer’, to help researchers to visualize the relationships between cancers and driver variants. Importantly, identification of actionable driver alterations provides promising druggable targets and repurposing opportunities of combinational therapies. OncoVar provides a user-friendly interface for browsing, searching and downloading somatic driver mutations, driver genes and pathogenic pathways in various cancer types. This platform will facilitate the identification of cancer drivers across individual cancer cohorts and helps to rank mutations or genes for better decision-making among clinical oncologists, cancer researchers and the broad scientific community interested in cancer precision medicine.</p>]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The 2021 <i>Nucleic Acids Research</i> database issue and the online molecular biology database collection]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609904458-1e829a01-7a07-4b5c-a95f-1f212a6d6897/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1216</link>
            <description><![CDATA[<p class="para" id="N65541">The 2021 <i>Nucleic Acids Research</i> database Issue contains 189 papers spanning a wide range of biological fields and investigation. It includes 89 papers reporting on new databases and 90 covering recent changes to resources previously published in the Issue. A further ten are updates on databases most recently published elsewhere. Seven new databases focus on COVID-19 and SARS-CoV-2 and many others offer resources for studying the virus. Major returning nucleic acid databases include NONCODE, Rfam and RNAcentral. Protein family and domain databases include COG, Pfam, SMART and Panther. Protein structures are covered by RCSB PDB and dispersed proteins by PED and MobiDB. In metabolism and signalling, STRING, KEGG and WikiPathways are featured, along with returning KLIFS and new DKK and KinaseMD, all focused on kinases. IMG/M and IMG/VR update in the microbial and viral genome resources section, while human and model organism genomics resources include Flybase, Ensembl and UCSC Genome Browser. Cancer studies are covered by updates from canSAR and PINA, as well as newcomers CNCdatabase and Oncovar for cancer drivers. Plant comparative genomics is catered for by updates from Gramene and GreenPhylDB. The entire Database Issue is freely available online on the <i>Nucleic Acids Research</i> website (https://academic.oup.com/nar). The NAR online Molecular Biology Database Collection has been substantially updated, revisiting nearly 1000 entries, adding 90 new resources and eliminating 86 obsolete databases, bringing the current total to 1641 databases. It is available at https://www.oxfordjournals.org/nar/database/c/.</p>]]></description>
            <pubDate><![CDATA[2020-12-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LncExpDB: an expression database of human long non-coding RNAs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609866860-22570d17-7020-43c5-89c0-e50983c27e51/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa850</link>
            <description><![CDATA[<p class="para" id="N65541">Expression profiles of long non-coding RNAs (lncRNAs) across diverse biological conditions provide significant insights into their biological functions, interacting targets as well as transcriptional reliability. However, there lacks a comprehensive resource that systematically characterizes the expression landscape of human lncRNAs by integrating their expression profiles across a wide range of biological conditions. Here, we present LncExpDB (https://bigd.big.ac.cn/lncexpdb), an expression database of human lncRNAs that is devoted to providing comprehensive expression profiles of lncRNA genes, exploring their expression features and capacities, identifying featured genes with potentially important functions, and building interactions with protein-coding genes across various biological contexts/conditions. Based on comprehensive integration and stringent curation, LncExpDB currently houses expression profiles of 101 293 high-quality human lncRNA genes derived from 1977 samples of 337 biological conditions across nine biological contexts. Consequently, LncExpDB estimates lncRNA genes’ expression reliability and capacities, identifies 25 191 featured genes, and further obtains 28 443 865 lncRNA-mRNA interactions. Moreover, user-friendly web interfaces enable interactive visualization of expression profiles across various conditions and easy exploration of featured lncRNAs and their interacting partners in specific contexts. Collectively, LncExpDB features comprehensive integration and curation of lncRNA expression profiles and thus will serve as a fundamental resource for functional studies on human lncRNAs.</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The European Nucleotide Archive in 2020]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609825854-f1528918-0316-471e-bca5-0b5e8e3cb076/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1028</link>
            <description><![CDATA[<p class="para" id="N65541">The European Nucleotide Archive (ENA; https://www.ebi.ac.uk/ena), provided by the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), has for almost forty years continued in its mission to freely archive and present the world's public sequencing data for the benefit of the entire scientific community and for the acceleration of the global research effort. Here we highlight the major developments to ENA services and content in 2020, focussing in particular on the recently released updated ENA browser, modernisation of our release process and our data coordination collaborations with specific research communities.</p>]]></description>
            <pubDate><![CDATA[2020-11-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DIGGER: exploring the functional role of alternative splicing in protein interactions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609820903-ac584128-37f8-4465-90d8-a715dbf6df4f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa768</link>
            <description><![CDATA[<p class="para" id="N65541">Alternative splicing plays a major role in regulating the functional repertoire of the proteome. However, isoform-specific effects to protein-protein interactions (PPIs) are usually overlooked, making it impossible to judge the functional role of individual exons on a systems biology level. We overcome this barrier by integrating protein-protein interactions, domain-domain interactions and residue-level interactions information to lift exon expression analysis to a network level. Our user-friendly database DIGGER is available at https://exbio.wzw.tum.de/digger and allows users to seamlessly switch between isoform and exon-centric views of the interactome and to extract sub-networks of relevant isoforms, making it an essential resource for studying mechanistic consequences of alternative splicing.</p>]]></description>
            <pubDate><![CDATA[2020-09-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PAGER-CoV: a comprehensive collection of pathways, annotated gene-lists and gene signatures for coronavirus disease studies]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609815586-d4a91df2-1533-4a58-8036-58773423a35b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1094</link>
            <description><![CDATA[<p class="para" id="N65541">
<b>PAGER-CoV</b> (http://discovery.informatics.uab.edu/PAGER-CoV/) is a new web-based database that can help biomedical researchers interpret coronavirus-related functional genomic study results in the context of curated knowledge of host viral infection, inflammatory response, organ damage, and tissue repair. The new database consists of 11 835 <b>PAG</b>s (<span style="text-decoration: underline">P</span>athways, <span style="text-decoration: underline">A</span>nnotated gene-lists, or <span style="text-decoration: underline">G</span>ene signatures) from 33 public data sources. Through the web user interface, users can search by a query gene or a query term and retrieve significantly matched PAGs with all the curated information. Users can navigate from a PAG of interest to other related PAGs through either shared PAG-to-PAG co-membership relationships or PAG-to-PAG regulatory relationships, totaling 19 996 993. Users can also retrieve enriched PAGs from an input list of COVID-19 functional study result genes, customize the search data sources, and export all results for subsequent offline data analysis. In a case study, we performed a gene set enrichment analysis (GSEA) of a COVID-19 RNA-seq data set from the Gene Expression Omnibus database. Compared with the results using the standard PAGER database, PAGER-CoV allows for more sensitive matching of known immune-related gene signatures. We expect PAGER-CoV to be invaluable for biomedical researchers to find molecular biology mechanisms and tailored therapeutics to treat COVID-19 patients.</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[AcrDB: a database of anti-CRISPR operons in prokaryotes and viruses]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609793973-8973b6b0-c3b9-4a04-808c-82c88ae9d218/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa857</link>
            <description><![CDATA[<p class="para" id="N65541">CRISPR–Cas is an anti-viral mechanism of prokaryotes that has been widely adopted for genome editing. To make CRISPR–Cas genome editing more controllable and safer to use, anti-CRISPR proteins have been recently exploited to prevent excessive/prolonged Cas nuclease cleavage. Anti-CRISPR (Acr) proteins are encoded by (pro)phages/(pro)viruses, and have the ability to inhibit their host's CRISPR–Cas systems. We have built an online database AcrDB (http://bcb.unl.edu/AcrDB) by scanning ∼19 000 genomes of prokaryotes and viruses with AcrFinder, a recently developed Acr-Aca (Acr-associated regulator) operon prediction program. Proteins in Acr-Aca operons were further processed by two machine learning-based programs (AcRanker and PaCRISPR) to obtain numerical scores/ranks. Compared to other anti-CRISPR databases, AcrDB has the following unique features: (i) It is a genome-scale database with the largest collection of data (39 799 Acr-Aca operons containing Aca or Acr homologs); (ii) It offers a user-friendly web interface with various functions for browsing, graphically viewing, searching, and batch downloading Acr-Aca operons; (iii) It focuses on the genomic context of <i>Acr</i> and <i>Aca</i> candidates instead of individual Acr protein family and (iv) It collects data with three independent programs each having a unique data mining algorithm for cross validation. AcrDB will be a valuable resource to the anti-CRISPR research community.</p>]]></description>
            <pubDate><![CDATA[2020-10-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CRISP-view: a database of functional genetic screens spanning multiple phenotypes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609773320-4144750e-a400-4f08-bdbd-b6cbcc10019a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa809</link>
            <description><![CDATA[<p class="para" id="N65541">High-throughput genetic screening based on CRISPR/Cas9 or RNA-interference (RNAi) enables the exploration of genes associated with the phenotype of interest on a large scale. The rapid accumulation of public available genetic screening data provides a wealth of knowledge about genotype-to-phenotype relationships and a valuable resource for the systematic analysis of gene functions. Here we present CRISP-view, a comprehensive database of CRISPR/Cas9 and RNAi screening datasets that span multiple phenotypes, including <i>in vitro</i> and <i>in vivo</i> cell proliferation and viability, response to cancer immunotherapy, virus response, protein expression, etc. By 22 September 2020, CRISP-view has collected 10 321 human samples and 825 mouse samples from 167 papers. All the datasets have been curated, annotated, and processed by a standard MAGeCK-VISPR analysis pipeline with quality control (QC) metrics. We also developed a user-friendly webserver to visualize, explore, and search these datasets. The webserver is freely available at http://crispview.weililab.org.</p>]]></description>
            <pubDate><![CDATA[2020-10-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ADPriboDB 2.0: an updated database of ADP-ribosylated proteins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609753653-a927145a-cdce-43fa-b81c-21171af3cb89/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa941</link>
            <description><![CDATA[<p class="para" id="N65541">ADP-ribosylation is a protein modification responsible for biological processes such as DNA repair, RNA regulation, cell cycle and biomolecular condensate formation. Dysregulation of ADP-ribosylation is implicated in cancer, neurodegeneration and viral infection. We developed ADPriboDB (adpribodb.leunglab.org) to facilitate studies in uncovering insights into the mechanisms and biological significance of ADP-ribosylation. ADPriboDB 2.0 serves as a one-stop repository comprising 48 346 entries and 9097 ADP-ribosylated proteins, of which 6708 were newly identified since the original database release. In this updated version, we provide information regarding the sites of ADP-ribosylation in 32 946 entries. The wealth of information allows us to interrogate existing databases or newly available data. For example, we found that ADP-ribosylated substrates are significantly associated with the recently identified human protein interaction networks associated with SARS-CoV-2, which encodes a conserved protein domain called macrodomain that binds and removes ADP-ribosylation. In addition, we create a new interactive tool to visualize the local context of ADP-ribosylation, such as structural and functional features as well as other post-translational modifications (e.g. phosphorylation, methylation and ubiquitination). This information provides opportunities to explore the biology of ADP-ribosylation and generate new hypotheses for experimental testing.</p>]]></description>
            <pubDate><![CDATA[2020-11-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Europe PMC in 2020]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609747802-c459c8b6-e220-4f71-878a-58e462c5caf3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa994</link>
            <description><![CDATA[<p class="para" id="N65541">Europe PMC (https://europepmc.org) is a database of research articles, including peer reviewed full text articles and abstracts, and preprints - all freely available for use via website, APIs and bulk download. This article outlines new developments since 2017 where work has focussed on three key areas: (i) Europe PMC has added to its core content to include life science preprint abstracts and a special collection of full text of COVID-19-related preprints. Europe PMC is unique as an aggregator of biomedical preprints alongside peer-reviewed articles, with over 180 000 preprints available to search. (ii) Europe PMC has significantly expanded its links to content related to the publications, such as links to Unpaywall, providing wider access to full text, preprint peer-review platforms, all major curated data resources in the life sciences, and experimental protocols. The redesigned Europe PMC website features the PubMed abstract and corresponding PMC full text merged into one article page; there is more evident and user-friendly navigation within articles and to related content, plus a figure browse feature. (iii) The expanded annotations platform offers ∼1.3 billion text mined biological terms and concepts sourced from 10 providers and over 40 global data resources.</p>]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The European Bioinformatics Institute: empowering cooperation in response to a global health crisis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609738204-0bcb2889-96ab-427c-af4d-0946ed2716e8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1077</link>
            <description><![CDATA[<p class="para" id="N65541">The European Bioinformatics Institute (EMBL-EBI; https://www.ebi.ac.uk/) provides freely available data and bioinformatics services to the scientific community, alongside its research activity and training provision. The 2020 COVID-19 pandemic has brought to the forefront a need for the scientific community to work even more cooperatively to effectively tackle a global health crisis. EMBL-EBI has been able to build on its position to contribute to the fight against COVID-19 in a number of ways. Firstly, EMBL-EBI has used its infrastructure, expertise and network of international collaborations to help build the European COVID-19 Data Platform (https://www.covid19dataportal.org/), which brings together COVID-19 biomolecular data and connects it to researchers, clinicians and public health professionals. By September 2020, the COVID-19 Data Platform has integrated in excess of 170 000 COVID-19 biomolecular data and literature records, collected through a number of EMBL-EBI resources. Secondly, EMBL-EBI has strived to continue its support of the life science communities through the crisis, with updated Training provision and improved service provision throughout its resources. The COVID-19 pandemic has highlighted the importance of EMBL-EBI’s core principles, including international cooperation, resource sharing and central data brokering, and has further empowered scientific cooperation.</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[tRFtarget: a database for transfer RNA-derived fragment targets]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609717546-a952ee47-160c-4a58-9a45-2a5b3c4ae386/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa831</link>
            <description><![CDATA[<p class="para" id="N65541">Transfer RNA-derived fragments (tRFs) are a new class of small non-coding RNAs and play important roles in biological and physiological processes. Prediction of tRF target genes and binding sites is crucial in understanding the biological functions of tRFs in the molecular mechanisms of human diseases. We developed a publicly accessible web-based database, tRFtarget (http://trftarget.net), for tRF target prediction. It contains the computationally predicted interactions between tRFs and mRNA transcripts using the two state-of-the-art prediction tools RNAhybrid and IntaRNA, including location of the binding sites on the target, the binding region, and free energy of the binding stability with graphic illustration. tRFtarget covers 936 tRFs and 135 thousand predicted targets in eight species. It allows researchers to search either target genes by tRF IDs or tRFs by gene symbols/transcript names. We also integrated the manually curated experimental evidence of the predicted interactions into the database. Furthermore, we provided a convenient link to the DAVID<sup>®</sup> web server to perform downstream functional pathway analysis and gene ontology annotation on the predicted target genes. This database provides useful information for the scientific community to experimentally validate tRF target genes and facilitate the investigation of the molecular functions and mechanisms of tRFs.</p>]]></description>
            <pubDate><![CDATA[2020-10-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609703446-79bebc4b-0b58-4eda-a915-cdd25f2e60d0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa991</link>
            <description><![CDATA[<p class="para" id="N65541">The Database of Antimicrobial Activity and Structure of Peptides (DBAASP) is an open-access, comprehensive database containing information on amino acid sequences, chemical modifications, 3D structures, bioactivities and toxicities of peptides that possess antimicrobial properties. DBAASP is updated continuously, and at present, version 3.0 (DBAASP v3) contains &gt;15 700 entries (8000 more than the previous version), including &gt;14 500 monomers and nearly 400 homo- and hetero-multimers. Of the monomeric antimicrobial peptides (AMPs), &gt;12 000 are synthetic, about 2700 are ribosomally synthesized, and about 170 are non-ribosomally synthesized. Approximately 3/4 of the entries were added after the initial release of the database in 2014 reflecting the recent sharp increase in interest in AMPs. Despite the increased interest, adoption of peptide antimicrobials in clinical practice is still limited as a consequence of several factors including side effects, problems with bioavailability and high production costs. To assist in developing and optimizing <i>de novo</i> peptides with desired biological activities, DBAASP offers several tools including a sophisticated multifactor analysis of relevant physicochemical properties. Furthermore, DBAASP has implemented a structure modelling pipeline that automates the setup, execution and upload of molecular dynamics (MD) simulations of database peptides. At present, &gt;3200 peptides have been populated with MD trajectories and related analyses that are both viewable within the web browser and available for download. More than 400 DBAASP entries also have links to experimentally determined structures in the Protein Data Bank. DBAASP v3 is freely accessible at http://dbaasp.org.</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CSEA-DB: an omnibus for human complex trait and cell type associations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609692071-52d4ea36-0f02-4990-aedb-feea5439dd84/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1064</link>
            <description><![CDATA[<p class="para" id="N65541">During the past decade, genome-wide association studies (GWAS) have identified many genetic variants with susceptibility to several thousands of complex diseases or traits. The genetic regulation of gene expression is highly tissue-specific and cell type-specific. Recently, single-cell technology has paved the way to dissect cellular heterogeneity in human tissues. Here, we present a reference database for GWAS trait-associated cell type-specificity, named Cell type-Specific Enrichment Analysis DataBase (CSEA-DB, available at https://bioinfo.uth.edu/CSEADB/). Specifically, we curated total of 5120 GWAS summary statistics data for a wide range of human traits and diseases followed by rigorous quality control. We further collected &gt;900 000 cells from the leading consortia such as Human Cell Landscape, Human Cell Atlas, and extensive literature mining, including 752 tissue cell types from 71 adult and fetal tissues across 11 human organ systems. The tissues and cell types were annotated with Uberon and Cell Ontology. By applying our deTS algorithm, we conducted 10 250 480 times of trait-cell type associations, reporting a total of 598 (11.68%) GWAS traits with at least one significantly associated cell type. In summary, CSEA-DB could serve as a repository of association map for human complex traits and their underlying cell types, manually curated GWAS, and single-cell transcriptome resources.</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The ModelSEED Biochemistry Database for the integration of metabolic annotations and the reconstruction, comparison and analysis of metabolic models for plants, fungi and microbes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609673360-c9656fd7-da16-4cf7-b415-7f4eb8c7e84a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1143</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[BastionHub: a universal platform for integrating and analyzing substrates secreted by Gram-negative bacteria]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609649825-f8f290b8-e455-49fb-b925-d0cb886d998c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa899</link>
            <description><![CDATA[<p class="para" id="N65541">Gram-negative bacteria utilize secretion systems to export substrates into their surrounding environment or directly into neighboring cells. These substrates are proteins that function to promote bacterial survival: by facilitating nutrient collection, disabling competitor species or, for pathogens, to disable host defenses. Following a rapid development of computational techniques, a growing number of substrates have been discovered and subsequently validated by wet lab experiments. To date, several online databases have been developed to catalogue these substrates but they have limited user options for in-depth analysis, and typically focus on a single type of secreted substrate. We therefore developed a universal platform, BastionHub, that incorporates extensive functional modules to facilitate substrate analysis and integrates the five major Gram-negative secreted substrate types (i.e. from types I–IV and VI secretion systems). To our knowledge, BastionHub is not only the most comprehensive online database available, it is also the first to incorporate substrates secreted by type I or type II secretion systems. By providing the most up-to-date details of secreted substrates and state-of-the-art prediction and visualized relationship analysis tools, BastionHub will be an important platform that can assist biologists in uncovering novel substrates and formulating new hypotheses. BastionHub is freely available at http://bastionhub.erc.monash.edu/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765609649825-f8f290b8-e455-49fb-b925-d0cb886d998c/assets/gkaa899gra1.jpg" alt="BastionHub: a universal platform for integrating and analyzing substrates secreted by Gram-negative bacteria."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      BastionHub: a universal platform for integrating and analyzing substrates secreted by Gram-negative bacteria.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DNAmoreDB, a database of DNAzymes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609620807-87c2b368-b8e1-4a5a-9bf6-60105fa7b80d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa867</link>
            <description><![CDATA[<p class="para" id="N65541">Deoxyribozymes, DNA enzymes or simply DNAzymes are single-stranded oligo-deoxyribonucleotide molecules that, like proteins and ribozymes, possess the ability to perform catalysis. Although DNAzymes have not yet been found in living organisms, they have been isolated in the laboratory through in vitro selection. The selected DNAzyme sequences have the ability to catalyze a broad range of chemical reactions, utilizing DNA, RNA, peptides or small organic compounds as substrates. DNAmoreDB is a comprehensive database resource for DNAzymes that collects and organizes the following types of information: sequences, conditions of the selection procedure, catalyzed reactions, kinetic parameters, substrates, cofactors, structural information whenever available, and literature references. Currently, DNAmoreDB contains information about DNAzymes that catalyze 20 different reactions. We included a submission form for new data, a REST-based API system that allows users to retrieve the database contents in a machine-readable format, and keyword and BLASTN search features. The database is publicly available at https://www.genesilico.pl/DNAmoreDB/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765609620807-87c2b368-b8e1-4a5a-9bf6-60105fa7b80d/assets/gkaa867gra1.jpg" alt="DNAmoreDB, a comprehensive database resource for DNAzymes."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      DNAmoreDB, a comprehensive database resource for DNAzymes.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-14T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609616246-bece6de7-238e-4bf4-ba9b-0e67cb663173/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa808</link>
            <description><![CDATA[<p class="para" id="N65541">The COVID-19 outbreak has become a global emergency since December 2019. Analysis of SARS-CoV-2 sequences can uncover single nucleotide variants (SNVs) and corresponding evolution patterns. The <span style="text-decoration: underline">G</span>lobal <span style="text-decoration: underline">E</span>valuation of <span style="text-decoration: underline">S</span>ARS-CoV-2/hCoV-19 <span style="text-decoration: underline">S</span>equences (GESS, https://wan-bioinfo.shinyapps.io/GESS/) is a resource to provide comprehensive analysis results based on tens of thousands of high-coverage and high-quality SARS-CoV-2 complete genomes. The database allows user to browse, search and download SNVs at any individual or multiple SARS-CoV-2 genomic positions, or within a chosen genomic region or protein, or in certain country/area of interest. GESS reveals geographical distributions of SNVs around the world and across the states of USA, while exhibiting time-dependent patterns for SNV occurrences which reflect development of SARS-CoV-2 genomes. For each month, the top 100 SNVs that were firstly identified world-widely can be retrieved. GESS also explores SNVs occurring simultaneously with specific SNVs of user's interests. Furthermore, the database can be of great help to calibrate mutation rates and identify conserved genome regions. Taken together, GESS is a powerful resource and tool to monitor SARS-CoV-2 migration and evolution according to featured genomic variations. It provides potential directive information for prevalence prediction, related public health policy making, and vaccine designs.</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609586510-e90bf525-5d2b-4ad8-9137-448ab805470b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa876</link>
            <description><![CDATA[<p class="para" id="N65541">Inhibitors that form covalent bonds with their targets have traditionally been considered highly adventurous due to their potential off-target effects and toxicity concerns. However, with the clinical validation and approval of many covalent inhibitors during the past decade, design and discovery of novel covalent inhibitors have attracted increasing attention. A large amount of scattered experimental data for covalent inhibitors have been reported, but a resource by integrating the experimental information for covalent inhibitor discovery is still lacking. In this study, we presented Covalent Inhibitor Database (CovalentInDB), the largest online database that provides the structural information and experimental data for covalent inhibitors. CovalentInDB contains 4511 covalent inhibitors (including 68 approved drugs) with 57 different reactive warheads for 280 protein targets. The crystal structures of some of the proteins bound with a covalent inhibitor are provided to visualize the protein–ligand interactions around the binding site. Each covalent inhibitor is annotated with the structure, warhead, experimental bioactivity, physicochemical properties, etc. Moreover, CovalentInDB provides the covalent reaction mechanism and the corresponding experimental verification methods for each inhibitor towards its target. High-quality datasets are downloadable for users to evaluate and develop computational methods for covalent drug design. CovalentInDB is freely accessible at http://cadd.zju.edu.cn/cidb/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765609586510-e90bf525-5d2b-4ad8-9137-448ab805470b/assets/gkaa876gra1.jpg" alt="The information for covalent inhibitors and related targets is deposited in the CovalentInDB database for users to browse, retrieve and download."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      The information for covalent inhibitors and related targets is deposited in the CovalentInDB database for users to browse, retrieve and download.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LnCeCell: a comprehensive database of predicted lncRNA-associated ceRNA networks at single-cell resolution]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609581751-5b18de8d-cc2e-49e6-afa7-520228ec533a/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1017</link>
            <description><![CDATA[<p class="para" id="N65541">Within the tumour microenvironment, cells exhibit different behaviours driven by fine-tuning of gene regulation. Identification of cellular-specific gene regulatory networks will deepen the understanding of disease pathology at single-cell resolution and contribute to the development of precision medicine. Here, we describe a database, LnCeCell (http://www.bio-bigdata.net/LnCeCell/ or http://bio-bigdata.hrbmu.edu.cn/LnCeCell/), which aims to document cellular-specific long non-coding RNA (lncRNA)-associated competing endogenous RNA (ceRNA) networks for personalised characterisation of diseases based on the ‘One Cell, One World’ theory. LnCeCell is curated with cellular-specific ceRNA regulations from &gt;94 000 cells across 25 types of cancers and provides &gt;9000 experimentally supported lncRNA biomarkers, associated with tumour metastasis, recurrence, prognosis, circulation, drug resistance, etc. For each cell, LnCeCell illustrates a global map of ceRNA sub-cellular locations, which have been manually curated from the literature and related data sources, and portrays a functional state atlas for a single cancer cell. LnCeCell also provides several flexible tools to infer ceRNA functions based on a specific cellular background. LnCeCell serves as an important resource for investigating the gene regulatory networks within a single cell and can help researchers understand the regulatory mechanisms underlying complex microbial ecosystems and individual phenotypes.</p>]]></description>
            <pubDate><![CDATA[2020-11-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MarkerDB: an online database of molecular biomarkers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609559654-36374233-ea6c-4e39-8296-6d1002dc517b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1067</link>
            <description><![CDATA[<p class="para" id="N65541">MarkerDB is a freely available electronic database that attempts to consolidate information on all known clinical and a selected set of pre-clinical molecular biomarkers into a single resource. The database includes four major types of molecular biomarkers (chemical, protein, DNA [genetic] and karyotypic) and four biomarker categories (diagnostic, predictive, prognostic and exposure). MarkerDB provides information such as: biomarker names and synonyms, associated conditions or pathologies, detailed disease descriptions, detailed biomarker descriptions, biomarker specificity, sensitivity and ROC curves, standard reference values (for protein and chemical markers), variants (for SNP or genetic markers), sequence information (for genetic and protein markers), molecular structures (for protein and chemical markers), tissue or biofluid sources (for protein and chemical markers), chromosomal location and structure (for genetic and karyotype markers), clinical approval status and relevant literature references. Users can browse the data by conditions, condition categories, biomarker types, biomarker categories or search by sequence similarity through the advanced search function. Currently, the database contains 142 protein biomarkers, 1089 chemical biomarkers, 154 karyotype biomarkers and 26 374 genetic markers. These are categorized into 25 560 diagnostic biomarkers, 102 prognostic biomarkers, 265 exposure biomarkers and 6746 predictive biomarkers or biomarker panels. Collectively, these markers can be used to detect, monitor or predict 670 specific human conditions which are grouped into 27 broad condition categories. MarkerDB is available at https://markerdb.ca.</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ProThermDB: thermodynamic database for proteins and mutants revisited after 15 years]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609555679-362ba0a0-eea9-4438-af47-b800f0d1d4c3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1035</link>
            <description><![CDATA[<p class="para" id="N65541">ProThermDB is an updated version of the thermodynamic database for proteins and mutants (ProTherm), which has ∼31 500 data on protein stability, an increase of 84% from the previous version. It contains several thermodynamic parameters such as melting temperature, free energy obtained with thermal and denaturant denaturation, enthalpy change and heat capacity change along with experimental methods and conditions, sequence, structure and literature information. Besides, the current version of the database includes about 120 000 thermodynamic data obtained for different organisms and cell lines, which are determined by recent high throughput proteomics techniques using whole-cell approaches. In addition, we provided a graphical interface for visualization of mutations at sequence and structure levels. ProThermDB is cross-linked with other relevant databases, PDB, UniProt, PubMed etc. It is freely available at https://web.iitm.ac.in/bioinfo2/prothermdb/index.html without any login requirements. It is implemented in Python, HTML and JavaScript, and supports the latest versions of major browsers, such as Firefox, Chrome and Safari.</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LectomeXplore, an update of UniLectin for the discovery of carbohydrate-binding proteins based on a new lectin classification]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609525898-d1a29522-89bd-4290-83ee-7bfb9fb9c782/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1019</link>
            <description><![CDATA[<p class="para" id="N65541">Lectins are non-covalent glycan-binding proteins mediating cellular interactions but their annotation in newly sequenced organisms is lacking. The limited size of functional domains and the low level of sequence similarity challenge usual bioinformatics tools. The identification of lectin domains in proteomes requires the manual curation of sequence alignments based on structural folds. A new lectin classification is proposed. It is built on three levels: (i) 35 lectin domain folds, (ii) 109 classes of lectins sharing at least 20% sequence similarity and (iii) 350 families of lectins sharing at least 70% sequence similarity. This information is compiled in the UniLectin platform that includes the previously described UniLectin3D database of curated lectin 3D structures. Since its first release, UniLectin3D has been updated with 485 additional 3D structures. The database is now complemented by two additional modules: PropLec containing predicted β-propeller lectins and LectomeXplore including predicted lectins from sequences of the NBCI-nr and UniProt for every curated lectin class. UniLectin is accessible at https://www.unilectin.eu/</p>]]></description>
            <pubDate><![CDATA[2020-11-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Dark Kinase Knowledgebase: an online compendium of knowledge and experimental results of understudied kinases]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609514600-732c4859-9d46-403e-8758-7ddde2998efa/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa853</link>
            <description><![CDATA[<p class="para" id="N65541">Kinases form the backbone of numerous cell signaling pathways, with their dysfunction similarly implicated in multiple pathologies. Further facilitated by their druggability, kinases are a major focus of therapeutic development efforts in diseases such as cancer, infectious disease and autoimmune disorders. While their importance is clear, the role or biological function of nearly one-third of kinases is largely unknown. Here, we describe a data resource, the Dark Kinase Knowledgebase (DKK; https://darkkinome.org), that is specifically focused on providing data and reagents for these understudied kinases to the broader research community. Supported through NIH’s Illuminating the Druggable Genome (IDG) Program, the DKK is focused on data and knowledge generation for 162 poorly studied or ‘dark’ kinases. Types of data provided through the DKK include parallel reaction monitoring (PRM) peptides for quantitative proteomics, protein interactions, NanoBRET reagents, and kinase-specific compounds. Higher-level data is similarly being generated and consolidated such as tissue gene expression profiles and, longer-term, functional relationships derived through perturbation studies. Associated web tools that help investigators interrogate both internal and external data are also provided through the site. As an evolving resource, the DKK seeks to continually support and enhance knowledge on these potentially high-impact druggable targets.</p>]]></description>
            <pubDate><![CDATA[2020-10-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GlycoPOST realizes FAIR principles for glycomics mass spectrometry data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609511264-c3d1538f-e2b5-418a-93df-6f6df7008ab8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1012</link>
            <description><![CDATA[<p class="para" id="N65541">For the reproducibility and sustainability of scientific research, FAIRness (Findable, Accessible, Interoperable and Re-usable), with respect to the release of raw data obtained by researchers, is one of the most important principles underpinning the future of open science. In genomics and transcriptomics, the sharing of raw data from next-generation sequencers is made possible through public repositories. In addition, in proteomics, the deposition of raw data from mass spectrometry (MS) experiments into repositories is becoming standardized. However, a standard repository for such MS data had not yet been established in glycomics. With the increasing number of glycomics MS data, therefore, we have developed GlycoPOST (https://glycopost.glycosmos.org/), a repository for raw MS data generated from glycomics experiments. In just the first year since the release of GlycoPOST, 73 projects have already been registered by researchers around the world, and the number of registered projects is continuously growing, making a significant contribution to the future FAIRness of the glycomics field. GlycoPOST is a free resource to the community and accepts (and will continue to accept in the future) raw data regardless of vendor-specific formats.</p>]]></description>
            <pubDate><![CDATA[2020-11-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[STAB: a spatio-temporal cell atlas of the human brain]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609482755-9cddf986-7720-4c62-8b75-86d5026dae5f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa762</link>
            <description><![CDATA[<p class="para" id="N65541">The human brain is the most complex organ consisting of billions of neuronal and non-neuronal cells that are organized into distinct anatomical and functional regions. Elucidating the cellular and transcriptome architecture underlying the brain is crucial for understanding brain functions and brain disorders. Thanks to the single-cell RNA sequencing technologies, it is becoming possible to dissect the cellular compositions of the brain. Although great effort has been made to explore the transcriptome architecture of the human brain, a comprehensive database with dynamic cellular compositions and molecular characteristics of the human brain during the lifespan is still not available. Here, we present STAB (a <span style="text-decoration: underline">S</span>patio-<span style="text-decoration: underline">T</span>emporal cell <span style="text-decoration: underline">A</span>tlas of the human <span style="text-decoration: underline">B</span>rain), a database consists of single-cell transcriptomes across multiple brain regions and developmental periods. Right now, STAB contains single-cell gene expression profiling of 42 cell subtypes across 20 brain regions and 11 developmental periods. With STAB, the landscape of cell types and their regional heterogeneity and temporal dynamics across the human brain can be clearly seen, which can help to understand both the development of the normal human brain and the etiology of neuropsychiatric disorders. STAB is available at http://stab.comp-sysbio.org.</p>]]></description>
            <pubDate><![CDATA[2020-09-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The international nucleotide sequence database collaboration]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609464051-de84e24d-311d-41e4-bdf7-343157de8490/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa967</link>
            <description><![CDATA[<p class="para" id="N65541">The International Nucleotide Sequence Database Collaboration (INSDC; http://www.insdc.org/) has been the core infrastructure for collecting and providing nucleotide sequence data and metadata for &gt;30 years. Three partner organizations, the DNA Data Bank of Japan (DDBJ) at the National Institute of Genetics in Mishima, Japan; the European Nucleotide Archive (ENA) at the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) in Hinxton, UK; and GenBank at National Center for Biotechnology Information (NCBI), National Library of Medicine, National Institutes of Health in Bethesda, Maryland, USA have been collaboratively maintaining the INSDC for the benefit of not only science but all types of community worldwide.</p>]]></description>
            <pubDate><![CDATA[2020-11-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LegumeIP V3: from models to crops—an integrative gene discovery platform for translational genomics in legumes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609460107-754c7580-6a40-4a05-b8a5-48640d44c22c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa976</link>
            <description><![CDATA[<p class="para" id="N65541">Legumes have contributed to human health, sustainable food and feed production worldwide for centuries. The study of model legumes has played vital roles in deciphering key genes, pathways, and networks regulating biological mechanisms and agronomic traits. Along with emerging breeding technology such as genome editing, translation of the knowledge gained from model plants to crops is in high demand. The updated database (V3) was redesigned for translational genomics targeting the discovery of novel key genes in less-studied non-model legume crops by referring to the knowledge gained in model legumes. The database contains genomic data for all 22 included species, and transcriptomic data covering thousands of RNA-seq samples mostly from model species. The rich biological data and analytic tools for gene expression and pathway analyses can be used to decipher critical genes, pathways, and networks in model legumes. The integrated comparative genomic functions further facilitate the translation of this knowledge to legume crops. Therefore, the database will be a valuable resource to identify important genes regulating specific biological mechanisms or agronomic traits in the non-model yet economically significant legume crops. LegumeIP V3 is available free to the public at https://plantgrn.noble.org/LegumeIP. Access to the database does not require login, registration, or password.</p>]]></description>
            <pubDate><![CDATA[2020-11-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PED in 2021: a major update of the protein ensemble database for intrinsically disordered proteins]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609447210-7f1b2195-8932-411c-a6a6-2516fcc873aa/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1021</link>
            <description><![CDATA[<p class="para" id="N65541">The Protein Ensemble Database (PED) (https://proteinensemble.org), which holds structural ensembles of intrinsically disordered proteins (IDPs), has been significantly updated and upgraded since its last release in 2016. The new version, PED 4.0, has been completely redesigned and reimplemented with cutting-edge technology and now holds about six times more data (162 versus 24 entries and 242 versus 60 structural ensembles) and a broader representation of state of the art ensemble generation methods than the previous version. The database has a completely renewed graphical interface with an interactive feature viewer for region-based annotations, and provides a series of descriptors of the qualitative and quantitative properties of the ensembles. High quality of the data is guaranteed by a new submission process, which combines both automatic and manual evaluation steps. A team of biocurators integrate structured metadata describing the ensemble generation methodology, experimental constraints and conditions. A new search engine allows the user to build advanced queries and search all entry fields including cross-references to IDP-related resources such as DisProt, MobiDB, BMRB and SASBDB. We expect that the renewed PED will be useful for researchers interested in the atomic-level understanding of IDP function, and promote the rational, structure-based design of IDP-targeting drugs.</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[SMART: recent updates, new developments and status in 2020]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609444292-c3e5719d-d425-4c7a-b53e-ea532168e962/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa937</link>
            <description><![CDATA[<p class="para" id="N65541">SMART (Simple Modular Architecture Research Tool) is a web resource (https://smart.embl.de) for the identification and annotation of protein domains and the analysis of protein domain architectures. SMART version 9 contains manually curated models for more than 1300 protein domains, with a topical set of 68 new models added since our last update article (<a href="#B1">1</a>). All the new models are for diverse recombinase families and subfamilies and as a set they provide a comprehensive overview of mobile element recombinases namely transposase, integrase, relaxase, resolvase, cas1 casposase and Xer like cellular recombinase. Further updates include the synchronization of the underlying protein databases with UniProt (<a href="#B2">2</a>), Ensembl (<a href="#B3">3</a>) and STRING (<a href="#B4">4</a>), greatly increasing the total number of annotated domains and other protein features available in architecture analysis mode. Furthermore, SMART’s vector-based protein display engine has been extended and updated to use the latest web technologies and the domain architecture analysis components have been optimized to handle the increased number of protein features available.</p>]]></description>
            <pubDate><![CDATA[2020-10-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[BacWGSTdb 2.0: a one-stop repository for bacterial whole-genome sequence typing and source tracking]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609420633-5261945c-f188-4386-b660-6ad95afe899d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa821</link>
            <description><![CDATA[<p class="para" id="N65541">An increasing prevalence of hospital acquired infections and foodborne illnesses caused by pathogenic and multidrug-resistant bacteria has stimulated a pressing need for benchtop computational techniques to rapidly and accurately classify bacteria from genomic sequence data, and based on that, to trace the source of infection. BacWGSTdb (http://bacdb.org/BacWGSTdb) is a free publicly accessible database we have developed for bacterial whole-genome sequence typing and source tracking. This database incorporates extensive resources for bacterial genome sequencing data and the corresponding metadata, combined with specialized bioinformatics tools that enable the systematic characterization of the bacterial isolates recovered from infections. Here, we present BacWGSTdb 2.0, which encompasses several major updates, including (i) the integration of the core genome multi-locus sequence typing (cgMLST) approach, which is highly scalable and appropriate for typing isolates belonging to different lineages; (ii) the addition of a multiple genome analysis module that can process dozens of user uploaded sequences in a batch mode; (iii) a new source tracking module for comparing user uploaded plasmid sequences to those deposited in the public databases; (iv) the number of species encompassed in BacWGSTdb 2.0 has increased from 9 to 20, which represents bacterial pathogens of medical importance; (v) a newly designed, user-friendly interface and a set of visualization tools for providing a convenient platform for users are also included. Overall, the updated BacWGSTdb 2.0 bears great utility in continuing to provide users, including epidemiologists, clinicians and bench scientists, with a one-stop solution to bacterial genome sequence analysis.</p>]]></description>
            <pubDate><![CDATA[2020-10-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The mouse Gene Expression Database (GXD): 2021 update]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609416055-dacf7621-4260-412f-a90f-cd0ad9e2d85f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa914</link>
            <description><![CDATA[<p class="para" id="N65541">The Gene Expression Database (GXD; www.informatics.jax.org/expression.shtml) is an extensive and well-curated community resource of mouse developmental gene expression information. For many years, GXD has collected and integrated data from RNA <i>in situ</i> hybridization, immunohistochemistry, RT-PCR, northern blot, and western blot experiments through curation of the scientific literature and by collaborations with large-scale expression projects. Since our last report in 2019, we have continued to acquire these classical types of expression data; developed a searchable index of RNA-Seq and microarray experiments that allows users to quickly and reliably find specific mouse expression studies in ArrayExpress (https://www.ebi.ac.uk/arrayexpress/) and GEO (https://www.ncbi.nlm.nih.gov/geo/); and expanded GXD to include RNA-Seq data. Uniformly processed RNA-Seq data are imported from the EBI Expression Atlas and then integrated with the other types of expression data in GXD, and with the genetic, functional, phenotypic and disease-related information in Mouse Genome Informatics (MGI). This integration has made the RNA-Seq data accessible via GXD’s enhanced searching and filtering capabilities. Further, we have embedded the Morpheus heat map utility into the GXD user interface to provide additional tools for display and analysis of RNA-Seq data, including heat map visualization, sorting, filtering, hierarchical clustering, nearest neighbors analysis and visual enrichment.</p>]]></description>
            <pubDate><![CDATA[2020-10-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MolluscDB: an integrated functional and evolutionary genomics database for the hyper-diverse animal phylum Mollusca]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609413572-ab9fe07b-2fb3-4373-9dc0-5a4ea2e80753/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1166</link>
            <description><![CDATA[]]></description>
            <pubDate><![CDATA[2020-11-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Planet Microbe: a platform for marine microbiology to discover and analyze interconnected ‘omics and environmental data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609314975-12e92a20-a482-45b8-b927-8b288ce651b0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa637</link>
            <description><![CDATA[<p class="para" id="N65541">In recent years, large-scale oceanic sequencing efforts have provided a deeper understanding of marine microbial communities and their dynamics. These research endeavors require the acquisition of complex and varied datasets through large, interdisciplinary and collaborative efforts. However, no unifying framework currently exists for the marine science community to integrate sequencing data with physical, geological, and geochemical datasets. Planet Microbe is a web-based platform that enables data discovery from curated historical and on-going oceanographic sequencing efforts. In Planet Microbe, each ‘omics sample is linked with other biological and physiochemical measurements collected for the same water samples or during the same sample collection event, to provide a broader environmental context. This work highlights the need for curated aggregation efforts that can enable new insights into high-quality metagenomic datasets. Planet Microbe is freely accessible from https://www.planetmicrobe.org/.</p>]]></description>
            <pubDate><![CDATA[2020-07-31T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TCRdb: a comprehensive database for T-cell receptor sequences with powerful search function]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609289041-3b7547f0-8a42-4de8-b59e-ef81fb428102/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa796</link>
            <description><![CDATA[<p class="para" id="N65541">T cells and the T-cell receptor (TCR) repertoire play pivotal roles in immune response and immunotherapy. TCR sequencing (TCR-Seq) technology has enabled accurate profiling TCR repertoire and currently a large number of TCR-Seq data are available in public. Based on the urgent need to effectively re-use these data, we developed TCRdb, a comprehensive human TCR sequences database, by a uniform pipeline to characterize TCR sequences on TCR-Seq data. TCRdb contains more than 277 million highly reliable TCR sequences from over 8265 TCR-Seq samples across hundreds of tissues/clinical conditions/cell types. The unique features of TCRdb include: (i) comprehensive and reliable sequences for TCR repertoire in different samples generated by a strict and uniform pipeline of TCRdb; (ii) powerful search function, allowing users to identify their interested TCR sequences in different conditions; (iii) categorized sample metadata, enabling comparison of TCRs in different sample types; (iv) interactive data visualization charts, describing the TCR repertoire in TCR diversity, length distribution and V-J gene utilization. The TCRdb database is freely available at http://bioinfo.life.hust.edu.cn/TCRdb/ and will be a useful resource in the research and application community of T cell immunology.</p>]]></description>
            <pubDate><![CDATA[2020-09-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RMDisease: a database of genetic variants that affect RNA modifications, with implications for epitranscriptome pathogenesis]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609272507-482c7f88-ac32-45d7-ab8a-bee2dc305426/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa790</link>
            <description><![CDATA[<p class="para" id="N65541">Deciphering the biological impacts of millions of single nucleotide variants remains a major challenge. Recent studies suggest that RNA modifications play versatile roles in essential biological mechanisms, and are closely related to the progression of various diseases including multiple cancers. To comprehensively unveil the association between disease-associated variants and their epitranscriptome disturbance, we built RMDisease, a database of genetic variants that can affect RNA modifications. By integrating the prediction results of 18 different RNA modification prediction tools and also 303,426 experimentally-validated RNA modification sites, RMDisease identified a total of 202,307 human SNPs that may affect (add or remove) sites of eight types of RNA modifications (m<sup>6</sup>A, m<sup>5</sup>C, m<sup>1</sup>A, m<sup>5</sup>U, Ψ, m<sup>6</sup>Am, m<sup>7</sup>G and Nm). These include 4,289 disease-associated variants that may imply disease pathogenesis functioning at the epitranscriptome layer. These SNPs were further annotated with essential information such as post-transcriptional regulations (sites for miRNA binding, interaction with RNA-binding proteins and alternative splicing) revealing putative regulatory circuits. A convenient graphical user interface was constructed to support the query, exploration and download of the relevant information. RMDisease should make a useful resource for studying the epitranscriptome impact of genetic variants via multiple RNA modifications with emphasis on their potential disease relevance. RMDisease is freely accessible at: www.xjtlu.edu.cn/biologicalsciences/rmd.</p>]]></description>
            <pubDate><![CDATA[2020-10-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609257516-0be66754-6a32-422a-84e0-ab7c5ce5e980/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1020</link>
            <description><![CDATA[<p class="para" id="N65541">Cancer immunotherapy targeting co-inhibitory pathways by checkpoint blockade shows remarkable efficacy in a variety of cancer types. However, only a minority of patients respond to treatment due to the stochastic heterogeneity of tumor microenvironment (TME). Recent advances in single-cell RNA-seq technologies enabled comprehensive characterization of the immune system heterogeneity in tumors but posed computational challenges on integrating and utilizing the massive published datasets to inform immunotherapy. Here, we present Tumor Immune Single Cell Hub (TISCH, http://tisch.comp-genomics.org), a large-scale curated database that integrates single-cell transcriptomic profiles of nearly 2 million cells from 76 high-quality tumor datasets across 27 cancer types. All the data were uniformly processed with a standardized workflow, including quality control, batch effect removal, clustering, cell-type annotation, malignant cell classification, differential expression analysis and functional enrichment analysis. TISCH provides interactive gene expression visualization across multiple datasets at the single-cell level or cluster level, allowing systematic comparison between different cell-types, patients, tissue origins, treatment and response groups, and even different cancer-types. In summary, TISCH provides a user-friendly interface for systematically visualizing, searching and downloading gene expression atlas in the TME from multiple cancer types, enabling fast, flexible and comprehensive exploration of the TME.</p>]]></description>
            <pubDate><![CDATA[2020-11-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Transporter Classification Database (TCDB): 2021 update]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609184305-118692e3-7195-4c66-b879-ba4e16fb3948/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1004</link>
            <description><![CDATA[<p class="para" id="N65541">The Transporter Classification Database (TCDB; tcdb.org) is a freely accessible reference resource, which provides functional, structural, mechanistic, medical and biotechnological information about transporters from organisms of all types. TCDB is the only transport protein classification database adopted by the International Union of Biochemistry and Molecular Biology (IUBMB) and now (October 1, 2020) consists of 20 653 proteins classified in 15 528 non-redundant transport systems with 1567 tabulated 3D structures, 18 336 reference citations describing 1536 transporter families, of which 26% are members of 82 recognized superfamilies. Overall, this is an increase of over 50% since the last published update of the database in 2016. This comprehensive update of the database contents and features include (i) adoption of a chemical ontology for substrates of transporters, (ii) inclusion of new superfamilies, (iii) a domain-based characterization of transporter families for the identification of new members as well as functional and evolutionary relationships between families, (iv) development of novel software to facilitate curation and use of the database, (v) addition of new subclasses of transport systems including 11 novel types of channels and 3 types of group translocators and (vi) the inclusion of many man-made (artificial) transmembrane pores/channels and carriers.</p>]]></description>
            <pubDate><![CDATA[2020-11-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The ModelSEED Biochemistry Database for the integration of metabolic annotations and the reconstruction, comparison and analysis of metabolic models for plants, fungi and microbes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609152536-f1c05abd-f917-4ab0-b571-33974aef19e9/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa746</link>
            <description><![CDATA[<p class="para" id="N65541">For over 10 years, ModelSEED has been a primary resource for the construction of draft genome-scale metabolic models based on annotated microbial or plant genomes. Now being released, the biochemistry database serves as the foundation of biochemical data underlying ModelSEED and KBase. The biochemistry database embodies several properties that, taken together, distinguish it from other published biochemistry resources by: (i) including compartmentalization, transport reactions, charged molecules and proton balancing on reactions; (ii) being extensible by the user community, with all data stored in GitHub; and (iii) design as a biochemical ‘Rosetta Stone’ to facilitate comparison and integration of annotations from many different tools and databases. The database was constructed by combining chemical data from many resources, applying standard transformations, identifying redundancies and computing thermodynamic properties. The ModelSEED biochemistry is continually tested using flux balance analysis to ensure the biochemical network is modeling-ready and capable of simulating diverse phenotypes. Ontologies can be designed to aid in comparing and reconciling metabolic reconstructions that differ in how they represent various metabolic pathways. ModelSEED now includes 33,978 compounds and 36,645 reactions, available as a set of extensible files on GitHub, and available to search at https://modelseed.org/biochem and KBase.</p>]]></description>
            <pubDate><![CDATA[2020-09-28T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[HMPDACC: a Human Microbiome Project Multi-omic data resource]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609133780-4090a526-70e7-4f6f-b669-ff6b2b1af361/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa996</link>
            <description><![CDATA[<p class="para" id="N65541">The Human Microbiome Project (HMP) explored microbial communities of the human body in both healthy and disease states. Two phases of the HMP (HMP and iHMP) together generated &gt;48TB of data (public and controlled access) from multiple, varied omics studies of both the microbiome and associated hosts. The Human Microbiome Project Data Coordination Center (HMPDACC) was established to provide a portal to access data and resources produced by the HMP. The HMPDACC provides a unified data repository, multi-faceted search functionality, analysis pipelines and standardized protocols to facilitate community use of HMP data. Recent efforts have been put toward making HMP data more findable, accessible, interoperable and reusable. HMPDACC resources are freely available at www.hmpdacc.org.</p>]]></description>
            <pubDate><![CDATA[2020-12-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DescribePROT: database of amino acid-level protein structure and function predictions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609118275-e18b7c3f-cdb0-4ffb-ab63-6aefe9953e01/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa931</link>
            <description><![CDATA[<p class="para" id="N65541">We present DescribePROT, the database of predicted amino acid-level descriptors of structure and function of proteins. DescribePROT delivers a comprehensive collection of 13 complementary descriptors predicted using 10 popular and accurate algorithms for 83 complete proteomes that cover key model organisms. The current version includes 7.8 billion predictions for close to 600 million amino acids in 1.4 million proteins. The descriptors encompass sequence conservation, position specific scoring matrix, secondary structure, solvent accessibility, intrinsic disorder, disordered linkers, signal peptides, MoRFs and interactions with proteins, DNA and RNAs. Users can search DescribePROT by the amino acid sequence and the UniProt accession number and entry name. The pre-computed results are made available instantaneously. The predictions can be accesses via an interactive graphical interface that allows simultaneous analysis of multiple descriptors and can be also downloaded in structured formats at the protein, proteome and whole database scale. The putative annotations included by DescriPROT are useful for a broad range of studies, including: investigations of protein function, applied projects focusing on therapeutics and diseases, and in the development of predictors for other protein sequence descriptors. Future releases will expand the coverage of DescribePROT. DescribePROT can be accessed at http://biomine.cs.vcu.edu/servers/DESCRIBEPROT/.</p>]]></description>
            <pubDate><![CDATA[2020-10-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TransCirc: an interactive database for translatable circular RNAs based on multi-omics evidence]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609035823-e4c989a2-f172-4cfc-a14c-4bbb2596f903/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa823</link>
            <description><![CDATA[<p class="para" id="N65541">TransCirc (https://www.biosino.org/transcirc/) is a specialized database that provide comprehensive evidences supporting the translation potential of circular RNAs (circRNAs). This database was generated by integrating various direct and indirect evidences to predict coding potential of each human circRNA and the putative translation products. Seven types of evidences for circRNA translation were included: (i) ribosome/polysome binding evidences supporting the occupancy of ribosomes onto circRNAs; (ii) experimentally mapped translation initiation sites on circRNAs; (iii) internal ribosome entry site on circRNAs; (iv) published N-6-methyladenosine modification data in circRNA that promote translation initiation; (v) lengths of the circRNA specific open reading frames; (vi) sequence composition scores from a machine learning prediction of all potential open reading frames; (vii) mass spectrometry data that directly support the circRNA encoded peptides across back-splice junctions. TransCirc provides a user-friendly searching/browsing interface and independent lines of evidences to predicte how likely a circRNA can be translated. In addition, several flexible tools have been developed to aid retrieval and analysis of the data. TransCirc can serve as an important resource for investigating the translation capacity of circRNAs and the potential circRNA-encoded peptides, and can be expanded to include new evidences or additional species in the future.</p>]]></description>
            <pubDate><![CDATA[2020-10-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CSVS, a crowdsourcing database of the Spanish population genetic variability]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765609000552-0aacf167-d450-4174-bb7c-bb29e5c34ca4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa794</link>
            <description><![CDATA[<p class="para" id="N65541">The knowledge of the genetic variability of the local population is of utmost importance in personalized medicine and has been revealed as a critical factor for the discovery of new disease variants. Here, we present the Collaborative Spanish Variability Server (CSVS), which currently contains more than 2000 genomes and exomes of unrelated Spanish individuals. This database has been generated in a collaborative crowdsourcing effort collecting sequencing data produced by local genomic projects and for other purposes. Sequences have been grouped by ICD10 upper categories. A web interface allows querying the database removing one or more ICD10 categories. In this way, aggregated counts of allele frequencies of the pseudo-control Spanish population can be obtained for diseases belonging to the category removed. Interestingly, in addition to pseudo-control studies, some population studies can be made, as, for example, prevalence of pharmacogenomic variants, etc. In addition, this genomic data has been used to define the first Spanish Genome Reference Panel (SGRP1.0) for imputation. This is the first local repository of variability entirely produced by a crowdsourcing effort and constitutes an example for future initiatives to characterize local variability worldwide. CSVS is also part of the GA4GH Beacon network.</p><p class="para" id="N65543">CSVS can be accessed at: http://csvs.babelomics.org/.</p>]]></description>
            <pubDate><![CDATA[2020-09-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[FlyRNAi.org—the database of the Drosophila RNAi screening center and transgenic RNAi project: 2021 update]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608996346-bf036295-bedd-4ec1-9f21-aa003f6acd36/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa936</link>
            <description><![CDATA[<p class="para" id="N65541">The FlyRNAi database at the Drosophila RNAi Screening Center and Transgenic RNAi Project (DRSC/TRiP) provides a suite of online resources that facilitate functional genomics studies with a special emphasis on <i>Drosophila melanogaster</i>. Currently, the database provides: gene-centric resources that facilitate ortholog mapping and mining of information about orthologs in common genetic model species; reagent-centric resources that help researchers identify RNAi and CRISPR sgRNA reagents or designs; and data-centric resources that facilitate visualization and mining of transcriptomics data, protein modification data, protein interactions, and more. Here, we discuss updated and new features that help biological and biomedical researchers efficiently identify, visualize, analyze, and integrate information and data for <i>Drosophila</i> and other species. Together, these resources facilitate multiple steps in functional genomics workflows, from building gene and reagent lists to management, analysis, and integration of data.</p>]]></description>
            <pubDate><![CDATA[2020-10-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Open Targets Platform: supporting systematic drug–target identification and prioritisation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608990890-c424c169-c7aa-4795-b8d3-270e7f632725/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1027</link>
            <description><![CDATA[<p class="para" id="N65541">The Open Targets Platform (https://www.targetvalidation.org/) provides users with a queryable knowledgebase and user interface to aid systematic target identification and prioritisation for drug discovery based upon underlying evidence. It is publicly available and the underlying code is open source. Since our last update two years ago, we have had 10 releases to maintain and continuously improve evidence for target–disease relationships from 20 different data sources. In addition, we have integrated new evidence from key datasets, including prioritised targets identified from genome-wide CRISPR knockout screens in 300 cancer models (Project Score), and GWAS/UK BioBank statistical genetic analysis evidence from the Open Targets Genetics Portal. We have evolved our evidence scoring framework to improve target identification. To aid the prioritisation of targets and inform on the potential impact of modulating a given target, we have added evaluation of post-marketing adverse drug reactions and new curated information on target tractability and safety. We have also developed the user interface and backend technologies to improve performance and usability. In this article, we describe the latest enhancements to the Platform, to address the fundamental challenge that developing effective and safe drugs is difficult and expensive.</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TREND-DB—a transcriptome-wide atlas of the dynamic landscape of alternative polyadenylation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608955862-55dfdeaa-267a-471d-b5e2-b955bdac581b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa722</link>
            <description><![CDATA[<p class="para" id="N65541">Alternative polyadenylation (APA) profoundly expands the transcriptome complexity. Perturbations of APA can disrupt biological processes, ultimately resulting in devastating disorders. A major challenge in identifying mechanisms and consequences of APA (and its perturbations) lies in the complexity of RNA 3′ end processing, involving poorly conserved RNA motifs and multi-component complexes consisting of far more than 50 proteins. This is further complicated in that RNA 3′ end maturation is closely linked to transcription, RNA processing and even epigenetic (histone/DNA/RNA) modifications. Here, we present TREND-DB (http://shiny.imbei.uni-mainz.de:3838/trend-db), a resource cataloging the dynamic landscape of APA after depletion of &gt;170 proteins involved in various facets of transcriptional, co- and post-transcriptional gene regulation, epigenetic modifications and further processes. TREND-DB visualizes the dynamics of transcriptome 3′ end diversification (TREND) in a highly interactive manner; it provides a global APA network map and allows interrogating genes affected by specific APA-regulators and vice versa. It also permits condition-specific functional enrichment analyses of APA-affected genes, which suggest wide biological and clinical relevance across all RNAi conditions. The implementation of the UCSC Genome Browser provides additional customizable layers of gene regulation accounting for individual transcript isoforms (e.g. epigenetics, miRNA-binding sites and RNA-binding proteins). TREND-DB thereby fosters disentangling the role of APA for various biological programs, including potential disease mechanisms, and helps identify their diagnostic and therapeutic potential.</p>]]></description>
            <pubDate><![CDATA[2020-09-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[mMGE: a database for human metagenomic extrachromosomal mobile genetic elements]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608949944-66208daa-b95c-4f4a-b136-ba0715869c08/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa869</link>
            <description><![CDATA[<p class="para" id="N65541">Extrachromosomal mobile genetic elements (eMGEs), including phages and plasmids, that can move across different microbes, play important roles in genome evolution and shaping the structure of microbial communities. However, we still know very little about eMGEs, especially their abundances, distributions and putative functions in microbiomes. Thus, a comprehensive description of eMGEs is of great utility. Here we present mMGE, a comprehensive catalog of 517 251 non-redundant eMGEs, including 92 492 plasmids and 424 759 phages, derived from diverse body sites of 66 425 human metagenomic samples. About half the eMGEs could be further grouped into 70 074 clusters using relaxed criteria (referred as to eMGE clusters below). We provide extensive annotations of the identified eMGEs including sequence characteristics, taxonomy affiliation, gene contents and their prokaryotic hosts. We also calculate the prevalence, both within and across samples for each eMGE and eMGE cluster, enabling users to see putative associations of eMGEs with human phenotypes or their distribution preferences. All eMGE records can be browsed or queried in multiple ways, such as eMGE clusters, metagenomic samples and associated hosts. The mMGE is equipped with a user-friendly interface and a BLAST server, facilitating easy access/queries to all its contents easily. mMGE is freely available for academic use at: https://mgedb.comp-sysbio.org.</p>]]></description>
            <pubDate><![CDATA[2020-10-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RBP2GO: a comprehensive pan-species database on RNA-binding proteins, their interactions and functions]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608944311-6f19245e-89ee-495f-aee6-457560bc8345/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1040</link>
            <description><![CDATA[<p class="para" id="N65541">RNA–protein complexes have emerged as central players in numerous key cellular processes with significant relevance in health and disease. To further deepen our knowledge of RNA-binding proteins (RBPs), multiple proteome-wide strategies have been developed to identify RBPs in different species leading to a large number of studies contributing experimentally identified as well as predicted RBP candidate catalogs. However, the rapid evolution of the field led to an accumulation of isolated datasets, hampering the access and comparison of their valuable content. Moreover, tools to link RBPs to cellular pathways and functions were lacking. Here, to facilitate the efficient screening of the RBP resources, we provide RBP2GO (https://RBP2GO.DKFZ.de), a comprehensive database of all currently available proteome-wide datasets for RBPs across 13 species from 53 studies including 105 datasets identifying altogether 22 552 RBP candidates. These are combined with the information on RBP interaction partners and on the related biological processes, molecular functions and cellular compartments. RBP2GO offers a user-friendly web interface with an RBP scoring system and powerful advanced search tools allowing forward and reverse searches connecting functions and RBPs to stimulate new research directions.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765608944311-6f19245e-89ee-495f-aee6-457560bc8345/assets/gkaa1040gra1.jpg" alt="RBP2GO (https://RBP2GO.DKFZ.de) is a comprehensive database of all currently available proteome-wide datasets for RNA-binding proteins, their functions and interaction partners.Question: is it necessary to have a caption for the graphical abstract? I cannot see them on the website or PDFs of the articles."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      RBP2GO (https://RBP2GO.DKFZ.de) is a comprehensive database of all currently available proteome-wide datasets for RNA-binding proteins, their functions and interaction partners.Question: is it necessary to have a caption for the graphical abstract? I cannot see them on the website or PDFs of the articles.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[COVID19 Drug Repository: text-mining the literature in search of putative COVID19 therapeutics]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608938800-ed2e9ac9-e388-4121-9467-468055a684bb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa969</link>
            <description><![CDATA[<p class="para" id="N65541">The recent outbreak of COVID-19 has generated an enormous amount of Big Data. To date, the COVID-19 Open Research Dataset (CORD-19), lists ∼130,000 articles from the WHO COVID-19 database, PubMed Central, medRxiv, and bioRxiv, as collected by Semantic Scholar. According to LitCovid (11 August 2020), ∼40,300 COVID19-related articles are currently listed in PubMed. It has been shown in clinical settings that the analysis of past research results and the mining of available data can provide novel opportunities for the successful application of currently approved therapeutics and their combinations for the treatment of conditions caused by a novel SARS-CoV-2 infection. As such, effective responses to the pandemic require the development of efficient applications, methods and algorithms for data navigation, text-mining, clustering, classification, analysis, and reasoning. Thus, our COVID19 Drug Repository represents a modular platform for drug data navigation and analysis, with an emphasis on COVID-19-related information currently being reported. The COVID19 Drug Repository enables users to focus on different levels of complexity, starting from general information about (FDA-) approved drugs, PubMed references, clinical trials, recipes as well as the descriptions of molecular mechanisms of drugs’ action. Our COVID19 drug repository provide a most updated world-wide collection of drugs that has been repurposed for COVID19 treatments around the world.</p>]]></description>
            <pubDate><![CDATA[2020-11-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DockCoV2: a drug database against SARS-CoV-2]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608922070-595be358-2b22-4b2b-8cd2-dcfc788e4cd1/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa861</link>
            <description><![CDATA[<p class="para" id="N65541">The current state of the COVID-19 pandemic is a global health crisis. To fight the novel coronavirus, one of the best-known ways is to block enzymes essential for virus replication. Currently, we know that the SARS-CoV-2 virus encodes about 29 proteins such as spike protein, 3C-like protease (3CLpro), RNA-dependent RNA polymerase (RdRp), Papain-like protease (PLpro), and nucleocapsid (N) protein. SARS-CoV-2 uses human angiotensin-converting enzyme 2 (ACE2) for viral entry and transmembrane serine protease family member II (TMPRSS2) for spike protein priming. Thus in order to speed up the discovery of potential drugs, we develop DockCoV2, a drug database for SARS-CoV-2. DockCoV2 focuses on predicting the binding affinity of FDA-approved and Taiwan National Health Insurance (NHI) drugs with the seven proteins mentioned above. This database contains a total of 3,109 drugs. DockCoV2 is easy to use and search against, is well cross-linked to external databases, and provides the state-of-the-art prediction results in one site. Users can download their drug-protein docking data of interest and examine additional drug-related information on DockCoV2. Furthermore, DockCoV2 provides experimental information to help users understand which drugs have already been reported to be effective against MERS or SARS-CoV. DockCoV2 is available at https://covirus.cc/drugs/.</p>]]></description>
            <pubDate><![CDATA[2020-10-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PROTAC-DB: an online database of PROTACs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608917647-008e9025-ffba-4ae5-8952-f8b6f46a4f7d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa807</link>
            <description><![CDATA[<p class="para" id="N65541">Proteolysis-targeting chimeras (PROTACs), which selectively degrade targeted proteins by the ubiquitin-proteasome system, have emerged as a novel therapeutic technology with potential advantages over traditional inhibition strategies. In the past few years, this technology has achieved substantial progress and two PROTACs have been advanced into phase I clinical trials. However, this technology is still maturing and the design of PROTACs remains a great challenge. In order to promote the rational design of PROTACs, we present PROTAC-DB, a web-based open-access database that integrates structural information and experimental data of PROTACs. Currently, PROTAC-DB consists of 1662 PROTACs, 202 warheads (small molecules that target the proteins of interest), 65 E3 ligands (small molecules capable of recruiting E3 ligases) and 806 linkers, as well as their chemical structures, biological activities, and physicochemical properties. Except the biological activities of warheads and E3 ligands, PROTAC-DB also provides the degradation capacities, binding affinities and cellular activities for PROTACs. PROTAC-DB can be queried with two general searching approaches: text-based (target name, compound name or ID) and structure-based. In addition, for the convenience of users, a filtering tool for the searching results based on the physicochemical properties of compounds is also offered. PROTAC-DB is freely accessible at http://cadd.zju.edu.cn/protacdb/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765608917647-008e9025-ffba-4ae5-8952-f8b6f46a4f7d/assets/gkaa807gra1.jpg" alt="The three basic steps to construct PROTAC-DB: (I) literature searching, (II) data collection, and (III) data processing by separating PROTACs into warheads, E3 ligands and linkers."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      The three basic steps to construct PROTAC-DB: (I) literature searching, (II) data collection, and (III) data processing by separating PROTACs into warheads, E3 ligands and linkers.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Genenames.org: the HGNC and VGNC resources in 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608904045-2da0512f-cada-4df9-bb35-cc762b8a2a9d/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa980</link>
            <description><![CDATA[<p class="para" id="N65541">The HUGO Gene Nomenclature Committee (HGNC) based at EMBL’s European Bioinformatics Institute (EMBL-EBI) assigns unique symbols and names to human genes. There are over 42,000 approved gene symbols in our current database of which over 19 000 are for protein-coding genes. While we still update placeholder and problematic symbols, we are working towards stabilizing symbols where possible; over 2000 symbols for disease associated genes are now marked as stable in our symbol reports. All of our data is available at the HGNC website https://www.genenames.org. The Vertebrate Gene Nomenclature Committee (VGNC) was established to assign standardized nomenclature in line with human for vertebrate species lacking their own nomenclature committee. In addition to the previous VGNC core species of chimpanzee, cow, horse and dog, we now name genes in cat, macaque and pig. Gene groups have been added to VGNC and currently include two complex families: olfactory receptors (ORs) and cytochrome P450s (CYPs). In collaboration with specialists we have also named CYPs in species beyond our core set. All VGNC data is available at https://vertebrate.genenames.org/. This article provides an overview of our online data and resources, focusing on updates over the last two years.</p>]]></description>
            <pubDate><![CDATA[2020-11-05T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PINA 3.0: mining cancer interactome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608899841-76bbecee-d98b-4663-bae8-769185f35ed3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1075</link>
            <description><![CDATA[<p class="para" id="N65541">Protein–protein interactions (PPIs) are crucial to mediate biological functions, and understanding PPIs in cancer type-specific context could help decipher the underlying molecular mechanisms of tumorigenesis and identify potential therapeutic options. Therefore, we update the Protein Interaction Network Analysis (PINA) platform to version 3.0, to integrate the unified human interactome with RNA-seq transcriptomes and mass spectrometry-based proteomes across tens of cancer types. A number of new analytical utilities were developed to help characterize the cancer context for a PPI network, which includes inferring proteins with expression specificity and identifying candidate prognosis biomarkers, putative cancer drivers, and therapeutic targets for a specific cancer type; as well as identifying pairs of co-expressing interacting proteins across cancer types. Furthermore, a brand-new web interface has been designed to integrate these new utilities within an interactive network visualization environment, which allows users to quickly and comprehensively investigate the roles of human interacting proteins in a cancer type-specific context. PINA is freely available at https://omics.bjcancer.org/pina/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765608899841-76bbecee-d98b-4663-bae8-769185f35ed3/assets/gkaa1075gra1.jpg" alt="A schematic overview of PINA 3.0."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      A schematic overview of PINA 3.0.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[ConjuPepDB: a database of peptide–drug conjugates]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608845247-9aa45b30-45c7-4a76-9d5a-c95dac44541f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa950</link>
            <description><![CDATA[<p class="para" id="N65541">Peptide–drug conjugates are organic molecules composed of (i) a small drug molecule, (ii) a peptide and (iii) a linker. The drug molecule is mandatory for the biological action, however, its efficacy can be enhanced by targeted delivery, which often also reduces unwanted side effects. For site-specificity the peptide part is mainly responsible. The linker attaches chemically the drug to the peptide, but it could also be biodegradable which ensures controlled liberation of the small drug. Despite the importance of the field, there is no public comprehensive database on these species. Herein we describe ConjuPepBD, a freely available, fully annotated and manually curated database of peptide drug conjugates. ConjuPepDB contains basic information about the entries, e.g. CAS number. Furthermore, it also implies their biomedical application and the type of chemical conjugation employed. It covers more than 1600 conjugates from ∼230 publications. The web-interface is user-friendly, intuitive, and useable on several devices, e.g. phones, tablets, PCs. The webpage allows the user to search for content using numerous criteria, chemical structure and a help page is also provided. Besides giving quick insight for newcomers, ConjuPepDB is hoped to be also helpful for researchers from various related fields. The database is accessible at: https://conjupepdb.ttk.hu/.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765608845247-9aa45b30-45c7-4a76-9d5a-c95dac44541f/assets/gkaa950gra1.jpg" alt="Peptide drug conjugates as novel class of potential drug candidates are collected."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Peptide drug conjugates as novel class of potential drug candidates are collected.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Genome Variation Map: a worldwide collection of genome variations across multiple species]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608841275-1971c587-5fb3-4795-af9e-fb3ad106c891/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1005</link>
            <description><![CDATA[<p class="para" id="N65541">The Genome Variation Map (GVM; http://bigd.big.ac.cn/gvm/) is a public data repository of genome variations. It aims to collect and integrate genome variations for a wide range of species, accepts submissions of different variation types from all over the world and provides free open access to all publicly available data in support of worldwide research activities. Compared with the previous version, particularly, a total of 22 species, 115 projects, 55 935 samples, 463 429 609 variants, 66 220 associations and 56 submissions (as of 7 September 2020) were newly added in the current version of GVM. In the current release, GVM houses a total of ∼960 million variants from 41 species, including 13 animals, 25 plants and 3 viruses. Moreover, it incorporates 64 819 individual genotypes and 260 393 manually curated high-quality genotype-to-phenotype associations. Since its inception, GVM has archived genomic variation data of 43 754 samples submitted by worldwide users and served &gt;1 million data download requests. Collectively, as a core resource in the National Genomics Data Center, GVM provides valuable genome variations for a diversity of species and thus plays an important role in both functional genomics studies and molecular breeding.</p>]]></description>
            <pubDate><![CDATA[2020-11-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[BiG-FAM: the biosynthetic gene cluster families database]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608792703-23e69fa1-30a1-4f5f-8f43-fb7650141ade/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa812</link>
            <description><![CDATA[<p class="para" id="N65541">Computational analysis of biosynthetic gene clusters (BGCs) has revolutionized natural product discovery by enabling the rapid investigation of secondary metabolic potential within microbial genome sequences. Grouping homologous BGCs into Gene Cluster Families (GCFs) facilitates mapping their architectural and taxonomic diversity and provides insights into the novelty of putative BGCs, through dereplication with BGCs of known function. While multiple databases exist for exploring BGCs from publicly available data, no public resources exist that focus on GCF relationships. Here, we present BiG-FAM, a database of 29,955 GCFs capturing the global diversity of 1,225,071 BGCs predicted from 209,206 publicly available microbial genomes and metagenome-assembled genomes (MAGs). The database offers rich functionalities, such as multi-criterion GCF searches, direct links to BGC databases such as antiSMASH-DB, and rapid GCF annotation of user-supplied BGCs from antiSMASH results. BiG-FAM can be accessed online at https://bigfam.bioinformatics.nl.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765608792703-23e69fa1-30a1-4f5f-8f43-fb7650141ade/assets/gkaa812gra1.jpg" alt="Constructed based on a large-scale homology analysis of 1.2 million biosynthetic gene clusters, BiG-FAM provides a platform to explore their genomic diversity and to discover their relationships to newly sequenced ones."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Constructed based on a large-scale homology analysis of 1.2 million biosynthetic gene clusters, BiG-FAM provides a platform to explore their genomic diversity and to discover their relationships to newly sequenced ones.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[EVLncRNAs 2.0: an updated database of manually curated functional long non-coding RNAs validated by low-throughput experiments]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608764401-f610cb2f-757f-431d-a6bc-e93441237197/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1076</link>
            <description><![CDATA[<p class="para" id="N65541">Long non-coding RNAs (lncRNAs) play important functional roles in many diverse biological processes. However, not all expressed lncRNAs are functional. Thus, it is necessary to manually collect all experimentally validated functional lncRNAs (EVlncRNA) with their sequences, structures, and functions annotated in a central database. The first release of such a database (EVLncRNAs) was made using the literature prior to 1 May 2016. Since then (till 15 May 2020), 19 245 articles related to lncRNAs have been published. In EVLncRNAs 2.0, these articles were manually examined for a major expansion of the data collected. Specifically, the number of annotated EVlncRNAs, associated diseases, lncRNA-disease associations, and interaction records were increased by 260%, 320%, 484% and 537%, respectively. Moreover, the database has added several new categories: 8 lncRNA structures, 33 exosomal lncRNAs, 188 circular RNAs, and 1079 drug-resistant, chemoresistant, and stress-resistant lncRNAs. All records have checked against known retraction and fake articles. This release also comes with a highly interactive visual interaction network that facilitates users to track the underlying relations among lncRNAs, miRNAs, proteins, genes and other functional elements. Furthermore, it provides links to four new bioinformatics tools with improved data browsing and searching functionality. EVLncRNAs 2.0 is freely available at https://www.sdklab-biophysics-dzu.net/EVLncRNAs2/.</p>]]></description>
            <pubDate><![CDATA[2020-11-22T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[OMA orthology in 2021: website overhaul, conserved isoforms, ancestral gene order and more]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608718197-4ab4ff15-3fb3-48e4-992f-52512303079f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1007</link>
            <description><![CDATA[<p class="para" id="N65541">OMA is an established resource to elucidate evolutionary relationships among genes from currently 2326 genomes covering all domains of life. OMA provides pairwise and groupwise orthologs, functional annotations, local and global gene order conservation (synteny) information, among many other functions. This update paper describes the reorganisation of the database into gene-, group- and genome-centric pages. Other new and improved features are detailed, such as reporting of the evolutionarily best conserved isoforms of alternatively spliced genes, the inferred local order of ancestral genes, phylogenetic profiling, better cross-references, fast genome mapping, semantic data sharing via RDF, as well as a special coronavirus OMA with 119 viruses from the Nidovirales order, including SARS-CoV-2, the agent of the COVID-19 pandemic. We conclude with improvements to the documentation of the resource through primers, tutorials and short videos. OMA is accessible at https://omabrowser.org.</p>]]></description>
            <pubDate><![CDATA[2020-11-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TBDB: a database of structurally annotated T-box riboswitch:tRNA pairs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608674614-a1a917fc-54b2-4c45-bb23-806cc54ff715/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa721</link>
            <description><![CDATA[<p class="para" id="N65541">T-box riboswitches constitute a large family of tRNA-binding leader sequences that play a central role in gene regulation in many gram-positive bacteria. Accurate inference of the tRNA binding to T-box riboswitches is critical to predict their cis-regulatory activity. However, there is no central repository of information on the tRNA binding specificities of T-box riboswitches, and <i>de novo</i> prediction of binding specificities requires advanced knowledge of computational tools to annotate riboswitch secondary structure features. Here, we present the T-box Riboswitch Annotation Database (TBDB, https://tbdb.io), an open-access database with a collection of 23,535 T-box riboswitch sequences, spanning the major phyla of 3,632 bacterial species. Among structural predictions, the TBDB also identifies specifier sequences, cognate tRNA binding partners, and downstream regulatory targets. To our knowledge, the TBDB presents the largest collection of feature, sequence, and structural annotations carried out on this important family of regulatory RNA.</p>]]></description>
            <pubDate><![CDATA[2020-09-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PLncDB V2.0: a comprehensive encyclopedia of plant long noncoding RNAs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608669943-1cc5351a-4253-4d63-a079-8a13e776d005/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa910</link>
            <description><![CDATA[<p class="para" id="N65541">Long noncoding RNAs (lncRNAs) are transcripts longer than 200 nucleotides with little or no protein coding potential. The expanding list of lncRNAs and accumulating evidence of their functions in plants have necessitated the creation of a comprehensive database for lncRNA research. However, currently available plant lncRNA databases have some deficiencies, including the lack of lncRNA data from some model plants, uneven annotation standards, a lack of visualization for expression patterns, and the absence of epigenetic information. To overcome these problems, we upgraded our Plant Long noncoding RNA Database (PLncDB, http://plncdb.tobaccodb.org/), which was based on a uniform annotation pipeline. PLncDB V2.0 currently contains 1 246 372 lncRNAs for 80 plant species based on 13 834 RNA-Seq datasets, integrating lncRNA information from four other resources including EVLncRNAs, RNAcentral and etc. Expression patterns and epigenetic signals can be visualized using multiple tools (JBrowse, eFP Browser and EPexplorer). Targets and regulatory networks for lncRNAs are also provided for function exploration. In addition, PLncDB V2.0 is hierarchical and user-friendly and has five built-in search engines. We believe PLncDB V2.0 is useful for the plant lncRNA community and data mining studies and provides a comprehensive resource for data-driven lncRNA research in plants.</p>]]></description>
            <pubDate><![CDATA[2020-10-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LincSNP 3.0: an updated database for linking functional variants to human long non-coding RNAs, circular RNAs and their regulatory elements]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608612253-2c66ec92-7d91-4e15-9e6a-7aad7b883592/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1037</link>
            <description><![CDATA[<p class="para" id="N65541">We describe an updated comprehensive database, LincSNP 3.0 (http://bioinfo.hrbmu.edu.cn/LincSNP), which aims to document and annotate disease or phenotype-associated variants in human long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) or their regulatory elements. LincSNP 3.0 has updated with several novel features, including (i) more types of variants including single nucleotide polymorphisms (SNPs), linkage disequilibrium SNPs (LD SNPs), somatic mutations and RNA editing sites have been expanded; (ii) more regulatory elements including transcription factor binding sites (TFBSs), enhancers, DNase I hypersensitive sites (DHSs), topologically associated domains (TADs), footprintss, methylations and open chromatin regions have been added; (iii) the associations among circRNAs, regulatory elements and variants have been identified; (iv) more experimentally supported variant-lncRNA/circRNA-disease/phenotype associations have been manually collected; (v) the sources of lncRNAs, circRNAs, SNPs, somatic mutations and RNA editing sites have been updated. Moreover, four flexible online tools including Genome Browser, Variant Mapper, Circos Plotter and Functional Annotation have been developed to retrieve, visualize and analyze the data. Collectively, LincSNP 3.0 provides associations among functional variants, regulatory elements, lncRNAs and circRNAs in diseases. It will serve as an important and continually updated resource for investigating functions and mechanisms of lncRNAs and circRNAs in diseases.</p>]]></description>
            <pubDate><![CDATA[2020-11-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[dbCAN-PUL: a database of experimentally characterized CAZyme gene clusters and their substrates]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608593483-2faafdd7-8f7f-4df3-aa7c-8f296cf0ba62/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa742</link>
            <description><![CDATA[<p class="para" id="N65541">PULs (<span style="text-decoration: underline">p</span>olysaccharide <span style="text-decoration: underline">u</span>tilization <span style="text-decoration: underline">l</span>oci) are discrete gene clusters of CAZymes (<span style="text-decoration: underline">C</span>arbohydrate <span style="text-decoration: underline">A</span>ctive En<span style="text-decoration: underline">Zymes</span>) and other genes that work together to digest and utilize carbohydrate substrates. While PULs have been extensively characterized in <i>Bacteroidetes</i>, there exist PULs from other bacterial phyla, as well as archaea and metagenomes, that remain to be catalogued in a database for efficient retrieval. We have developed an online database dbCAN-PUL (http://bcb.unl.edu/dbCAN_PUL/) to display experimentally verified CAZyme-containing PULs from literature with pertinent metadata, sequences, and annotation. Compared to other online CAZyme and PUL resources, dbCAN-PUL has the following new features: (i) Batch download of PUL data by target substrate, species/genome, genus, or experimental characterization method; (ii) Annotation for each PUL that displays associated metadata such as substrate(s), experimental characterization method(s) and protein sequence information, (iii) Links to external annotation pages for CAZymes (CAZy), transporters (UniProt) and other genes, (iv) Display of homologous gene clusters in GenBank sequences via integrated MultiGeneBlast tool and (v) An integrated BLASTX service available for users to query their sequences against PUL proteins in dbCAN-PUL. With these features, dbCAN-PUL will be an important repository for CAZyme and PUL research, complementing our other web servers and databases (dbCAN2, dbCAN-seq).</p>]]></description>
            <pubDate><![CDATA[2020-09-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[MetaNetX/MNXref: unified namespace for metabolites and biochemical reactions in the context of metabolic models]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608586010-9863c858-5162-495b-9d41-3c76b2057aea/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa992</link>
            <description><![CDATA[<p class="para" id="N65541">MetaNetX/MNXref is a reconciliation of metabolites and biochemical reactions providing cross-links between major public biochemistry and Genome-Scale Metabolic Network (GSMN) databases. The new release brings several improvements with respect to the quality of the reconciliation, with particular attention dedicated to preserving the intrinsic properties of GSMN models. The MetaNetX website (https://www.metanetx.org/) provides access to the full database and online services. A major improvement is for mapping of user-provided GSMNs to MXNref, which now provides diagnostic messages about model content. In addition to the website and flat files, the resource can now be accessed through a SPARQL endpoint (https://rdf.metanetx.org).</p>]]></description>
            <pubDate><![CDATA[2020-11-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[IndiGenomes: a comprehensive resource of genetic variants from over 1000 Indian genomes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608578997-e3132a42-a5a6-41a4-8e8e-f3ab0657bb2e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa923</link>
            <description><![CDATA[<p class="para" id="N65541">With the advent of next-generation sequencing, large-scale initiatives for mining whole genomes and exomes have been employed to better understand global or population-level genetic architecture. India encompasses more than 17% of the world population with extensive genetic diversity, but is under-represented in the global sequencing datasets. This gave us the impetus to perform and analyze the whole genome sequencing of 1029 healthy Indian individuals under the pilot phase of the ‘IndiGen’ program. We generated a compendium of 55,898,122 single allelic genetic variants from geographically distinct Indian genomes and calculated the allele frequency, allele count, allele number, along with the number of heterozygous or homozygous individuals. In the present study, these variants were systematically annotated using publicly available population databases and can be accessed through a browsable online database named as ‘IndiGenomes’ http://clingen.igib.res.in/indigen/. The IndiGenomes database will help clinicians and researchers in exploring the genetic component underlying medical conditions. Till date, this is the most comprehensive genetic variant resource for the Indian population and is made freely available for academic utility. The resource has also been accessed extensively by the worldwide community since it's launch.</p><p class="para" id="N65542">
<div class="section" id="ga1"><div class="img"><div class="imgeVideo"><div class="img-fullscreenIcon" onClick="javascript:showImageContent('ga1');"><img src="/public/images/journalImg/fullscreen.png"/></div><div class="imageVideo"><img src="/dataresources/secured/content-1765608578997-e3132a42-a5a6-41a4-8e8e-f3ab0657bb2e/assets/gkaa923gra1.jpg" alt="Overview of the Indigenomes sample collection and data analysis."/></div></div><div class="imgeVideoCaption" id="N65544"><div class="captionTitle">Graphical Abstract</div><div class="captionText">                                      Overview of the Indigenomes sample collection and data analysis.</div></div></div></div>
</p>]]></description>
            <pubDate><![CDATA[2020-10-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Chewie Nomenclature Server (chewie-NS): a deployable nomenclature server for easy sharing of core and whole genome MLST schemas]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608555511-62d52a6e-fb2c-4af7-9748-6587e4112c60/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa889</link>
            <description><![CDATA[<p class="para" id="N65541">Chewie Nomenclature Server (chewie-NS, https://chewbbaca.online/) allows users to share genome-based gene-by-gene typing schemas and to maintain a common nomenclature, simplifying the comparison of results. The combination between local analyses and a public repository of allelic data strikes a balance between potential confidentiality issues and the need to compare results. The possibility of deploying private instances of chewie-NS facilitates the creation of nomenclature servers with a restricted user base to allow compliance with the strictest data policies. Chewie-NS allows users to easily share their own schemas and to explore publicly available schemas, including informative statistics on schemas and loci presented in interactive charts and tables. Users can retrieve all the information necessary to run a schema locally or all the alleles identified at a particular locus. The integration with the chewBBACA suite enables users to directly upload new schemas to chewie-NS, download existing schemas and synchronize local and remote schemas from chewBBACA command line version, allowing an easier integration into high-throughput analysis pipelines. The same REST API linking chewie-NS and the chewBBACA suite supports the interaction of other interfaces or pipelines with the databases available at chewie-NS, facilitating the reusability of the stored data.</p>]]></description>
            <pubDate><![CDATA[2020-10-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Ensembl 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608532315-5a6404d2-d449-4a36-8c8c-a35ac5d5e8de/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa942</link>
            <description><![CDATA[<p class="para" id="N65541">The Ensembl project (https://www.ensembl.org) annotates genomes and disseminates genomic data for vertebrate species. We create detailed and comprehensive annotation of gene structures, regulatory elements and variants, and enable comparative genomics by inferring the evolutionary history of genes and genomes. Our integrated genomic data are made available in a variety of ways, including genome browsers, search interfaces, specialist tools such as the Ensembl Variant Effect Predictor, download files and programmatic interfaces. Here, we present recent Ensembl developments including two new website portals. Ensembl Rapid Release (http://rapid.ensembl.org) is designed to provide core tools and services for genomes as soon as possible and has been deployed to support large biodiversity sequencing projects. Our SARS-CoV-2 genome browser (https://covid-19.ensembl.org) integrates our own annotation with publicly available genomic data from numerous sources to facilitate the use of genomics in the international scientific response to the COVID-19 pandemic. We also report on other updates to our annotation resources, tools and services. All Ensembl data and software are freely available without restriction.</p>]]></description>
            <pubDate><![CDATA[2020-11-02T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608519687-69687228-947f-420e-a6d2-c76b351d7eb0/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa959</link>
            <description><![CDATA[<p class="para" id="N65541">HbVar (http://globin.bx.psu.edu/hbvar) is a widely-used locus-specific database (LSDB) launched 20 years ago by a multi-center academic effort to provide timely information on the numerous genomic variants leading to hemoglobin variants and all types of thalassemia and hemoglobinopathies. Here, we report several advances for the database. We made clinically relevant updates of HbVar, implemented as additional querying options in the HbVar query page, allowing the user to explore the clinical phenotype of compound heterozygous patients. We also made significant improvements to the HbVar front page, making comparative data querying, analysis and output more user-friendly. We continued to expand and enrich the regular data content, involving 1820 variants, 230 of which are new entries. We also increased the querying potential and expanded the usefulness of HbVar database in the clinical setting. These several additions, expansions and updates should improve the utility of HbVar both for the globin research community and in a clinical setting.</p>]]></description>
            <pubDate><![CDATA[2020-10-30T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[FireProt<sup>DB</sup>: database of manually curated protein stability data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608389124-5cdd82af-878e-4aa1-ab30-231e45251b62/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa981</link>
            <description><![CDATA[<p class="para" id="N65541">The majority of naturally occurring proteins have evolved to function under mild conditions inside the living organisms. One of the critical obstacles for the use of proteins in biotechnological applications is their insufficient stability at elevated temperatures or in the presence of salts. Since experimental screening for stabilizing mutations is typically laborious and expensive, <i>in silico</i> predictors are often used for narrowing down the mutational landscape. The recent advances in machine learning and artificial intelligence further facilitate the development of such computational tools. However, the accuracy of these predictors strongly depends on the quality and amount of data used for training and testing, which have often been reported as the current bottleneck of the approach. To address this problem, we present a novel database of experimental thermostability data for single-point mutants FireProt<sup>DB</sup>. The database combines the published datasets, data extracted manually from the recent literature, and the data collected in our laboratory. Its user interface is designed to facilitate both types of the expected use: (i) the interactive explorations of individual entries on the level of a protein or mutation and (ii) the construction of highly customized and machine learning-friendly datasets using advanced searching and filtering. The database is freely available at https://loschmidt.chemi.muni.cz/fireprotdb.</p>]]></description>
            <pubDate><![CDATA[2020-11-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CancerImmunityQTL: a database to systematically evaluate the impact of genetic variants on immune infiltration in human cancer]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608384474-2d076930-0a99-4ae5-a8b9-dfa7af496fad/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa805</link>
            <description><![CDATA[<p class="para" id="N65541">Tumor-infiltrating immune cells as integral component of the tumor microenvironment are associated with tumor progress, prognosis and responses to immunotherapy. Genetic variants have been demonstrated to impact tumor-infiltrating, underscoring the heritable character of immune landscape. Therefore, identification of immunity quantitative trait loci (immunQTLs), which evaluate the effect of genetic variants on immune cells infiltration, might present a critical step toward fully understanding the contribution of genetic variants in tumor development. Although emerging studies have demonstrated the determinants of germline variants on immune infiltration, no database has yet been developed to systematically analyze immunQTLs across multiple cancer types. Using genotype data from TCGA database and immune cell fractions estimated by CIBERSORT, we developed a computational pipeline to identify immunQTLs in 33 cancer types. A total of 913 immunQTLs across different cancer types were identified. Among them, 5 immunQTLs are associated with patient overall survival. Furthermore, by integrating immunQTLs with GWAS data, we identified 527 immunQTLs overlapping with known GWAS linkage disequilibrium regions. Finally, we constructed a user-friendly database, CancerImmunityQTL (http://www.cancerimmunityqtl-hust.com/) for users to browse, search and download data of interest. This database provides an informative resource to understand the germline determinants of immune infiltration in human cancer and benefit from personalized cancer immunotherapy.</p>]]></description>
            <pubDate><![CDATA[2020-10-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Comparative Toxicogenomics Database (CTD): update 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608344973-c9ccf5bf-d468-452e-94a3-064e7de33c2b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa891</link>
            <description><![CDATA[<p class="para" id="N65541">The public Comparative Toxicogenomics Database (CTD; http://ctdbase.org/) is an innovative digital ecosystem that relates toxicological information for chemicals, genes, phenotypes, diseases, and exposures to advance understanding about human health. Literature-based, manually curated interactions are integrated to create a knowledgebase that harmonizes cross-species heterogeneous data for chemical exposures and their biological repercussions. In this biennial update, we report a 20% increase in CTD curated content and now provide 45 million toxicogenomic relationships for over 16 300 chemicals, 51 300 genes, 5500 phenotypes, 7200 diseases and 163 000 exposure events, from 600 comparative species. Furthermore, we increase the functionality of chemical–phenotype content with new data-tabs on CTD Disease pages (to help fill in knowledge gaps for environmental health) and new phenotype search parameters (for Batch Query and Venn analysis tools). As well, we introduce new CTD Anatomy pages that allow users to uniquely explore and analyze chemical–phenotype interactions from an anatomical perspective. Finally, we have enhanced CTD Chemical pages with new literature-based chemical synonyms (to improve querying) and added 1600 amino acid-based compounds (to increase chemical landscape). Together, these updates continue to augment CTD as a powerful resource for generating testable hypotheses about the etiologies and molecular mechanisms underlying environmentally influenced diseases.</p>]]></description>
            <pubDate><![CDATA[2020-10-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608332363-dd42c57a-98dd-4bae-9faf-7ce574b86f5b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1084</link>
            <description><![CDATA[<p class="para" id="N65541">The Drug-Gene Interaction Database (DGIdb, www.dgidb.org) is a web resource that provides information on drug-gene interactions and druggable genes from publications, databases, and other web-based sources. Drug, gene, and interaction data are normalized and merged into conceptual groups. The information contained in this resource is available to users through a straightforward search interface, an application programming interface (API), and TSV data downloads. DGIdb 4.0 is the latest major version release of this database. A primary focus of this update was integration with crowdsourced efforts, leveraging the Drug Target Commons for community-contributed interaction data, Wikidata to facilitate term normalization, and export to NDEx for drug-gene interaction network representations. Seven new sources have been added since the last major version release, bringing the total number of sources included to 41. Of the previously aggregated sources, 15 have been updated. DGIdb 4.0 also includes improvements to the process of drug normalization and grouping of imported sources. Other notable updates include the introduction of a more sophisticated Query Score for interaction search results, an updated Interaction Score, the inclusion of interaction directionality, and several additional improvements to search features, data releases, licensing documentation and the application framework.</p>]]></description>
            <pubDate><![CDATA[2020-11-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[tsRBase: a comprehensive database for expression and function of tsRNAs in multiple species]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608319817-33f06d09-584c-4a4b-ab7d-ccd10338f68b/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa888</link>
            <description><![CDATA[<p class="para" id="N65541">tRNA-derived small RNAs (tsRNAs) are a class of novel small RNAs, ubiquitously present in prokaryotes and eukaryotes. It has been reported that tsRNAs exhibit spatiotemporal expression patterns and can function as regulatory molecules in many biological processes. Current tsRNA databases only cover limited organisms and ignore tsRNA functional characteristics. Thus, integrating more relevant tsRNA information is helpful for further exploration. Here, we present a tsRNA database, named tsRBase, which integrates the expression pattern and functional information of tsRNAs in multiple species. In tsRBase, we identified 121 942 tsRNAs by analyzing more than 14 000 publicly available small RNA-seq data covering 20 species. This database collects samples from different tissues/cell-lines, or under different treatments and genetic backgrounds, thus helps depict specific expression patterns of tsRNAs under different conditions. Importantly, to enrich our understanding of biological significance, we collected tsRNAs experimentally validated from published literatures, obtained protein-binding tsRNAs from CLIP/RIP-seq data, and identified targets of tsRNAs from CLASH and CLEAR-CLIP data. Taken together, tsRBase is the most comprehensive and systematic tsRNA repository, exhibiting all-inclusive information of tsRNAs from diverse data sources of multiple species. tsRBase is freely available at http://www.tsrbase.org.</p>]]></description>
            <pubDate><![CDATA[2020-10-17T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[cncRNAdb: a manually curated resource of experimentally supported RNAs with both protein-coding and noncoding function]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608256716-e0adf79e-adb1-40c2-ac87-7f45f2905feb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa791</link>
            <description><![CDATA[<p class="para" id="N65541">RNA endowed with both protein-coding and noncoding functions is referred to as ‘dual-function RNA’, ‘binary functional RNA (bifunctional RNA)’ or ‘cncRNA (coding and noncoding RNA)’. Recently, an increasing number of cncRNAs have been identified, including both translated ncRNAs (ncRNAs with coding functions) and untranslated mRNAs (mRNAs with noncoding functions). However, an appropriate database for storing and organizing cncRNAs is still lacking. Here, we developed cncRNAdb, a manually curated database of experimentally supported cncRNAs, which aims to provide a resource for efficient manipulation, browsing and analysis of cncRNAs. The current version of cncRNAdb documents about 2600 manually curated entries of cncRNA functions with experimental evidence, involving more than 2,000 RNAs (including over 1300 translated ncRNAs and over 600 untranslated mRNAs) across over 20 species. In summary, we believe that cncRNAdb will help elucidate the functions and mechanisms of cncRNAs and develop new prediction methods. The database is available at http://www.rna-society.org/cncrnadb/.</p>]]></description>
            <pubDate><![CDATA[2020-10-03T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[From ArrayExpress to BioStudies]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608225115-9ae70b7a-cbf4-42a9-9fd6-478f6000b133/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1062</link>
            <description><![CDATA[<p class="para" id="N65541">ArrayExpress (https://www.ebi.ac.uk/arrayexpress) is an archive of functional genomics data at EMBL-EBI, established in 2002, initially as an archive for publication-related microarray data and was later extended to accept sequencing-based data. Over the last decade an increasing share of biological experiments involve multiple technologies assaying different biological modalities, such as epigenetics, and RNA and protein expression, and thus the BioStudies database (https://www.ebi.ac.uk/biostudies) was established to deal with such multimodal data. Its central concept is a <i>study</i>, which typically is associated with a publication. BioStudies stores metadata describing the study, provides links to the relevant databases, such as European Nucleotide Archive (ENA), as well as hosts the types of data for which specialized databases do not exist. With BioStudies now fully functional, we are able to further harmonize the archival data infrastructure at EMBL-EBI, and ArrayExpress is being migrated to BioStudies. In future, all functional genomics data will be archived at BioStudies. The process will be seamless for the users, who will continue to submit data using the online tool Annotare and will be able to query and download data largely in the same manner as before. Nevertheless, some technical aspects, particularly programmatic access, will change. This update guides the users through these changes.</p>]]></description>
            <pubDate><![CDATA[2020-11-19T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The MemMoRF database for recognizing disordered protein regions interacting with cellular membranes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608203486-63f42805-3a43-4428-91f5-fdc3fcff2c1e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa954</link>
            <description><![CDATA[<p class="para" id="N65541">Protein and lipid membrane interactions play fundamental roles in a large number of cellular processes (e.g. signalling, vesicle trafficking, or viral invasion). A growing number of examples indicate that such interactions can also rely on intrinsically disordered protein regions (IDRs), which can form specific reversible interactions not only with proteins but also with lipids. We named IDRs involved in such membrane lipid-induced disorder-to-order transition as MemMoRFs, in an analogy to IDRs exhibiting disorder-to-order transition upon interaction with protein partners termed Molecular Recognition Features (MoRFs). Currently, both the experimental detection and computational characterization of MemMoRFs are challenging, and information about these regions are scattered in the literature. To facilitate the related investigations we generated a comprehensive database of experimentally validated MemMoRFs based on manual curation of literature and structural data. To characterize the dynamics of MemMoRFs, secondary structure propensity and flexibility calculated from nuclear magnetic resonance chemical shifts were incorporated into the database. These data were supplemented by inclusion of sentences from papers, functional data and disease-related information. The MemMoRF database can be accessed via a user-friendly interface at https://memmorf.hegelab.org, potentially providing a central resource for the characterization of disordered regions in transmembrane and membrane-associated proteins.</p>]]></description>
            <pubDate><![CDATA[2020-10-29T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PSORTdb 4.0: expanded and redesigned bacterial and archaeal protein subcellular localization database incorporating new secondary localizations]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608189966-4070ebf7-3b1c-4c29-a99d-976d82ab9862/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1095</link>
            <description><![CDATA[<p class="para" id="N65541">Protein subcellular localization (SCL) is important for understanding protein function, genome annotation, and aids identification of potential cell surface diagnostic markers, drug targets, or vaccine components. PSORTdb comprises ePSORTdb, a manually curated database of experimentally verified protein SCLs, and cPSORTdb, a pre-computed database of PSORTb-predicted SCLs for NCBI’s RefSeq deduced bacterial and archaeal proteomes. We now report PSORTdb 4.0 (http://db.psort.org/). It features a website refresh, in particular a more user-friendly database search. It also addresses the need to uniquely identify proteins from NCBI genomes now that GI numbers have been retired. It further expands both ePSORTdb and cPSORTdb, including additional data about novel secondary localizations, such as proteins found in bacterial outer membrane vesicles. Protein predictions in cPSORTdb have increased along with the number of available microbial genomes, from approximately 13 million when PSORTdb 3.0 was released, to over 66 million currently. Now, analyses of both complete and draft genomes are included. This expanded database will be of wide use to researchers developing SCL predictors or studying diverse microbes, including medically, agriculturally and industrially important species that have both classic or atypical cell envelope structures or vesicles.</p>]]></description>
            <pubDate><![CDATA[2020-12-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CATH: increased structural coverage of functional space]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608177709-936848e0-28c4-491f-9257-253672d2442f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1079</link>
            <description><![CDATA[<p class="para" id="N65541">CATH (https://www.cathdb.info) identifies domains in protein structures from wwPDB and classifies these into evolutionary superfamilies, thereby providing structural and functional annotations. There are two levels: CATH-B, a daily snapshot of the latest domain structures and superfamily assignments, and CATH+, with additional derived data, such as predicted sequence domains, and functionally coherent sequence subsets (Functional Families or FunFams). The latest CATH+ release, version 4.3, significantly increases coverage of structural and sequence data, with an addition of 65,351 fully-classified domains structures (+15%), providing 500 238 structural domains, and 151 million predicted sequence domains (+59%) assigned to 5481 superfamilies. The FunFam generation pipeline has been re-engineered to cope with the increased influx of data. Three times more sequences are captured in FunFams, with a concomitant increase in functional purity, information content and structural coverage. FunFam expansion increases the structural annotations provided for experimental GO terms (+59%). We also present CATH-FunVar web-pages displaying variations in protein sequences and their proximity to known or predicted functional sites. We present two case studies (1) putative cancer drivers and (2) SARS-CoV-2 proteins. Finally, we have improved links to and from CATH including SCOP, InterPro, Aquaria and 2DProt.</p>]]></description>
            <pubDate><![CDATA[2020-11-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608172955-63aefe37-f027-447a-ab40-1115894a16fc/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa698</link>
            <description><![CDATA[<p class="para" id="N65541">Although cancer is the leading cause of disease-related mortality in children, the relative rarity of pediatric cancers poses a significant challenge for developing novel therapeutics to further improve prognosis. Patient-derived xenograft (PDX) models, which are usually developed from high-risk tumors, are a useful platform to study molecular driver events, identify biomarkers and prioritize therapeutic agents. Here, we develop PDX for Childhood Cancer Therapeutics (PCAT), a new integrated portal for pediatric cancer PDX models. Distinct from previously reported PDX portals, PCAT is focused on pediatric cancer models and provides intuitive interfaces for querying and data mining. The current release comprises 324 models and their associated clinical and genomic data, including gene expression, mutation and copy number alteration. Importantly, PCAT curates preclinical testing results for 68 models and 79 therapeutic agents manually collected from individual agent testing studies published since 2008. To facilitate comparisons of patterns between patient tumors and PDX models, PCAT curates clinical and molecular data of patient tumors from the TARGET project. In addition, PCAT provides access to gene fusions identified in nearly 1000 TARGET samples. PCAT was built using R-shiny and MySQL. The portal can be accessed at http://pcat.zhenglab.info or http://www.pedtranscriptome.org.</p>]]></description>
            <pubDate><![CDATA[2020-08-18T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[TCRD and Pharos 2021: mining the human proteome for disease biology]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608145655-225ac362-268f-4481-96d3-ec7b48605526/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa993</link>
            <description><![CDATA[<p class="para" id="N65541">In 2014, the National Institutes of Health (NIH) initiated the Illuminating the Druggable Genome (IDG) program to identify and improve our understanding of poorly characterized proteins that can potentially be modulated using small molecules or biologics. Two resources produced from these efforts are: The Target Central Resource Database (TCRD) (http://juniper.health.unm.edu/tcrd/) and Pharos (https://pharos.nih.gov/), a web interface to browse the TCRD. The ultimate goal of these resources is to highlight and facilitate research into currently understudied proteins, by aggregating a multitude of data sources, and ranking targets based on the amount of data available, and presenting data in machine learning ready format. Since the 2017 release, both TCRD and Pharos have produced two major releases, which have incorporated or expanded an additional 25 data sources. Recently incorporated data types include human and viral-human protein–protein interactions, protein–disease and protein–phenotype associations, and drug-induced gene signatures, among others. These aggregated data have enabled us to generate new visualizations and content sections in Pharos, in order to empower users to find new areas of study in the druggable genome.</p>]]></description>
            <pubDate><![CDATA[2020-11-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608120362-aed6e89f-b3de-41a9-be1a-b49000910c44/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1106</link>
            <description><![CDATA[<p class="para" id="N65541">PANTHER (Protein Analysis Through Evolutionary Relationships, http://www.pantherdb.org) is a resource for the evolutionary and functional classification of protein-coding genes from all domains of life. The evolutionary classification is based on a library of over 15,000 phylogenetic trees, and the functional classifications include Gene Ontology terms and pathways. Here, we analyze the current coverage of genes from genomes in different taxonomic groups, so that users can better understand what to expect when analyzing a gene list using PANTHER tools. We also describe extensive improvements to PANTHER made in the past two years. The PANTHER Protein Class ontology has been completely refactored, and 6101 PANTHER families have been manually assigned to a Protein Class, providing a high level classification of protein families and their genes. Users can access the TreeGrafter tool to add their own protein sequences to the reference phylogenetic trees in PANTHER, to infer evolutionary context as well as fine-grained annotations. We have added human enhancer-gene links that associate non-coding regions with the annotated human genes in PANTHER. We have also expanded the available services for programmatic access to PANTHER tools and data via application programming interfaces (APIs). Other improvements include additional plant genomes and an updated PANTHER GO-slim.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[LitCovid: an open database of COVID-19 literature]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608115966-f3ba1e4b-90e6-4230-ad87-44f849698b2f/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa952</link>
            <description><![CDATA[<p class="para" id="N65541">Since the outbreak of the current pandemic in 2020, there has been a rapid growth of published articles on COVID-19 and SARS-CoV-2, with about 10 000 new articles added each month. This is causing an increasingly serious information overload, making it difficult for scientists, healthcare professionals and the general public to remain up to date on the latest SARS-CoV-2 and COVID-19 research. Hence, we developed LitCovid (https://www.ncbi.nlm.nih.gov/research/coronavirus/), a curated literature hub, to track up-to-date scientific information in PubMed. LitCovid is updated daily with newly identified relevant articles organized into curated categories. To support manual curation, advanced machine-learning and deep-learning algorithms have been developed, evaluated and integrated into the curation workflow. To the best of our knowledge, LitCovid is the first-of-its-kind COVID-19-specific literature resource, with all of its collected articles and curated data freely available. Since its release, LitCovid has been widely used, with millions of accesses by users worldwide for various information needs, such as evidence synthesis, drug discovery and text and data mining, among others.</p>]]></description>
            <pubDate><![CDATA[2020-11-09T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GTRD: an integrated view of transcription regulation]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608091136-0472dc36-65b0-4433-ab2b-065f301c8715/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1057</link>
            <description><![CDATA[<p class="para" id="N65541">The Gene Transcription Regulation Database (GTRD; http://gtrd.biouml.org/) contains uniformly annotated and processed NGS data related to gene transcription regulation: ChIP-seq, ChIP-exo, DNase-seq, MNase-seq, ATAC-seq and RNA-seq. With the latest release, the database has reached a new level of data integration. All cell types (cell lines and tissues) presented in the GTRD were arranged into a dictionary and linked with different ontologies (BRENDA, Cell Ontology, Uberon, Cellosaurus and Experimental Factor Ontology) and with related experiments in specialized databases on transcription regulation (FANTOM5, ENCODE and GTEx). The updated version of the GTRD provides an integrated view of transcription regulation through a dedicated web interface with advanced browsing and search capabilities, an integrated genome browser, and table reports by cell types, transcription factors, and genes of interest.</p>]]></description>
            <pubDate><![CDATA[2020-11-24T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Gene Ontology resource: enriching a GOld mine]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608056700-1c297d16-ff14-459d-a629-5d2d202bd2d3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1113</link>
            <description><![CDATA[<p class="para" id="N65541">The Gene Ontology Consortium (GOC) provides the most comprehensive resource currently available for computable knowledge regarding the functions of genes and gene products. Here, we report the advances of the consortium over the past two years. The new GO-CAM annotation framework was notably improved, and we formalized the model with a computational schema to check and validate the rapidly increasing repository of 2838 GO-CAMs. In addition, we describe the impacts of several collaborations to refine GO and report a 10% increase in the number of GO annotations, a 25% increase in annotated gene products, and over 9,400 new scientific articles annotated. As the project matures, we continue our efforts to review older annotations in light of newer findings, and, to maintain consistency with other ontologies. As a result, 20 000 annotations derived from experimental data were reviewed, corresponding to 2.5% of experimental GO annotations. The website (http://geneontology.org) was redesigned for quick access to documentation, downloads and tools. To maintain an accurate resource and support traceability and reproducibility, we have made available a historical archive covering the past 15 years of GO data with a consistent format and file structure for both the ontology and annotations.</p>]]></description>
            <pubDate><![CDATA[2020-12-08T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[deepBase v3.0: expression atlas and interactive analysis of ncRNAs from thousands of deep-sequencing data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765608039251-65efa067-8ee2-448d-9214-4d024fd1ada4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1039</link>
            <description><![CDATA[<p class="para" id="N65541">Eukaryotic genomes encode thousands of small and large non-coding RNAs (ncRNAs). However, the expression, functions and evolution of these ncRNAs are still largely unknown. In this study, we have updated deepBase to version 3.0 (deepBase v3.0, http://rna.sysu.edu.cn/deepbase3/index.html), an increasingly popular and openly licensed resource that facilitates integrative and interactive display and analysis of the expression, evolution, and functions of various ncRNAs by deeply mining thousands of high-throughput sequencing data from tissue, tumor and exosome samples. We updated deepBase v3.0 to provide the most comprehensive expression atlas of small RNAs and lncRNAs by integrating ∼67 620 data from 80 normal tissues and ∼50 cancer tissues. The extracellular patterns of various ncRNAs were profiled to explore their applications for discovery of noninvasive biomarkers. Moreover, we constructed survival maps of tRNA-derived RNA Fragments (tRFs), miRNAs, snoRNAs and lncRNAs by analyzing &gt;45 000 cancer sample data and corresponding clinical information. We also developed interactive webs to analyze the differential expression and biological functions of various ncRNAs in ∼50 types of cancers. This update is expected to provide a variety of new modules and graphic visualizations to facilitate analyses and explorations of the functions and mechanisms of various types of ncRNAs.</p>]]></description>
            <pubDate><![CDATA[2020-11-11T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DualSeqDB: the host–pathogen dual RNA sequencing database for infection processes]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765603906832-7f35e860-b2ba-4af8-8d6b-b77bed4efb0e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa890</link>
            <description><![CDATA[<p class="para" id="N65541">Despite antibiotic resistance being a matter of growing concern worldwide, the bacterial mechanisms of pathogenesis remain underexplored, restraining our ability to develop new antimicrobials. The rise of high-throughput sequencing technology has made available a massive amount of transcriptomic data that could help elucidate the mechanisms underlying bacterial infection. Here, we introduce the DualSeqDB database, a resource that helps the identification of gene transcriptional changes in both pathogenic bacteria and their natural hosts upon infection. DualSeqDB comprises nearly 300 000 entries from eight different studies, with information on bacterial and host differential gene expression under <i>in vivo</i> and <i>in vitro</i> conditions. Expression data values were calculated entirely from raw data and analyzed through a standardized pipeline to ensure consistency between different studies. It includes information on seven different strains of pathogenic bacteria and a variety of cell types and tissues in <i>Homo sapiens</i>, <i>Mus musculus</i> and <i>Macaca fascicularis</i> at different time points. We envisage that DualSeqDB can help the research community in the systematic characterization of genes involved in host infection and help the development and tailoring of new molecules against infectious diseases. DualSeqDB is freely available at http://www.tartaglialab.com/dualseq.</p>]]></description>
            <pubDate><![CDATA[2020-10-21T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DrugSpaceX: a large screenable and synthetically tractable database extending drug space]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765603883043-39a4df70-93bd-4e18-807e-c0d9707c1629/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa920</link>
            <description><![CDATA[<p class="para" id="N65541">One of the most prominent topics in drug discovery is efficient exploration of the vast drug-like chemical space to find synthesizable and novel chemical structures with desired biological properties. To address this challenge, we created the DrugSpaceX (https://drugspacex.simm.ac.cn/) database based on expert-defined transformations of approved drug molecules. The current version of DrugSpaceX contains &gt;100 million transformed chemical products for virtual screening, with outstanding characteristics in terms of structural novelty, diversity and large three-dimensional chemical space coverage. To illustrate its practical application in drug discovery, we used a case study of discoidin domain receptor 1 (DDR1), a kinase target implicated in fibrosis and other diseases, to show DrugSpaceX performing a quick search of initial hit compounds. Additionally, for ligand identification and optimization purposes, DrugSpaceX also provides several subsets for download, including a 10% diversity subset, an extended drug-like subset, a drug-like subset, a lead-like subset, and a fragment-like subset. In addition to chemical properties and transformation instructions, DrugSpaceX can locate the position of transformation, which will enable medicinal chemists to easily integrate strategy planning and protection design.</p>]]></description>
            <pubDate><![CDATA[2020-10-26T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[CNCDatabase: a database of non-coding cancer drivers]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765603832037-872ee5e9-e971-420f-be8b-2ec34070dfe3/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa915</link>
            <description><![CDATA[<p class="para" id="N65541">Most mutations in cancer genomes occur in the non-coding regions with unknown impact on tumor development. Although the increase in the number of cancer whole-genome sequences has revealed numerous putative non-coding cancer drivers, their information is dispersed across multiple studies making it difficult to understand their roles in tumorigenesis of different cancer types. We have developed CNCDatabase, Cornell Non-coding Cancer driver Database (https://cncdatabase.med.cornell.edu/) that contains detailed information about predicted non-coding drivers at gene promoters, 5′ and 3′ UTRs (untranslated regions), enhancers, CTCF insulators and non-coding RNAs. CNCDatabase documents 1111 protein-coding genes and 90 non-coding RNAs with reported drivers in their non-coding regions from 32 cancer types by computational predictions of positive selection using whole-genome sequences; differential gene expression in samples with and without mutations; or another set of experimental validations including luciferase reporter assays and genome editing. The database can be easily modified and scaled as lists of non-coding drivers are revised in the community with larger whole-genome sequencing studies, CRISPR screens and further experimental validations. Overall, CNCDatabase provides a helpful resource for researchers to explore the pathological role of non-coding alterations in human cancers.</p>]]></description>
            <pubDate><![CDATA[2020-10-23T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[UniProt: the universal protein knowledgebase in 2021]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765603814441-494a9f23-5ed5-42cf-8c84-6a544007b00c/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1100</link>
            <description><![CDATA[<p class="para" id="N65541">The aim of the UniProt Knowledgebase is to provide users with a comprehensive, high-quality and freely accessible set of protein sequences annotated with functional information. In this article, we describe significant updates that we have made over the last two years to the resource. The number of sequences in UniProtKB has risen to approximately 190 million, despite continued work to reduce sequence redundancy at the proteome level. We have adopted new methods of assessing proteome completeness and quality. We continue to extract detailed annotations from the literature to add to reviewed entries and supplement these in unreviewed entries with annotations provided by automated systems such as the newly implemented Association-Rule-Based Annotator (ARBA). We have developed a credit-based publication submission interface to allow the community to contribute publications and annotations to UniProt entries. We describe how UniProtKB responded to the COVID-19 pandemic through expert curation of relevant entries that were rapidly made available to the research community through a dedicated portal. UniProt resources are available under a CC-BY (4.0) license via the web at https://www.uniprot.org/.</p>]]></description>
            <pubDate><![CDATA[2020-11-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[3DIV update for 2021: a comprehensive resource of 3D genome and 3D cancer genome]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602167220-7f5fc953-18c9-4ca6-b138-e4428935b798/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1078</link>
            <description><![CDATA[<p class="para" id="N65541">Three-dimensional (3D) genome organization is tightly coupled with gene regulation in various biological processes and diseases. In cancer, various types of large-scale genomic rearrangements can disrupt the 3D genome, leading to oncogenic gene expression. However, unraveling the pathogenicity of the 3D cancer genome remains a challenge since closer examinations have been greatly limited due to the lack of appropriate tools specialized for disorganized higher-order chromatin structure. Here, we updated a 3D-genome Interaction Viewer and database named 3DIV by uniformly processing ∼230 billion raw Hi-C reads to expand our contents to the 3D cancer genome. The updates of 3DIV are listed as follows: (i) the collection of 401 samples including 220 cancer cell line/tumor Hi-C data, 153 normal cell line/tissue Hi-C data, and 28 promoter capture Hi-C data, (ii) the live interactive manipulation of the 3D cancer genome to simulate the impact of structural variations and (iii) the reconstruction of Hi-C contact maps by user-defined chromosome order to investigate the 3D genome of the complex genomic rearrangement. In summary, the updated 3DIV will be the most comprehensive resource to explore the gene regulatory effects of both the normal and cancer 3D genome. ‘3DIV’ is freely available at http://3div.kr.</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[RepeatsDB in 2021: improved data and extended classification for protein tandem repeat structures]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602155498-48010892-811d-4565-8ed1-117c8c602234/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1097</link>
            <description><![CDATA[<p class="para" id="N65541">The RepeatsDB database (URL: https://repeatsdb.org/) provides annotations and classification for protein tandem repeat structures from the Protein Data Bank (PDB). Protein tandem repeats are ubiquitous in all branches of the tree of life. The accumulation of solved repeat structures provides new possibilities for classification and detection, but also increasing the need for annotation. Here we present RepeatsDB 3.0, which addresses these challenges and presents an extended classification scheme. The major conceptual change compared to the previous version is the hierarchical classification combining top levels based solely on structural similarity (Class &gt; Topology &gt; Fold) with two new levels (Clan &gt; Family) requiring sequence similarity and describing repeat motifs in collaboration with Pfam. Data growth has been addressed with improved mechanisms for browsing the classification hierarchy. A new UniProt-centric view unifies the increasingly frequent annotation of structures from identical or similar sequences. This update of RepeatsDB aligns with our commitment to develop a resource that extracts, organizes and distributes specialized information on tandem repeat protein structures.</p>]]></description>
            <pubDate><![CDATA[2020-11-25T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[iModulonDB: a knowledgebase of microbial transcriptional regulation derived from machine learning]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602151124-cb4bd30f-1796-4613-86ce-9047e4b5c9e8/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa810</link>
            <description><![CDATA[<p class="para" id="N65541">Independent component analysis (ICA) of bacterial transcriptomes has emerged as a powerful tool for obtaining co-regulated, independently-modulated gene sets (iModulons), inferring their activities across a range of conditions, and enabling their association to known genetic regulators. By grouping and analyzing genes based on observations from big data alone, iModulons can provide a novel perspective into how the composition of the transcriptome adapts to environmental conditions. Here, we present iModulonDB (imodulondb.org), a knowledgebase of prokaryotic transcriptional regulation computed from high-quality transcriptomic datasets using ICA. Users select an organism from the home page and then search or browse the curated iModulons that make up its transcriptome. Each iModulon and gene has its own interactive dashboard, featuring plots and tables with clickable, hoverable, and downloadable features. This site enhances research by presenting scientists of all backgrounds with co-expressed gene sets and their activity levels, which lead to improved understanding of regulator-gene relationships, discovery of transcription factors, and the elucidation of unexpected relationships between conditions and genetic regulatory activity. The current release of iModulonDB covers three organisms (<i>Escherichia coli, Staphylococcus aureus</i> and <i>Bacillus subtilis</i>) with 204 iModulons, and can be expanded to cover many additional organisms.</p>]]></description>
            <pubDate><![CDATA[2020-10-12T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[GenBank]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602148071-a8d1db33-9674-457b-898a-45a24cec6a0e/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1023</link>
            <description><![CDATA[<p class="para" id="N65541">GenBank<sup>®</sup> (https://www.ncbi.nlm.nih.gov/genbank/) is a comprehensive, public database that contains 9.9 trillion base pairs from over 2.1 billion nucleotide sequences for 478 000 formally described species. Daily data exchange with the European Nucleotide Archive and the DNA Data Bank of Japan ensures worldwide coverage. Recent updates include new resources for data from the SARS-CoV-2 virus, updates to the NCBI Submission Portal and associated submission wizards for dengue and SARS-CoV-2 viruses, new taxonomy queries for viruses and prokaryotes, and simplified submission processes for EST and GSS sequences.</p>]]></description>
            <pubDate><![CDATA[2020-11-16T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[DIANA-miRGen v4: indexing promoters and regulators for more than 1500 microRNAs]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602143791-e4900677-7def-452b-a176-bfe4b4d27dfb/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1060</link>
            <description><![CDATA[<p class="para" id="N65541">Deregulation of microRNA (miRNA) expression plays a critical role in the transition from a physiological to a pathological state. The accurate miRNA promoter identification in multiple cell types is a fundamental endeavor towards understanding and characterizing the underlying mechanisms of both physiological as well as pathological conditions. DIANA-miRGen v4 (www.microrna.gr/mirgenv4) provides cell type specific miRNA transcription start sites (TSSs) for over 1500 miRNAs retrieved from the analysis of &gt;1000 cap analysis of gene expression (CAGE) samples corresponding to 133 tissues, cell lines and primary cells available in FANTOM repository. MiRNA TSS locations were associated with transcription factor binding site (TFBSs) annotation, for &gt;280 TFs, derived from analyzing the majority of ENCODE ChIP-Seq datasets. For the first time, clusters of cell types having common miRNA TSSs are characterized and provided through a user friendly interface with multiple layers of customization. DIANA-miRGen v4 significantly improves our understanding of miRNA biogenesis regulation at the transcriptional level by providing a unique integration of high-quality annotations for hundreds of cell specific miRNA promoters with experimentally derived TFBSs.</p>]]></description>
            <pubDate><![CDATA[2020-11-27T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[NASA GeneLab: interfaces for the exploration of space omics data]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602130993-caac6cb1-3ae3-4413-b12d-30f9c56574fa/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa887</link>
            <description><![CDATA[<p class="para" id="N65541">The mission of NASA’s GeneLab database (https://genelab.nasa.gov/) is to collect, curate, and provide access to the genomic, transcriptomic, proteomic and metabolomic (so-called ‘omics’) data from biospecimens flown in space or exposed to simulated space stressors, maximizing their utilization. This large collection of data enables the exploration of molecular network responses to space environments using a systems biology approach. We review here the various components of the GeneLab platform, including the new data repository web interface, and the GeneLab Online Data Entry (GEODE) web portal, which will support the expansion of the database in the future to include companion non-omics assay data. We discuss our design for GEODE, particularly how it promotes investigators providing more accurate metadata, reducing the curation effort required of GeneLab staff. We also introduce here a new GeneLab Application Programming Interface (API) specifically designed to support tools for the visualization of processed omics data. We review the outreach efforts by GeneLab to utilize the spaceflight data in the repository to generate novel discoveries and develop new hypotheses, including spearheading data analysis working groups, and a high school student training program. All these efforts are aimed ultimately at supporting precision risk management for human space exploration.</p>]]></description>
            <pubDate><![CDATA[2020-10-20T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The Zebrafish Information Network: major gene page and home page updates]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602084677-043a856b-27ac-4bc6-9e04-0ffda80ba341/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa1010</link>
            <description><![CDATA[<p class="para" id="N65541">The Zebrafish Information Network (ZFIN) (https://zfin.org/) is the database for the model organism, zebrafish (<i>Danio rerio</i>). ZFIN expertly curates, organizes, and provides a wide array of zebrafish genetic and genomic data, including genes, alleles, transgenic lines, gene expression, gene function, mutant phenotypes, orthology, human disease models, gene and mutant nomenclature, and reagents. New features at ZFIN include major updates to the home page and the gene page, the two most used pages at ZFIN. Data including disease models, phenotypes, expression, mutants and gene function continue to be contributed to The Alliance of Genome Resources for integration with similar data from other model organisms.</p>]]></description>
            <pubDate><![CDATA[2020-11-10T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[The InterPro protein families and domains database: 20 years on]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602077586-ba26a897-b043-4785-b315-52de814e48d4/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa977</link>
            <description><![CDATA[<p class="para" id="N65541">The InterPro database (https://www.ebi.ac.uk/interpro/) provides an integrative classification of protein sequences into families, and identifies functionally important domains and conserved sites. InterProScan is the underlying software that allows protein and nucleic acid sequences to be searched against InterPro's signatures. Signatures are predictive models which describe protein families, domains or sites, and are provided by multiple databases. InterPro combines signatures representing equivalent families, domains or sites, and provides additional information such as descriptions, literature references and Gene Ontology (GO) terms, to produce a comprehensive resource for protein classification. Founded in 1999, InterPro has become one of the most widely used resources for protein family annotation. Here, we report the status of InterPro (version 81.0) in its 20th year of operation, and its associated software, including updates to database content, the release of a new website and REST API, and performance improvements in InterProScan.</p>]]></description>
            <pubDate><![CDATA[2020-11-06T00:00]]></pubDate>
        </item><item>
            <title><![CDATA[SC2disease: a manually curated database of single-cell transcriptome for human diseases]]></title>
            <media:thumbnail url="https://storage.googleapis.com/nova-demo-unsecured-files/unsecured/content-1765602052758-b2f8b9ef-d6f5-4464-9188-a37085235d91/cover.png"></media:thumbnail>
            <link>https://www.novareader.co/book/isbn/10.1093/nar/gkaa838</link>
            <description><![CDATA[<p class="para" id="N65541">SC2disease (http://easybioai.com/sc2disease/) is a manually curated database that aims to provide a comprehensive and accurate resource of gene expression profiles in various cell types for different diseases. With the development of single-cell RNA sequencing (scRNA-seq) technologies, uncovering cellular heterogeneity of different tissues for different diseases has become feasible by profiling transcriptomes across cell types at the cellular level. In particular, comparing gene expression profiles between different cell types and identifying cell-type-specific genes in various diseases offers new possibilities to address biological and medical questions. However, systematic, hierarchical and vast databases of gene expression profiles in human diseases at the cellular level are lacking. Thus, we reviewed the literature prior to March 2020 for studies which used scRNA-seq to study diseases with human samples, and developed the SC2disease database to summarize all the data by different diseases, tissues and cell types. SC2disease documents 946 481 entries, corresponding to 341 cell types, 29 tissues and 25 diseases. Each entry in the SC2disease database contains comparisons of differentially expressed genes between different cell types, tissues and disease-related health status. Furthermore, we reanalyzed gene expression matrix by unified pipeline to improve the comparability between different studies. For each disease, we also compare cell-type-specific genes with the corresponding genes of lead single nucleotide polymorphisms (SNPs) identified in genome-wide association studies (GWAS) to implicate cell type specificity of the traits.</p>]]></description>
            <pubDate><![CDATA[2020-10-03T00:00]]></pubDate>
        </item>
    </channel>
</rss>